https://www.cepheid.com/en-US.htmldaily1.0https://www.cepheid.com/en-US/tests.htmldaily1.0https://www.cepheid.com/en-US/tests/respiratory.htmldaily1.0https://www.cepheid.com/en-US/tests/respiratory/xpert-xpress-cov-2-flu-rsv-plus-mc.htmldaily1.0https://www.cepheid.com/en-US/tests/respiratory/xpert-xpress-cov-2-plus-mc.htmldaily1.0https://www.cepheid.com/en-US/tests/respiratory/xpert-xpress-strep-a.htmldaily1.0https://www.cepheid.com/en-US/tests/respiratory/xpert-xpress-cov-2-plus.htmldaily1.0https://www.cepheid.com/en-US/tests/respiratory/xpert-xpress-cov-2-flu-rsv-plus.htmldaily1.0https://www.cepheid.com/en-US/tests/respiratory/xpert-xpress-flu.htmldaily1.0https://www.cepheid.com/en-US/tests/respiratory/xpert-xpress-flu-rsv.htmldaily1.0https://www.cepheid.com/en-US/tests/hai-other-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-US/tests/hai-other-infectious-diseases/xpert-gi-panel.htmldaily1.0https://www.cepheid.com/en-US/tests/hai-other-infectious-diseases/xpert-sa-nasal-complete.htmldaily1.0https://www.cepheid.com/en-US/tests/hai-other-infectious-diseases/xpert-mrsa-sa-ssti.htmldaily1.0https://www.cepheid.com/en-US/tests/hai-other-infectious-diseases/xpert-norovirus.htmldaily1.0https://www.cepheid.com/en-US/tests/hai-other-infectious-diseases/xpert-c-difficile-epi.htmldaily1.0https://www.cepheid.com/en-US/tests/hai-other-infectious-diseases/xpert-mrsa-sa-blood-culture.htmldaily1.0https://www.cepheid.com/en-US/tests/hai-other-infectious-diseases/xpert-mrsa-nxg.htmldaily1.0https://www.cepheid.com/en-US/tests/hai-other-infectious-diseases/xpert-vana.htmldaily1.0https://www.cepheid.com/en-US/tests/hai-other-infectious-diseases/xpert-carba-r.htmldaily1.0https://www.cepheid.com/en-US/tests/blood-virology-womens-health-sexual-health.htmldaily1.0https://www.cepheid.com/en-US/tests/blood-virology-womens-health-sexual-health/xpert-xpress-mvp.htmldaily1.0https://www.cepheid.com/en-US/tests/blood-virology-womens-health-sexual-health/xpert-ct-ng.htmldaily1.0https://www.cepheid.com/en-US/tests/blood-virology-womens-health-sexual-health/xpert-gbs-lb-xc.htmldaily1.0https://www.cepheid.com/en-US/tests/blood-virology-womens-health-sexual-health/xpert-tv.htmldaily1.0https://www.cepheid.com/en-US/tests/blood-virology-womens-health-sexual-health/xpert-xpress-gbs.htmldaily1.0https://www.cepheid.com/en-US/tests/blood-virology-womens-health-sexual-health/xpert-hcv-info.htmldaily1.0https://www.cepheid.com/en-US/tests/blood-virology-womens-health-sexual-health/xpert-hcv.htmldaily1.0https://www.cepheid.com/en-US/tests/tb-emerging-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-US/tests/tb-emerging-infectious-diseases/xpert-ebola.htmldaily1.0https://www.cepheid.com/en-US/tests/tb-emerging-infectious-diseases/xpert-mpox.htmldaily1.0https://www.cepheid.com/en-US/tests/tb-emerging-infectious-diseases/xpert-mtb-rif.htmldaily1.0https://www.cepheid.com/en-US/tests/oncology-human-genetics.htmldaily1.0https://www.cepheid.com/en-US/tests/oncology-human-genetics/xpert-fii-fv.htmldaily1.0https://www.cepheid.com/en-US/tests/oncology-human-genetics/xpert-bcr-abl-ultra.htmldaily1.0https://www.cepheid.com/en-US/tests/oncology-human-genetics/xpert-npm1-mutation-ruo.htmldaily1.0https://www.cepheid.com/en-US/tests/oncology-human-genetics/xpert-bcr-abl-ultra-p190-ruo.htmldaily1.0https://www.cepheid.com/en-US/tests/oncology-human-genetics/xpert-pml-rara-ruo.htmldaily1.0https://www.cepheid.com/en-US/systems.htmldaily1.0https://www.cepheid.com/en-US/systems/genexpert-family-of-systems.htmldaily1.0https://www.cepheid.com/en-US/systems/genexpert-family-of-systems/genexpert-system.htmldaily1.0https://www.cepheid.com/en-US/systems/genexpert-family-of-systems/genexpert-infinity.htmldaily1.0https://www.cepheid.com/en-US/systems/genexpert-family-of-systems/genexpert-xpress.htmldaily1.0https://www.cepheid.com/en-US/systems/genexpert-software.htmldaily1.0https://www.cepheid.com/en-US/systems/genexpert-software/gx-software.htmldaily1.0https://www.cepheid.com/en-US/systems/genexpert-software/xpertise-software.htmldaily1.0https://www.cepheid.com/en-US/systems/connectivity.htmldaily1.0https://www.cepheid.com/en-US/systems/connectivity/cepheid-c360.htmldaily1.0https://www.cepheid.com/en-US/systems/connectivity/interface-capabilities.htmldaily1.0https://www.cepheid.com/en-US/systems/data-processing-agreement.htmldaily1.0https://www.cepheid.com/en-US/systems/partner-communities.htmldaily1.0https://www.cepheid.com/en-US/systems/business-associates-agreement.htmldaily1.0https://www.cepheid.com/en-US/solutions.htmldaily1.0https://www.cepheid.com/en-US/solutions/global-access.htmldaily1.0https://www.cepheid.com/en-US/solutions/global-access/eligibility-and-pricing.htmldaily1.0https://www.cepheid.com/en-US/solutions/global-access/everything-about-our-fight-against-tb.htmldaily1.0https://www.cepheid.com/en-US/solutions/point-of-care.htmldaily1.0https://www.cepheid.com/en-US/solutions/point-of-care/primary-care.htmldaily1.0https://www.cepheid.com/en-US/solutions/point-of-care/urgent-care.htmldaily1.0https://www.cepheid.com/en-US/solutions/point-of-care/pediatrics.htmldaily1.0https://www.cepheid.com/en-US/solutions/antibiotic-stewardship.htmldaily1.0https://www.cepheid.com/en-US/solutions/customized-menu-scalability.htmldaily1.0https://www.cepheid.com/en-US/solutions/testing-everywhere.htmldaily1.0https://www.cepheid.com/en-US/solutions/knowing-more-matters.htmldaily1.0https://www.cepheid.com/en-US/solutions/knowing-more-matters/campaign-resources.htmldaily1.0https://www.cepheid.com/en-US/solutions/knowing-more-matters/pcr-vs-antigen.htmldaily1.0https://www.cepheid.com/en-US/solutions/knowing-more-matters/covid-flu-rsv.htmldaily1.0https://www.cepheid.com/en-US/solutions/patient-management/cepheid-solutions-to-healthcare.htmldaily1.0https://www.cepheid.com/en-US/solutions/patient-management/cepheid-solutions-to-healthcare-v2.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/all-posts.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/respiratory-health.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/respiratory-health/2024/09/proactive-surveillance-to-ensure-broad-flu-strain-detection.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/respiratory-health/2024/09/emerging-evolving-respiratory-viruses-test-design-matters.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/respiratory-health/2024/09/the-genexpert-xpress-system-can-change-your-pediatric-practice.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/respiratory-health/2024/09/Norwegian-ED-improves-Resource-Management-with-Rapid-PCR-Testing.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/respiratory-health/2024/09/key-steps-pandemic-preparedness.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/respiratory-health/2025/01/what-does-it-mean-to-have-a-pandemic-ready-pcr-test.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like-illnesses.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/respiratory-health/2025/03/in-house-pcr-testing-clinical-leaders-explore-the-ripple-effect.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/respiratory-health/2025/04/real-world-clinical-impact-of-in-house-pcr-testing.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/respiratory-health/2025/04/what-is-the-difference-between-pcr-and-antigen-testing.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/respiratory-health/2025/05/a-quick-primer-on-the-adlm-guidance-on-respiratory-virus-testing.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/respiratory-health/2025/09/revolutionizing-respiratory-care-the-power-of-rapid-molecular-testing.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/respiratory-health/2025/09/antigen-testing-vs-pcr-less-haste-more-speed-please.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/respiratory-health/2025/09/the-time-for-widespread-adoption-of-mdx-testing-for-gas-pharyngi.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/respiratory-health/2025/11/why-test-type-matters-pcr-vs-antigen-in-outpatient-respiratory-care.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/respiratory-health/2025/11/transforming-respiratory-tnfection-diagnosis-embracing-molecular-innovation-clinical-practice.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/respiratory-health/2026/01/staying-ahead-of-influenza.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/respiratory-health/2026/02/revolutionizing-rheumatic-heart-disease-prevention.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2024/09/accelerating-the-pace-for-hep-c-elimination-in-the-us.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2024/09/can-molecular-tests-revolutionize-tuberculosis-control.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2024/09/near-patient-testing-for-hep-c-xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2024/09/danish-hcv-testing-program-improves-patient-management-and-access.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2024/09/faster-prison-testing-for-hcv-drastically-improves-treatment-in-the-uk.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2024/09/innovative-POC-testing-shortens-time-between-testing-and-treatment.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2024/09/finnish-hospital-improves-care-for-expectant-mothers-with-gbs-pcr-screening.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2024/09/a-not-for-profit-in-vietnam-fights-to-end-tuberculosis.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2024/09/cepheid-expands-in-india-to-support-global-efforts-to-fight-tb.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2024/09/covid-19-and-tuberculosis-testing-in-south-africa.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2024/09/cepheid-supports-the-international-mpox-emergency-declared-august-2024.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2024/10/hpv-testing-south-african-clinic-may-prevent-cervical-cancer.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2024/12/strides-toward-early-infant-diagnosis-for-hiv-elimination-in-sou.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2025/02/common-misconceptions-about-vaginitis.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2025/03/the-fight-to-end-tuberculosis-in-pakistan.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2025/03/devasena-gnanashanmugam-discusses-cepheids-global-access-program.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2025/03/desmond-tutu-foundation-reduces-impact-of-hiv-and-tb.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2025/03/tuberculosis-care-and-treatment-in-the-republic-of-indonesia.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2025/03/finding-missing-tuberculosis-tb-cases-philippines-need-for-speed.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2025/03/a-decade-of-health-and-economic-benefits-infographic.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2025/03/state-tb-in-us-overlooked-opportunity-better-results.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2025/03/fighting-tb-everything-10-years-of-impact-in-south-africa.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2025/04/tuberculosis-staying-one-step-ahead.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2025/04/how-three-countries-are-fighting-back-against-tuberculosis.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2025/04/a-mdr-tb-survivor-in-india-shares-her-remarkable-story.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2025/05/revisiting-bacterial-vaginosis-evidence-for-sexual-transmission.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2025/05/a-breakthrough-in-hcv-elimination--how-hcv-point-of-care-rna-tes.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2025/05/decentralising-diagnostics-bringing-patient-centred-testing-closer-to-communities.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2025/05/integration-of-poc-viral-diagnostics-with-substance-use-disorder-treatment-to-improve-hepatitis-c-nfection-outcomes.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2025/06/womens-health-testing-advantages-of-same-day-diagnosis-and-treatment.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2025/07/five-surprising-stats-that-reveal-the-hidden-burden-of-vaginitis.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2025/07/5-ways-vaginitis-treatment-goes-wrong-and-how-better-testing-can-fix-It.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2025/08/kentucky-viral-hepatitis-treatment-projects-mission-to-eradicate-hcv.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2025/08/the-state-of-vaginitis-testing-in-the-us.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2025/08/improving-vaginitis-care-through-better-diagnostics.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2025/09/in-memory-of-john-bishop-a-visionary-leader-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2025/10/time-to-act-stopping-group-b-strep-infections-in-newborn-babies.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2025/10/real-user-experiences-with-xpert-xpress-mvp-oint-of-care-test.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2025/12/wecare-humanitarian-medical-mission.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2026/02/advancing-pandemic-preparedness-through-public-private-collaboration.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2026/02/norovirus-surge-critical-actions-for-the-2026-season.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/community-and-global-health/2026/02/hepatitis-c-elimination-in-the-us-is-within-reach-experts-report.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/tech-disease-trends.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/tech-disease-trends/2024/09/discussing-pharma-clinical-trials-utilizing-poc-diagnostics.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/tech-disease-trends/2024/09/poc-testing-increases-the-efficiency-of-patient-management-in-the-ed.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/tech-disease-trends/2024/09/candida-auris-rising-threat-and-future-implications.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/tech-disease-trends/2024/10/dave-persing-legacy-and-leadership-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/tech-disease-trends/2024/11/invasive-group-streptococcal-disease.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/tech-disease-trends/2024/11/what-is-pcr--understanding-the-magic.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/tech-disease-trends/2024/11/decentralized-pcr-testing-and-the-quadruple-aim-insights-for-health-systems.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/tech-disease-trends/2025/01/how-a-cepheid-molecular-test-is-made.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/tech-disease-trends/2025/04/standardization-of-pcr-testing-across-healthcare-testing-sites.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/tech-disease-trends/2025/06/innovation-in-times-of-need-cepheids-legacy-of-outbreak-response.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/tech-disease-trends/2025/07/celebrating-the-cepheid-bike-where-art-meets-innovation.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/tech-disease-trends/2025/09/cepheid-advances-innovation-and-reach-with-key-partnerships.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/tech-disease-trends/2025/10/learn-about-cepheid-system-innovation.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/tech-disease-trends/2025/11/multiplex-with-meaning--cepheid-s-smart-approach-to-molecular-di.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/tech-disease-trends/2026/01/innovation-in-era-of-dxex.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/antimicrobial-stewardship.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/antimicrobial-stewardship/2024/09/a-public-health-dialogue-on-antibiotic-resistance-surveillance.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/antimicrobial-stewardship/2024/09/mortality-associated-with-carbapenem-resistant-gram-negative-infections.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/antimicrobial-stewardship/2024/09/decentralized-testing-for-the-surveillance-of-hospital-acquired-infections.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/antimicrobial-stewardship/2024/09/rapid-mrsa-screening-of-ortho-trauma-patients-improves-experience.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/antimicrobial-stewardship/2024/09/pcr-screening-at-a-british-hospital-enables-timely-infection-control.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/antimicrobial-stewardship/2024/10/fleming-initiative-cepheid-announce-partnership-tackle-amr.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/antimicrobial-stewardship/2024/10/link-between-colonization-multi-drug-resistant-infection.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/antimicrobial-stewardship/2024/12/point-of-care-testing-emergency-department-faster-decision-making-halle.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-schulz.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/antimicrobial-stewardship/2025/05/antimicrobial-and-diagnostic-stewardship-frost-and-sullivan-visual-whitepaper.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/antimicrobial-stewardship/2025/08/industry-voices-time-to-rethink-our-approach-to-using-modern-medicine.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/antimicrobial-stewardship/2025/10/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/antimicrobial-stewardship/2025/11/vanessa-carter-s-journey--inspiring-action-against-amr.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/antimicrobial-stewardship/2025/11/advancing-antimicrobial-stewardship-in-small-and-rural-hospital.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/expert-spotlight.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/expert-spotlight/2025/10/expert-spotlight--michael-loeffelholz.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--devasena-gnanashanmugam-vice-president--me.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--jennifer-rakeman-cagno-senior-director--sc.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/expert-spotlight/2026/02/expert-spotlight-jordan-chase.htmldaily1.0https://www.cepheid.com/en-US/insights/insight-hub/expert-spotlight/2026/02/expert-spotlight-juan-cruz-cuevas.htmldaily1.0https://www.cepheid.com/en-US/insights/webinars.htmldaily1.0https://www.cepheid.com/en-US/insights/webinars/featured-webinars.htmldaily1.0https://www.cepheid.com/en-US/support.htmldaily1.0https://www.cepheid.com/en-US/support/order-management.htmldaily1.0https://www.cepheid.com/en-US/support/xpert-check.htmldaily1.0https://www.cepheid.com/en-US/support/contact-us.htmldaily1.0https://www.cepheid.com/en-US/about.htmldaily1.0https://www.cepheid.com/en-US/about/mission-history.htmldaily1.0https://www.cepheid.com/en-US/about/leadership.htmldaily1.0https://www.cepheid.com/en-US/about/leadership/vitor-rocha.htmldaily1.0https://www.cepheid.com/en-US/about/leadership/laurent-bellon.htmldaily1.0https://www.cepheid.com/en-US/about/leadership/anette-engelhardt.htmldaily1.0https://www.cepheid.com/en-US/about/leadership/peter-farrell.htmldaily1.0https://www.cepheid.com/en-US/about/leadership/deborah-gonyea.htmldaily1.0https://www.cepheid.com/en-US/about/leadership/nichole-halsey.htmldaily1.0https://www.cepheid.com/en-US/about/leadership/luben-li.htmldaily1.0https://www.cepheid.com/en-US/about/leadership/luke-maitland.htmldaily1.0https://www.cepheid.com/en-US/about/leadership/david-h-persing.htmldaily1.0https://www.cepheid.com/en-US/about/leadership/ammar-qadan.htmldaily1.0https://www.cepheid.com/en-US/about/leadership/charles-mwangi.htmldaily1.0https://www.cepheid.com/en-US/about/leadership/samson-wu.htmldaily1.0https://www.cepheid.com/en-US/about/leadership/anupama-mokkapati.htmldaily1.0https://www.cepheid.com/en-US/about/leadership/scott-campbell.htmldaily1.0https://www.cepheid.com/en-US/about/leadership/traci-wicks.htmldaily1.0https://www.cepheid.com/en-US/about/leadership/ephraim-tsalik.htmldaily1.0https://www.cepheid.com/en-US/about/leadership/patrick-harkins.htmldaily1.0https://www.cepheid.com/en-US/about/leadership/anne-beauburn.htmldaily1.0https://www.cepheid.com/en-US/about/leadership/somesh-lalithraj.htmldaily1.0https://www.cepheid.com/en-US/about/leadership/connie-savor.htmldaily1.0https://www.cepheid.com/en-US/about/reimbursement-support.htmldaily1.0https://www.cepheid.com/en-US/about/business-development-opportunities.htmldaily1.0https://www.cepheid.com/en-US/about/innovation-form.htmldaily1.0https://www.cepheid.com/en-US/about/innovation-form/unsolicited-submission-agreement.htmldaily1.0https://www.cepheid.com/en-US/about/events.htmldaily1.0https://www.cepheid.com/en-US/about/sustainability.htmldaily1.0https://www.cepheid.com/en-US/about/sustainability/environmental-sustainability.htmldaily1.0https://www.cepheid.com/en-US/about/sustainability/product-stewardship.htmldaily1.0https://www.cepheid.com/en-US/about/sustainability/conflict-minerals.htmldaily1.0https://www.cepheid.com/en-US/about/careers/internship-opportunities.htmldaily1.0https://www.cepheid.com/en-US/about/careers/join-the-team.htmldaily1.0https://www.cepheid.com/en-US/about/policies-reports.htmldaily1.0https://www.cepheid.com/en-US/about/sars-cov-2-test-development-information.htmldaily1.0https://www.cepheid.com/en-US/about/sars-cov-2-product-resources.htmldaily1.0https://www.cepheid.com/en-US/about/government-molecular-solutions-partnership.htmldaily1.0https://www.cepheid.com/en-US/legal/privacy.htmldaily1.0https://www.cepheid.com/en-US/legal/terms-of-use.htmldaily1.0https://www.cepheid.com/en-US/legal/california-consumer-privacy-act.htmldaily1.0https://www.cepheid.com/en-US/legal/trademarks.htmldaily1.0https://www.cepheid.com/en-US/legal/product-security.htmldaily1.0https://www.cepheid.com/en-US/legal/product-security/product-security-updates.htmldaily1.0https://www.cepheid.com/en-US/legal/cookies-notice.htmldaily1.0https://www.cepheid.com/en-US/personas/laboratory-professionals.htmldaily1.0https://www.cepheid.com/en-US/personas/healthcare-providers.htmldaily1.0https://www.cepheid.com/en-US/personas/health-system-administrators.htmldaily1.0https://www.cepheid.com/en-US/contact/messages/thank-you.htmldaily1.0https://www.cepheid.com/en-US/contact/request-cd.htmldaily1.0https://www.cepheid.com/en-US/contact/request-express-hub.htmldaily1.0https://www.cepheid.com/en-US/contact/select-info-path.htmldaily1.0https://www.cepheid.com/en-US/contact/thank-you.htmldaily1.0https://www.cepheid.com/en-US/campaigns/pcr-plus.htmldaily1.0https://www.cepheid.com/en-US/campaigns/india/cepheid-india.htmldaily1.0https://www.cepheid.com/en-US/campaigns/india/india-submission.htmldaily1.0https://www.cepheid.com/en-US/campaigns/india/cepheid-india-display.htmldaily1.0https://www.cepheid.com/en-US/campaigns/india/cepheid-india-bangladesh.htmldaily1.0https://www.cepheid.com/en-US/coronavirus-portfolio.htmldaily1.0https://www.cepheid.com/en-GB.htmldaily1.0https://www.cepheid.com/en-GB/tests.htmldaily1.0https://www.cepheid.com/en-GB/tests/respiratory.htmldaily1.0https://www.cepheid.com/en-GB/tests/respiratory/xpert-xpress-strep-a.htmldaily1.0https://www.cepheid.com/en-GB/tests/respiratory/xpert-xpress-sars-cov-2.htmldaily1.0https://www.cepheid.com/en-GB/tests/respiratory/xpert-xpress-flu-rsv.htmldaily1.0https://www.cepheid.com/en-GB/tests/respiratory/xpert-xpress-cov-2-flu-rsv-plus.htmldaily1.0https://www.cepheid.com/en-GB/tests/hai-other-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-GB/tests/hai-other-infectious-diseases/xpert-sa-nasal-complete.htmldaily1.0https://www.cepheid.com/en-GB/tests/hai-other-infectious-diseases/xpert-mrsa-sa-ssti.htmldaily1.0https://www.cepheid.com/en-GB/tests/hai-other-infectious-diseases/xpert-c-difficile-bt.htmldaily1.0https://www.cepheid.com/en-GB/tests/hai-other-infectious-diseases/xpert-norovirus.htmldaily1.0https://www.cepheid.com/en-GB/tests/hai-other-infectious-diseases/xpert-mrsa-sa-blood-culture.htmldaily1.0https://www.cepheid.com/en-GB/tests/hai-other-infectious-diseases/xpert-vana-vanb.htmldaily1.0https://www.cepheid.com/en-GB/tests/hai-other-infectious-diseases/xpert-mrsa-nxg.htmldaily1.0https://www.cepheid.com/en-GB/tests/hai-other-infectious-diseases/xpert-carba-r.htmldaily1.0https://www.cepheid.com/en-GB/tests/blood-virology-womens-health-sexual-health.htmldaily1.0https://www.cepheid.com/en-GB/tests/blood-virology-womens-health-sexual-health/xpert-hbv-viral-load.htmldaily1.0https://www.cepheid.com/en-GB/tests/blood-virology-womens-health-sexual-health/resistanceplusmg-flexible.htmldaily1.0https://www.cepheid.com/en-GB/tests/blood-virology-womens-health-sexual-health/xpert-xpress-gbs.htmldaily1.0https://www.cepheid.com/en-GB/tests/blood-virology-womens-health-sexual-health/xpert-ct-ng.htmldaily1.0https://www.cepheid.com/en-GB/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-qual-xc.htmldaily1.0https://www.cepheid.com/en-GB/tests/blood-virology-womens-health-sexual-health/xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-GB/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-viral-load-xc.htmldaily1.0https://www.cepheid.com/en-GB/tests/blood-virology-womens-health-sexual-health/xpert-tv.htmldaily1.0https://www.cepheid.com/en-GB/tests/blood-virology-womens-health-sexual-health/xpert-hpv-v2.htmldaily1.0https://www.cepheid.com/en-GB/tests/blood-virology-womens-health-sexual-health/xpert-hcv-viral-load.htmldaily1.0https://www.cepheid.com/en-GB/tests/tb-emerging-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-GB/tests/tb-emerging-infectious-diseases/xpert-mtb-xdr.htmldaily1.0https://www.cepheid.com/en-GB/tests/tb-emerging-infectious-diseases/xpert-mtb-rif-ultra.htmldaily1.0https://www.cepheid.com/en-GB/tests/oncology-human-genetics.htmldaily1.0https://www.cepheid.com/en-GB/tests/oncology-human-genetics/expert-bladder-cancer-monitor.htmldaily1.0https://www.cepheid.com/en-GB/tests/oncology-human-genetics/xpert-bcr-abl-ultra-p190.htmldaily1.0https://www.cepheid.com/en-GB/tests/oncology-human-genetics/xpert-breast-cancer-strat4.htmldaily1.0https://www.cepheid.com/en-GB/tests/oncology-human-genetics/xpert-bladder-cancer-detection.htmldaily1.0https://www.cepheid.com/en-GB/tests/oncology-human-genetics/xpert-bcr-abl-ultra.htmldaily1.0https://www.cepheid.com/en-GB/tests/oncology-human-genetics/xpert-npm1-mutation.htmldaily1.0https://www.cepheid.com/en-GB/systems.htmldaily1.0https://www.cepheid.com/en-GB/systems/genexpert-family-of-systems.htmldaily1.0https://www.cepheid.com/en-GB/systems/genexpert-family-of-systems/genexpert-system.htmldaily1.0https://www.cepheid.com/en-GB/systems/genexpert-family-of-systems/genexpert-infinity.htmldaily1.0https://www.cepheid.com/en-GB/systems/genexpert-software.htmldaily1.0https://www.cepheid.com/en-GB/systems/genexpert-software/gx-software.htmldaily1.0https://www.cepheid.com/en-GB/systems/genexpert-software/xpertise-software.htmldaily1.0https://www.cepheid.com/en-GB/systems/connectivity.htmldaily1.0https://www.cepheid.com/en-GB/systems/connectivity/cepheid-c360.htmldaily1.0https://www.cepheid.com/en-GB/systems/connectivity/interface-capabilities.htmldaily1.0https://www.cepheid.com/en-GB/systems/data-processing-agreement.htmldaily1.0https://www.cepheid.com/en-GB/systems/partner-communities.htmldaily1.0https://www.cepheid.com/en-GB/systems/business-associates-agreement.htmldaily1.0https://www.cepheid.com/en-GB/solutions.htmldaily1.0https://www.cepheid.com/en-GB/solutions/global-access.htmldaily1.0https://www.cepheid.com/en-GB/solutions/global-access/eligibility-and-pricing.htmldaily1.0https://www.cepheid.com/en-GB/solutions/global-access/everything-about-our-fight-against-tb.htmldaily1.0https://www.cepheid.com/en-GB/solutions/testing-everywhere.htmldaily1.0https://www.cepheid.com/en-GB/solutions/antibiotic-stewardship.htmldaily1.0https://www.cepheid.com/en-GB/solutions/customized-testing-institution.htmldaily1.0https://www.cepheid.com/en-GB/solutions/knowing-more-matters.htmldaily1.0https://www.cepheid.com/en-GB/solutions/knowing-more-matters/pcr-vs-antigen.htmldaily1.0https://www.cepheid.com/en-GB/solutions/knowing-more-matters/covid-flu-rsv.htmldaily1.0https://www.cepheid.com/en-GB/insights.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/all-posts.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/respiratory-health.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/respiratory-health/2024/09/proactive-surveillance-to-ensure-broad-flu-strain-detection.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/respiratory-health/2024/09/emerging-evolving-respiratory-viruses-test-design-matters.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/respiratory-health/2024/09/the-genexpert-xpress-system-can-change-your-pediatric-practice.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/respiratory-health/2024/09/Norwegian-ED-improves-Resource-Management-with-Rapid-PCR-Testing.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/respiratory-health/2024/09/key-steps-pandemic-preparedness.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/respiratory-health/2025/01/what-does-it-mean-to-have-a-pandemic-ready-pcr-test.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like-ilnesses.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/respiratory-health/2025/03/in-house-pcr-testing-clinical-leaders-explore-the-ripple-effect.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/respiratory-health/2025/04/real-world-clinical-impact-of-in-house-pcr-testing.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/respiratory-health/2025/04/what-is-the-difference-between-pcr-and-antigen-testing.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/respiratory-health/2025/05/a-quick-primer-on-the-adlm-guidance-on-respiratory-virus-testing.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/respiratory-health/2025/09/revolutionizing-respiratory-care-the-power-of-rapid-molecular-testing.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/respiratory-health/2025/09/antigen-testing-vs-pcr-less-haste-more-speed-please.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/respiratory-health/2025/09/the-time-for-widespread-adoption-of-mdx-testing-for-gas-pharyngi.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/respiratory-health/2025/11/why-test-type-matters-pcr-vs-antigen-in-outpatient-respiratory-care.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/respiratory-health/2025/11/transforming-respiratory-tnfection-diagnosis-embracing-molecular-innovation-clinical-practice1.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/respiratory-health/2026/01/staying-ahead-of-influenza.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2024/09/accelerating-the-pace-for-hep-c-elimination-in-the-us.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2024/09/can-molecular-tests-revolutionize-tuberculosis-control.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2024/09/near-patient-testing-for-hep-c-xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2024/09/danish-hcv-testing-program-improves-patient-management-and-access.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2024/09/faster-prison-testing-for-hcv-drastically-improves-treatment-in-the-uk.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2024/09/innovative-POC-testing-shortens-time-between-testing-and-treatment.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2024/09/finnish-hospital-improves-care-for-expectant-mothers-with-gbs-pcr-screening.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2024/09/a-not-for-profit-in-vietnam-fights-to-end-tuberculosis.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2024/09/cepheid-expands-in-india-to-support-global-efforts-to-fight-tb.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2024/09/covid-19-and-tuberculosis-testing-in-south-africa.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2024/09/cepheid-supports-the-international-mpox-emergency-declared-august-2024.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2024/10/hpv-testing-south-african-clinic-may-prevent-cervical-cancer.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2024/12/strides-toward-early-infant-diagnosis-for-hiv-elimination-in-sou.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2025/02/common-misconceptions-about-vaginitis.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2025/05/revisiting-bacterial-vaginosis-evidence-for-sexual-transmission.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2025/05/a-breakthrough-in-hcv-elimination--how-hcv-point-of-care-rna-tes.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2025/05/decentralising-diagnostics-bringing-patient-centred-testing-closer-to-communities.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2025/05/integration-of-poc-viral-diagnostics-with-substance-use-disorder-treatment-to-improve-hepatitis-c-nfection-outcomes.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2025/04/tuberculosis-staying-one-step-ahead.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2025/04/how-three-countries-are-fighting-back-against-tuberculosis.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2025/04/a-mdr-tb-survivor-in-india-shares-her-remarkable-story.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2025/06/womens-health-testing-advantages-of-same-day-diagnosis-and-treatment.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2025/07/five-surprising-stats-that-reveal-the-hidden-burden-of-vaginitis.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2025/07/5-ways-vaginitis-treatment-goes-wrong-and-how-better-testing-can-fix-It.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2025/03/the-fight-to-end-tuberculosis-in-pakistan.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2025/03/devasena-gnanashanmugam-discusses-cepheids-global-access-program.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2025/03/desmond-tutu-foundation-reduces-impact-of-hiv-and-tb.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2025/03/tuberculosis-care-and-treatment-in-the-republic-of-indonesia.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2025/03/finding-missing-tuberculosis-tb-cases-philippines-need-for-speed.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2025/03/a-decade-of-health-and-economic-benefits-infographic.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2025/03/state-tb-in-us-overlooked-opportunity-better-results.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2025/03/fighting-tb-everything-10-years-of-impact-in-south-africa.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2025/09/in-memory-of-john-bishop-a-visionary-leader-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2025/08/kentucky-viral-hepatitis-treatment-projects-mission-to-eradicate-hcv.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2025/08/the-state-of-vaginitis-testing-in-the-us.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2025/08/improving-vaginitis-care-through-better-diagnostics.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2025/10/time-to-act-stopping-group-b-strep-infections-in-newborn-babies.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2025/10/real-user-experiences-with-xpert-xpress-mvp-oint-of-care-test.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2025/12/wecare-humanitarian-medical-mission.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2026/02/advancing-pandemic-preparedness-through-public-private-collaboration.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/community-and-global-health/2026/02/hepatitis-c-elimination-in-the-us-is-within-reach-experts-report.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/tech-disease-trends.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/tech-disease-trends/2024/09/candida-auris--rising-threat-and-future-implications.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/tech-disease-trends/2024/09/discussing-pharma-clinical-trials-utilizing-poc-diagnostics.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/tech-disease-trends/2024/09/poc-testing-increases-the-efficiency-of-patient-management-in-the-ed.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/tech-disease-trends/2024/10/dave-persing-legacy-and-leadership-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/tech-disease-trends/2024/11/invasive-group-streptococcal-disease.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/tech-disease-trends/2024/11/what-is-pcr--understanding-the-magic.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/tech-disease-trends/2024/11/decentralized-pcr-testing-and-the-quadruple-aim-insights-for-health-systems.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/tech-disease-trends/2025/01/how-a-cepheid-molecular-test-is-made.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/tech-disease-trends/2025/04/standardization-of-pcr-testing-across-healthcare-testing-sites.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/tech-disease-trends/2025/06/innovation-in-times-of-need-cepheids-legacy-of-outbreak-response.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/tech-disease-trends/2025/07/celebrating-the-cepheid-bike-where-art-meets-innovation.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/tech-disease-trends/2025/09/cepheid-advances-innovation-and-reach-with-key-partnerships.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/tech-disease-trends/2025/10/learn-about-cepheid-system-innovation.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/tech-disease-trends/2025/11/multiplex-with-meaning--cepheid-s-smart-approach-to-molecular-di.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/antimicrobial-stewardship.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/antimicrobial-stewardship/2024/09/a-public-health-dialogue-on-antibiotic-resistance-surveillance.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/antimicrobial-stewardship/2024/09/mortality-associated-with-carbapenem-resistant-gram-negative-infections.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/antimicrobial-stewardship/2024/09/decentralized-testing-for-the-surveillance-of-hospital-acquired-infections.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/antimicrobial-stewardship/2024/09/rapid-mrsa-screening-of-ortho-trauma-patients-improves-experience.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/antimicrobial-stewardship/2024/09/pcr-screening-at-a-british-hospital-enables-timely-infection-control.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/antimicrobial-stewardship/2024/10/fleming-initiative-cepheid-announce-partnership-tackle-amr.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/antimicrobial-stewardship/2024/10/link-between-colonization-multi-drug-resistant-infection.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/antimicrobial-stewardship/2024/12/point-of-care-testing-emergency-department-faster-decision-making-halle.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-schulz.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/antimicrobial-stewardship/2025/05/antimicrobial-and-diagnostic-stewardship-frost-and-sullivan-visual-whitepaper.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/antimicrobial-stewardship/2025/08/industry-voices-time-to-rethink-our-approach-to-using-modern-medicine.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/antimicrobial-stewardship/2025/09/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/antimicrobial-stewardship/2025/10/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/antimicrobial-stewardship/2025/11/vanessa-carter-s-journey--inspiring-action-against-amr.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/antimicrobial-stewardship/2025/11/advancing-antimicrobial-stewardship-in-small-and-rural-hospital.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/expert-spotlight.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/expert-spotlight/2025/10/expert-spotlight--michael-loeffelholz.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--devasena-gnanashanmugam-vice-president--me.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--jennifer-rakeman-cagno-senior-director--sc.htmldaily1.0https://www.cepheid.com/en-GB/insights/insight-hub/expert-spotlight/2026/02/expert-spotlight-jordan-chase.htmldaily1.0https://www.cepheid.com/en-GB/insights/webinars.htmldaily1.0https://www.cepheid.com/en-GB/insights/resources.htmldaily1.0https://www.cepheid.com/en-GB/support.htmldaily1.0https://www.cepheid.com/en-GB/support/ivdr-update.htmldaily1.0https://www.cepheid.com/en-GB/support/contact-us.htmldaily1.0https://www.cepheid.com/en-GB/about.htmldaily1.0https://www.cepheid.com/en-GB/about/mission-history.htmldaily1.0https://www.cepheid.com/en-GB/about/leadership.htmldaily1.0https://www.cepheid.com/en-GB/about/leadership/vitor-rocha.htmldaily1.0https://www.cepheid.com/en-GB/about/leadership/laurent-bellon.htmldaily1.0https://www.cepheid.com/en-GB/about/leadership/anette-engelhardt.htmldaily1.0https://www.cepheid.com/en-GB/about/leadership/peter-farrell.htmldaily1.0https://www.cepheid.com/en-GB/about/leadership/deborah-gonyea.htmldaily1.0https://www.cepheid.com/en-GB/about/leadership/nichole-halsey.htmldaily1.0https://www.cepheid.com/en-GB/about/leadership/luben-li.htmldaily1.0https://www.cepheid.com/en-GB/about/leadership/luke-maitland.htmldaily1.0https://www.cepheid.com/en-GB/about/leadership/david-h-persing.htmldaily1.0https://www.cepheid.com/en-GB/about/leadership/ammar-qadan.htmldaily1.0https://www.cepheid.com/en-GB/about/leadership/charles-mwangi.htmldaily1.0https://www.cepheid.com/en-GB/about/leadership/samson-wu.htmldaily1.0https://www.cepheid.com/en-GB/about/leadership/anupama-mokkapati.htmldaily1.0https://www.cepheid.com/en-GB/about/leadership/traci-wicks.htmldaily1.0https://www.cepheid.com/en-GB/about/leadership/scott-campbell.htmldaily1.0https://www.cepheid.com/en-GB/about/leadership/anne-beauburn.htmldaily1.0https://www.cepheid.com/en-GB/about/leadership/patrick-harkins.htmldaily1.0https://www.cepheid.com/en-GB/about/leadership/ephraim-tsalik.htmldaily1.0https://www.cepheid.com/en-GB/about/leadership/somesh-lalithraj.htmldaily1.0https://www.cepheid.com/en-GB/about/leadership/connie-savor.htmldaily1.0https://www.cepheid.com/en-GB/about/sustainability.htmldaily1.0https://www.cepheid.com/en-GB/about/sustainability/environmental-sustainability.htmldaily1.0https://www.cepheid.com/en-GB/about/sustainability/product-stewardship.htmldaily1.0https://www.cepheid.com/en-GB/about/sustainability/conflict-materials.htmldaily1.0https://www.cepheid.com/en-GB/about/sustainability/CarbonReductionPlan.htmldaily1.0https://www.cepheid.com/en-GB/about/policies-reports.htmldaily1.0https://www.cepheid.com/en-GB/about/business-development-opportunities.htmldaily1.0https://www.cepheid.com/en-GB/about/events.htmldaily1.0https://www.cepheid.com/en-GB/about/innovation-form.htmldaily1.0https://www.cepheid.com/en-GB/about/innovation-form/unsolicited-submission-agreement.htmldaily1.0https://www.cepheid.com/en-GB/about/sars-cov-2-test-development-information.htmldaily1.0https://www.cepheid.com/en-GB/about/sars-cov-2-product-resources.htmldaily1.0https://www.cepheid.com/en-GB/contact/request-info2.htmldaily1.0https://www.cepheid.com/en-GB/contact/messages/thank-you.htmldaily1.0https://www.cepheid.com/en-GB/contact/messages/thank-you-patient-pathways.htmldaily1.0https://www.cepheid.com/en-GB/contact/messages/thank-you-patient-pathways-fr.htmldaily1.0https://www.cepheid.com/en-GB/contact/messages/thank-you-patient-pathways-de.htmldaily1.0https://www.cepheid.com/en-GB/contact/messages/thank-you-patient-pathways-it.htmldaily1.0https://www.cepheid.com/en-GB/contact/messages/thank-you-patient-pathways-sp.htmldaily1.0https://www.cepheid.com/en-GB/contact/messages/thank-you-patient-pathways-pl.htmldaily1.0https://www.cepheid.com/en-GB/contact/messages/thank-you-patient-pathways-pt.htmldaily1.0https://www.cepheid.com/en-GB/contact/request-cd-international.htmldaily1.0https://www.cepheid.com/en-GB/contact/select-info-path.htmldaily1.0https://www.cepheid.com/en-GB/personas/laboratory-professionals.htmldaily1.0https://www.cepheid.com/en-GB/personas/healthcare-professsional.htmldaily1.0https://www.cepheid.com/en-GB/personas/health-system-administrators.htmldaily1.0https://www.cepheid.com/en-GB/legal/privacy.htmldaily1.0https://www.cepheid.com/en-GB/legal/terms-of-use.htmldaily1.0https://www.cepheid.com/en-GB/legal/product-security-updates.htmldaily1.0https://www.cepheid.com/en-GB/legal/terms-of-sale.htmldaily1.0https://www.cepheid.com/en-GB/legal/india-e-waste.htmldaily1.0https://www.cepheid.com/en-GB/legal/trademarks.htmldaily1.0https://www.cepheid.com/en-GB/legal/cookies-notice.htmldaily1.0https://www.cepheid.com/en-GB/campaigns/2020-emea-renewed-messaging/french/patient-pathways.htmldaily1.0https://www.cepheid.com/en-GB/campaigns/2020-emea-renewed-messaging/german/patient-pathways.htmldaily1.0https://www.cepheid.com/en-GB/campaigns/2020-emea-renewed-messaging/italian/patient-pathways.htmldaily1.0https://www.cepheid.com/en-GB/campaigns/2020-emea-renewed-messaging/portuguese/patient-pathways.htmldaily1.0https://www.cepheid.com/en-GB/campaigns/2020-emea-renewed-messaging/polish/patient-pathways.htmldaily1.0https://www.cepheid.com/en-GB/campaigns/india/cepheid-india.htmldaily1.0https://www.cepheid.com/en-GB/campaigns/india/india-submission.htmldaily1.0https://www.cepheid.com/en-GB/campaigns/india/cepheid-india-display.htmldaily1.0https://www.cepheid.com/en-GB/campaigns/india/cepheid-india-bangladesh.htmldaily1.0https://www.cepheid.com/en-GB/campaigns/pcr-plus.htmldaily1.0https://www.cepheid.com/en-GB/coronavirus-portfolio.htmldaily1.0https://www.cepheid.com/de-DE.htmldaily1.0https://www.cepheid.com/de-DE/tests.htmldaily1.0https://www.cepheid.com/de-DE/tests/respiratory.htmldaily1.0https://www.cepheid.com/de-DE/tests/respiratory/xpert-xpress-strep-a.htmldaily1.0https://www.cepheid.com/de-DE/tests/respiratory/xpert-xpress-cov-2-plus.htmldaily1.0https://www.cepheid.com/de-DE/tests/respiratory/xpert-xpress-flu-rsv.htmldaily1.0https://www.cepheid.com/de-DE/tests/respiratory/xpert-xpress-cov-2-flu-rsv-plus.htmldaily1.0https://www.cepheid.com/de-DE/tests/hai-other-infectious-diseases.htmldaily1.0https://www.cepheid.com/de-DE/tests/hai-other-infectious-diseases/xpert-sa-nasal-complete.htmldaily1.0https://www.cepheid.com/de-DE/tests/hai-other-infectious-diseases/xpert-mrsa-sa-ssti.htmldaily1.0https://www.cepheid.com/de-DE/tests/hai-other-infectious-diseases/xpert-c-difficile-bt.htmldaily1.0https://www.cepheid.com/de-DE/tests/hai-other-infectious-diseases/xpert-norovirus.htmldaily1.0https://www.cepheid.com/de-DE/tests/hai-other-infectious-diseases/xpert-mrsa-sa-blood-culture.htmldaily1.0https://www.cepheid.com/de-DE/tests/hai-other-infectious-diseases/xpert-vana-vanb.htmldaily1.0https://www.cepheid.com/de-DE/tests/hai-other-infectious-diseases/xpert-mrsa-nxg.htmldaily1.0https://www.cepheid.com/de-DE/tests/hai-other-infectious-diseases/xpert-carba-r.htmldaily1.0https://www.cepheid.com/de-DE/tests/blood-virology-womens-health-sexual-health.htmldaily1.0https://www.cepheid.com/de-DE/tests/blood-virology-womens-health-sexual-health/xpert-hbv-viral-load.htmldaily1.0https://www.cepheid.com/de-DE/tests/blood-virology-womens-health-sexual-health/resistanceplusmg-flexible.htmldaily1.0https://www.cepheid.com/de-DE/tests/blood-virology-womens-health-sexual-health/xpert-xpress-gbs.htmldaily1.0https://www.cepheid.com/de-DE/tests/blood-virology-womens-health-sexual-health/xpert-ct-ng.htmldaily1.0https://www.cepheid.com/de-DE/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-qual-xc.htmldaily1.0https://www.cepheid.com/de-DE/tests/blood-virology-womens-health-sexual-health/xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/de-DE/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-viral-load-xc.htmldaily1.0https://www.cepheid.com/de-DE/tests/blood-virology-womens-health-sexual-health/xpert-tv.htmldaily1.0https://www.cepheid.com/de-DE/tests/blood-virology-womens-health-sexual-health/xpert-hpv-v2.htmldaily1.0https://www.cepheid.com/de-DE/tests/blood-virology-womens-health-sexual-health/xpert-hcv-viral-load.htmldaily1.0https://www.cepheid.com/de-DE/tests/tb-emerging-infectious-diseases.htmldaily1.0https://www.cepheid.com/de-DE/tests/tb-emerging-infectious-diseases/xpert-mtb-xdr.htmldaily1.0https://www.cepheid.com/de-DE/tests/tb-emerging-infectious-diseases/xpert-mtb-rif-ultra.htmldaily1.0https://www.cepheid.com/de-DE/tests/oncology-human-genetics.htmldaily1.0https://www.cepheid.com/de-DE/tests/oncology-human-genetics/expert-bladder-cancer-monitor.htmldaily1.0https://www.cepheid.com/de-DE/tests/oncology-human-genetics/xpert-fii-fv.htmldaily1.0https://www.cepheid.com/de-DE/tests/oncology-human-genetics/xpert-bcr-abl-ultra-p190.htmldaily1.0https://www.cepheid.com/de-DE/tests/oncology-human-genetics/xpert-breast-cancer-strat4.htmldaily1.0https://www.cepheid.com/de-DE/tests/oncology-human-genetics/xpert-bladder-cancer-detection.htmldaily1.0https://www.cepheid.com/de-DE/tests/oncology-human-genetics/xpert-bcr-abl-ultra.htmldaily1.0https://www.cepheid.com/de-DE/tests/oncology-human-genetics/xpert-npm1-mutation.htmldaily1.0https://www.cepheid.com/de-DE/systems.htmldaily1.0https://www.cepheid.com/de-DE/systems/genexpert-family-of-systems.htmldaily1.0https://www.cepheid.com/de-DE/systems/genexpert-family-of-systems/genexpert-system.htmldaily1.0https://www.cepheid.com/de-DE/systems/genexpert-family-of-systems/genexpert-infinity.htmldaily1.0https://www.cepheid.com/de-DE/systems/genexpert-software.htmldaily1.0https://www.cepheid.com/de-DE/systems/genexpert-software/gx-software.htmldaily1.0https://www.cepheid.com/de-DE/systems/genexpert-software/xpertise-software.htmldaily1.0https://www.cepheid.com/de-DE/systems/connectivity.htmldaily1.0https://www.cepheid.com/de-DE/systems/connectivity/cepheid-c360.htmldaily1.0https://www.cepheid.com/de-DE/systems/connectivity/interface-capabilities.htmldaily1.0https://www.cepheid.com/de-DE/systems/data-processing-agreement.htmldaily1.0https://www.cepheid.com/de-DE/systems/partner-communities.htmldaily1.0https://www.cepheid.com/de-DE/systems/business-associates-agreement.htmldaily1.0https://www.cepheid.com/de-DE/solutions.htmldaily1.0https://www.cepheid.com/de-DE/solutions/global-access.htmldaily1.0https://www.cepheid.com/de-DE/solutions/global-access/eligibility-and-pricing.htmldaily1.0https://www.cepheid.com/de-DE/solutions/testing-everywhere.htmldaily1.0https://www.cepheid.com/de-DE/solutions/antibiotic-stewardship.htmldaily1.0https://www.cepheid.com/de-DE/solutions/customized-testing-institution.htmldaily1.0https://www.cepheid.com/de-DE/solutions/knowing-more-matters.htmldaily1.0https://www.cepheid.com/de-DE/solutions/knowing-more-matters/pcr-vs-antigen.htmldaily1.0https://www.cepheid.com/de-DE/solutions/knowing-more-matters/covid-flu-rsv.htmldaily1.0https://www.cepheid.com/de-DE/insights.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/all-posts.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/respiratory-health.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/respiratory-health/2024/09/proactive-surveillance-to-ensure-broad-flu-strain-detection.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/respiratory-health/2024/09/emerging-evolving-respiratory-viruses-test-design-matters.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/respiratory-health/2024/09/the-genexpert-xpress-system-can-change-your-pediatric-practice.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/respiratory-health/2024/09/Norwegian-ED-improves-Resource-Management-with-Rapid-PCR-Testing.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/respiratory-health/2024/09/key-steps-pandemic-preparedness.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/respiratory-health/2025/01/what-does-it-mean-to-have-a-pandemic-ready-pcr-test.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like-ilnesses.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/respiratory-health/2025/03/in-house-pcr-testing-clinical-leaders-explore-the-ripple-effect.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/respiratory-health/2025/04/real-world-clinical-impact-of-in-house-pcr-testing.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/respiratory-health/2025/04/what-is-the-difference-between-pcr-and-antigen-testing.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/respiratory-health/2025/05/a-quick-primer-on-the-adlm-guidance-on-respiratory-virus-testing.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/respiratory-health/2025/09/revolutionizing-respiratory-care-the-power-of-rapid-molecular-testing.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/respiratory-health/2025/09/antigen-testing-vs-pcr-less-haste-more-speed-please.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/respiratory-health/2025/09/the-time-for-widespread-adoption-of-mdx-testing-for-gas-pharyngi.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/respiratory-health/2025/11/why-test-type-matters-pcr-vs-antigen-in-outpatient-respiratory-care.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/respiratory-health/2025/11/transforming-respiratory-tnfection-diagnosis-embracing-molecular-innovation-clinical-practice1.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/respiratory-health/2026/01/staying-ahead-of-influenza.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2024/09/accelerating-the-pace-for-hep-c-elimination-in-the-us.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2024/09/can-molecular-tests-revolutionize-tuberculosis-control.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2024/09/near-patient-testing-for-hep-c-xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2024/09/danish-hcv-testing-program-improves-patient-management-and-access.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2024/09/faster-prison-testing-for-hcv-drastically-improves-treatment-in-the-uk.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2024/09/innovative-POC-testing-shortens-time-between-testing-and-treatment.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2024/09/finnish-hospital-improves-care-for-expectant-mothers-with-gbs-pcr-screening.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2024/09/a-not-for-profit-in-vietnam-fights-to-end-tuberculosis.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2024/09/cepheid-expands-in-india-to-support-global-efforts-to-fight-tb.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2024/09/covid-19-and-tuberculosis-testing-in-south-africa.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2024/09/cepheid-supports-the-international-mpox-emergency-declared-august-2024.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2024/10/hpv-testing-south-african-clinic-may-prevent-cervical-cancer.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2024/12/strides-toward-early-infant-diagnosis-for-hiv-elimination-in-sou.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2025/02/common-misconceptions-about-vaginitis.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2025/06/womens-health-testing-advantages-of-same-day-diagnosis-and-treatment.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2025/05/revisiting-bacterial-vaginosis-evidence-for-sexual-transmission.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2025/05/a-breakthrough-in-hcv-elimination--how-hcv-point-of-care-rna-tes.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2025/05/decentralising-diagnostics-bringing-patient-centred-testing-closer-to-communities.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2025/05/integration-of-poc-viral-diagnostics-with-substance-use-disorder-treatment-to-improve-hepatitis-c-nfection-outcomes.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2025/04/tuberculosis-staying-one-step-ahead.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2025/04/how-three-countries-are-fighting-back-against-tuberculosis.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2025/04/a-mdr-tb-survivor-in-india-shares-her-remarkable-story.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2025/03/the-fight-to-end-tuberculosis-in-pakistan.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2025/03/devasena-gnanashanmugam-discusses-cepheids-global-access-program.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2025/03/desmond-tutu-foundation-reduces-impact-of-hiv-and-tb.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2025/03/tuberculosis-care-and-treatment-in-the-republic-of-indonesia.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2025/03/finding-missing-tuberculosis-tb-cases-philippines-need-for-speed.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2025/03/a-decade-of-health-and-economic-benefits-infographic.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2025/03/state-tb-in-us-overlooked-opportunity-better-results.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2025/03/fighting-tb-everything-10-years-of-impact-in-south-africa.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2025/07/five-surprising-stats-that-reveal-the-hidden-burden-of-vaginitis.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2025/07/5-ways-vaginitis-treatment-goes-wrong-and-how-better-testing-can-fix-It.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2025/09/in-memory-of-john-bishop-a-visionary-leader-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2025/08/kentucky-viral-hepatitis-treatment-projects-mission-to-eradicate-hcv.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2025/08/the-state-of-vaginitis-testing-in-the-us.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2025/08/improving-vaginitis-care-through-better-diagnostics.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2025/10/time-to-act-stopping-group-b-strep-infections-in-newborn-babies.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2025/10/real-user-experiences-with-xpert-xpress-mvp-oint-of-care-test.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2025/12/wecare-humanitarian-medical-mission.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2026/02/advancing-pandemic-preparedness-through-public-private-collaboration.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/community-and-global-health/2026/02/hepatitis-c-elimination-in-the-us-is-within-reach-experts-report.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/tech-disease-trends.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/tech-disease-trends/2024/09/candida-auris--rising-threat-and-future-implications.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/tech-disease-trends/2024/09/discussing-pharma-clinical-trials-utilizing-poc-diagnostics.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/tech-disease-trends/2024/09/poc-testing-increases-the-efficiency-of-patient-management-in-the-ed.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/tech-disease-trends/2024/10/dave-persing-legacy-and-leadership-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/tech-disease-trends/2024/11/invasive-group-streptococcal-disease.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/tech-disease-trends/2024/11/what-is-pcr--understanding-the-magic.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/tech-disease-trends/2024/11/decentralized-pcr-testing-and-the-quadruple-aim-insights-for-health-systems.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/tech-disease-trends/2025/01/how-a-cepheid-molecular-test-is-made.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/tech-disease-trends/2025/04/standardization-of-pcr-testing-across-healthcare-testing-sites.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/tech-disease-trends/2025/06/innovation-in-times-of-need-cepheids-legacy-of-outbreak-response.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/tech-disease-trends/2025/07/celebrating-the-cepheid-bike-where-art-meets-innovation.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/tech-disease-trends/2025/09/cepheid-advances-innovation-and-reach-with-key-partnerships.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/tech-disease-trends/2025/10/learn-about-cepheid-system-innovation.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/tech-disease-trends/2025/11/multiplex-with-meaning--cepheid-s-smart-approach-to-molecular-di.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/antimicrobial-stewardship.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/antimicrobial-stewardship/2024/09/a-public-health-dialogue-on-antibiotic-resistance-surveillance.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/antimicrobial-stewardship/2024/09/mortality-associated-with-carbapenem-resistant-gram-negative-infections.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/antimicrobial-stewardship/2024/09/decentralized-testing-for-the-surveillance-of-hospital-acquired-infections.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/antimicrobial-stewardship/2024/09/rapid-mrsa-screening-of-ortho-trauma-patients-improves-experience.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/antimicrobial-stewardship/2024/09/pcr-screening-at-a-british-hospital-enables-timely-infection-control.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/antimicrobial-stewardship/2024/10/fleming-initiative-cepheid-announce-partnership-tackle-amr.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/antimicrobial-stewardship/2024/10/link-between-colonization-multi-drug-resistant-infection.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/antimicrobial-stewardship/2024/12/point-of-care-testing-emergency-department-faster-decision-making-halle.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-schulz.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/antimicrobial-stewardship/2025/05/antimicrobial-and-diagnostic-stewardship-frost-and-sullivan-visual-whitepaper.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/antimicrobial-stewardship/2025/08/industry-voices-time-to-rethink-our-approach-to-using-modern-medicine.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/antimicrobial-stewardship/2025/09/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/antimicrobial-stewardship/2025/10/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/antimicrobial-stewardship/2025/11/vanessa-carter-s-journey--inspiring-action-against-amr.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/antimicrobial-stewardship/2025/11/advancing-antimicrobial-stewardship-in-small-and-rural-hospital.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/expert-spotlight.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/expert-spotlight/2025/10/expert-spotlight--michael-loeffelholz.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--devasena-gnanashanmugam-vice-president--me.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--jennifer-rakeman-cagno-senior-director--sc.htmldaily1.0https://www.cepheid.com/de-DE/insights/insight-hub/expert-spotlight/2026/02/expert-spotlight-jordan-chase.htmldaily1.0https://www.cepheid.com/de-DE/insights/webinars.htmldaily1.0https://www.cepheid.com/de-DE/insights/resources.htmldaily1.0https://www.cepheid.com/de-DE/support.htmldaily1.0https://www.cepheid.com/de-DE/support/ivdr-update.htmldaily1.0https://www.cepheid.com/de-DE/support/contact-us.htmldaily1.0https://www.cepheid.com/de-DE/about.htmldaily1.0https://www.cepheid.com/de-DE/about/mission-history.htmldaily1.0https://www.cepheid.com/de-DE/about/leadership.htmldaily1.0https://www.cepheid.com/de-DE/about/leadership/vitor-rocha.htmldaily1.0https://www.cepheid.com/de-DE/about/leadership/laurent-bellon.htmldaily1.0https://www.cepheid.com/de-DE/about/leadership/anette-engelhardt.htmldaily1.0https://www.cepheid.com/de-DE/about/leadership/peter-farrell.htmldaily1.0https://www.cepheid.com/de-DE/about/leadership/deborah-gonyea.htmldaily1.0https://www.cepheid.com/de-DE/about/leadership/nichole-halsey.htmldaily1.0https://www.cepheid.com/de-DE/about/leadership/luben-li.htmldaily1.0https://www.cepheid.com/de-DE/about/leadership/luke-maitland.htmldaily1.0https://www.cepheid.com/de-DE/about/leadership/david-h-persing.htmldaily1.0https://www.cepheid.com/de-DE/about/leadership/ammar-qadan.htmldaily1.0https://www.cepheid.com/de-DE/about/leadership/charles-mwangi.htmldaily1.0https://www.cepheid.com/de-DE/about/leadership/samson-wu.htmldaily1.0https://www.cepheid.com/de-DE/about/leadership/anupama-mokkapati.htmldaily1.0https://www.cepheid.com/de-DE/about/leadership/traci-wicks.htmldaily1.0https://www.cepheid.com/de-DE/about/leadership/scott-campbell.htmldaily1.0https://www.cepheid.com/de-DE/about/leadership/anne-beauburn.htmldaily1.0https://www.cepheid.com/de-DE/about/leadership/patrick-harkins.htmldaily1.0https://www.cepheid.com/de-DE/about/leadership/ephraim-tsalik.htmldaily1.0https://www.cepheid.com/de-DE/about/leadership/somesh-lalithraj.htmldaily1.0https://www.cepheid.com/de-DE/about/leadership/connie-savor.htmldaily1.0https://www.cepheid.com/de-DE/about/sustainability.htmldaily1.0https://www.cepheid.com/de-DE/about/sustainability/environmental-sustainability.htmldaily1.0https://www.cepheid.com/de-DE/about/sustainability/product-stewardship.htmldaily1.0https://www.cepheid.com/de-DE/about/sustainability/conflict-materials.htmldaily1.0https://www.cepheid.com/de-DE/about/policies-reports.htmldaily1.0https://www.cepheid.com/de-DE/about/business-development-opportunities.htmldaily1.0https://www.cepheid.com/de-DE/about/events.htmldaily1.0https://www.cepheid.com/de-DE/about/innovation-form.htmldaily1.0https://www.cepheid.com/de-DE/about/innovation-form/unsolicited-submission-agreement.htmldaily1.0https://www.cepheid.com/de-DE/about/sars-cov-2-test-development-information.htmldaily1.0https://www.cepheid.com/de-DE/about/sars-cov-2-product-resources.htmldaily1.0https://www.cepheid.com/de-DE/contact/select-info-path.htmldaily1.0https://www.cepheid.com/de-DE/contact/messages/thank-you.htmldaily1.0https://www.cepheid.com/de-DE/contact/messages/thank-you-patient-pathways.htmldaily1.0https://www.cepheid.com/de-DE/contact/messages/thank-you-patient-pathways-fr.htmldaily1.0https://www.cepheid.com/de-DE/contact/messages/thank-you-patient-pathways-de.htmldaily1.0https://www.cepheid.com/de-DE/contact/messages/thank-you-patient-pathways-it.htmldaily1.0https://www.cepheid.com/de-DE/contact/messages/thank-you-patient-pathways-sp.htmldaily1.0https://www.cepheid.com/de-DE/contact/messages/thank-you-patient-pathways-pl.htmldaily1.0https://www.cepheid.com/de-DE/contact/messages/thank-you-patient-pathways-pt.htmldaily1.0https://www.cepheid.com/de-DE/contact/request-cd-international.htmldaily1.0https://www.cepheid.com/de-DE/personas/laboratory-professionals.htmldaily1.0https://www.cepheid.com/de-DE/personas/healthcare-professsional.htmldaily1.0https://www.cepheid.com/de-DE/personas/health-system-administrators.htmldaily1.0https://www.cepheid.com/de-DE/legal/privacy.htmldaily1.0https://www.cepheid.com/de-DE/legal/terms-of-use.htmldaily1.0https://www.cepheid.com/de-DE/legal/product-security-updates.htmldaily1.0https://www.cepheid.com/de-DE/legal/terms-of-sale.htmldaily1.0https://www.cepheid.com/de-DE/legal/trademarks.htmldaily1.0https://www.cepheid.com/de-DE/legal/cookies-notice.htmldaily1.0https://www.cepheid.com/de-DE/legal/impressum.htmldaily1.0https://www.cepheid.com/de-DE/campaigns/2020-emea-renewed-messaging/french/patient-pathways.htmldaily1.0https://www.cepheid.com/de-DE/campaigns/2020-emea-renewed-messaging/german/patient-pathways.htmldaily1.0https://www.cepheid.com/de-DE/campaigns/2020-emea-renewed-messaging/italian/patient-pathways.htmldaily1.0https://www.cepheid.com/de-DE/campaigns/2020-emea-renewed-messaging/portuguese/patient-pathways.htmldaily1.0https://www.cepheid.com/de-DE/campaigns/2020-emea-renewed-messaging/polish/patient-pathways.htmldaily1.0https://www.cepheid.com/de-DE/campaigns/india/cepheid-india.htmldaily1.0https://www.cepheid.com/de-DE/campaigns/india/india-submission.htmldaily1.0https://www.cepheid.com/de-DE/campaigns/india/cepheid-india-display.htmldaily1.0https://www.cepheid.com/de-DE/campaigns/india/cepheid-india-bangladesh.htmldaily1.0https://www.cepheid.com/de-DE/campaigns/pcr-plus.htmldaily1.0https://www.cepheid.com/de-DE/coronavirus-portfolio.htmldaily1.0https://www.cepheid.com/es-ES.htmldaily1.0https://www.cepheid.com/es-ES/tests.htmldaily1.0https://www.cepheid.com/es-ES/tests/respiratory.htmldaily1.0https://www.cepheid.com/es-ES/tests/respiratory/xpert-xpress-strep-a.htmldaily1.0https://www.cepheid.com/es-ES/tests/respiratory/xpert-xpress-cov-2-plus.htmldaily1.0https://www.cepheid.com/es-ES/tests/respiratory/xpert-xpress-sars-cov-2.htmldaily1.0https://www.cepheid.com/es-ES/tests/respiratory/xpert-xpress-flu-rsv.htmldaily1.0https://www.cepheid.com/es-ES/tests/respiratory/xpert-xpress-cov-2-flu-rsv-plus.htmldaily1.0https://www.cepheid.com/es-ES/tests/hai-other-infectious-diseases.htmldaily1.0https://www.cepheid.com/es-ES/tests/hai-other-infectious-diseases/xpert-sa-nasal-complete.htmldaily1.0https://www.cepheid.com/es-ES/tests/hai-other-infectious-diseases/xpert-mrsa-sa-ssti.htmldaily1.0https://www.cepheid.com/es-ES/tests/hai-other-infectious-diseases/xpert-c-difficile-bt.htmldaily1.0https://www.cepheid.com/es-ES/tests/hai-other-infectious-diseases/xpert-norovirus.htmldaily1.0https://www.cepheid.com/es-ES/tests/hai-other-infectious-diseases/xpert-mrsa-sa-blood-culture.htmldaily1.0https://www.cepheid.com/es-ES/tests/hai-other-infectious-diseases/xpert-vana-vanb.htmldaily1.0https://www.cepheid.com/es-ES/tests/hai-other-infectious-diseases/xpert-mrsa-nxg.htmldaily1.0https://www.cepheid.com/es-ES/tests/hai-other-infectious-diseases/xpert-carba-r.htmldaily1.0https://www.cepheid.com/es-ES/tests/blood-virology-womens-health-sexual-health.htmldaily1.0https://www.cepheid.com/es-ES/tests/blood-virology-womens-health-sexual-health/xpert-hbv-viral-load.htmldaily1.0https://www.cepheid.com/es-ES/tests/blood-virology-womens-health-sexual-health/resistanceplusmg-flexible.htmldaily1.0https://www.cepheid.com/es-ES/tests/blood-virology-womens-health-sexual-health/xpert-xpress-gbs.htmldaily1.0https://www.cepheid.com/es-ES/tests/blood-virology-womens-health-sexual-health/xpert-ct-ng.htmldaily1.0https://www.cepheid.com/es-ES/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-qual-xc.htmldaily1.0https://www.cepheid.com/es-ES/tests/blood-virology-womens-health-sexual-health/xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/es-ES/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-viral-load-xc.htmldaily1.0https://www.cepheid.com/es-ES/tests/blood-virology-womens-health-sexual-health/xpert-tv.htmldaily1.0https://www.cepheid.com/es-ES/tests/blood-virology-womens-health-sexual-health/xpert-hpv-v2.htmldaily1.0https://www.cepheid.com/es-ES/tests/blood-virology-womens-health-sexual-health/xpert-hcv-viral-load.htmldaily1.0https://www.cepheid.com/es-ES/tests/tb-emerging-infectious-diseases.htmldaily1.0https://www.cepheid.com/es-ES/tests/tb-emerging-infectious-diseases/xpert-mtb-xdr.htmldaily1.0https://www.cepheid.com/es-ES/tests/tb-emerging-infectious-diseases/xpert-mtb-rif-ultra.htmldaily1.0https://www.cepheid.com/es-ES/tests/oncology-human-genetics.htmldaily1.0https://www.cepheid.com/es-ES/tests/oncology-human-genetics/expert-bladder-cancer-monitor.htmldaily1.0https://www.cepheid.com/es-ES/tests/oncology-human-genetics/xpert-fii-fv.htmldaily1.0https://www.cepheid.com/es-ES/tests/oncology-human-genetics/xpert-bcr-abl-ultra-p190.htmldaily1.0https://www.cepheid.com/es-ES/tests/oncology-human-genetics/xpert-breast-cancer-strat4.htmldaily1.0https://www.cepheid.com/es-ES/tests/oncology-human-genetics/xpert-bladder-cancer-detection.htmldaily1.0https://www.cepheid.com/es-ES/tests/oncology-human-genetics/xpert-bcr-abl-ultra.htmldaily1.0https://www.cepheid.com/es-ES/tests/oncology-human-genetics/xpert-npm1-mutation.htmldaily1.0https://www.cepheid.com/es-ES/systems.htmldaily1.0https://www.cepheid.com/es-ES/systems/genexpert-family-of-systems.htmldaily1.0https://www.cepheid.com/es-ES/systems/genexpert-family-of-systems/genexpert-system.htmldaily1.0https://www.cepheid.com/es-ES/systems/genexpert-family-of-systems/genexpert-infinity.htmldaily1.0https://www.cepheid.com/es-ES/systems/genexpert-software.htmldaily1.0https://www.cepheid.com/es-ES/systems/genexpert-software/gx-software.htmldaily1.0https://www.cepheid.com/es-ES/systems/genexpert-software/xpertise-software.htmldaily1.0https://www.cepheid.com/es-ES/systems/connectivity.htmldaily1.0https://www.cepheid.com/es-ES/systems/connectivity/cepheid-c360.htmldaily1.0https://www.cepheid.com/es-ES/systems/connectivity/interface-capabilities.htmldaily1.0https://www.cepheid.com/es-ES/systems/data-processing-agreement.htmldaily1.0https://www.cepheid.com/es-ES/systems/partner-communities.htmldaily1.0https://www.cepheid.com/es-ES/systems/business-associates-agreement.htmldaily1.0https://www.cepheid.com/es-ES/solutions.htmldaily1.0https://www.cepheid.com/es-ES/solutions/global-access.htmldaily1.0https://www.cepheid.com/es-ES/solutions/global-access/eligibility-and-pricing.htmldaily1.0https://www.cepheid.com/es-ES/solutions/testing-everywhere.htmldaily1.0https://www.cepheid.com/es-ES/solutions/antibiotic-stewardship.htmldaily1.0https://www.cepheid.com/es-ES/solutions/oncology-diagnostics.htmldaily1.0https://www.cepheid.com/es-ES/solutions/customized-testing-institution.htmldaily1.0https://www.cepheid.com/es-ES/solutions/knowing-more-matters.htmldaily1.0https://www.cepheid.com/es-ES/solutions/knowing-more-matters/pcr-vs-antigen.htmldaily1.0https://www.cepheid.com/es-ES/solutions/knowing-more-matters/covid-flu-rsv.htmldaily1.0https://www.cepheid.com/es-ES/insights.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/all-posts.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/respiratory-health.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/respiratory-health/2024/09/proactive-surveillance-to-ensure-broad-flu-strain-detection.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/respiratory-health/2024/09/emerging-evolving-respiratory-viruses-test-design-matters.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/respiratory-health/2024/09/the-genexpert-xpress-system-can-change-your-pediatric-practice.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/respiratory-health/2024/09/Norwegian-ED-improves-Resource-Management-with-Rapid-PCR-Testing.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/respiratory-health/2024/09/key-steps-pandemic-preparedness.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/respiratory-health/2025/01/what-does-it-mean-to-have-a-pandemic-ready-pcr-test.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like-ilnesses.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/respiratory-health/2025/03/in-house-pcr-testing-clinical-leaders-explore-the-ripple-effect.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/respiratory-health/2025/04/real-world-clinical-impact-of-in-house-pcr-testing.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/respiratory-health/2025/04/what-is-the-difference-between-pcr-and-antigen-testing.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/respiratory-health/2025/05/a-quick-primer-on-the-adlm-guidance-on-respiratory-virus-testing.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/respiratory-health/2025/09/revolutionizing-respiratory-care-the-power-of-rapid-molecular-testing.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/respiratory-health/2025/09/antigen-testing-vs-pcr-less-haste-more-speed-please.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/respiratory-health/2025/09/the-time-for-widespread-adoption-of-mdx-testing-for-gas-pharyngi.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/respiratory-health/2025/11/why-test-type-matters-pcr-vs-antigen-in-outpatient-respiratory-care.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/respiratory-health/2025/11/transforming-respiratory-tnfection-diagnosis-embracing-molecular-innovation-clinical-practice1.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/respiratory-health/2026/01/staying-ahead-of-influenza.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/respiratory-health/2026/02/revolutionizing-rheumatic-heart-disease-prevention.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2024/09/accelerating-the-pace-for-hep-c-elimination-in-the-us.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2024/09/can-molecular-tests-revolutionize-tuberculosis-control.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2024/09/near-patient-testing-for-hep-c-xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2024/09/danish-hcv-testing-program-improves-patient-management-and-access.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2024/09/faster-prison-testing-for-hcv-drastically-improves-treatment-in-the-uk.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2024/09/innovative-POC-testing-shortens-time-between-testing-and-treatment.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2024/09/finnish-hospital-improves-care-for-expectant-mothers-with-gbs-pcr-screening.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2024/09/a-not-for-profit-in-vietnam-fights-to-end-tuberculosis.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2024/09/cepheid-expands-in-india-to-support-global-efforts-to-fight-tb.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2024/09/covid-19-and-tuberculosis-testing-in-south-africa.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2024/09/cepheid-supports-the-international-mpox-emergency-declared-august-2024.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2024/10/hpv-testing-south-african-clinic-may-prevent-cervical-cancer.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2024/12/strides-toward-early-infant-diagnosis-for-hiv-elimination-in-sou.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2025/02/common-misconceptions-about-vaginitis.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2025/05/revisiting-bacterial-vaginosis-evidence-for-sexual-transmission.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2025/05/a-breakthrough-in-hcv-elimination--how-hcv-point-of-care-rna-tes.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2025/05/decentralising-diagnostics-bringing-patient-centred-testing-closer-to-communities.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2025/05/integration-of-poc-viral-diagnostics-with-substance-use-disorder-treatment-to-improve-hepatitis-c-nfection-outcomes.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2025/04/tuberculosis-staying-one-step-ahead.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2025/04/how-three-countries-are-fighting-back-against-tuberculosis.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2025/04/a-mdr-tb-survivor-in-india-shares-her-remarkable-story.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2025/06/womens-health-testing-advantages-of-same-day-diagnosis-and-treatment.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2025/07/five-surprising-stats-that-reveal-the-hidden-burden-of-vaginitis.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2025/07/5-ways-vaginitis-treatment-goes-wrong-and-how-better-testing-can-fix-It.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2025/03/the-fight-to-end-tuberculosis-in-pakistan.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2025/03/devasena-gnanashanmugam-discusses-cepheids-global-access-program.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2025/03/desmond-tutu-foundation-reduces-impact-of-hiv-and-tb.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2025/03/tuberculosis-care-and-treatment-in-the-republic-of-indonesia.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2025/03/finding-missing-tuberculosis-tb-cases-philippines-need-for-speed.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2025/03/a-decade-of-health-and-economic-benefits-infographic.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2025/03/state-tb-in-us-overlooked-opportunity-better-results.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2025/03/fighting-tb-everything-10-years-of-impact-in-south-africa.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2025/09/in-memory-of-john-bishop-a-visionary-leader-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2025/08/kentucky-viral-hepatitis-treatment-projects-mission-to-eradicate-hcv.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2025/08/the-state-of-vaginitis-testing-in-the-us.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2025/08/improving-vaginitis-care-through-better-diagnostics.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2025/12/wecare-humanitarian-medical-mission.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2025/10/time-to-act-stopping-group-b-strep-infections-in-newborn-babies.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2025/10/real-user-experiences-with-xpert-xpress-mvp-oint-of-care-test.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2026/02/advancing-pandemic-preparedness-through-public-private-collaboration.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/community-and-global-health/2026/02/hepatitis-c-elimination-in-the-us-is-within-reach-experts-report.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/tech-disease-trends.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/tech-disease-trends/2024/09/candida-auris--rising-threat-and-future-implications.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/tech-disease-trends/2024/09/discussing-pharma-clinical-trials-utilizing-poc-diagnostics.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/tech-disease-trends/2024/09/poc-testing-increases-the-efficiency-of-patient-management-in-the-ed.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/tech-disease-trends/2024/10/dave-persing-legacy-and-leadership-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/tech-disease-trends/2024/11/invasive-group-streptococcal-disease.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/tech-disease-trends/2024/11/what-is-pcr--understanding-the-magic.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/tech-disease-trends/2024/11/decentralized-pcr-testing-and-the-quadruple-aim-insights-for-health-systems.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/tech-disease-trends/2025/01/how-a-cepheid-molecular-test-is-made.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/tech-disease-trends/2025/04/standardization-of-pcr-testing-across-healthcare-testing-sites.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/tech-disease-trends/2025/06/innovation-in-times-of-need-cepheids-legacy-of-outbreak-response.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/tech-disease-trends/2025/07/celebrating-the-cepheid-bike-where-art-meets-innovation.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/tech-disease-trends/2025/09/cepheid-advances-innovation-and-reach-with-key-partnerships.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/tech-disease-trends/2025/10/learn-about-cepheid-system-innovation.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/tech-disease-trends/2025/11/multiplex-with-meaning--cepheid-s-smart-approach-to-molecular-di.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/antimicrobial-stewardship.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/antimicrobial-stewardship/2024/09/a-public-health-dialogue-on-antibiotic-resistance-surveillance.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/antimicrobial-stewardship/2024/09/mortality-associated-with-carbapenem-resistant-gram-negative-infections.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/antimicrobial-stewardship/2024/09/decentralized-testing-for-the-surveillance-of-hospital-acquired-infections.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/antimicrobial-stewardship/2024/09/rapid-mrsa-screening-of-ortho-trauma-patients-improves-experience.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/antimicrobial-stewardship/2024/09/pcr-screening-at-a-british-hospital-enables-timely-infection-control.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/antimicrobial-stewardship/2024/10/fleming-initiative-cepheid-announce-partnership-tackle-amr.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/antimicrobial-stewardship/2024/10/link-between-colonization-multi-drug-resistant-infection.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/antimicrobial-stewardship/2024/12/point-of-care-testing-emergency-department-faster-decision-making-halle.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-schulz.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/antimicrobial-stewardship/2025/05/antimicrobial-and-diagnostic-stewardship-frost-and-sullivan-visual-whitepaper.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/antimicrobial-stewardship/2025/08/industry-voices-time-to-rethink-our-approach-to-using-modern-medicine.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/antimicrobial-stewardship/2025/09/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/antimicrobial-stewardship/2025/10/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/antimicrobial-stewardship/2025/11/vanessa-carter-s-journey--inspiring-action-against-amr.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/antimicrobial-stewardship/2025/11/advancing-antimicrobial-stewardship-in-small-and-rural-hospital.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/expert-spotlight.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/expert-spotlight/2025/10/expert-spotlight--michael-loeffelholz.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--devasena-gnanashanmugam-vice-president--me.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--jennifer-rakeman-cagno-senior-director--sc.htmldaily1.0https://www.cepheid.com/es-ES/insights/insight-hub/expert-spotlight/2026/02/expert-spotlight-jordan-chase.htmldaily1.0https://www.cepheid.com/es-ES/insights/webinars.htmldaily1.0https://www.cepheid.com/es-ES/insights/resources.htmldaily1.0https://www.cepheid.com/es-ES/support.htmldaily1.0https://www.cepheid.com/es-ES/support/ivdr-update.htmldaily1.0https://www.cepheid.com/es-ES/support/contact-us.htmldaily1.0https://www.cepheid.com/es-ES/about.htmldaily1.0https://www.cepheid.com/es-ES/about/mission-history.htmldaily1.0https://www.cepheid.com/es-ES/about/leadership.htmldaily1.0https://www.cepheid.com/es-ES/about/leadership/vitor-rocha.htmldaily1.0https://www.cepheid.com/es-ES/about/leadership/laurent-bellon.htmldaily1.0https://www.cepheid.com/es-ES/about/leadership/anette-engelhardt.htmldaily1.0https://www.cepheid.com/es-ES/about/leadership/peter-farrell.htmldaily1.0https://www.cepheid.com/es-ES/about/leadership/deborah-gonyea.htmldaily1.0https://www.cepheid.com/es-ES/about/leadership/nichole-halsey.htmldaily1.0https://www.cepheid.com/es-ES/about/leadership/luben-li.htmldaily1.0https://www.cepheid.com/es-ES/about/leadership/luke-maitland.htmldaily1.0https://www.cepheid.com/es-ES/about/leadership/david-h-persing.htmldaily1.0https://www.cepheid.com/es-ES/about/leadership/ammar-qadan.htmldaily1.0https://www.cepheid.com/es-ES/about/leadership/charles-mwangi.htmldaily1.0https://www.cepheid.com/es-ES/about/leadership/samson-wu.htmldaily1.0https://www.cepheid.com/es-ES/about/leadership/anupama-mokkapati.htmldaily1.0https://www.cepheid.com/es-ES/about/leadership/traci-wicks.htmldaily1.0https://www.cepheid.com/es-ES/about/leadership/scott-campbell.htmldaily1.0https://www.cepheid.com/es-ES/about/leadership/anne-beauburn.htmldaily1.0https://www.cepheid.com/es-ES/about/leadership/patrick-harkins.htmldaily1.0https://www.cepheid.com/es-ES/about/leadership/ephraim-tsalik.htmldaily1.0https://www.cepheid.com/es-ES/about/leadership/somesh-lalithraj.htmldaily1.0https://www.cepheid.com/es-ES/about/leadership/connie-savor.htmldaily1.0https://www.cepheid.com/es-ES/about/sustainability.htmldaily1.0https://www.cepheid.com/es-ES/about/sustainability/environmental-sustainability.htmldaily1.0https://www.cepheid.com/es-ES/about/sustainability/product-stewardship.htmldaily1.0https://www.cepheid.com/es-ES/about/sustainability/conflict-materials.htmldaily1.0https://www.cepheid.com/es-ES/about/policies-reports.htmldaily1.0https://www.cepheid.com/es-ES/about/business-development-opportunities.htmldaily1.0https://www.cepheid.com/es-ES/about/events.htmldaily1.0https://www.cepheid.com/es-ES/about/innovation-form.htmldaily1.0https://www.cepheid.com/es-ES/about/innovation-form/unsolicited-submission-agreement.htmldaily1.0https://www.cepheid.com/es-ES/about/sars-cov-2-test-development-information.htmldaily1.0https://www.cepheid.com/es-ES/about/sars-cov-2-product-resources.htmldaily1.0https://www.cepheid.com/es-ES/contact/select-info-path.htmldaily1.0https://www.cepheid.com/es-ES/contact/messages/thank-you.htmldaily1.0https://www.cepheid.com/es-ES/contact/messages/thank-you-patient-pathways.htmldaily1.0https://www.cepheid.com/es-ES/contact/messages/thank-you-patient-pathways-fr.htmldaily1.0https://www.cepheid.com/es-ES/contact/messages/thank-you-patient-pathways-de.htmldaily1.0https://www.cepheid.com/es-ES/contact/messages/thank-you-patient-pathways-it.htmldaily1.0https://www.cepheid.com/es-ES/contact/messages/thank-you-patient-pathways-sp.htmldaily1.0https://www.cepheid.com/es-ES/contact/messages/thank-you-patient-pathways-pl.htmldaily1.0https://www.cepheid.com/es-ES/contact/messages/thank-you-patient-pathways-pt.htmldaily1.0https://www.cepheid.com/es-ES/contact/request-cd-international.htmldaily1.0https://www.cepheid.com/es-ES/personas/laboratory-professionals.htmldaily1.0https://www.cepheid.com/es-ES/personas/healthcare-professsional.htmldaily1.0https://www.cepheid.com/es-ES/personas/health-system-administrators.htmldaily1.0https://www.cepheid.com/es-ES/legal/privacy.htmldaily1.0https://www.cepheid.com/es-ES/legal/terms-of-use.htmldaily1.0https://www.cepheid.com/es-ES/legal/product-security-updates.htmldaily1.0https://www.cepheid.com/es-ES/legal/terms-of-sale.htmldaily1.0https://www.cepheid.com/es-ES/legal/trademarks.htmldaily1.0https://www.cepheid.com/es-ES/legal/cookies-notice.htmldaily1.0https://www.cepheid.com/es-ES/campaigns/2020-emea-renewed-messaging/french/patient-pathways.htmldaily1.0https://www.cepheid.com/es-ES/campaigns/2020-emea-renewed-messaging/german/patient-pathways.htmldaily1.0https://www.cepheid.com/es-ES/campaigns/2020-emea-renewed-messaging/italian/patient-pathways.htmldaily1.0https://www.cepheid.com/es-ES/campaigns/2020-emea-renewed-messaging/portuguese/patient-pathways.htmldaily1.0https://www.cepheid.com/es-ES/campaigns/2020-emea-renewed-messaging/polish/patient-pathways.htmldaily1.0https://www.cepheid.com/es-ES/campaigns/india/cepheid-india.htmldaily1.0https://www.cepheid.com/es-ES/campaigns/india/india-submission.htmldaily1.0https://www.cepheid.com/es-ES/campaigns/india/cepheid-india-display.htmldaily1.0https://www.cepheid.com/es-ES/campaigns/india/cepheid-india-bangladesh.htmldaily1.0https://www.cepheid.com/es-ES/campaigns/pcr-plus.htmldaily1.0https://www.cepheid.com/es-ES/coronavirus-portfolio.htmldaily1.0https://www.cepheid.com/de-AT.htmldaily1.0https://www.cepheid.com/de-AT/tests.htmldaily1.0https://www.cepheid.com/de-AT/tests/respiratory.htmldaily1.0https://www.cepheid.com/de-AT/tests/respiratory/xpert-xpress-strep-a.htmldaily1.0https://www.cepheid.com/de-AT/tests/respiratory/xpert-xpress-cov-2-plus.htmldaily1.0https://www.cepheid.com/de-AT/tests/respiratory/xpert-xpress-flu-rsv.htmldaily1.0https://www.cepheid.com/de-AT/tests/respiratory/xpert-xpress-cov-2-flu-rsv-plus.htmldaily1.0https://www.cepheid.com/de-AT/tests/hai-other-infectious-diseases.htmldaily1.0https://www.cepheid.com/de-AT/tests/hai-other-infectious-diseases/xpert-sa-nasal-complete.htmldaily1.0https://www.cepheid.com/de-AT/tests/hai-other-infectious-diseases/xpert-mrsa-sa-ssti.htmldaily1.0https://www.cepheid.com/de-AT/tests/hai-other-infectious-diseases/xpert-c-difficile-bt.htmldaily1.0https://www.cepheid.com/de-AT/tests/hai-other-infectious-diseases/xpert-norovirus.htmldaily1.0https://www.cepheid.com/de-AT/tests/hai-other-infectious-diseases/xpert-mrsa-sa-blood-culture.htmldaily1.0https://www.cepheid.com/de-AT/tests/hai-other-infectious-diseases/xpert-vana-vanb.htmldaily1.0https://www.cepheid.com/de-AT/tests/hai-other-infectious-diseases/xpert-mrsa-nxg.htmldaily1.0https://www.cepheid.com/de-AT/tests/hai-other-infectious-diseases/xpert-carba-r.htmldaily1.0https://www.cepheid.com/de-AT/tests/blood-virology-womens-health-sexual-health.htmldaily1.0https://www.cepheid.com/de-AT/tests/blood-virology-womens-health-sexual-health/xpert-hbv-viral-load.htmldaily1.0https://www.cepheid.com/de-AT/tests/blood-virology-womens-health-sexual-health/resistanceplusmg-flexible.htmldaily1.0https://www.cepheid.com/de-AT/tests/blood-virology-womens-health-sexual-health/xpert-xpress-gbs.htmldaily1.0https://www.cepheid.com/de-AT/tests/blood-virology-womens-health-sexual-health/xpert-ct-ng.htmldaily1.0https://www.cepheid.com/de-AT/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-qual-xc.htmldaily1.0https://www.cepheid.com/de-AT/tests/blood-virology-womens-health-sexual-health/xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/de-AT/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-viral-load-xc.htmldaily1.0https://www.cepheid.com/de-AT/tests/blood-virology-womens-health-sexual-health/xpert-tv.htmldaily1.0https://www.cepheid.com/de-AT/tests/blood-virology-womens-health-sexual-health/xpert-hpv-v2.htmldaily1.0https://www.cepheid.com/de-AT/tests/blood-virology-womens-health-sexual-health/xpert-hcv-viral-load.htmldaily1.0https://www.cepheid.com/de-AT/tests/tb-emerging-infectious-diseases.htmldaily1.0https://www.cepheid.com/de-AT/tests/tb-emerging-infectious-diseases/xpert-mtb-xdr.htmldaily1.0https://www.cepheid.com/de-AT/tests/tb-emerging-infectious-diseases/xpert-mtb-rif-ultra.htmldaily1.0https://www.cepheid.com/de-AT/tests/oncology-human-genetics.htmldaily1.0https://www.cepheid.com/de-AT/tests/oncology-human-genetics/expert-bladder-cancer-monitor.htmldaily1.0https://www.cepheid.com/de-AT/tests/oncology-human-genetics/xpert-fii-fv.htmldaily1.0https://www.cepheid.com/de-AT/tests/oncology-human-genetics/xpert-bcr-abl-ultra-p190.htmldaily1.0https://www.cepheid.com/de-AT/tests/oncology-human-genetics/xpert-breast-cancer-strat4.htmldaily1.0https://www.cepheid.com/de-AT/tests/oncology-human-genetics/xpert-bladder-cancer-detection.htmldaily1.0https://www.cepheid.com/de-AT/tests/oncology-human-genetics/xpert-bcr-abl-ultra.htmldaily1.0https://www.cepheid.com/de-AT/tests/oncology-human-genetics/xpert-npm1-mutation.htmldaily1.0https://www.cepheid.com/de-AT/systems.htmldaily1.0https://www.cepheid.com/de-AT/systems/genexpert-family-of-systems.htmldaily1.0https://www.cepheid.com/de-AT/systems/genexpert-family-of-systems/genexpert-system.htmldaily1.0https://www.cepheid.com/de-AT/systems/genexpert-family-of-systems/genexpert-infinity.htmldaily1.0https://www.cepheid.com/de-AT/systems/genexpert-software.htmldaily1.0https://www.cepheid.com/de-AT/systems/genexpert-software/gx-software.htmldaily1.0https://www.cepheid.com/de-AT/systems/genexpert-software/xpertise-software.htmldaily1.0https://www.cepheid.com/de-AT/systems/connectivity.htmldaily1.0https://www.cepheid.com/de-AT/systems/connectivity/cepheid-c360.htmldaily1.0https://www.cepheid.com/de-AT/systems/connectivity/interface-capabilities.htmldaily1.0https://www.cepheid.com/de-AT/systems/data-processing-agreement.htmldaily1.0https://www.cepheid.com/de-AT/systems/partner-communities.htmldaily1.0https://www.cepheid.com/de-AT/systems/business-associates-agreement.htmldaily1.0https://www.cepheid.com/de-AT/solutions.htmldaily1.0https://www.cepheid.com/de-AT/solutions/global-access.htmldaily1.0https://www.cepheid.com/de-AT/solutions/global-access/eligibility-and-pricing.htmldaily1.0https://www.cepheid.com/de-AT/solutions/testing-everywhere.htmldaily1.0https://www.cepheid.com/de-AT/solutions/antibiotic-stewardship.htmldaily1.0https://www.cepheid.com/de-AT/solutions/oncology-diagnostics.htmldaily1.0https://www.cepheid.com/de-AT/solutions/customized-testing-institution.htmldaily1.0https://www.cepheid.com/de-AT/solutions/knowing-more-matters.htmldaily1.0https://www.cepheid.com/de-AT/solutions/knowing-more-matters/pcr-vs-antigen.htmldaily1.0https://www.cepheid.com/de-AT/solutions/knowing-more-matters/covid-flu-rsv.htmldaily1.0https://www.cepheid.com/de-AT/insights.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/all-posts.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/respiratory-health.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/respiratory-health/2024/09/proactive-surveillance-to-ensure-broad-flu-strain-detection.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/respiratory-health/2024/09/emerging-evolving-respiratory-viruses-test-design-matters.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/respiratory-health/2024/09/the-genexpert-xpress-system-can-change-your-pediatric-practice.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/respiratory-health/2024/09/Norwegian-ED-improves-Resource-Management-with-Rapid-PCR-Testing.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/respiratory-health/2024/09/key-steps-pandemic-preparedness.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/respiratory-health/2025/01/what-does-it-mean-to-have-a-pandemic-ready-pcr-test.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like-ilnesses.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/respiratory-health/2025/03/in-house-pcr-testing-clinical-leaders-explore-the-ripple-effect.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/respiratory-health/2025/04/real-world-clinical-impact-of-in-house-pcr-testing.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/respiratory-health/2025/04/what-is-the-difference-between-pcr-and-antigen-testing.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/respiratory-health/2025/05/a-quick-primer-on-the-adlm-guidance-on-respiratory-virus-testing.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/respiratory-health/2025/09/revolutionizing-respiratory-care-the-power-of-rapid-molecular-testing.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/respiratory-health/2025/09/antigen-testing-vs-pcr-less-haste-more-speed-please.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/respiratory-health/2025/09/the-time-for-widespread-adoption-of-mdx-testing-for-gas-pharyngi.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/respiratory-health/2025/11/why-test-type-matters-pcr-vs-antigen-in-outpatient-respiratory-care.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/respiratory-health/2025/11/transforming-respiratory-tnfection-diagnosis-embracing-molecular-innovation-clinical-practice1.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/respiratory-health/2026/01/staying-ahead-of-influenza.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/respiratory-health/2026/02/revolutionizing-rheumatic-heart-disease-prevention.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2024/09/accelerating-the-pace-for-hep-c-elimination-in-the-us.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2024/09/can-molecular-tests-revolutionize-tuberculosis-control.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2024/09/near-patient-testing-for-hep-c-xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2024/09/danish-hcv-testing-program-improves-patient-management-and-access.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2024/09/faster-prison-testing-for-hcv-drastically-improves-treatment-in-the-uk.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2024/09/innovative-POC-testing-shortens-time-between-testing-and-treatment.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2024/09/finnish-hospital-improves-care-for-expectant-mothers-with-gbs-pcr-screening.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2024/09/a-not-for-profit-in-vietnam-fights-to-end-tuberculosis.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2024/09/cepheid-expands-in-india-to-support-global-efforts-to-fight-tb.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2024/09/covid-19-and-tuberculosis-testing-in-south-africa.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2024/09/cepheid-supports-the-international-mpox-emergency-declared-august-2024.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2024/10/hpv-testing-south-african-clinic-may-prevent-cervical-cancer.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2024/12/strides-toward-early-infant-diagnosis-for-hiv-elimination-in-sou.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2025/02/common-misconceptions-about-vaginitis.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2025/04/tuberculosis-staying-one-step-ahead.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2025/04/how-three-countries-are-fighting-back-against-tuberculosis.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2025/04/a-mdr-tb-survivor-in-india-shares-her-remarkable-story.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2025/07/five-surprising-stats-that-reveal-the-hidden-burden-of-vaginitis.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2025/07/5-ways-vaginitis-treatment-goes-wrong-and-how-better-testing-can-fix-It.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2025/06/womens-health-testing-advantages-of-same-day-diagnosis-and-treatment.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2025/05/revisiting-bacterial-vaginosis-evidence-for-sexual-transmission.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2025/05/a-breakthrough-in-hcv-elimination--how-hcv-point-of-care-rna-tes.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2025/05/decentralising-diagnostics-bringing-patient-centred-testing-closer-to-communities.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2025/05/integration-of-poc-viral-diagnostics-with-substance-use-disorder-treatment-to-improve-hepatitis-c-nfection-outcomes.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2025/03/the-fight-to-end-tuberculosis-in-pakistan.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2025/03/devasena-gnanashanmugam-discusses-cepheids-global-access-program.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2025/03/desmond-tutu-foundation-reduces-impact-of-hiv-and-tb.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2025/03/tuberculosis-care-and-treatment-in-the-republic-of-indonesia.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2025/03/finding-missing-tuberculosis-tb-cases-philippines-need-for-speed.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2025/03/a-decade-of-health-and-economic-benefits-infographic.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2025/03/state-tb-in-us-overlooked-opportunity-better-results.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2025/03/fighting-tb-everything-10-years-of-impact-in-south-africa.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2025/09/in-memory-of-john-bishop-a-visionary-leader-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2025/10/time-to-act-stopping-group-b-strep-infections-in-newborn-babies.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2025/10/real-user-experiences-with-xpert-xpress-mvp-oint-of-care-test.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2025/12/wecare-humanitarian-medical-mission.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2025/08/kentucky-viral-hepatitis-treatment-projects-mission-to-eradicate-hcv.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2025/08/the-state-of-vaginitis-testing-in-the-us.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2025/08/improving-vaginitis-care-through-better-diagnostics.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2026/02/advancing-pandemic-preparedness-through-public-private-collaboration.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/community-and-global-health/2026/02/hepatitis-c-elimination-in-the-us-is-within-reach-experts-report.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/tech-disease-trends.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/tech-disease-trends/2024/09/candida-auris--rising-threat-and-future-implications.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/tech-disease-trends/2024/09/discussing-pharma-clinical-trials-utilizing-poc-diagnostics.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/tech-disease-trends/2024/09/poc-testing-increases-the-efficiency-of-patient-management-in-the-ed.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/tech-disease-trends/2024/10/dave-persing-legacy-and-leadership-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/tech-disease-trends/2024/11/invasive-group-streptococcal-disease.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/tech-disease-trends/2024/11/what-is-pcr--understanding-the-magic.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/tech-disease-trends/2024/11/decentralized-pcr-testing-and-the-quadruple-aim-insights-for-health-systems.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/tech-disease-trends/2025/01/how-a-cepheid-molecular-test-is-made.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct-.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/tech-disease-trends/2025/04/standardization-of-pcr-testing-across-healthcare-testing-sites.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/tech-disease-trends/2025/06/innovation-in-times-of-need-cepheids-legacy-of-outbreak-response.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/tech-disease-trends/2025/07/celebrating-the-cepheid-bike-where-art-meets-innovation.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/tech-disease-trends/2025/09/cepheid-advances-innovation-and-reach-with-key-partnerships.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/tech-disease-trends/2025/10/learn-about-cepheid-system-innovation.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/tech-disease-trends/2025/11/multiplex-with-meaning--cepheid-s-smart-approach-to-molecular-di.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/antimicrobial-stewardship.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/antimicrobial-stewardship/2024/09/a-public-health-dialogue-on-antibiotic-resistance-surveillance.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/antimicrobial-stewardship/2024/09/mortality-associated-with-carbapenem-resistant-gram-negative-infections.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/antimicrobial-stewardship/2024/09/decentralized-testing-for-the-surveillance-of-hospital-acquired-infections.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/antimicrobial-stewardship/2024/09/rapid-mrsa-screening-of-ortho-trauma-patients-improves-experience.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/antimicrobial-stewardship/2024/09/pcr-screening-at-a-british-hospital-enables-timely-infection-control.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/antimicrobial-stewardship/2024/10/fleming-initiative-cepheid-announce-partnership-tackle-amr.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/antimicrobial-stewardship/2024/10/link-between-colonization-multi-drug-resistant-infection.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/antimicrobial-stewardship/2024/12/point-of-care-testing-emergency-department-faster-decision-making-halle.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-shulz.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-schulz.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/antimicrobial-stewardship/2025/05/antimicrobial-and-diagnostic-stewardship-frost-and-sullivan-visual-whitepaper.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/antimicrobial-stewardship/2025/08/industry-voices-time-to-rethink-our-approach-to-using-modern-medicine.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/antimicrobial-stewardship/2025/09/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/antimicrobial-stewardship/2025/10/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/antimicrobial-stewardship/2025/11/vanessa-carter-s-journey--inspiring-action-against-amr.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/antimicrobial-stewardship/2025/11/advancing-antimicrobial-stewardship-in-small-and-rural-hospital.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/expert-spotlight.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/expert-spotlight/2025/10/expert-spotlight--michael-loeffelholz.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--devasena-gnanashanmugam-vice-president--me.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--jennifer-rakeman-cagno-senior-director--sc.htmldaily1.0https://www.cepheid.com/de-AT/insights/insight-hub/expert-spotlight/2026/02/expert-spotlight-jordan-chase.htmldaily1.0https://www.cepheid.com/de-AT/insights/webinars.htmldaily1.0https://www.cepheid.com/de-AT/insights/resources.htmldaily1.0https://www.cepheid.com/de-AT/support.htmldaily1.0https://www.cepheid.com/de-AT/support/ivdr-update.htmldaily1.0https://www.cepheid.com/de-AT/support/contact-us.htmldaily1.0https://www.cepheid.com/de-AT/about.htmldaily1.0https://www.cepheid.com/de-AT/about/mission-history.htmldaily1.0https://www.cepheid.com/de-AT/about/leadership.htmldaily1.0https://www.cepheid.com/de-AT/about/leadership/vitor-rocha.htmldaily1.0https://www.cepheid.com/de-AT/about/leadership/laurent-bellon.htmldaily1.0https://www.cepheid.com/de-AT/about/leadership/anette-engelhardt.htmldaily1.0https://www.cepheid.com/de-AT/about/leadership/peter-farrell.htmldaily1.0https://www.cepheid.com/de-AT/about/leadership/deborah-gonyea.htmldaily1.0https://www.cepheid.com/de-AT/about/leadership/nichole-halsey.htmldaily1.0https://www.cepheid.com/de-AT/about/leadership/luben-li.htmldaily1.0https://www.cepheid.com/de-AT/about/leadership/luke-maitland.htmldaily1.0https://www.cepheid.com/de-AT/about/leadership/david-h-persing.htmldaily1.0https://www.cepheid.com/de-AT/about/leadership/ammar-qadan.htmldaily1.0https://www.cepheid.com/de-AT/about/leadership/charles-mwangi.htmldaily1.0https://www.cepheid.com/de-AT/about/leadership/samson-wu.htmldaily1.0https://www.cepheid.com/de-AT/about/leadership/anupama-mokkapati.htmldaily1.0https://www.cepheid.com/de-AT/about/leadership/traci-wicks.htmldaily1.0https://www.cepheid.com/de-AT/about/leadership/scott-campbell.htmldaily1.0https://www.cepheid.com/de-AT/about/leadership/anne-beauburn.htmldaily1.0https://www.cepheid.com/de-AT/about/leadership/patrick-harkins.htmldaily1.0https://www.cepheid.com/de-AT/about/leadership/ephraim-tsalik.htmldaily1.0https://www.cepheid.com/de-AT/about/leadership/somesh-lalithraj.htmldaily1.0https://www.cepheid.com/de-AT/about/leadership/connie-savor.htmldaily1.0https://www.cepheid.com/de-AT/about/sustainability.htmldaily1.0https://www.cepheid.com/de-AT/about/sustainability/environmental-sustainability.htmldaily1.0https://www.cepheid.com/de-AT/about/sustainability/product-stewardship.htmldaily1.0https://www.cepheid.com/de-AT/about/sustainability/conflict-materials.htmldaily1.0https://www.cepheid.com/de-AT/about/policies-reports.htmldaily1.0https://www.cepheid.com/de-AT/about/business-development-opportunities.htmldaily1.0https://www.cepheid.com/de-AT/about/events.htmldaily1.0https://www.cepheid.com/de-AT/about/innovation-form.htmldaily1.0https://www.cepheid.com/de-AT/about/innovation-form/unsolicited-submission-agreement.htmldaily1.0https://www.cepheid.com/de-AT/about/sars-cov-2-test-development-information.htmldaily1.0https://www.cepheid.com/de-AT/about/sars-cov-2-product-resources.htmldaily1.0https://www.cepheid.com/de-AT/contact/select-info-path.htmldaily1.0https://www.cepheid.com/de-AT/contact/messages/thank-you.htmldaily1.0https://www.cepheid.com/de-AT/contact/messages/thank-you-patient-pathways.htmldaily1.0https://www.cepheid.com/de-AT/contact/messages/thank-you-patient-pathways-fr.htmldaily1.0https://www.cepheid.com/de-AT/contact/messages/thank-you-patient-pathways-de.htmldaily1.0https://www.cepheid.com/de-AT/contact/messages/thank-you-patient-pathways-it.htmldaily1.0https://www.cepheid.com/de-AT/contact/messages/thank-you-patient-pathways-sp.htmldaily1.0https://www.cepheid.com/de-AT/contact/messages/thank-you-patient-pathways-pl.htmldaily1.0https://www.cepheid.com/de-AT/contact/messages/thank-you-patient-pathways-pt.htmldaily1.0https://www.cepheid.com/de-AT/contact/request-cd-international.htmldaily1.0https://www.cepheid.com/de-AT/personas/laboratory-professionals.htmldaily1.0https://www.cepheid.com/de-AT/personas/healthcare-professsional.htmldaily1.0https://www.cepheid.com/de-AT/personas/health-system-administrators.htmldaily1.0https://www.cepheid.com/de-AT/legal/privacy.htmldaily1.0https://www.cepheid.com/de-AT/legal/terms-of-use.htmldaily1.0https://www.cepheid.com/de-AT/legal/product-security-updates.htmldaily1.0https://www.cepheid.com/de-AT/legal/terms-of-sale.htmldaily1.0https://www.cepheid.com/de-AT/legal/trademarks.htmldaily1.0https://www.cepheid.com/de-AT/legal/cookies-notice.htmldaily1.0https://www.cepheid.com/de-AT/campaigns/2020-emea-renewed-messaging/french/patient-pathways.htmldaily1.0https://www.cepheid.com/de-AT/campaigns/2020-emea-renewed-messaging/german/patient-pathways.htmldaily1.0https://www.cepheid.com/de-AT/campaigns/2020-emea-renewed-messaging/italian/patient-pathways.htmldaily1.0https://www.cepheid.com/de-AT/campaigns/2020-emea-renewed-messaging/portuguese/patient-pathways.htmldaily1.0https://www.cepheid.com/de-AT/campaigns/2020-emea-renewed-messaging/polish/patient-pathways.htmldaily1.0https://www.cepheid.com/de-AT/campaigns/india/cepheid-india.htmldaily1.0https://www.cepheid.com/de-AT/campaigns/india/india-submission.htmldaily1.0https://www.cepheid.com/de-AT/campaigns/india/cepheid-india-display.htmldaily1.0https://www.cepheid.com/de-AT/campaigns/india/cepheid-india-bangladesh.htmldaily1.0https://www.cepheid.com/de-AT/campaigns/pcr-plus.htmldaily1.0https://www.cepheid.com/de-AT/coronavirus-portfolio.htmldaily1.0https://www.cepheid.com/de-CH.htmldaily1.0https://www.cepheid.com/de-CH/tests.htmldaily1.0https://www.cepheid.com/de-CH/tests/respiratory.htmldaily1.0https://www.cepheid.com/de-CH/tests/respiratory/xpert-xpress-strep-a.htmldaily1.0https://www.cepheid.com/de-CH/tests/respiratory/xpert-xpress-cov-2-plus.htmldaily1.0https://www.cepheid.com/de-CH/tests/respiratory/xpert-xpress-sars-cov-2.htmldaily1.0https://www.cepheid.com/de-CH/tests/respiratory/xpert-xpress-flu-rsv.htmldaily1.0https://www.cepheid.com/de-CH/tests/respiratory/xpert-xpress-cov-2-flu-rsv-plus.htmldaily1.0https://www.cepheid.com/de-CH/tests/hai-other-infectious-diseases.htmldaily1.0https://www.cepheid.com/de-CH/tests/hai-other-infectious-diseases/xpert-sa-nasal-complete.htmldaily1.0https://www.cepheid.com/de-CH/tests/hai-other-infectious-diseases/xpert-mrsa-sa-ssti.htmldaily1.0https://www.cepheid.com/de-CH/tests/hai-other-infectious-diseases/xpert-c-difficile-bt.htmldaily1.0https://www.cepheid.com/de-CH/tests/hai-other-infectious-diseases/xpert-norovirus.htmldaily1.0https://www.cepheid.com/de-CH/tests/hai-other-infectious-diseases/xpert-mrsa-sa-blood-culture.htmldaily1.0https://www.cepheid.com/de-CH/tests/hai-other-infectious-diseases/xpert-vana-vanb.htmldaily1.0https://www.cepheid.com/de-CH/tests/hai-other-infectious-diseases/xpert-mrsa-nxg.htmldaily1.0https://www.cepheid.com/de-CH/tests/hai-other-infectious-diseases/xpert-carba-r.htmldaily1.0https://www.cepheid.com/de-CH/tests/blood-virology-womens-health-sexual-health.htmldaily1.0https://www.cepheid.com/de-CH/tests/blood-virology-womens-health-sexual-health/xpert-gbs.htmldaily1.0https://www.cepheid.com/de-CH/tests/blood-virology-womens-health-sexual-health/xpert-hbv-viral-load.htmldaily1.0https://www.cepheid.com/de-CH/tests/blood-virology-womens-health-sexual-health/resistanceplusmg-flexible.htmldaily1.0https://www.cepheid.com/de-CH/tests/blood-virology-womens-health-sexual-health/xpert-xpress-gbs.htmldaily1.0https://www.cepheid.com/de-CH/tests/blood-virology-womens-health-sexual-health/xpert-ct-ng.htmldaily1.0https://www.cepheid.com/de-CH/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-qual-xc.htmldaily1.0https://www.cepheid.com/de-CH/tests/blood-virology-womens-health-sexual-health/xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/de-CH/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-viral-load-xc.htmldaily1.0https://www.cepheid.com/de-CH/tests/blood-virology-womens-health-sexual-health/xpert-tv.htmldaily1.0https://www.cepheid.com/de-CH/tests/blood-virology-womens-health-sexual-health/xpert-hpv-v2.htmldaily1.0https://www.cepheid.com/de-CH/tests/blood-virology-womens-health-sexual-health/xpert-hcv-viral-load.htmldaily1.0https://www.cepheid.com/de-CH/tests/tb-emerging-infectious-diseases.htmldaily1.0https://www.cepheid.com/de-CH/tests/tb-emerging-infectious-diseases/xpert-mtb-xdr.htmldaily1.0https://www.cepheid.com/de-CH/tests/tb-emerging-infectious-diseases/xpert-mtb-rif-ultra.htmldaily1.0https://www.cepheid.com/de-CH/tests/oncology-human-genetics.htmldaily1.0https://www.cepheid.com/de-CH/tests/oncology-human-genetics/expert-bladder-cancer-monitor.htmldaily1.0https://www.cepheid.com/de-CH/tests/oncology-human-genetics/xpert-fii-fv.htmldaily1.0https://www.cepheid.com/de-CH/tests/oncology-human-genetics/xpert-bcr-abl-ultra-p190.htmldaily1.0https://www.cepheid.com/de-CH/tests/oncology-human-genetics/xpert-breast-cancer-strat4.htmldaily1.0https://www.cepheid.com/de-CH/tests/oncology-human-genetics/xpert-bladder-cancer-detection.htmldaily1.0https://www.cepheid.com/de-CH/tests/oncology-human-genetics/xpert-bcr-abl-ultra.htmldaily1.0https://www.cepheid.com/de-CH/systems.htmldaily1.0https://www.cepheid.com/de-CH/systems/genexpert-family-of-systems.htmldaily1.0https://www.cepheid.com/de-CH/systems/genexpert-family-of-systems/genexpert-system.htmldaily1.0https://www.cepheid.com/de-CH/systems/genexpert-family-of-systems/genexpert-infinity.htmldaily1.0https://www.cepheid.com/de-CH/systems/genexpert-software.htmldaily1.0https://www.cepheid.com/de-CH/systems/genexpert-software/gx-software.htmldaily1.0https://www.cepheid.com/de-CH/systems/genexpert-software/xpertise-software.htmldaily1.0https://www.cepheid.com/de-CH/systems/connectivity.htmldaily1.0https://www.cepheid.com/de-CH/systems/connectivity/cepheid-c360.htmldaily1.0https://www.cepheid.com/de-CH/systems/connectivity/interface-capabilities.htmldaily1.0https://www.cepheid.com/de-CH/systems/data-processing-agreement.htmldaily1.0https://www.cepheid.com/de-CH/systems/partner-communities.htmldaily1.0https://www.cepheid.com/de-CH/systems/business-associates-agreement.htmldaily1.0https://www.cepheid.com/de-CH/solutions.htmldaily1.0https://www.cepheid.com/de-CH/solutions/global-access.htmldaily1.0https://www.cepheid.com/de-CH/solutions/global-access/eligibility-and-pricing.htmldaily1.0https://www.cepheid.com/de-CH/solutions/testing-everywhere.htmldaily1.0https://www.cepheid.com/de-CH/solutions/antibiotic-stewardship.htmldaily1.0https://www.cepheid.com/de-CH/solutions/oncology-diagnostics.htmldaily1.0https://www.cepheid.com/de-CH/solutions/customized-testing-institution.htmldaily1.0https://www.cepheid.com/de-CH/solutions/knowing-more-matters.htmldaily1.0https://www.cepheid.com/de-CH/solutions/knowing-more-matters/pcr-vs-antigen.htmldaily1.0https://www.cepheid.com/de-CH/solutions/knowing-more-matters/covid-flu-rsv.htmldaily1.0https://www.cepheid.com/de-CH/insights.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/all-posts.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/respiratory-health.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/respiratory-health/2024/09/proactive-surveillance-to-ensure-broad-flu-strain-detection.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/respiratory-health/2024/09/emerging-evolving-respiratory-viruses-test-design-matters.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/respiratory-health/2024/09/the-genexpert-xpress-system-can-change-your-pediatric-practice.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/respiratory-health/2024/09/Norwegian-ED-improves-Resource-Management-with-Rapid-PCR-Testing.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/respiratory-health/2024/09/key-steps-pandemic-preparedness.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/respiratory-health/2025/01/what-does-it-mean-to-have-a-pandemic-ready-pcr-test.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like-ilnesses.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/respiratory-health/2025/03/in-house-pcr-testing-clinical-leaders-explore-the-ripple-effect.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/respiratory-health/2025/04/real-world-clinical-impact-of-in-house-pcr-testing.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/respiratory-health/2025/04/what-is-the-difference-between-pcr-and-antigen-testing.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/respiratory-health/2025/05/a-quick-primer-on-the-adlm-guidance-on-respiratory-virus-testing.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/respiratory-health/2025/09/revolutionizing-respiratory-care-the-power-of-rapid-molecular-testing.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/respiratory-health/2025/09/antigen-testing-vs-pcr-less-haste-more-speed-please.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/respiratory-health/2025/09/the-time-for-widespread-adoption-of-mdx-testing-for-gas-pharyngi.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/respiratory-health/2025/11/why-test-type-matters-pcr-vs-antigen-in-outpatient-respiratory-care.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/respiratory-health/2025/11/transforming-respiratory-tnfection-diagnosis-embracing-molecular-innovation-clinical-practice1.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/respiratory-health/2026/01/staying-ahead-of-influenza.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/respiratory-health/2026/02/revolutionizing-rheumatic-heart-disease-prevention.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2024/09/accelerating-the-pace-for-hep-c-elimination-in-the-us.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2024/09/can-molecular-tests-revolutionize-tuberculosis-control.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2024/09/near-patient-testing-for-hep-c-xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2024/09/danish-hcv-testing-program-improves-patient-management-and-access.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2024/09/faster-prison-testing-for-hcv-drastically-improves-treatment-in-the-uk.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2024/09/innovative-POC-testing-shortens-time-between-testing-and-treatment.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2024/09/finnish-hospital-improves-care-for-expectant-mothers-with-gbs-pcr-screening.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2024/09/a-not-for-profit-in-vietnam-fights-to-end-tuberculosis.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2024/09/cepheid-expands-in-india-to-support-global-efforts-to-fight-tb.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2024/09/covid-19-and-tuberculosis-testing-in-south-africa.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2024/09/cepheid-supports-the-international-mpox-emergency-declared-august-2024.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2024/10/hpv-testing-south-african-clinic-may-prevent-cervical-cancer.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2024/12/strides-toward-early-infant-diagnosis-for-hiv-elimination-in-sou.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2025/02/common-misconceptions-about-vaginitis.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2025/06/womens-health-testing-advantages-of-same-day-diagnosis-and-treatment.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2025/05/revisiting-bacterial-vaginosis-evidence-for-sexual-transmission.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2025/05/a-breakthrough-in-hcv-elimination--how-hcv-point-of-care-rna-tes.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2025/05/decentralising-diagnostics-bringing-patient-centred-testing-closer-to-communities.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2025/05/integration-of-poc-viral-diagnostics-with-substance-use-disorder-treatment-to-improve-hepatitis-c-nfection-outcomes.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2025/04/tuberculosis-staying-one-step-ahead.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2025/04/how-three-countries-are-fighting-back-against-tuberculosis.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2025/04/a-mdr-tb-survivor-in-india-shares-her-remarkable-story.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2025/07/five-surprising-stats-that-reveal-the-hidden-burden-of-vaginitis.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2025/07/5-ways-vaginitis-treatment-goes-wrong-and-how-better-testing-can-fix-It.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2025/03/the-fight-to-end-tuberculosis-in-pakistan.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2025/03/devasena-gnanashanmugam-discusses-cepheids-global-access-program.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2025/03/desmond-tutu-foundation-reduces-impact-of-hiv-and-tb.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2025/03/tuberculosis-care-and-treatment-in-the-republic-of-indonesia.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2025/03/finding-missing-tuberculosis-tb-cases-philippines-need-for-speed.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2025/03/a-decade-of-health-and-economic-benefits-infographic.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2025/03/state-tb-in-us-overlooked-opportunity-better-results.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2025/03/fighting-tb-everything-10-years-of-impact-in-south-africa.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2025/09/in-memory-of-john-bishop-a-visionary-leader-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2025/08/kentucky-viral-hepatitis-treatment-projects-mission-to-eradicate-hcv.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2025/08/the-state-of-vaginitis-testing-in-the-us.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2025/08/improving-vaginitis-care-through-better-diagnostics.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2025/10/time-to-act-stopping-group-b-strep-infections-in-newborn-babies.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2025/10/real-user-experiences-with-xpert-xpress-mvp-oint-of-care-test.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2025/12/wecare-humanitarian-medical-mission.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2026/02/advancing-pandemic-preparedness-through-public-private-collaboration.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/community-and-global-health/2026/02/hepatitis-c-elimination-in-the-us-is-within-reach-experts-report.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/tech-disease-trends.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/tech-disease-trends/2024/09/candida-auris--rising-threat-and-future-implications.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/tech-disease-trends/2024/09/discussing-pharma-clinical-trials-utilizing-poc-diagnostics.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/tech-disease-trends/2024/09/poc-testing-increases-the-efficiency-of-patient-management-in-the-ed.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/tech-disease-trends/2024/10/dave-persing-legacy-and-leadership-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/tech-disease-trends/2024/11/invasive-group-streptococcal-disease.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/tech-disease-trends/2024/11/what-is-pcr--understanding-the-magic.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/tech-disease-trends/2024/11/decentralized-pcr-testing-and-the-quadruple-aim-insights-for-health-systems.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/tech-disease-trends/2025/01/how-a-cepheid-molecular-test-is-made.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/tech-disease-trends/2025/04/standardization-of-pcr-testing-across-healthcare-testing-sites.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/tech-disease-trends/2025/06/innovation-in-times-of-need-cepheids-legacy-of-outbreak-response.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/tech-disease-trends/2025/07/celebrating-the-cepheid-bike-where-art-meets-innovation.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/tech-disease-trends/2025/09/cepheid-advances-innovation-and-reach-with-key-partnerships.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/tech-disease-trends/2025/10/learn-about-cepheid-system-innovation.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/tech-disease-trends/2025/11/multiplex-with-meaning--cepheid-s-smart-approach-to-molecular-di.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/antimicrobial-stewardship.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/antimicrobial-stewardship/2024/09/a-public-health-dialogue-on-antibiotic-resistance-surveillance.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/antimicrobial-stewardship/2024/09/mortality-associated-with-carbapenem-resistant-gram-negative-infections.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/antimicrobial-stewardship/2024/09/decentralized-testing-for-the-surveillance-of-hospital-acquired-infections.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/antimicrobial-stewardship/2024/09/rapid-mrsa-screening-of-ortho-trauma-patients-improves-experience.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/antimicrobial-stewardship/2024/09/pcr-screening-at-a-british-hospital-enables-timely-infection-control.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/antimicrobial-stewardship/2024/10/fleming-initiative-cepheid-announce-partnership-tackle-amr.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/antimicrobial-stewardship/2024/10/link-between-colonization-multi-drug-resistant-infection.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/antimicrobial-stewardship/2024/12/point-of-care-testing-emergency-department-faster-decision-making-halle.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-schulz.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/antimicrobial-stewardship/2025/05/antimicrobial-and-diagnostic-stewardship-frost-and-sullivan-visual-whitepaper.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/antimicrobial-stewardship/2025/08/industry-voices-time-to-rethink-our-approach-to-using-modern-medicine.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/antimicrobial-stewardship/2025/09/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/antimicrobial-stewardship/2025/10/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/antimicrobial-stewardship/2025/11/vanessa-carter-s-journey--inspiring-action-against-amr.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/antimicrobial-stewardship/2025/11/advancing-antimicrobial-stewardship-in-small-and-rural-hospital.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/expert-spotlight.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/expert-spotlight/2025/10/expert-spotlight--michael-loeffelholz.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--devasena-gnanashanmugam-vice-president--me.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--jennifer-rakeman-cagno-senior-director--sc.htmldaily1.0https://www.cepheid.com/de-CH/insights/insight-hub/expert-spotlight/2026/02/expert-spotlight-jordan-chase.htmldaily1.0https://www.cepheid.com/de-CH/support.htmldaily1.0https://www.cepheid.com/de-CH/support/ivdr-update.htmldaily1.0https://www.cepheid.com/de-CH/support/contact-us.htmldaily1.0https://www.cepheid.com/de-CH/about.htmldaily1.0https://www.cepheid.com/de-CH/about/mission-history.htmldaily1.0https://www.cepheid.com/de-CH/about/leadership.htmldaily1.0https://www.cepheid.com/de-CH/about/leadership/vitor-rocha.htmldaily1.0https://www.cepheid.com/de-CH/about/leadership/laurent-bellon.htmldaily1.0https://www.cepheid.com/de-CH/about/leadership/anette-engelhardt.htmldaily1.0https://www.cepheid.com/de-CH/about/leadership/peter-farrell.htmldaily1.0https://www.cepheid.com/de-CH/about/leadership/deborah-gonyea.htmldaily1.0https://www.cepheid.com/de-CH/about/leadership/nichole-halsey.htmldaily1.0https://www.cepheid.com/de-CH/about/leadership/luben-li.htmldaily1.0https://www.cepheid.com/de-CH/about/leadership/luke-maitland.htmldaily1.0https://www.cepheid.com/de-CH/about/leadership/david-h-persing.htmldaily1.0https://www.cepheid.com/de-CH/about/leadership/ammar-qadan.htmldaily1.0https://www.cepheid.com/de-CH/about/leadership/charles-mwangi.htmldaily1.0https://www.cepheid.com/de-CH/about/leadership/samson-wu.htmldaily1.0https://www.cepheid.com/de-CH/about/leadership/anupama-mokkapati.htmldaily1.0https://www.cepheid.com/de-CH/about/leadership/traci-wicks.htmldaily1.0https://www.cepheid.com/de-CH/about/leadership/scott-campbell.htmldaily1.0https://www.cepheid.com/de-CH/about/leadership/anne-beauburn.htmldaily1.0https://www.cepheid.com/de-CH/about/leadership/patrick-harkins.htmldaily1.0https://www.cepheid.com/de-CH/about/leadership/ephraim-tsalik.htmldaily1.0https://www.cepheid.com/de-CH/about/leadership/somesh-lalithraj.htmldaily1.0https://www.cepheid.com/de-CH/about/leadership/connie-savor.htmldaily1.0https://www.cepheid.com/de-CH/about/sustainability.htmldaily1.0https://www.cepheid.com/de-CH/about/sustainability/environmental-sustainability.htmldaily1.0https://www.cepheid.com/de-CH/about/sustainability/product-stewardship.htmldaily1.0https://www.cepheid.com/de-CH/about/sustainability/conflict-materials.htmldaily1.0https://www.cepheid.com/de-CH/about/policies-reports.htmldaily1.0https://www.cepheid.com/de-CH/about/business-development-opportunities.htmldaily1.0https://www.cepheid.com/de-CH/about/events.htmldaily1.0https://www.cepheid.com/de-CH/about/innovation-form.htmldaily1.0https://www.cepheid.com/de-CH/about/innovation-form/unsolicited-submission-agreement.htmldaily1.0https://www.cepheid.com/de-CH/about/sars-cov-2-test-development-information.htmldaily1.0https://www.cepheid.com/de-CH/about/sars-cov-2-product-resources.htmldaily1.0https://www.cepheid.com/de-CH/contact/select-info-path.htmldaily1.0https://www.cepheid.com/de-CH/contact/messages/thank-you.htmldaily1.0https://www.cepheid.com/de-CH/contact/messages/thank-you-patient-pathways.htmldaily1.0https://www.cepheid.com/de-CH/contact/messages/thank-you-patient-pathways-fr.htmldaily1.0https://www.cepheid.com/de-CH/contact/messages/thank-you-patient-pathways-de.htmldaily1.0https://www.cepheid.com/de-CH/contact/messages/thank-you-patient-pathways-it.htmldaily1.0https://www.cepheid.com/de-CH/contact/messages/thank-you-patient-pathways-sp.htmldaily1.0https://www.cepheid.com/de-CH/contact/messages/thank-you-patient-pathways-pl.htmldaily1.0https://www.cepheid.com/de-CH/contact/messages/thank-you-patient-pathways-pt.htmldaily1.0https://www.cepheid.com/de-CH/contact/request-cd-international.htmldaily1.0https://www.cepheid.com/de-CH/personas/laboratory-professionals.htmldaily1.0https://www.cepheid.com/de-CH/personas/healthcare-professsional.htmldaily1.0https://www.cepheid.com/de-CH/personas/health-system-administrators.htmldaily1.0https://www.cepheid.com/de-CH/legal/privacy.htmldaily1.0https://www.cepheid.com/de-CH/legal/terms-of-use.htmldaily1.0https://www.cepheid.com/de-CH/legal/product-security-updates.htmldaily1.0https://www.cepheid.com/de-CH/legal/terms-of-sale.htmldaily1.0https://www.cepheid.com/de-CH/legal/trademarks.htmldaily1.0https://www.cepheid.com/de-CH/legal/cookies-notice.htmldaily1.0https://www.cepheid.com/de-CH/campaigns/2020-emea-renewed-messaging/french/patient-pathways.htmldaily1.0https://www.cepheid.com/de-CH/campaigns/2020-emea-renewed-messaging/german/patient-pathways.htmldaily1.0https://www.cepheid.com/de-CH/campaigns/2020-emea-renewed-messaging/italian/patient-pathways.htmldaily1.0https://www.cepheid.com/de-CH/campaigns/2020-emea-renewed-messaging/portuguese/patient-pathways.htmldaily1.0https://www.cepheid.com/de-CH/campaigns/2020-emea-renewed-messaging/polish/patient-pathways.htmldaily1.0https://www.cepheid.com/de-CH/campaigns/india/cepheid-india.htmldaily1.0https://www.cepheid.com/de-CH/campaigns/india/india-submission.htmldaily1.0https://www.cepheid.com/de-CH/campaigns/india/cepheid-india-display.htmldaily1.0https://www.cepheid.com/de-CH/campaigns/india/cepheid-india-bangladesh.htmldaily1.0https://www.cepheid.com/de-CH/campaigns/pcr-plus.htmldaily1.0https://www.cepheid.com/de-CH/coronavirus-portfolio.htmldaily1.0https://www.cepheid.com/en-AU.htmldaily1.0https://www.cepheid.com/en-AU/tests.htmldaily1.0https://www.cepheid.com/en-AU/tests/respiratory.htmldaily1.0https://www.cepheid.com/en-AU/tests/respiratory/xpert-xpress-sars-cov-2.htmldaily1.0https://www.cepheid.com/en-AU/tests/respiratory/xpert-xpress-flu-rsv.htmldaily1.0https://www.cepheid.com/en-AU/tests/respiratory/xpert-xpress-cov-2-flu-rsv-plus.htmldaily1.0https://www.cepheid.com/en-AU/tests/respiratory/xpert-xpress-cov-2-plus.htmldaily1.0https://www.cepheid.com/en-AU/tests/respiratory/xpert-xpress-strep-a.htmldaily1.0https://www.cepheid.com/en-AU/tests/hai-other-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-AU/tests/hai-other-infectious-diseases/xpert-sa-nasal-complete.htmldaily1.0https://www.cepheid.com/en-AU/tests/hai-other-infectious-diseases/xpert-mrsa-sa-ssti.htmldaily1.0https://www.cepheid.com/en-AU/tests/hai-other-infectious-diseases/xpert-c-difficile-bt.htmldaily1.0https://www.cepheid.com/en-AU/tests/hai-other-infectious-diseases/xpert-norovirus.htmldaily1.0https://www.cepheid.com/en-AU/tests/hai-other-infectious-diseases/xpert-vana-vanb.htmldaily1.0https://www.cepheid.com/en-AU/tests/hai-other-infectious-diseases/xpert-mrsa-nxg.htmldaily1.0https://www.cepheid.com/en-AU/tests/hai-other-infectious-diseases/xpert-carba-r.htmldaily1.0https://www.cepheid.com/en-AU/tests/hai-other-infectious-diseases/xpert-mrsa-sa-blood-culture.htmldaily1.0https://www.cepheid.com/en-AU/tests/blood-virology-womens-health-sexual-health.htmldaily1.0https://www.cepheid.com/en-AU/tests/blood-virology-womens-health-sexual-health/xpert-gbs.htmldaily1.0https://www.cepheid.com/en-AU/tests/blood-virology-womens-health-sexual-health/xpert-hbv-viral-load.htmldaily1.0https://www.cepheid.com/en-AU/tests/blood-virology-womens-health-sexual-health/xpert-hpv.htmldaily1.0https://www.cepheid.com/en-AU/tests/blood-virology-womens-health-sexual-health/resistanceplusmg-flexible.htmldaily1.0https://www.cepheid.com/en-AU/tests/blood-virology-womens-health-sexual-health/xpert-ct-ng.htmldaily1.0https://www.cepheid.com/en-AU/tests/blood-virology-womens-health-sexual-health/xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-AU/tests/blood-virology-womens-health-sexual-health/xpert-tv.htmldaily1.0https://www.cepheid.com/en-AU/tests/blood-virology-womens-health-sexual-health/xpert-hcv-viral-load.htmldaily1.0https://www.cepheid.com/en-AU/tests/tb-emerging-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-AU/tests/tb-emerging-infectious-diseases/xpert-mtb-rif-ultra.htmldaily1.0https://www.cepheid.com/en-AU/tests/tb-emerging-infectious-diseases/xpert-mtb-rif.htmldaily1.0https://www.cepheid.com/en-AU/tests/oncology-human-genetics.htmldaily1.0https://www.cepheid.com/en-AU/tests/oncology-human-genetics/xpert-fii-fv.htmldaily1.0https://www.cepheid.com/en-AU/tests/oncology-human-genetics/xpert-bcr-abl-ultra-p190.htmldaily1.0https://www.cepheid.com/en-AU/tests/oncology-human-genetics/xpert-bcr-abl-ultra.htmldaily1.0https://www.cepheid.com/en-AU/systems.htmldaily1.0https://www.cepheid.com/en-AU/systems/genexpert-family-of-systems.htmldaily1.0https://www.cepheid.com/en-AU/systems/genexpert-family-of-systems/genexpert-system.htmldaily1.0https://www.cepheid.com/en-AU/systems/genexpert-family-of-systems/genexpert-infinity.htmldaily1.0https://www.cepheid.com/en-AU/systems/genexpert-software.htmldaily1.0https://www.cepheid.com/en-AU/systems/genexpert-software/gx-software.htmldaily1.0https://www.cepheid.com/en-AU/systems/genexpert-software/xpertise-software.htmldaily1.0https://www.cepheid.com/en-AU/systems/connectivity.htmldaily1.0https://www.cepheid.com/en-AU/systems/connectivity/cepheid-c360.htmldaily1.0https://www.cepheid.com/en-AU/systems/connectivity/interface-capabilities.htmldaily1.0https://www.cepheid.com/en-AU/systems/data-processing-agreement.htmldaily1.0https://www.cepheid.com/en-AU/systems/partner-communities.htmldaily1.0https://www.cepheid.com/en-AU/systems/business-associates-agreement.htmldaily1.0https://www.cepheid.com/en-AU/solutions.htmldaily1.0https://www.cepheid.com/en-AU/solutions/global-access.htmldaily1.0https://www.cepheid.com/en-AU/solutions/global-access/eligibility-and-pricing.htmldaily1.0https://www.cepheid.com/en-AU/solutions/testing-everywhere.htmldaily1.0https://www.cepheid.com/en-AU/solutions/antibiotic-stewardship.htmldaily1.0https://www.cepheid.com/en-AU/solutions/oncology-diagnostics.htmldaily1.0https://www.cepheid.com/en-AU/solutions/customized-testing-institution.htmldaily1.0https://www.cepheid.com/en-AU/solutions/knowing-more-matters.htmldaily1.0https://www.cepheid.com/en-AU/solutions/knowing-more-matters/pcr-vs-antigen.htmldaily1.0https://www.cepheid.com/en-AU/solutions/knowing-more-matters/covid-flu-rsv.htmldaily1.0https://www.cepheid.com/en-AU/insights.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/all-posts.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/respiratory-health.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/respiratory-health/2024/09/proactive-surveillance-to-ensure-broad-flu-strain-detection.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/respiratory-health/2024/09/emerging-evolving-respiratory-viruses-test-design-matters.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/respiratory-health/2024/09/the-genexpert-xpress-system-can-change-your-pediatric-practice.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/respiratory-health/2024/09/Norwegian-ED-improves-Resource-Management-with-Rapid-PCR-Testing.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/respiratory-health/2024/09/key-steps-pandemic-preparedness.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/respiratory-health/2025/01/what-does-it-mean-to-have-a-pandemic-ready-pcr-test.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like-ilnesses.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/respiratory-health/2025/03/in-house-pcr-testing-clinical-leaders-explore-the-ripple-effect.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/respiratory-health/2025/04/real-world-clinical-impact-of-in-house-pcr-testing.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/respiratory-health/2025/04/what-is-the-difference-between-pcr-and-antigen-testing.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/respiratory-health/2025/05/a-quick-primer-on-the-adlm-guidance-on-respiratory-virus-testing.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/respiratory-health/2025/09/revolutionizing-respiratory-care-the-power-of-rapid-molecular-testing.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/respiratory-health/2025/09/antigen-testing-vs-pcr-less-haste-more-speed-please.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/respiratory-health/2025/09/the-time-for-widespread-adoption-of-mdx-testing-for-gas-pharyngi.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/respiratory-health/2025/11/why-test-type-matters-pcr-vs-antigen-in-outpatient-respiratory-care.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/respiratory-health/2025/11/transforming-respiratory-tnfection-diagnosis-embracing-molecular-innovation-clinical-practice1.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/respiratory-health/2026/01/staying-ahead-of-influenza.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/respiratory-health/2026/02/revolutionizing-rheumatic-heart-disease-prevention.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2024/09/accelerating-the-pace-for-hep-c-elimination-in-the-us.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2024/09/can-molecular-tests-revolutionize-tuberculosis-control.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2024/09/near-patient-testing-for-hep-c-xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2024/09/danish-hcv-testing-program-improves-patient-management-and-access.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2024/09/faster-prison-testing-for-hcv-drastically-improves-treatment-in-the-uk.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2024/09/innovative-POC-testing-shortens-time-between-testing-and-treatment.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2024/09/finnish-hospital-improves-care-for-expectant-mothers-with-gbs-pcr-screening.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2024/09/a-not-for-profit-in-vietnam-fights-to-end-tuberculosis.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2024/09/cepheid-expands-in-india-to-support-global-efforts-to-fight-tb.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2024/09/covid-19-and-tuberculosis-testing-in-south-africa.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2024/09/cepheid-supports-the-international-mpox-emergency-declared-august-2024.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2024/10/hpv-testing-south-african-clinic-may-prevent-cervical-cancer.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2024/12/strides-toward-early-infant-diagnosis-for-hiv-elimination-in-sou.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2025/02/common-misconceptions-about-vaginitis.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2025/05/revisiting-bacterial-vaginosis-evidence-for-sexual-transmission.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2025/05/a-breakthrough-in-hcv-elimination--how-hcv-point-of-care-rna-tes.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2025/05/decentralising-diagnostics-bringing-patient-centred-testing-closer-to-communities.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2025/05/integration-of-poc-viral-diagnostics-with-substance-use-disorder-treatment-to-improve-hepatitis-c-nfection-outcomes.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2025/06/womens-health-testing-advantages-of-same-day-diagnosis-and-treatment.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2025/04/tuberculosis-staying-one-step-ahead.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2025/04/how-three-countries-are-fighting-back-against-tuberculosis.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2025/04/a-mdr-tb-survivor-in-india-shares-her-remarkable-story.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2025/07/five-surprising-stats-that-reveal-the-hidden-burden-of-vaginitis.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2025/07/5-ways-vaginitis-treatment-goes-wrong-and-how-better-testing-can-fix-It.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2025/03/the-fight-to-end-tuberculosis-in-pakistan.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2025/03/devasena-gnanashanmugam-discusses-cepheids-global-access-program.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2025/03/desmond-tutu-foundation-reduces-impact-of-hiv-and-tb.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2025/03/tuberculosis-care-and-treatment-in-the-republic-of-indonesia.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2025/03/finding-missing-tuberculosis-tb-cases-philippines-need-for-speed.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2025/03/a-decade-of-health-and-economic-benefits-infographic.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2025/03/state-tb-in-us-overlooked-opportunity-better-results.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2025/03/fighting-tb-everything-10-years-of-impact-in-south-africa.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2025/09/in-memory-of-john-bishop-a-visionary-leader-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2025/08/kentucky-viral-hepatitis-treatment-projects-mission-to-eradicate-hcv.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2025/08/the-state-of-vaginitis-testing-in-the-us.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2025/08/improving-vaginitis-care-through-better-diagnostics.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2025/12/wecare-humanitarian-medical-mission.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2025/10/time-to-act-stopping-group-b-strep-infections-in-newborn-babies.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2025/10/real-user-experiences-with-xpert-xpress-mvp-oint-of-care-test.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2026/02/advancing-pandemic-preparedness-through-public-private-collaboration.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/community-and-global-health/2026/02/hepatitis-c-elimination-in-the-us-is-within-reach-experts-report.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/tech-disease-trends.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/tech-disease-trends/2024/09/candida-auris--rising-threat-and-future-implications.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/tech-disease-trends/2024/09/discussing-pharma-clinical-trials-utilizing-poc-diagnostics.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/tech-disease-trends/2024/09/poc-testing-increases-the-efficiency-of-patient-management-in-the-ed.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/tech-disease-trends/2024/10/dave-persing-legacy-and-leadership-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/tech-disease-trends/2024/11/invasive-group-streptococcal-disease.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/tech-disease-trends/2024/11/what-is-pcr--understanding-the-magic.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/tech-disease-trends/2024/11/decentralized-pcr-testing-and-the-quadruple-aim-insights-for-health-systems.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/tech-disease-trends/2025/01/how-a-cepheid-molecular-test-is-made.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/tech-disease-trends/2025/04/standardization-of-pcr-testing-across-healthcare-testing-sites.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/tech-disease-trends/2025/06/innovation-in-times-of-need-cepheids-legacy-of-outbreak-response.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/tech-disease-trends/2025/07/celebrating-the-cepheid-bike-where-art-meets-innovation.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/tech-disease-trends/2025/09/cepheid-advances-innovation-and-reach-with-key-partnerships.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/tech-disease-trends/2025/10/learn-about-cepheid-system-innovation.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/tech-disease-trends/2025/11/multiplex-with-meaning--cepheid-s-smart-approach-to-molecular-di.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/antimicrobial-stewardship.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/antimicrobial-stewardship/2024/09/a-public-health-dialogue-on-antibiotic-resistance-surveillance.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/antimicrobial-stewardship/2024/09/mortality-associated-with-carbapenem-resistant-gram-negative-infections.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/antimicrobial-stewardship/2024/09/decentralized-testing-for-the-surveillance-of-hospital-acquired-infections.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/antimicrobial-stewardship/2024/09/rapid-mrsa-screening-of-ortho-trauma-patients-improves-experience.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/antimicrobial-stewardship/2024/09/pcr-screening-at-a-british-hospital-enables-timely-infection-control.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/antimicrobial-stewardship/2024/10/fleming-initiative-cepheid-announce-partnership-tackle-amr.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/antimicrobial-stewardship/2024/10/link-between-colonization-multi-drug-resistant-infection.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/antimicrobial-stewardship/2024/12/point-of-care-testing-emergency-department-faster-decision-making-halle.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-schulz.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/antimicrobial-stewardship/2025/05/antimicrobial-and-diagnostic-stewardship-frost-and-sullivan-visual-whitepaper.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/antimicrobial-stewardship/2025/08/industry-voices-time-to-rethink-our-approach-to-using-modern-medicine.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/antimicrobial-stewardship/2025/09/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/antimicrobial-stewardship/2025/10/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/antimicrobial-stewardship/2025/11/vanessa-carter-s-journey--inspiring-action-against-amr.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/antimicrobial-stewardship/2025/11/advancing-antimicrobial-stewardship-in-small-and-rural-hospital.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/expert-spotlight.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/expert-spotlight/2025/10/expert-spotlight--michael-loeffelholz.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--devasena-gnanashanmugam-vice-president--me.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--jennifer-rakeman-cagno-senior-director--sc.htmldaily1.0https://www.cepheid.com/en-AU/insights/insight-hub/expert-spotlight/2026/02/expert-spotlight-jordan-chase.htmldaily1.0https://www.cepheid.com/en-AU/insights/webinars.htmldaily1.0https://www.cepheid.com/en-AU/insights/resources.htmldaily1.0https://www.cepheid.com/en-AU/support.htmldaily1.0https://www.cepheid.com/en-AU/support/ivdr-update.htmldaily1.0https://www.cepheid.com/en-AU/support/contact-us.htmldaily1.0https://www.cepheid.com/en-AU/about.htmldaily1.0https://www.cepheid.com/en-AU/about/mission-history.htmldaily1.0https://www.cepheid.com/en-AU/about/leadership.htmldaily1.0https://www.cepheid.com/en-AU/about/leadership/vitor-rocha.htmldaily1.0https://www.cepheid.com/en-AU/about/leadership/laurent-bellon.htmldaily1.0https://www.cepheid.com/en-AU/about/leadership/anette-engelhardt.htmldaily1.0https://www.cepheid.com/en-AU/about/leadership/peter-farrell.htmldaily1.0https://www.cepheid.com/en-AU/about/leadership/deborah-gonyea.htmldaily1.0https://www.cepheid.com/en-AU/about/leadership/nichole-halsey.htmldaily1.0https://www.cepheid.com/en-AU/about/leadership/luben-li.htmldaily1.0https://www.cepheid.com/en-AU/about/leadership/luke-maitland.htmldaily1.0https://www.cepheid.com/en-AU/about/leadership/david-h-persing.htmldaily1.0https://www.cepheid.com/en-AU/about/leadership/ammar-qadan.htmldaily1.0https://www.cepheid.com/en-AU/about/leadership/charles-mwangi.htmldaily1.0https://www.cepheid.com/en-AU/about/leadership/samson-wu.htmldaily1.0https://www.cepheid.com/en-AU/about/leadership/anupama-mokkapati.htmldaily1.0https://www.cepheid.com/en-AU/about/leadership/traci-wicks.htmldaily1.0https://www.cepheid.com/en-AU/about/leadership/scott-campbell.htmldaily1.0https://www.cepheid.com/en-AU/about/leadership/anne-beauburn.htmldaily1.0https://www.cepheid.com/en-AU/about/leadership/patrick-harkins.htmldaily1.0https://www.cepheid.com/en-AU/about/leadership/ephraim-tsalik.htmldaily1.0https://www.cepheid.com/en-AU/about/leadership/somesh-lalithraj.htmldaily1.0https://www.cepheid.com/en-AU/about/leadership/connie-savor.htmldaily1.0https://www.cepheid.com/en-AU/about/sustainability.htmldaily1.0https://www.cepheid.com/en-AU/about/sustainability/environmental-sustainability.htmldaily1.0https://www.cepheid.com/en-AU/about/sustainability/product-stewardship.htmldaily1.0https://www.cepheid.com/en-AU/about/sustainability/conflict-materials.htmldaily1.0https://www.cepheid.com/en-AU/about/policies-reports.htmldaily1.0https://www.cepheid.com/en-AU/about/business-development-opportunities.htmldaily1.0https://www.cepheid.com/en-AU/about/events.htmldaily1.0https://www.cepheid.com/en-AU/about/innovation-form.htmldaily1.0https://www.cepheid.com/en-AU/about/innovation-form/unsolicited-submission-agreement.htmldaily1.0https://www.cepheid.com/en-AU/about/sars-cov-2-test-development-information.htmldaily1.0https://www.cepheid.com/en-AU/about/sars-cov-2-product-resources.htmldaily1.0https://www.cepheid.com/en-AU/contact/select-info-path.htmldaily1.0https://www.cepheid.com/en-AU/contact/messages/thank-you.htmldaily1.0https://www.cepheid.com/en-AU/contact/messages/thank-you-patient-pathways.htmldaily1.0https://www.cepheid.com/en-AU/contact/messages/thank-you-patient-pathways-fr.htmldaily1.0https://www.cepheid.com/en-AU/contact/messages/thank-you-patient-pathways-de.htmldaily1.0https://www.cepheid.com/en-AU/contact/messages/thank-you-patient-pathways-it.htmldaily1.0https://www.cepheid.com/en-AU/contact/messages/thank-you-patient-pathways-sp.htmldaily1.0https://www.cepheid.com/en-AU/contact/messages/thank-you-patient-pathways-pl.htmldaily1.0https://www.cepheid.com/en-AU/contact/messages/thank-you-patient-pathways-pt.htmldaily1.0https://www.cepheid.com/en-AU/contact/request-cd-international.htmldaily1.0https://www.cepheid.com/en-AU/personas/laboratory-professionals.htmldaily1.0https://www.cepheid.com/en-AU/personas/healthcare-professsional.htmldaily1.0https://www.cepheid.com/en-AU/personas/health-system-administrators.htmldaily1.0https://www.cepheid.com/en-AU/legal/privacy.htmldaily1.0https://www.cepheid.com/en-AU/legal/terms-of-use.htmldaily1.0https://www.cepheid.com/en-AU/legal/product-security-updates.htmldaily1.0https://www.cepheid.com/en-AU/legal/terms-of-sale.htmldaily1.0https://www.cepheid.com/en-AU/legal/trademarks.htmldaily1.0https://www.cepheid.com/en-AU/legal/cookies-notice.htmldaily1.0https://www.cepheid.com/en-AU/campaigns/2020-emea-renewed-messaging/french/patient-pathways.htmldaily1.0https://www.cepheid.com/en-AU/campaigns/2020-emea-renewed-messaging/german/patient-pathways.htmldaily1.0https://www.cepheid.com/en-AU/campaigns/2020-emea-renewed-messaging/italian/patient-pathways.htmldaily1.0https://www.cepheid.com/en-AU/campaigns/2020-emea-renewed-messaging/portuguese/patient-pathways.htmldaily1.0https://www.cepheid.com/en-AU/campaigns/2020-emea-renewed-messaging/polish/patient-pathways.htmldaily1.0https://www.cepheid.com/en-AU/campaigns/india/cepheid-india.htmldaily1.0https://www.cepheid.com/en-AU/campaigns/india/india-submission.htmldaily1.0https://www.cepheid.com/en-AU/campaigns/india/cepheid-india-display.htmldaily1.0https://www.cepheid.com/en-AU/campaigns/india/cepheid-india-bangladesh.htmldaily1.0https://www.cepheid.com/en-AU/campaigns/pcr-plus.htmldaily1.0https://www.cepheid.com/en-AU/coronavirus-portfolio.htmldaily1.0https://www.cepheid.com/en-BE.htmldaily1.0https://www.cepheid.com/en-BE/tests.htmldaily1.0https://www.cepheid.com/en-BE/tests/respiratory.htmldaily1.0https://www.cepheid.com/en-BE/tests/respiratory/xpert-xpress-strep-a.htmldaily1.0https://www.cepheid.com/en-BE/tests/respiratory/xpert-xpress-cov-2-plus.htmldaily1.0https://www.cepheid.com/en-BE/tests/respiratory/xpert-xpress-sars-cov-2.htmldaily1.0https://www.cepheid.com/en-BE/tests/respiratory/xpert-xpress-flu-rsv.htmldaily1.0https://www.cepheid.com/en-BE/tests/respiratory/xpert-xpress-cov-2-flu-rsv-plus.htmldaily1.0https://www.cepheid.com/en-BE/tests/hai-other-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-BE/tests/hai-other-infectious-diseases/xpert-sa-nasal-complete.htmldaily1.0https://www.cepheid.com/en-BE/tests/hai-other-infectious-diseases/xpert-mrsa-sa-ssti.htmldaily1.0https://www.cepheid.com/en-BE/tests/hai-other-infectious-diseases/xpert-c-difficile-bt.htmldaily1.0https://www.cepheid.com/en-BE/tests/hai-other-infectious-diseases/xpert-norovirus.htmldaily1.0https://www.cepheid.com/en-BE/tests/hai-other-infectious-diseases/xpert-mrsa-sa-blood-culture.htmldaily1.0https://www.cepheid.com/en-BE/tests/hai-other-infectious-diseases/xpert-vana-vanb.htmldaily1.0https://www.cepheid.com/en-BE/tests/hai-other-infectious-diseases/xpert-mrsa-nxg.htmldaily1.0https://www.cepheid.com/en-BE/tests/hai-other-infectious-diseases/xpert-carba-r.htmldaily1.0https://www.cepheid.com/en-BE/tests/blood-virology-womens-health-sexual-health.htmldaily1.0https://www.cepheid.com/en-BE/tests/blood-virology-womens-health-sexual-health/xpert-hbv-viral-load.htmldaily1.0https://www.cepheid.com/en-BE/tests/blood-virology-womens-health-sexual-health/resistanceplusmg-flexible.htmldaily1.0https://www.cepheid.com/en-BE/tests/blood-virology-womens-health-sexual-health/xpert-xpress-gbs.htmldaily1.0https://www.cepheid.com/en-BE/tests/blood-virology-womens-health-sexual-health/xpert-ct-ng.htmldaily1.0https://www.cepheid.com/en-BE/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-qual-xc.htmldaily1.0https://www.cepheid.com/en-BE/tests/blood-virology-womens-health-sexual-health/xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-BE/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-viral-load-xc.htmldaily1.0https://www.cepheid.com/en-BE/tests/blood-virology-womens-health-sexual-health/xpert-tv.htmldaily1.0https://www.cepheid.com/en-BE/tests/blood-virology-womens-health-sexual-health/xpert-hpv-v2.htmldaily1.0https://www.cepheid.com/en-BE/tests/blood-virology-womens-health-sexual-health/xpert-hcv-viral-load.htmldaily1.0https://www.cepheid.com/en-BE/tests/tb-emerging-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-BE/tests/tb-emerging-infectious-diseases/xpert-mtb-xdr.htmldaily1.0https://www.cepheid.com/en-BE/tests/tb-emerging-infectious-diseases/xpert-mtb-rif-ultra.htmldaily1.0https://www.cepheid.com/en-BE/tests/oncology-human-genetics.htmldaily1.0https://www.cepheid.com/en-BE/tests/oncology-human-genetics/expert-bladder-cancer-monitor.htmldaily1.0https://www.cepheid.com/en-BE/tests/oncology-human-genetics/xpert-fii-fv.htmldaily1.0https://www.cepheid.com/en-BE/tests/oncology-human-genetics/xpert-bcr-abl-ultra-p190.htmldaily1.0https://www.cepheid.com/en-BE/tests/oncology-human-genetics/xpert-breast-cancer-strat4.htmldaily1.0https://www.cepheid.com/en-BE/tests/oncology-human-genetics/xpert-bladder-cancer-detection.htmldaily1.0https://www.cepheid.com/en-BE/tests/oncology-human-genetics/xpert-bcr-abl-ultra.htmldaily1.0https://www.cepheid.com/en-BE/tests/oncology-human-genetics/xpert-npm1-mutation.htmldaily1.0https://www.cepheid.com/en-BE/systems.htmldaily1.0https://www.cepheid.com/en-BE/systems/genexpert-family-of-systems.htmldaily1.0https://www.cepheid.com/en-BE/systems/genexpert-family-of-systems/genexpert-system.htmldaily1.0https://www.cepheid.com/en-BE/systems/genexpert-family-of-systems/genexpert-infinity.htmldaily1.0https://www.cepheid.com/en-BE/systems/genexpert-software.htmldaily1.0https://www.cepheid.com/en-BE/systems/genexpert-software/gx-software.htmldaily1.0https://www.cepheid.com/en-BE/systems/genexpert-software/xpertise-software.htmldaily1.0https://www.cepheid.com/en-BE/systems/connectivity.htmldaily1.0https://www.cepheid.com/en-BE/systems/connectivity/cepheid-c360.htmldaily1.0https://www.cepheid.com/en-BE/systems/connectivity/interface-capabilities.htmldaily1.0https://www.cepheid.com/en-BE/systems/data-processing-agreement.htmldaily1.0https://www.cepheid.com/en-BE/systems/partner-communities.htmldaily1.0https://www.cepheid.com/en-BE/systems/business-associates-agreement.htmldaily1.0https://www.cepheid.com/en-BE/solutions.htmldaily1.0https://www.cepheid.com/en-BE/solutions/global-access.htmldaily1.0https://www.cepheid.com/en-BE/solutions/global-access/eligibility-and-pricing.htmldaily1.0https://www.cepheid.com/en-BE/solutions/testing-everywhere.htmldaily1.0https://www.cepheid.com/en-BE/solutions/antibiotic-stewardship.htmldaily1.0https://www.cepheid.com/en-BE/solutions/oncology-diagnostics.htmldaily1.0https://www.cepheid.com/en-BE/solutions/customized-testing-institution.htmldaily1.0https://www.cepheid.com/en-BE/solutions/knowing-more-matters.htmldaily1.0https://www.cepheid.com/en-BE/solutions/knowing-more-matters/pcr-vs-antigen.htmldaily1.0https://www.cepheid.com/en-BE/solutions/knowing-more-matters/covid-flu-rsv.htmldaily1.0https://www.cepheid.com/en-BE/insights.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/all-posts.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/respiratory-health.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/respiratory-health/2024/09/proactive-surveillance-to-ensure-broad-flu-strain-detection.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/respiratory-health/2024/09/emerging-evolving-respiratory-viruses-test-design-matters.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/respiratory-health/2024/09/the-genexpert-xpress-system-can-change-your-pediatric-practice.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/respiratory-health/2024/09/Norwegian-ED-improves-Resource-Management-with-Rapid-PCR-Testing.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/respiratory-health/2024/09/key-steps-pandemic-preparedness.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/respiratory-health/2025/01/what-does-it-mean-to-have-a--pandemic-ready--pcr-test-.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/respiratory-health/2025/01/what-does-it-mean-to-have-a-pandemic-ready-pcr-test.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like-ilnesses.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/respiratory-health/2025/03/in-house-pcr-testing-clinical-leaders-explore-the-ripple-effect.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/respiratory-health/2025/04/real-world-clinical-impact-of-in-house-pcr-testing.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/respiratory-health/2025/04/what-is-the-difference-between-pcr-and-antigen-testing.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/respiratory-health/2025/05/a-quick-primer-on-the-adlm-guidance-on-respiratory-virus-testing.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/respiratory-health/2025/09/revolutionizing-respiratory-care-the-power-of-rapid-molecular-testing.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/respiratory-health/2025/09/antigen-testing-vs-pcr-less-haste-more-speed-please.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/respiratory-health/2025/09/the-time-for-widespread-adoption-of-mdx-testing-for-gas-pharyngi.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/respiratory-health/2025/11/why-test-type-matters-pcr-vs-antigen-in-outpatient-respiratory-care.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/respiratory-health/2025/11/transforming-respiratory-tnfection-diagnosis-embracing-molecular-innovation-clinical-practice1.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/respiratory-health/2026/01/staying-ahead-of-influenza.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/respiratory-health/2026/02/revolutionizing-rheumatic-heart-disease-prevention.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2024/09/accelerating-the-pace-for-hep-c-elimination-in-the-us.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2024/09/can-molecular-tests-revolutionize-tuberculosis-control.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2024/09/near-patient-testing-for-hep-c-xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2024/09/danish-hcv-testing-program-improves-patient-management-and-access.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2024/09/faster-prison-testing-for-hcv-drastically-improves-treatment-in-the-uk.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2024/09/innovative-POC-testing-shortens-time-between-testing-and-treatment.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2024/09/finnish-hospital-improves-care-for-expectant-mothers-with-gbs-pcr-screening.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2024/09/a-not-for-profit-in-vietnam-fights-to-end-tuberculosis.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2024/09/cepheid-expands-in-india-to-support-global-efforts-to-fight-tb.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2024/09/covid-19-and-tuberculosis-testing-in-south-africa.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2024/09/cepheid-supports-the-international-mpox-emergency-declared-august-2024.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2024/10/hpv-testing-south-african-clinic-may-prevent-cervical-cancer.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2024/12/strides-toward-early-infant-diagnosis-for-hiv-elimination-in-sou.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2025/02/common-misconceptions-about-vaginitis.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2025/07/five-surprising-stats-that-reveal-the-hidden-burden-of-vaginitis.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2025/07/5-ways-vaginitis-treatment-goes-wrong-and-how-better-testing-can-fix-It.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2025/05/revisiting-bacterial-vaginosis-evidence-for-sexual-transmission.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2025/05/a-breakthrough-in-hcv-elimination--how-hcv-point-of-care-rna-tes.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2025/05/decentralising-diagnostics-bringing-patient-centred-testing-closer-to-communities.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2025/05/integration-of-poc-viral-diagnostics-with-substance-use-disorder-treatment-to-improve-hepatitis-c-nfection-outcomes.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2025/04/tuberculosis-staying-one-step-ahead.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2025/04/how-three-countries-are-fighting-back-against-tuberculosis.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2025/04/a-mdr-tb-survivor-in-india-shares-her-remarkable-story.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2025/06/womens-health-testing-advantages-of-same-day-diagnosis-and-treatment.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2025/03/the-fight-to-end-tuberculosis-in-pakistan.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2025/03/devasena-gnanashanmugam-discusses-cepheids-global-access-program.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2025/03/desmond-tutu-foundation-reduces-impact-of-hiv-and-tb.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2025/03/tuberculosis-care-and-treatment-in-the-republic-of-indonesia.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2025/03/finding-missing-tuberculosis-tb-cases-philippines-need-for-speed.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2025/03/a-decade-of-health-and-economic-benefits-infographic.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2025/03/state-tb-in-us-overlooked-opportunity-better-results.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2025/03/fighting-tb-everything-10-years-of-impact-in-south-africa.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2025/08/kentucky-viral-hepatitis-treatment-projects-mission-to-eradicate-hcv.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2025/08/the-state-of-vaginitis-testing-in-the-us.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2025/08/improving-vaginitis-care-through-better-diagnostics.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2025/09/in-memory-of-john-bishop-a-visionary-leader-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2025/12/wecare-humanitarian-medical-mission.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2025/10/time-to-act-stopping-group-b-strep-infections-in-newborn-babies.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2025/10/real-user-experiences-with-xpert-xpress-mvp-oint-of-care-test.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2026/02/advancing-pandemic-preparedness-through-public-private-collaboration.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/community-and-global-health/2026/02/hepatitis-c-elimination-in-the-us-is-within-reach-experts-report.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/tech-disease-trends.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/tech-disease-trends/2024/09/candida-auris--rising-threat-and-future-implications.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/tech-disease-trends/2024/09/discussing-pharma-clinical-trials-utilizing-poc-diagnostics.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/tech-disease-trends/2024/09/poc-testing-increases-the-efficiency-of-patient-management-in-the-ed.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/tech-disease-trends/2024/10/dave-persing-legacy-and-leadership-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/tech-disease-trends/2024/11/invasive-group-streptococcal-disease.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/tech-disease-trends/2024/11/what-is-pcr--understanding-the-magic.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/tech-disease-trends/2024/11/decentralized-pcr-testing-and-the-quadruple-aim-insights-for-health-systems.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/tech-disease-trends/2025/01/how-a-cepheid-molecular-test-is-made.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/tech-disease-trends/2025/04/standardization-of-pcr-testing-across-healthcare-testing-sites.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/tech-disease-trends/2025/06/innovation-in-times-of-need-cepheids-legacy-of-outbreak-response.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/tech-disease-trends/2025/07/celebrating-the-cepheid-bike-where-art-meets-innovation.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/tech-disease-trends/2025/09/cepheid-advances-innovation-and-reach-with-key-partnerships.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/tech-disease-trends/2025/10/learn-about-cepheid-system-innovation.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/tech-disease-trends/2025/11/multiplex-with-meaning--cepheid-s-smart-approach-to-molecular-di.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/antimicrobial-stewardship.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/antimicrobial-stewardship/2024/09/a-public-health-dialogue-on-antibiotic-resistance-surveillance.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/antimicrobial-stewardship/2024/09/mortality-associated-with-carbapenem-resistant-gram-negative-infections.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/antimicrobial-stewardship/2024/09/decentralized-testing-for-the-surveillance-of-hospital-acquired-infections.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/antimicrobial-stewardship/2024/09/rapid-mrsa-screening-of-ortho-trauma-patients-improves-experience.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/antimicrobial-stewardship/2024/09/pcr-screening-at-a-british-hospital-enables-timely-infection-control.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/antimicrobial-stewardship/2024/10/fleming-initiative-cepheid-announce-partnership-tackle-amr.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/antimicrobial-stewardship/2024/10/link-between-colonization-multi-drug-resistant-infection.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/antimicrobial-stewardship/2024/12/point-of-care-testing-emergency-department-faster-decision-making-halle.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-schulz.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/antimicrobial-stewardship/2025/05/antimicrobial-and-diagnostic-stewardship-frost-and-sullivan-visual-whitepaper.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/antimicrobial-stewardship/2025/08/industry-voices-time-to-rethink-our-approach-to-using-modern-medicine.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/antimicrobial-stewardship/2025/09/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/antimicrobial-stewardship/2025/10/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/antimicrobial-stewardship/2025/11/vanessa-carter-s-journey--inspiring-action-against-amr.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/antimicrobial-stewardship/2025/11/advancing-antimicrobial-stewardship-in-small-and-rural-hospital.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/expert-spotlight.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/expert-spotlight/2025/10/expert-spotlight--michael-loeffelholz.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--devasena-gnanashanmugam-vice-president--me.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--jennifer-rakeman-cagno-senior-director--sc.htmldaily1.0https://www.cepheid.com/en-BE/insights/insight-hub/expert-spotlight/2026/02/expert-spotlight-jordan-chase.htmldaily1.0https://www.cepheid.com/en-BE/insights/webinars.htmldaily1.0https://www.cepheid.com/en-BE/insights/resources.htmldaily1.0https://www.cepheid.com/en-BE/support.htmldaily1.0https://www.cepheid.com/en-BE/support/ivdr-update.htmldaily1.0https://www.cepheid.com/en-BE/support/contact-us.htmldaily1.0https://www.cepheid.com/en-BE/about.htmldaily1.0https://www.cepheid.com/en-BE/about/mission-history.htmldaily1.0https://www.cepheid.com/en-BE/about/leadership.htmldaily1.0https://www.cepheid.com/en-BE/about/leadership/vitor-rocha.htmldaily1.0https://www.cepheid.com/en-BE/about/leadership/laurent-bellon.htmldaily1.0https://www.cepheid.com/en-BE/about/leadership/anette-engelhardt.htmldaily1.0https://www.cepheid.com/en-BE/about/leadership/peter-farrell.htmldaily1.0https://www.cepheid.com/en-BE/about/leadership/deborah-gonyea.htmldaily1.0https://www.cepheid.com/en-BE/about/leadership/nichole-halsey.htmldaily1.0https://www.cepheid.com/en-BE/about/leadership/luben-li.htmldaily1.0https://www.cepheid.com/en-BE/about/leadership/luke-maitland.htmldaily1.0https://www.cepheid.com/en-BE/about/leadership/david-h-persing.htmldaily1.0https://www.cepheid.com/en-BE/about/leadership/ammar-qadan.htmldaily1.0https://www.cepheid.com/en-BE/about/leadership/charles-mwangi.htmldaily1.0https://www.cepheid.com/en-BE/about/leadership/samson-wu.htmldaily1.0https://www.cepheid.com/en-BE/about/leadership/anupama-mokkapati.htmldaily1.0https://www.cepheid.com/en-BE/about/leadership/traci-wicks.htmldaily1.0https://www.cepheid.com/en-BE/about/leadership/scott-campbell.htmldaily1.0https://www.cepheid.com/en-BE/about/leadership/anne-beauburn.htmldaily1.0https://www.cepheid.com/en-BE/about/leadership/patrick-harkins.htmldaily1.0https://www.cepheid.com/en-BE/about/leadership/ephraim-tsalik.htmldaily1.0https://www.cepheid.com/en-BE/about/leadership/somesh-lalithraj.htmldaily1.0https://www.cepheid.com/en-BE/about/leadership/connie-savor.htmldaily1.0https://www.cepheid.com/en-BE/about/sustainability.htmldaily1.0https://www.cepheid.com/en-BE/about/sustainability/environmental-sustainability.htmldaily1.0https://www.cepheid.com/en-BE/about/sustainability/product-stewardship.htmldaily1.0https://www.cepheid.com/en-BE/about/sustainability/conflict-materials.htmldaily1.0https://www.cepheid.com/en-BE/about/policies-reports.htmldaily1.0https://www.cepheid.com/en-BE/about/business-development-opportunities.htmldaily1.0https://www.cepheid.com/en-BE/about/events.htmldaily1.0https://www.cepheid.com/en-BE/about/innovation-form.htmldaily1.0https://www.cepheid.com/en-BE/about/innovation-form/unsolicited-submission-agreement.htmldaily1.0https://www.cepheid.com/en-BE/about/sars-cov-2-test-development-information.htmldaily1.0https://www.cepheid.com/en-BE/about/sars-cov-2-product-resources.htmldaily1.0https://www.cepheid.com/en-BE/contact/select-info-path.htmldaily1.0https://www.cepheid.com/en-BE/contact/messages/thank-you.htmldaily1.0https://www.cepheid.com/en-BE/contact/messages/thank-you-patient-pathways.htmldaily1.0https://www.cepheid.com/en-BE/contact/messages/thank-you-patient-pathways-fr.htmldaily1.0https://www.cepheid.com/en-BE/contact/messages/thank-you-patient-pathways-de.htmldaily1.0https://www.cepheid.com/en-BE/contact/messages/thank-you-patient-pathways-it.htmldaily1.0https://www.cepheid.com/en-BE/contact/messages/thank-you-patient-pathways-sp.htmldaily1.0https://www.cepheid.com/en-BE/contact/messages/thank-you-patient-pathways-pl.htmldaily1.0https://www.cepheid.com/en-BE/contact/messages/thank-you-patient-pathways-pt.htmldaily1.0https://www.cepheid.com/en-BE/contact/request-cd-international.htmldaily1.0https://www.cepheid.com/en-BE/personas/laboratory-professionals.htmldaily1.0https://www.cepheid.com/en-BE/personas/healthcare-professsional.htmldaily1.0https://www.cepheid.com/en-BE/personas/health-system-administrators.htmldaily1.0https://www.cepheid.com/en-BE/legal/privacy.htmldaily1.0https://www.cepheid.com/en-BE/legal/terms-of-use.htmldaily1.0https://www.cepheid.com/en-BE/legal/product-security-updates.htmldaily1.0https://www.cepheid.com/en-BE/legal/terms-of-sale.htmldaily1.0https://www.cepheid.com/en-BE/legal/trademarks.htmldaily1.0https://www.cepheid.com/en-BE/legal/cookies-notice.htmldaily1.0https://www.cepheid.com/en-BE/campaigns/2020-emea-renewed-messaging/french/patient-pathways.htmldaily1.0https://www.cepheid.com/en-BE/campaigns/2020-emea-renewed-messaging/german/patient-pathways.htmldaily1.0https://www.cepheid.com/en-BE/campaigns/2020-emea-renewed-messaging/italian/patient-pathways.htmldaily1.0https://www.cepheid.com/en-BE/campaigns/2020-emea-renewed-messaging/portuguese/patient-pathways.htmldaily1.0https://www.cepheid.com/en-BE/campaigns/2020-emea-renewed-messaging/polish/patient-pathways.htmldaily1.0https://www.cepheid.com/en-BE/campaigns/india/cepheid-india.htmldaily1.0https://www.cepheid.com/en-BE/campaigns/india/india-submission.htmldaily1.0https://www.cepheid.com/en-BE/campaigns/india/cepheid-india-display.htmldaily1.0https://www.cepheid.com/en-BE/campaigns/india/cepheid-india-bangladesh.htmldaily1.0https://www.cepheid.com/en-BE/campaigns/pcr-plus.htmldaily1.0https://www.cepheid.com/en-BE/coronavirus-portfolio.htmldaily1.0https://www.cepheid.com/en-CA.htmldaily1.0https://www.cepheid.com/en-CA/tests.htmldaily1.0https://www.cepheid.com/en-CA/tests/respiratory.htmldaily1.0https://www.cepheid.com/en-CA/tests/respiratory/xpert-xpress-flu-rsv.htmldaily1.0https://www.cepheid.com/en-CA/tests/respiratory/xpert-xpress-strep-a.htmldaily1.0https://www.cepheid.com/en-CA/tests/respiratory/xpert-xpress-cov-2-plus.htmldaily1.0https://www.cepheid.com/en-CA/tests/respiratory/xpert-xpress-cov-2-flu-rsv-plus.htmldaily1.0https://www.cepheid.com/en-CA/tests/hai-other-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-CA/tests/hai-other-infectious-diseases/xpert-sa-nasal-complete.htmldaily1.0https://www.cepheid.com/en-CA/tests/hai-other-infectious-diseases/xpert-mrsa-sa-ssti.htmldaily1.0https://www.cepheid.com/en-CA/tests/hai-other-infectious-diseases/xpert-norovirus.htmldaily1.0https://www.cepheid.com/en-CA/tests/hai-other-infectious-diseases/xpert-c-difficile-epi.htmldaily1.0https://www.cepheid.com/en-CA/tests/hai-other-infectious-diseases/xpert-mrsa-sa-blood-culture.htmldaily1.0https://www.cepheid.com/en-CA/tests/hai-other-infectious-diseases/xpert-mrsa-nxg.htmldaily1.0https://www.cepheid.com/en-CA/tests/hai-other-infectious-diseases/xpert-vana.htmldaily1.0https://www.cepheid.com/en-CA/tests/hai-other-infectious-diseases/xpert-vana-vanb.htmldaily1.0https://www.cepheid.com/en-CA/tests/hai-other-infectious-diseases/xpert-carba-r.htmldaily1.0https://www.cepheid.com/en-CA/tests/blood-virology-womens-health-sexual-health.htmldaily1.0https://www.cepheid.com/en-CA/tests/blood-virology-womens-health-sexual-health/xpert-ct-ng.htmldaily1.0https://www.cepheid.com/en-CA/tests/blood-virology-womens-health-sexual-health/xpert-tv.htmldaily1.0https://www.cepheid.com/en-CA/tests/blood-virology-womens-health-sexual-health/xpert-hpv.htmldaily1.0https://www.cepheid.com/en-CA/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-viral-load-xc.htmldaily1.0https://www.cepheid.com/en-CA/tests/blood-virology-womens-health-sexual-health/xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-CA/tests/tb-emerging-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-CA/tests/tb-emerging-infectious-diseases/xpert-mtb-rif-ultra.htmldaily1.0https://www.cepheid.com/en-CA/tests/oncology-human-genetics.htmldaily1.0https://www.cepheid.com/en-CA/tests/oncology-human-genetics/xpert-fii-fv.htmldaily1.0https://www.cepheid.com/en-CA/tests/oncology-human-genetics/xpert-bcr-abl-ultra.htmldaily1.0https://www.cepheid.com/en-CA/systems.htmldaily1.0https://www.cepheid.com/en-CA/systems/genexpert-family-of-systems.htmldaily1.0https://www.cepheid.com/en-CA/systems/genexpert-family-of-systems/genexpert-system.htmldaily1.0https://www.cepheid.com/en-CA/systems/genexpert-family-of-systems/genexpert-infinity.htmldaily1.0https://www.cepheid.com/en-CA/systems/genexpert-family-of-systems/genexpert-xpress.htmldaily1.0https://www.cepheid.com/en-CA/systems/genexpert-software.htmldaily1.0https://www.cepheid.com/en-CA/systems/genexpert-software/gx-software.htmldaily1.0https://www.cepheid.com/en-CA/systems/genexpert-software/xpertise-software.htmldaily1.0https://www.cepheid.com/en-CA/systems/connectivity.htmldaily1.0https://www.cepheid.com/en-CA/systems/connectivity/cepheid-c360.htmldaily1.0https://www.cepheid.com/en-CA/systems/connectivity/interface-capabilities.htmldaily1.0https://www.cepheid.com/en-CA/systems/data-processing-agreement.htmldaily1.0https://www.cepheid.com/en-CA/systems/partner-communities.htmldaily1.0https://www.cepheid.com/en-CA/systems/business-associates-agreement.htmldaily1.0https://www.cepheid.com/en-CA/solutions.htmldaily1.0https://www.cepheid.com/en-CA/solutions/global-access.htmldaily1.0https://www.cepheid.com/en-CA/solutions/global-access/eligibility-and-pricing.htmldaily1.0https://www.cepheid.com/en-CA/solutions/global-access/everything-about-our-fight-against-tb.htmldaily1.0https://www.cepheid.com/en-CA/solutions/customized-menu-scalability.htmldaily1.0https://www.cepheid.com/en-CA/solutions/knowing-more-matters.htmldaily1.0https://www.cepheid.com/en-CA/solutions/knowing-more-matters/campaign-resources.htmldaily1.0https://www.cepheid.com/en-CA/solutions/knowing-more-matters/pcr-vs-antigen.htmldaily1.0https://www.cepheid.com/en-CA/solutions/knowing-more-matters/covid-flu-rsv.htmldaily1.0https://www.cepheid.com/en-CA/solutions/testing-everywhere.htmldaily1.0https://www.cepheid.com/en-CA/solutions/antibiotic-stewardship.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/all-posts.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/respiratory-health.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/respiratory-health/2024/09/proactive-surveillance-to-ensure-broad-flu-strain-detection.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/respiratory-health/2024/09/emerging-evolving-respiratory-viruses-test-design-matters.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/respiratory-health/2024/09/the-genexpert-xpress-system-can-change-your-pediatric-practice.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/respiratory-health/2024/09/Norwegian-ED-improves-Resource-Management-with-Rapid-PCR-Testing.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/respiratory-health/2024/09/key-steps-pandemic-preparedness.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/respiratory-health/2025/01/what-does-it-mean-to-have-a-pandemic-ready-pcr-test.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like-illnesses.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/respiratory-health/2025/03/in-house-pcr-testing-clinical-leaders-explore-the-ripple-effect.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/respiratory-health/2025/04/real-world-clinical-impact-of-in-house-pcr-testing.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/respiratory-health/2025/04/what-is-the-difference-between-pcr-and-antigen-testing.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/respiratory-health/2025/05/a-quick-primer-on-the-adlm-guidance-on-respiratory-virus-testing.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/respiratory-health/2025/09/revolutionizing-respiratory-care-the-power-of-rapid-molecular-testing.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/respiratory-health/2025/09/antigen-testing-vs-pcr-less-haste-more-speed-please.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/respiratory-health/2025/09/the-time-for-widespread-adoption-of-mdx-testing-for-gas-pharyngi.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/respiratory-health/2025/11/why-test-type-matters-pcr-vs-antigen-in-outpatient-respiratory-care.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/respiratory-health/2025/11/transforming-respiratory-tnfection-diagnosis-embracing-molecular-innovation-clinical-practice.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/respiratory-health/2026/01/staying-ahead-of-influenza.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2024/09/accelerating-the-pace-for-hep-c-elimination-in-the-us.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2024/09/can-molecular-tests-revolutionize-tuberculosis-control.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2024/09/near-patient-testing-for-hep-c-xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2024/09/danish-hcv-testing-program-improves-patient-management-and-access.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2024/09/faster-prison-testing-for-hcv-drastically-improves-treatment-in-the-uk.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2024/09/innovative-POC-testing-shortens-time-between-testing-and-treatment.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2024/09/finnish-hospital-improves-care-for-expectant-mothers-with-gbs-pcr-screening.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2024/09/a-not-for-profit-in-vietnam-fights-to-end-tuberculosis.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2024/09/cepheid-expands-in-india-to-support-global-efforts-to-fight-tb.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2024/09/covid-19-and-tuberculosis-testing-in-south-africa.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2024/09/cepheid-supports-the-international-mpox-emergency-declared-august-2024.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2024/10/hpv-testing-south-african-clinic-may-prevent-cervical-cancer.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2024/12/strides-toward-early-infant-diagnosis-for-hiv-elimination-in-sou.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2025/01/common-misconceptions-about-vaginitis.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2025/03/the-fight-to-end-tuberculosis-in-pakistan.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2025/03/devasena-gnanashanmugam-discusses-cepheids-global-access-program.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2025/03/desmond-tutu-foundation-reduces-impact-of-hiv-and-tb.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2025/03/tuberculosis-care-and-treatment-in-the-republic-of-indonesia.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2025/03/finding-missing-tuberculosis-tb-cases-philippines-need-for-speed.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2025/03/a-decade-of-health-and-economic-benefits-infographic.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2025/03/state-tb-in-us-overlooked-opportunity-better-results.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2025/03/fighting-tb-everything-10-years-of-impact-in-south-africa.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2025/04/tuberculosis-staying-one-step-ahead.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2025/04/how-three-countries-are-fighting-back-against-tuberculosis.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2025/04/a-mdr-tb-survivor-in-india-shares-her-remarkable-story.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2025/07/five-surprising-stats-that-reveal-the-hidden-burden-of-vaginitis.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2025/07/5-ways-vaginitis-treatment-goes-wrong-and-how-better-testing-can-fix-It.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2025/05/revisiting-bacterial-vaginosis-evidence-for-sexual-transmission.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2025/05/a-breakthrough-in-hcv-elimination--how-hcv-point-of-care-rna-tes.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2025/05/decentralising-diagnostics-bringing-patient-centred-testing-closer-to-communities.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2025/05/integration-of-poc-viral-diagnostics-with-substance-use-disorder-treatment-to-improve-hepatitis-c-nfection-outcomes.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2025/06/womens-health-testing-advantages-of-same-day-diagnosis-and-treatment.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2025/08/kentucky-viral-hepatitis-treatment-projects-mission-to-eradicate-hcv.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2025/08/the-state-of-vaginitis-testing-in-the-us.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2025/08/improving-vaginitis-care-through-better-diagnostics.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2025/10/time-to-act-stopping-group-b-strep-infections-in-newborn-babies.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2025/10/real-user-experiences-with-xpert-xpress-mvp-oint-of-care-test.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2025/09/in-memory-of-john-bishop-a-visionary-leader-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2025/12/wecare-humanitarian-medical-mission.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2026/02/advancing-pandemic-preparedness-through-public-private-collaboration.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/community-and-global-health/2026/02/hepatitis-c-elimination-in-the-us-is-within-reach-experts-report.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/tech-disease-trends.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/tech-disease-trends/2024/09/candida-auris--rising-threat-and-future-implications.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/tech-disease-trends/2024/09/discussing-pharma-clinical-trials-utilizing-poc-diagnostics.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/tech-disease-trends/2024/09/poc-testing-increases-the-efficiency-of-patient-management-in-the-ed.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/tech-disease-trends/2024/10/dave-persing-legacy-and-leadership-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/tech-disease-trends/2024/11/invasive-group-streptococcal-disease.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/tech-disease-trends/2024/11/what-is-pcr--understanding-the-magic.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/tech-disease-trends/2024/11/decentralized-pcr-testing-and-the-quadruple-aim-insights-for-health-systems.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/tech-disease-trends/2025/01/how-a-cepheid-molecular-test-is-made.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/tech-disease-trends/2025/04/standardization-of-pcr-testing-across-healthcare-testing-sites.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/tech-disease-trends/2025/06/innovation-in-times-of-need-cepheids-legacy-of-outbreak-response.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/tech-disease-trends/2025/07/celebrating-the-cepheid-bike-where-art-meets-innovation.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/tech-disease-trends/2025/09/cepheid-advances-innovation-and-reach-with-key-partnerships.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/tech-disease-trends/2025/10/learn-about-cepheid-system-innovation.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/tech-disease-trends/2025/11/multiplex-with-meaning--cepheid-s-smart-approach-to-molecular-di.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/tech-disease-trends/2026/01/innovation-in-era-of-dxex.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/antimicrobial-stewardship.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/antimicrobial-stewardship/2024/09/a-public-health-dialogue-on-antibiotic-resistance-surveillance.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/antimicrobial-stewardship/2024/09/mortality-associated-with-carbapenem-resistant-gram-negative-infections.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/antimicrobial-stewardship/2024/09/decentralized-testing-for-the-surveillance-of-hospital-acquired-infections.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/antimicrobial-stewardship/2024/09/rapid-mrsa-screening-of-ortho-trauma-patients-improves-experience.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/antimicrobial-stewardship/2024/09/pcr-screening-at-a-british-hospital-enables-timely-infection-control.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/antimicrobial-stewardship/2024/10/fleming-initiative-cepheid-announce-partnership-tackle-amr.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/antimicrobial-stewardship/2024/10/link-between-colonization-multi-drug-resistant-infection.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/antimicrobial-stewardship/2024/12/point-of-care-testing-emergency-department-faster-decision-making-halle.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-schulz.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/antimicrobial-stewardship/2025/05/antimicrobial-and-diagnostic-stewardship-frost-and-sullivan-visual-whitepaper.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/antimicrobial-stewardship/2025/08/industry-voices-time-to-rethink-our-approach-to-using-modern-medicine.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/antimicrobial-stewardship/2025/10/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/antimicrobial-stewardship/2025/11/vanessa-carter-s-journey--inspiring-action-against-amr.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/antimicrobial-stewardship/2025/11/advancing-antimicrobial-stewardship-in-small-and-rural-hospital.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/expert-spotlight.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/expert-spotlight/2025/10/expert-spotlight--michael-loeffelholz.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--devasena-gnanashanmugam-vice-president--me.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--jennifer-rakeman-cagno-senior-director--sc.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/expert-spotlight/2026/02/expert-spotlight-jordan-chase.htmldaily1.0https://www.cepheid.com/en-CA/insights/insight-hub/expert-spotlight/2026/02/expert-spotlight-juan-cruz-cuevas.htmldaily1.0https://www.cepheid.com/en-CA/insights/webinars.htmldaily1.0https://www.cepheid.com/en-CA/insights/webinars/featured-webinars.htmldaily1.0https://www.cepheid.com/en-CA/support.htmldaily1.0https://www.cepheid.com/en-CA/support/order-management.htmldaily1.0https://www.cepheid.com/en-CA/support/contact-us.htmldaily1.0https://www.cepheid.com/en-CA/about.htmldaily1.0https://www.cepheid.com/en-CA/about/mission-history.htmldaily1.0https://www.cepheid.com/en-CA/about/leadership.htmldaily1.0https://www.cepheid.com/en-CA/about/leadership/vitor-rocha.htmldaily1.0https://www.cepheid.com/en-CA/about/leadership/laurent-bellon.htmldaily1.0https://www.cepheid.com/en-CA/about/leadership/anette-engelhardt.htmldaily1.0https://www.cepheid.com/en-CA/about/leadership/peter-farrell.htmldaily1.0https://www.cepheid.com/en-CA/about/leadership/deborah-gonyea.htmldaily1.0https://www.cepheid.com/en-CA/about/leadership/nichole-halsey.htmldaily1.0https://www.cepheid.com/en-CA/about/leadership/luben-li.htmldaily1.0https://www.cepheid.com/en-CA/about/leadership/luke-maitland.htmldaily1.0https://www.cepheid.com/en-CA/about/leadership/david-h-persing.htmldaily1.0https://www.cepheid.com/en-CA/about/leadership/ammar-qadan.htmldaily1.0https://www.cepheid.com/en-CA/about/leadership/charles-mwangi.htmldaily1.0https://www.cepheid.com/en-CA/about/leadership/samson-wu.htmldaily1.0https://www.cepheid.com/en-CA/about/leadership/anupama-mokkapati.htmldaily1.0https://www.cepheid.com/en-CA/about/leadership/scott-campbell.htmldaily1.0https://www.cepheid.com/en-CA/about/leadership/traci-wicks.htmldaily1.0https://www.cepheid.com/en-CA/about/leadership/ephraim-tsalik.htmldaily1.0https://www.cepheid.com/en-CA/about/leadership/patrick-harkins.htmldaily1.0https://www.cepheid.com/en-CA/about/leadership/anne-beauburn.htmldaily1.0https://www.cepheid.com/en-CA/about/leadership/somesh-lalithraj.htmldaily1.0https://www.cepheid.com/en-CA/about/leadership/connie-savor.htmldaily1.0https://www.cepheid.com/en-CA/about/reimbursement-support.htmldaily1.0https://www.cepheid.com/en-CA/about/business-development-opportunities.htmldaily1.0https://www.cepheid.com/en-CA/about/innovation-form.htmldaily1.0https://www.cepheid.com/en-CA/about/innovation-form/unsolicited-submission-agreement.htmldaily1.0https://www.cepheid.com/en-CA/about/events.htmldaily1.0https://www.cepheid.com/en-CA/about/sustainability.htmldaily1.0https://www.cepheid.com/en-CA/about/sustainability/environmental-sustainability.htmldaily1.0https://www.cepheid.com/en-CA/about/sustainability/product-stewardship.htmldaily1.0https://www.cepheid.com/en-CA/about/sustainability/conflict-minerals.htmldaily1.0https://www.cepheid.com/en-CA/about/careers/internship-opportunities.htmldaily1.0https://www.cepheid.com/en-CA/about/careers/join-the-team.htmldaily1.0https://www.cepheid.com/en-CA/about/policies-reports.htmldaily1.0https://www.cepheid.com/en-CA/about/sars-cov-2-test-development-information.htmldaily1.0https://www.cepheid.com/en-CA/about/sars-cov-2-product-resources.htmldaily1.0https://www.cepheid.com/en-CA/legal/privacy.htmldaily1.0https://www.cepheid.com/en-CA/legal/terms-of-use.htmldaily1.0https://www.cepheid.com/en-CA/legal/california-consumer-privacy-act.htmldaily1.0https://www.cepheid.com/en-CA/legal/trademarks.htmldaily1.0https://www.cepheid.com/en-CA/legal/product-security.htmldaily1.0https://www.cepheid.com/en-CA/legal/product-security/product-security-updates.htmldaily1.0https://www.cepheid.com/en-CA/legal/cookies-notice.htmldaily1.0https://www.cepheid.com/en-CA/personas/laboratory-professionals.htmldaily1.0https://www.cepheid.com/en-CA/personas/healthcare-providers.htmldaily1.0https://www.cepheid.com/en-CA/personas/health-system-administrators.htmldaily1.0https://www.cepheid.com/en-CA/contact/messages/thank-you.htmldaily1.0https://www.cepheid.com/en-CA/contact/request-cd.htmldaily1.0https://www.cepheid.com/en-CA/contact/request-express-hub.htmldaily1.0https://www.cepheid.com/en-CA/contact/select-info-path.htmldaily1.0https://www.cepheid.com/en-CA/contact/thank-you.htmldaily1.0https://www.cepheid.com/en-CA/campaigns/pcr-plus.htmldaily1.0https://www.cepheid.com/en-CA/coronavirus-portfolio.htmldaily1.0https://www.cepheid.com/en-CH.htmldaily1.0https://www.cepheid.com/en-CH/tests.htmldaily1.0https://www.cepheid.com/en-CH/tests/respiratory.htmldaily1.0https://www.cepheid.com/en-CH/tests/respiratory/xpert-xpress-strep-a.htmldaily1.0https://www.cepheid.com/en-CH/tests/respiratory/xpert-xpress-cov-2-plus.htmldaily1.0https://www.cepheid.com/en-CH/tests/respiratory/xpert-xpress-sars-cov-2.htmldaily1.0https://www.cepheid.com/en-CH/tests/respiratory/xpert-xpress-flu-rsv.htmldaily1.0https://www.cepheid.com/en-CH/tests/respiratory/xpert-xpress-cov-2-flu-rsv-plus.htmldaily1.0https://www.cepheid.com/en-CH/tests/hai-other-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-CH/tests/hai-other-infectious-diseases/xpert-sa-nasal-complete.htmldaily1.0https://www.cepheid.com/en-CH/tests/hai-other-infectious-diseases/xpert-mrsa-sa-ssti.htmldaily1.0https://www.cepheid.com/en-CH/tests/hai-other-infectious-diseases/xpert-c-difficile-bt.htmldaily1.0https://www.cepheid.com/en-CH/tests/hai-other-infectious-diseases/xpert-norovirus.htmldaily1.0https://www.cepheid.com/en-CH/tests/hai-other-infectious-diseases/xpert-mrsa-sa-blood-culture.htmldaily1.0https://www.cepheid.com/en-CH/tests/hai-other-infectious-diseases/xpert-vana-vanb.htmldaily1.0https://www.cepheid.com/en-CH/tests/hai-other-infectious-diseases/xpert-mrsa-nxg.htmldaily1.0https://www.cepheid.com/en-CH/tests/hai-other-infectious-diseases/xpert-carba-r.htmldaily1.0https://www.cepheid.com/en-CH/tests/blood-virology-womens-health-sexual-health.htmldaily1.0https://www.cepheid.com/en-CH/tests/blood-virology-womens-health-sexual-health/xpert-gbs.htmldaily1.0https://www.cepheid.com/en-CH/tests/blood-virology-womens-health-sexual-health/xpert-hbv-viral-load.htmldaily1.0https://www.cepheid.com/en-CH/tests/blood-virology-womens-health-sexual-health/resistanceplusmg-flexible.htmldaily1.0https://www.cepheid.com/en-CH/tests/blood-virology-womens-health-sexual-health/xpert-xpress-gbs.htmldaily1.0https://www.cepheid.com/en-CH/tests/blood-virology-womens-health-sexual-health/xpert-ct-ng.htmldaily1.0https://www.cepheid.com/en-CH/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-qual-xc.htmldaily1.0https://www.cepheid.com/en-CH/tests/blood-virology-womens-health-sexual-health/xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-CH/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-viral-load-xc.htmldaily1.0https://www.cepheid.com/en-CH/tests/blood-virology-womens-health-sexual-health/xpert-tv.htmldaily1.0https://www.cepheid.com/en-CH/tests/blood-virology-womens-health-sexual-health/xpert-hpv-v2.htmldaily1.0https://www.cepheid.com/en-CH/tests/blood-virology-womens-health-sexual-health/xpert-hcv-viral-load.htmldaily1.0https://www.cepheid.com/en-CH/tests/tb-emerging-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-CH/tests/tb-emerging-infectious-diseases/xpert-mtb-xdr.htmldaily1.0https://www.cepheid.com/en-CH/tests/tb-emerging-infectious-diseases/xpert-mtb-rif-ultra.htmldaily1.0https://www.cepheid.com/en-CH/tests/oncology-human-genetics.htmldaily1.0https://www.cepheid.com/en-CH/tests/oncology-human-genetics/expert-bladder-cancer-monitor.htmldaily1.0https://www.cepheid.com/en-CH/tests/oncology-human-genetics/xpert-fii-fv.htmldaily1.0https://www.cepheid.com/en-CH/tests/oncology-human-genetics/xpert-bcr-abl-ultra-p190.htmldaily1.0https://www.cepheid.com/en-CH/tests/oncology-human-genetics/xpert-breast-cancer-strat4.htmldaily1.0https://www.cepheid.com/en-CH/tests/oncology-human-genetics/xpert-bladder-cancer-detection.htmldaily1.0https://www.cepheid.com/en-CH/tests/oncology-human-genetics/xpert-bcr-abl-ultra.htmldaily1.0https://www.cepheid.com/en-CH/systems.htmldaily1.0https://www.cepheid.com/en-CH/systems/genexpert-family-of-systems.htmldaily1.0https://www.cepheid.com/en-CH/systems/genexpert-family-of-systems/genexpert-system.htmldaily1.0https://www.cepheid.com/en-CH/systems/genexpert-family-of-systems/genexpert-infinity.htmldaily1.0https://www.cepheid.com/en-CH/systems/genexpert-software.htmldaily1.0https://www.cepheid.com/en-CH/systems/genexpert-software/gx-software.htmldaily1.0https://www.cepheid.com/en-CH/systems/genexpert-software/xpertise-software.htmldaily1.0https://www.cepheid.com/en-CH/systems/connectivity.htmldaily1.0https://www.cepheid.com/en-CH/systems/connectivity/cepheid-c360.htmldaily1.0https://www.cepheid.com/en-CH/systems/connectivity/interface-capabilities.htmldaily1.0https://www.cepheid.com/en-CH/systems/data-processing-agreement.htmldaily1.0https://www.cepheid.com/en-CH/systems/partner-communities.htmldaily1.0https://www.cepheid.com/en-CH/systems/business-associates-agreement.htmldaily1.0https://www.cepheid.com/en-CH/solutions.htmldaily1.0https://www.cepheid.com/en-CH/solutions/global-access.htmldaily1.0https://www.cepheid.com/en-CH/solutions/global-access/eligibility-and-pricing.htmldaily1.0https://www.cepheid.com/en-CH/solutions/testing-everywhere.htmldaily1.0https://www.cepheid.com/en-CH/solutions/antibiotic-stewardship.htmldaily1.0https://www.cepheid.com/en-CH/solutions/oncology-diagnostics.htmldaily1.0https://www.cepheid.com/en-CH/solutions/customized-testing-institution.htmldaily1.0https://www.cepheid.com/en-CH/solutions/knowing-more-matters.htmldaily1.0https://www.cepheid.com/en-CH/solutions/knowing-more-matters/pcr-vs-antigen.htmldaily1.0https://www.cepheid.com/en-CH/solutions/knowing-more-matters/covid-flu-rsv.htmldaily1.0https://www.cepheid.com/en-CH/insights.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/all-posts.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/respiratory-health.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/respiratory-health/2024/09/proactive-surveillance-to-ensure-broad-flu-strain-detection.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/respiratory-health/2024/09/emerging-evolving-respiratory-viruses-test-design-matters.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/respiratory-health/2024/09/the-genexpert-xpress-system-can-change-your-pediatric-practice.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/respiratory-health/2024/09/Norwegian-ED-improves-Resource-Management-with-Rapid-PCR-Testing.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/respiratory-health/2024/09/key-steps-pandemic-preparedness.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/respiratory-health/2025/01/what-does-it-mean-to-have-a-pandemic-ready-pcr-test.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like-ilnesses.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/respiratory-health/2025/03/in-house-pcr-testing-clinical-leaders-explore-the-ripple-effect.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/respiratory-health/2025/04/real-world-clinical-impact-of-in-house-pcr-testing.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/respiratory-health/2025/04/what-is-the-difference-between-pcr-and-antigen-testing.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/respiratory-health/2025/05/a-quick-primer-on-the-adlm-guidance-on-respiratory-virus-testing.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/respiratory-health/2025/09/revolutionizing-respiratory-care-the-power-of-rapid-molecular-testing.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/respiratory-health/2025/09/antigen-testing-vs-pcr-less-haste-more-speed-please.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/respiratory-health/2025/09/the-time-for-widespread-adoption-of-mdx-testing-for-gas-pharyngi.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/respiratory-health/2025/11/why-test-type-matters-pcr-vs-antigen-in-outpatient-respiratory-care.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/respiratory-health/2025/11/transforming-respiratory-tnfection-diagnosis-embracing-molecular-innovation-clinical-practice1.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/respiratory-health/2026/01/staying-ahead-of-influenza.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/respiratory-health/2026/02/revolutionizing-rheumatic-heart-disease-prevention.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2024/09/accelerating-the-pace-for-hep-c-elimination-in-the-us.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2024/09/can-molecular-tests-revolutionize-tuberculosis-control.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2024/09/near-patient-testing-for-hep-c-xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2024/09/danish-hcv-testing-program-improves-patient-management-and-access.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2024/09/faster-prison-testing-for-hcv-drastically-improves-treatment-in-the-uk.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2024/09/innovative-POC-testing-shortens-time-between-testing-and-treatment.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2024/09/finnish-hospital-improves-care-for-expectant-mothers-with-gbs-pcr-screening.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2024/09/a-not-for-profit-in-vietnam-fights-to-end-tuberculosis.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2024/09/cepheid-expands-in-india-to-support-global-efforts-to-fight-tb.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2024/09/covid-19-and-tuberculosis-testing-in-south-africa.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2024/09/cepheid-supports-the-international-mpox-emergency-declared-august-2024.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2024/10/hpv-testing-south-african-clinic-may-prevent-cervical-cancer.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2024/12/strides-toward-early-infant-diagnosis-for-hiv-elimination-in-sou.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2025/02/common-misconceptions-about-vaginitis.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2025/05/revisiting-bacterial-vaginosis-evidence-for-sexual-transmission.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2025/05/a-breakthrough-in-hcv-elimination--how-hcv-point-of-care-rna-tes.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2025/05/decentralising-diagnostics-bringing-patient-centred-testing-closer-to-communities.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2025/05/integration-of-poc-viral-diagnostics-with-substance-use-disorder-treatment-to-improve-hepatitis-c-nfection-outcomes.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2025/04/tuberculosis-staying-one-step-ahead.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2025/04/how-three-countries-are-fighting-back-against-tuberculosis.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2025/04/a-mdr-tb-survivor-in-india-shares-her-remarkable-story.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2025/06/womens-health-testing-advantages-of-same-day-diagnosis-and-treatment.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2025/03/the-fight-to-end-tuberculosis-in-pakistan.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2025/03/devasena-gnanashanmugam-discusses-cepheids-global-access-program.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2025/03/desmond-tutu-foundation-reduces-impact-of-hiv-and-tb.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2025/03/tuberculosis-care-and-treatment-in-the-republic-of-indonesia.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2025/03/finding-missing-tuberculosis-tb-cases-philippines-need-for-speed.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2025/03/a-decade-of-health-and-economic-benefits-infographic.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2025/03/state-tb-in-us-overlooked-opportunity-better-results.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2025/03/fighting-tb-everything-10-years-of-impact-in-south-africa.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2025/07/five-surprising-stats-that-reveal-the-hidden-burden-of-vaginitis.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2025/07/5-ways-vaginitis-treatment-goes-wrong-and-how-better-testing-can-fix-It.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2025/09/in-memory-of-john-bishop-a-visionary-leader-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2025/12/wecare-humanitarian-medical-mission.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2025/08/kentucky-viral-hepatitis-treatment-projects-mission-to-eradicate-hcv.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2025/08/the-state-of-vaginitis-testing-in-the-us.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2025/08/improving-vaginitis-care-through-better-diagnostics.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2025/10/time-to-act-stopping-group-b-strep-infections-in-newborn-babies.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2025/10/real-user-experiences-with-xpert-xpress-mvp-oint-of-care-test.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2026/02/advancing-pandemic-preparedness-through-public-private-collaboration.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/community-and-global-health/2026/02/hepatitis-c-elimination-in-the-us-is-within-reach-experts-report.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/tech-disease-trends.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/tech-disease-trends/2024/09/candida-auris--rising-threat-and-future-implications.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/tech-disease-trends/2024/09/discussing-pharma-clinical-trials-utilizing-poc-diagnostics.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/tech-disease-trends/2024/09/poc-testing-increases-the-efficiency-of-patient-management-in-the-ed.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/tech-disease-trends/2024/10/dave-persing-legacy-and-leadership-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/tech-disease-trends/2024/11/invasive-group-streptococcal-disease.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/tech-disease-trends/2024/11/what-is-pcr--understanding-the-magic.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/tech-disease-trends/2024/11/decentralized-pcr-testing-and-the-quadruple-aim-insights-for-health-systems.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/tech-disease-trends/2025/01/how-a-cepheid-molecular-test-is-made.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/tech-disease-trends/2025/04/standardization-of-pcr-testing-across-healthcare-testing-sites.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/tech-disease-trends/2025/06/innovation-in-times-of-need-cepheids-legacy-of-outbreak-response.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/tech-disease-trends/2025/07/celebrating-the-cepheid-bike-where-art-meets-innovation.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/tech-disease-trends/2025/09/cepheid-advances-innovation-and-reach-with-key-partnerships.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/tech-disease-trends/2025/10/learn-about-cepheid-system-innovation.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/tech-disease-trends/2025/11/multiplex-with-meaning--cepheid-s-smart-approach-to-molecular-di.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/antimicrobial-stewardship.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/antimicrobial-stewardship/2024/09/a-public-health-dialogue-on-antibiotic-resistance-surveillance.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/antimicrobial-stewardship/2024/09/mortality-associated-with-carbapenem-resistant-gram-negative-infections.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/antimicrobial-stewardship/2024/09/decentralized-testing-for-the-surveillance-of-hospital-acquired-infections.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/antimicrobial-stewardship/2024/09/rapid-mrsa-screening-of-ortho-trauma-patients-improves-experience.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/antimicrobial-stewardship/2024/09/pcr-screening-at-a-british-hospital-enables-timely-infection-control.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/antimicrobial-stewardship/2024/10/fleming-initiative-cepheid-announce-partnership-tackle-amr.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/antimicrobial-stewardship/2024/10/link-between-colonization-multi-drug-resistant-infection.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/antimicrobial-stewardship/2024/12/point-of-care-testing-emergency-department-faster-decision-making-halle.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-shulz.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-schulz.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/antimicrobial-stewardship/2025/05/antimicrobial-and-diagnostic-stewardship-frost-and-sullivan-visual-whitepaper.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/antimicrobial-stewardship/2025/08/industry-voices-time-to-rethink-our-approach-to-using-modern-medicine.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/antimicrobial-stewardship/2025/09/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/antimicrobial-stewardship/2025/10/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/antimicrobial-stewardship/2025/11/vanessa-carter-s-journey--inspiring-action-against-amr.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/antimicrobial-stewardship/2025/11/advancing-antimicrobial-stewardship-in-small-and-rural-hospital.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/expert-spotlight.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/expert-spotlight/2025/10/expert-spotlight--michael-loeffelholz.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--devasena-gnanashanmugam-vice-president--me.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--jennifer-rakeman-cagno-senior-director--sc.htmldaily1.0https://www.cepheid.com/en-CH/insights/insight-hub/expert-spotlight/2026/02/expert-spotlight-jordan-chase.htmldaily1.0https://www.cepheid.com/en-CH/insights/webinars.htmldaily1.0https://www.cepheid.com/en-CH/insights/resources.htmldaily1.0https://www.cepheid.com/en-CH/support.htmldaily1.0https://www.cepheid.com/en-CH/support/ivdr-update.htmldaily1.0https://www.cepheid.com/en-CH/support/contact-us.htmldaily1.0https://www.cepheid.com/en-CH/about.htmldaily1.0https://www.cepheid.com/en-CH/about/mission-history.htmldaily1.0https://www.cepheid.com/en-CH/about/leadership.htmldaily1.0https://www.cepheid.com/en-CH/about/leadership/vitor-rocha.htmldaily1.0https://www.cepheid.com/en-CH/about/leadership/laurent-bellon.htmldaily1.0https://www.cepheid.com/en-CH/about/leadership/anette-engelhardt.htmldaily1.0https://www.cepheid.com/en-CH/about/leadership/peter-farrell.htmldaily1.0https://www.cepheid.com/en-CH/about/leadership/deborah-gonyea.htmldaily1.0https://www.cepheid.com/en-CH/about/leadership/nichole-halsey.htmldaily1.0https://www.cepheid.com/en-CH/about/leadership/luben-li.htmldaily1.0https://www.cepheid.com/en-CH/about/leadership/luke-maitland.htmldaily1.0https://www.cepheid.com/en-CH/about/leadership/david-h-persing.htmldaily1.0https://www.cepheid.com/en-CH/about/leadership/ammar-qadan.htmldaily1.0https://www.cepheid.com/en-CH/about/leadership/charles-mwangi.htmldaily1.0https://www.cepheid.com/en-CH/about/leadership/samson-wu.htmldaily1.0https://www.cepheid.com/en-CH/about/leadership/anupama-mokkapati.htmldaily1.0https://www.cepheid.com/en-CH/about/leadership/traci-wicks.htmldaily1.0https://www.cepheid.com/en-CH/about/leadership/scott-campbell.htmldaily1.0https://www.cepheid.com/en-CH/about/leadership/anne-beauburn.htmldaily1.0https://www.cepheid.com/en-CH/about/leadership/patrick-harkins.htmldaily1.0https://www.cepheid.com/en-CH/about/leadership/ephraim-tsalik.htmldaily1.0https://www.cepheid.com/en-CH/about/leadership/somesh-lalithraj.htmldaily1.0https://www.cepheid.com/en-CH/about/leadership/connie-savor.htmldaily1.0https://www.cepheid.com/en-CH/about/sustainability.htmldaily1.0https://www.cepheid.com/en-CH/about/sustainability/environmental-sustainability.htmldaily1.0https://www.cepheid.com/en-CH/about/sustainability/product-stewardship.htmldaily1.0https://www.cepheid.com/en-CH/about/sustainability/conflict-materials.htmldaily1.0https://www.cepheid.com/en-CH/about/policies-reports.htmldaily1.0https://www.cepheid.com/en-CH/about/business-development-opportunities.htmldaily1.0https://www.cepheid.com/en-CH/about/events.htmldaily1.0https://www.cepheid.com/en-CH/about/innovation-form.htmldaily1.0https://www.cepheid.com/en-CH/about/innovation-form/unsolicited-submission-agreement.htmldaily1.0https://www.cepheid.com/en-CH/about/sars-cov-2-test-development-information.htmldaily1.0https://www.cepheid.com/en-CH/about/sars-cov-2-product-resources.htmldaily1.0https://www.cepheid.com/en-CH/contact/select-info-path.htmldaily1.0https://www.cepheid.com/en-CH/contact/messages/thank-you.htmldaily1.0https://www.cepheid.com/en-CH/contact/messages/thank-you-patient-pathways.htmldaily1.0https://www.cepheid.com/en-CH/contact/messages/thank-you-patient-pathways-fr.htmldaily1.0https://www.cepheid.com/en-CH/contact/messages/thank-you-patient-pathways-de.htmldaily1.0https://www.cepheid.com/en-CH/contact/messages/thank-you-patient-pathways-it.htmldaily1.0https://www.cepheid.com/en-CH/contact/messages/thank-you-patient-pathways-sp.htmldaily1.0https://www.cepheid.com/en-CH/contact/messages/thank-you-patient-pathways-pl.htmldaily1.0https://www.cepheid.com/en-CH/contact/messages/thank-you-patient-pathways-pt.htmldaily1.0https://www.cepheid.com/en-CH/contact/request-cd-international.htmldaily1.0https://www.cepheid.com/en-CH/personas/laboratory-professionals.htmldaily1.0https://www.cepheid.com/en-CH/personas/healthcare-professsional.htmldaily1.0https://www.cepheid.com/en-CH/personas/health-system-administrators.htmldaily1.0https://www.cepheid.com/en-CH/legal/privacy.htmldaily1.0https://www.cepheid.com/en-CH/legal/terms-of-use.htmldaily1.0https://www.cepheid.com/en-CH/legal/product-security-updates.htmldaily1.0https://www.cepheid.com/en-CH/legal/terms-of-sale.htmldaily1.0https://www.cepheid.com/en-CH/legal/trademarks.htmldaily1.0https://www.cepheid.com/en-CH/legal/cookies-notice.htmldaily1.0https://www.cepheid.com/en-CH/campaigns/2020-emea-renewed-messaging/french/patient-pathways.htmldaily1.0https://www.cepheid.com/en-CH/campaigns/2020-emea-renewed-messaging/german/patient-pathways.htmldaily1.0https://www.cepheid.com/en-CH/campaigns/2020-emea-renewed-messaging/italian/patient-pathways.htmldaily1.0https://www.cepheid.com/en-CH/campaigns/2020-emea-renewed-messaging/portuguese/patient-pathways.htmldaily1.0https://www.cepheid.com/en-CH/campaigns/2020-emea-renewed-messaging/polish/patient-pathways.htmldaily1.0https://www.cepheid.com/en-CH/campaigns/india/cepheid-india.htmldaily1.0https://www.cepheid.com/en-CH/campaigns/india/india-submission.htmldaily1.0https://www.cepheid.com/en-CH/campaigns/india/cepheid-india-display.htmldaily1.0https://www.cepheid.com/en-CH/campaigns/india/cepheid-india-bangladesh.htmldaily1.0https://www.cepheid.com/en-CH/campaigns/pcr-plus.htmldaily1.0https://www.cepheid.com/en-CH/coronavirus-portfolio.htmldaily1.0https://www.cepheid.com/en-CY.htmldaily1.0https://www.cepheid.com/en-CY/tests.htmldaily1.0https://www.cepheid.com/en-CY/tests/respiratory.htmldaily1.0https://www.cepheid.com/en-CY/tests/respiratory/xpert-xpress-strep-a.htmldaily1.0https://www.cepheid.com/en-CY/tests/respiratory/xpert-xpress-cov-2-plus.htmldaily1.0https://www.cepheid.com/en-CY/tests/respiratory/xpert-xpress-flu-rsv.htmldaily1.0https://www.cepheid.com/en-CY/tests/respiratory/xpert-xpress-cov-2-flu-rsv-plus.htmldaily1.0https://www.cepheid.com/en-CY/tests/hai-other-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-CY/tests/hai-other-infectious-diseases/xpert-sa-nasal-complete.htmldaily1.0https://www.cepheid.com/en-CY/tests/hai-other-infectious-diseases/xpert-mrsa-sa-ssti.htmldaily1.0https://www.cepheid.com/en-CY/tests/hai-other-infectious-diseases/xpert-c-difficile-bt.htmldaily1.0https://www.cepheid.com/en-CY/tests/hai-other-infectious-diseases/xpert-norovirus.htmldaily1.0https://www.cepheid.com/en-CY/tests/hai-other-infectious-diseases/xpert-mrsa-sa-blood-culture.htmldaily1.0https://www.cepheid.com/en-CY/tests/hai-other-infectious-diseases/xpert-vana-vanb.htmldaily1.0https://www.cepheid.com/en-CY/tests/hai-other-infectious-diseases/xpert-mrsa-nxg.htmldaily1.0https://www.cepheid.com/en-CY/tests/hai-other-infectious-diseases/xpert-carba-r.htmldaily1.0https://www.cepheid.com/en-CY/tests/blood-virology-womens-health-sexual-health.htmldaily1.0https://www.cepheid.com/en-CY/tests/blood-virology-womens-health-sexual-health/xpert-hbv-viral-load.htmldaily1.0https://www.cepheid.com/en-CY/tests/blood-virology-womens-health-sexual-health/resistanceplusmg-flexible.htmldaily1.0https://www.cepheid.com/en-CY/tests/blood-virology-womens-health-sexual-health/xpert-xpress-gbs.htmldaily1.0https://www.cepheid.com/en-CY/tests/blood-virology-womens-health-sexual-health/xpert-ct-ng.htmldaily1.0https://www.cepheid.com/en-CY/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-qual-xc.htmldaily1.0https://www.cepheid.com/en-CY/tests/blood-virology-womens-health-sexual-health/xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-CY/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-viral-load-xc.htmldaily1.0https://www.cepheid.com/en-CY/tests/blood-virology-womens-health-sexual-health/xpert-tv.htmldaily1.0https://www.cepheid.com/en-CY/tests/blood-virology-womens-health-sexual-health/xpert-hpv-v2.htmldaily1.0https://www.cepheid.com/en-CY/tests/blood-virology-womens-health-sexual-health/xpert-hcv-viral-load.htmldaily1.0https://www.cepheid.com/en-CY/tests/tb-emerging-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-CY/tests/tb-emerging-infectious-diseases/xpert-mtb-xdr.htmldaily1.0https://www.cepheid.com/en-CY/tests/tb-emerging-infectious-diseases/xpert-mtb-rif-ultra.htmldaily1.0https://www.cepheid.com/en-CY/tests/oncology-human-genetics.htmldaily1.0https://www.cepheid.com/en-CY/tests/oncology-human-genetics/expert-bladder-cancer-monitor.htmldaily1.0https://www.cepheid.com/en-CY/tests/oncology-human-genetics/xpert-fii-fv.htmldaily1.0https://www.cepheid.com/en-CY/tests/oncology-human-genetics/xpert-bcr-abl-ultra-p190.htmldaily1.0https://www.cepheid.com/en-CY/tests/oncology-human-genetics/xpert-breast-cancer-strat4.htmldaily1.0https://www.cepheid.com/en-CY/tests/oncology-human-genetics/xpert-bladder-cancer-detection.htmldaily1.0https://www.cepheid.com/en-CY/tests/oncology-human-genetics/xpert-bcr-abl-ultra.htmldaily1.0https://www.cepheid.com/en-CY/tests/oncology-human-genetics/xpert-npm1-mutation.htmldaily1.0https://www.cepheid.com/en-CY/systems.htmldaily1.0https://www.cepheid.com/en-CY/systems/genexpert-family-of-systems.htmldaily1.0https://www.cepheid.com/en-CY/systems/genexpert-family-of-systems/genexpert-system.htmldaily1.0https://www.cepheid.com/en-CY/systems/genexpert-family-of-systems/genexpert-infinity.htmldaily1.0https://www.cepheid.com/en-CY/systems/genexpert-software.htmldaily1.0https://www.cepheid.com/en-CY/systems/genexpert-software/gx-software.htmldaily1.0https://www.cepheid.com/en-CY/systems/genexpert-software/xpertise-software.htmldaily1.0https://www.cepheid.com/en-CY/systems/connectivity.htmldaily1.0https://www.cepheid.com/en-CY/systems/connectivity/cepheid-c360.htmldaily1.0https://www.cepheid.com/en-CY/systems/connectivity/interface-capabilities.htmldaily1.0https://www.cepheid.com/en-CY/systems/data-processing-agreement.htmldaily1.0https://www.cepheid.com/en-CY/systems/partner-communities.htmldaily1.0https://www.cepheid.com/en-CY/systems/business-associates-agreement.htmldaily1.0https://www.cepheid.com/en-CY/solutions.htmldaily1.0https://www.cepheid.com/en-CY/solutions/global-access.htmldaily1.0https://www.cepheid.com/en-CY/solutions/global-access/eligibility-and-pricing.htmldaily1.0https://www.cepheid.com/en-CY/solutions/testing-everywhere.htmldaily1.0https://www.cepheid.com/en-CY/solutions/antibiotic-stewardship.htmldaily1.0https://www.cepheid.com/en-CY/solutions/oncology-diagnostics.htmldaily1.0https://www.cepheid.com/en-CY/solutions/customized-testing-institution.htmldaily1.0https://www.cepheid.com/en-CY/solutions/knowing-more-matters.htmldaily1.0https://www.cepheid.com/en-CY/solutions/knowing-more-matters/pcr-vs-antigen.htmldaily1.0https://www.cepheid.com/en-CY/solutions/knowing-more-matters/covid-flu-rsv.htmldaily1.0https://www.cepheid.com/en-CY/insights.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/all-posts.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/respiratory-health.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/respiratory-health/2024/09/proactive-surveillance-to-ensure-broad-flu-strain-detection.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/respiratory-health/2024/09/emerging-evolving-respiratory-viruses-test-design-matters.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/respiratory-health/2024/09/the-genexpert-xpress-system-can-change-your-pediatric-practice.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/respiratory-health/2024/09/Norwegian-ED-improves-Resource-Management-with-Rapid-PCR-Testing.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/respiratory-health/2024/09/key-steps-pandemic-preparedness.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/respiratory-health/2025/01/what-does-it-mean-to-have-a-pandemic-ready-pcr-test.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like-ilnesses.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/respiratory-health/2025/03/in-house-pcr-testing-clinical-leaders-explore-the-ripple-effect.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/respiratory-health/2025/04/real-world-clinical-impact-of-in-house-pcr-testing.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/respiratory-health/2025/04/what-is-the-difference-between-pcr-and-antigen-testing.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/respiratory-health/2025/05/a-quick-primer-on-the-adlm-guidance-on-respiratory-virus-testing.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/respiratory-health/2025/09/revolutionizing-respiratory-care-the-power-of-rapid-molecular-testing.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/respiratory-health/2025/09/antigen-testing-vs-pcr-less-haste-more-speed-please.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/respiratory-health/2025/09/the-time-for-widespread-adoption-of-mdx-testing-for-gas-pharyngi.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/respiratory-health/2025/11/why-test-type-matters-pcr-vs-antigen-in-outpatient-respiratory-care.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/respiratory-health/2025/11/transforming-respiratory-tnfection-diagnosis-embracing-molecular-innovation-clinical-practice1.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/respiratory-health/2026/01/staying-ahead-of-influenza.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/respiratory-health/2026/02/revolutionizing-rheumatic-heart-disease-prevention.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2024/09/accelerating-the-pace-for-hep-c-elimination-in-the-us.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2024/09/can-molecular-tests-revolutionize-tuberculosis-control.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2024/09/near-patient-testing-for-hep-c-xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2024/09/danish-hcv-testing-program-improves-patient-management-and-access.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2024/09/faster-prison-testing-for-hcv-drastically-improves-treatment-in-the-uk.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2024/09/innovative-POC-testing-shortens-time-between-testing-and-treatment.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2024/09/finnish-hospital-improves-care-for-expectant-mothers-with-gbs-pcr-screening.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2024/09/a-not-for-profit-in-vietnam-fights-to-end-tuberculosis.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2024/09/cepheid-expands-in-india-to-support-global-efforts-to-fight-tb.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2024/09/covid-19-and-tuberculosis-testing-in-south-africa.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2024/09/cepheid-supports-the-international-mpox-emergency-declared-august-2024.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2024/10/hpv-testing-south-african-clinic-may-prevent-cervical-cancer.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2024/12/strides-toward-early-infant-diagnosis-for-hiv-elimination-in-sou.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2025/02/common-misconceptions-about-vaginitis.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2025/05/revisiting-bacterial-vaginosis-evidence-for-sexual-transmission.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2025/05/a-breakthrough-in-hcv-elimination--how-hcv-point-of-care-rna-tes.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2025/05/decentralising-diagnostics-bringing-patient-centred-testing-closer-to-communities.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2025/05/integration-of-poc-viral-diagnostics-with-substance-use-disorder-treatment-to-improve-hepatitis-c-nfection-outcomes.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2025/04/tuberculosis-staying-one-step-ahead.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2025/04/how-three-countries-are-fighting-back-against-tuberculosis.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2025/04/a-mdr-tb-survivor-in-india-shares-her-remarkable-story.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2025/06/womens-health-testing-advantages-of-same-day-diagnosis-and-treatment.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2025/07/five-surprising-stats-that-reveal-the-hidden-burden-of-vaginitis.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2025/07/5-ways-vaginitis-treatment-goes-wrong-and-how-better-testing-can-fix-It.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2025/03/the-fight-to-end-tuberculosis-in-pakistan.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2025/03/devasena-gnanashanmugam-discusses-cepheids-global-access-program.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2025/03/desmond-tutu-foundation-reduces-impact-of-hiv-and-tb.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2025/03/tuberculosis-care-and-treatment-in-the-republic-of-indonesia.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2025/03/finding-missing-tuberculosis-tb-cases-philippines-need-for-speed.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2025/03/a-decade-of-health-and-economic-benefits-infographic.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2025/03/state-tb-in-us-overlooked-opportunity-better-results.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2025/03/fighting-tb-everything-10-years-of-impact-in-south-africa.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2025/09/in-memory-of-john-bishop-a-visionary-leader-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2025/12/wecare-humanitarian-medical-mission.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2025/10/time-to-act-stopping-group-b-strep-infections-in-newborn-babies.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2025/10/real-user-experiences-with-xpert-xpress-mvp-oint-of-care-test.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2025/08/kentucky-viral-hepatitis-treatment-projects-mission-to-eradicate-hcv.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2025/08/the-state-of-vaginitis-testing-in-the-us.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2025/08/improving-vaginitis-care-through-better-diagnostics.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2026/02/advancing-pandemic-preparedness-through-public-private-collaboration.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/community-and-global-health/2026/02/hepatitis-c-elimination-in-the-us-is-within-reach-experts-report.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/tech-disease-trends.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/tech-disease-trends/2024/09/candida-auris--rising-threat-and-future-implications.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/tech-disease-trends/2024/09/discussing-pharma-clinical-trials-utilizing-poc-diagnostics.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/tech-disease-trends/2024/09/poc-testing-increases-the-efficiency-of-patient-management-in-the-ed.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/tech-disease-trends/2024/10/dave-persing-legacy-and-leadership-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/tech-disease-trends/2024/11/invasive-group-streptococcal-disease.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/tech-disease-trends/2024/11/what-is-pcr--understanding-the-magic.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/tech-disease-trends/2024/11/decentralized-pcr-testing-and-the-quadruple-aim-insights-for-health-systems.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/tech-disease-trends/2025/01/how-a-cepheid-molecular-test-is-made.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct-.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/tech-disease-trends/2025/04/standardization-of-pcr-testing-across-healthcare-testing-sites.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/tech-disease-trends/2025/06/innovation-in-times-of-need-cepheids-legacy-of-outbreak-response.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/tech-disease-trends/2025/07/celebrating-the-cepheid-bike-where-art-meets-innovation.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/tech-disease-trends/2025/09/cepheid-advances-innovation-and-reach-with-key-partnerships.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/tech-disease-trends/2025/10/learn-about-cepheid-system-innovation.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/tech-disease-trends/2025/11/multiplex-with-meaning--cepheid-s-smart-approach-to-molecular-di.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/antimicrobial-stewardship.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/antimicrobial-stewardship/2024/09/a-public-health-dialogue-on-antibiotic-resistance-surveillance.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/antimicrobial-stewardship/2024/09/mortality-associated-with-carbapenem-resistant-gram-negative-infections.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/antimicrobial-stewardship/2024/09/decentralized-testing-for-the-surveillance-of-hospital-acquired-infections.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/antimicrobial-stewardship/2024/09/rapid-mrsa-screening-of-ortho-trauma-patients-improves-experience.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/antimicrobial-stewardship/2024/09/pcr-screening-at-a-british-hospital-enables-timely-infection-control.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/antimicrobial-stewardship/2024/10/fleming-initiative-cepheid-announce-partnership-tackle-amr.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/antimicrobial-stewardship/2024/10/link-between-colonization-multi-drug-resistant-infection.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/antimicrobial-stewardship/2024/12/point-of-care-testing-emergency-department-faster-decision-making-halle.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-shulz.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-schulz.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/antimicrobial-stewardship/2025/05/antimicrobial-and-diagnostic-stewardship-frost-and-sullivan-visual-whitepaper.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/antimicrobial-stewardship/2025/08/industry-voices-time-to-rethink-our-approach-to-using-modern-medicine.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/antimicrobial-stewardship/2025/09/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/antimicrobial-stewardship/2025/10/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/antimicrobial-stewardship/2025/11/vanessa-carter-s-journey--inspiring-action-against-amr.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/antimicrobial-stewardship/2025/11/advancing-antimicrobial-stewardship-in-small-and-rural-hospital.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/expert-spotlight.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/expert-spotlight/2025/10/expert-spotlight--michael-loeffelholz.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--devasena-gnanashanmugam-vice-president--me.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--jennifer-rakeman-cagno-senior-director--sc.htmldaily1.0https://www.cepheid.com/en-CY/insights/insight-hub/expert-spotlight/2026/02/expert-spotlight-jordan-chase.htmldaily1.0https://www.cepheid.com/en-CY/insights/webinars.htmldaily1.0https://www.cepheid.com/en-CY/insights/resources.htmldaily1.0https://www.cepheid.com/en-CY/support.htmldaily1.0https://www.cepheid.com/en-CY/support/ivdr-update.htmldaily1.0https://www.cepheid.com/en-CY/support/contact-us.htmldaily1.0https://www.cepheid.com/en-CY/about.htmldaily1.0https://www.cepheid.com/en-CY/about/mission-history.htmldaily1.0https://www.cepheid.com/en-CY/about/leadership.htmldaily1.0https://www.cepheid.com/en-CY/about/leadership/vitor-rocha.htmldaily1.0https://www.cepheid.com/en-CY/about/leadership/laurent-bellon.htmldaily1.0https://www.cepheid.com/en-CY/about/leadership/anette-engelhardt.htmldaily1.0https://www.cepheid.com/en-CY/about/leadership/peter-farrell.htmldaily1.0https://www.cepheid.com/en-CY/about/leadership/deborah-gonyea.htmldaily1.0https://www.cepheid.com/en-CY/about/leadership/nichole-halsey.htmldaily1.0https://www.cepheid.com/en-CY/about/leadership/luben-li.htmldaily1.0https://www.cepheid.com/en-CY/about/leadership/luke-maitland.htmldaily1.0https://www.cepheid.com/en-CY/about/leadership/david-h-persing.htmldaily1.0https://www.cepheid.com/en-CY/about/leadership/ammar-qadan.htmldaily1.0https://www.cepheid.com/en-CY/about/leadership/charles-mwangi.htmldaily1.0https://www.cepheid.com/en-CY/about/leadership/samson-wu.htmldaily1.0https://www.cepheid.com/en-CY/about/leadership/anupama-mokkapati.htmldaily1.0https://www.cepheid.com/en-CY/about/leadership/traci-wicks.htmldaily1.0https://www.cepheid.com/en-CY/about/leadership/scott-campbell.htmldaily1.0https://www.cepheid.com/en-CY/about/leadership/anne-beauburn.htmldaily1.0https://www.cepheid.com/en-CY/about/leadership/patrick-harkins.htmldaily1.0https://www.cepheid.com/en-CY/about/leadership/ephraim-tsalik.htmldaily1.0https://www.cepheid.com/en-CY/about/leadership/somesh-lalithraj.htmldaily1.0https://www.cepheid.com/en-CY/about/leadership/connie-savor.htmldaily1.0https://www.cepheid.com/en-CY/about/sustainability.htmldaily1.0https://www.cepheid.com/en-CY/about/sustainability/environmental-sustainability.htmldaily1.0https://www.cepheid.com/en-CY/about/sustainability/product-stewardship.htmldaily1.0https://www.cepheid.com/en-CY/about/sustainability/conflict-materials.htmldaily1.0https://www.cepheid.com/en-CY/about/policies-reports.htmldaily1.0https://www.cepheid.com/en-CY/about/business-development-opportunities.htmldaily1.0https://www.cepheid.com/en-CY/about/events.htmldaily1.0https://www.cepheid.com/en-CY/about/innovation-form.htmldaily1.0https://www.cepheid.com/en-CY/about/innovation-form/unsolicited-submission-agreement.htmldaily1.0https://www.cepheid.com/en-CY/about/sars-cov-2-test-development-information.htmldaily1.0https://www.cepheid.com/en-CY/about/sars-cov-2-product-resources.htmldaily1.0https://www.cepheid.com/en-CY/contact/select-info-path.htmldaily1.0https://www.cepheid.com/en-CY/contact/messages/thank-you.htmldaily1.0https://www.cepheid.com/en-CY/contact/messages/thank-you-patient-pathways.htmldaily1.0https://www.cepheid.com/en-CY/contact/messages/thank-you-patient-pathways-fr.htmldaily1.0https://www.cepheid.com/en-CY/contact/messages/thank-you-patient-pathways-de.htmldaily1.0https://www.cepheid.com/en-CY/contact/messages/thank-you-patient-pathways-it.htmldaily1.0https://www.cepheid.com/en-CY/contact/messages/thank-you-patient-pathways-sp.htmldaily1.0https://www.cepheid.com/en-CY/contact/messages/thank-you-patient-pathways-pl.htmldaily1.0https://www.cepheid.com/en-CY/contact/messages/thank-you-patient-pathways-pt.htmldaily1.0https://www.cepheid.com/en-CY/contact/request-cd-international.htmldaily1.0https://www.cepheid.com/en-CY/personas/laboratory-professionals.htmldaily1.0https://www.cepheid.com/en-CY/personas/healthcare-professsional.htmldaily1.0https://www.cepheid.com/en-CY/personas/health-system-administrators.htmldaily1.0https://www.cepheid.com/en-CY/legal/privacy.htmldaily1.0https://www.cepheid.com/en-CY/legal/terms-of-use.htmldaily1.0https://www.cepheid.com/en-CY/legal/product-security-updates.htmldaily1.0https://www.cepheid.com/en-CY/legal/terms-of-sale.htmldaily1.0https://www.cepheid.com/en-CY/legal/trademarks.htmldaily1.0https://www.cepheid.com/en-CY/legal/cookies-notice.htmldaily1.0https://www.cepheid.com/en-CY/campaigns/2020-emea-renewed-messaging/french/patient-pathways.htmldaily1.0https://www.cepheid.com/en-CY/campaigns/2020-emea-renewed-messaging/german/patient-pathways.htmldaily1.0https://www.cepheid.com/en-CY/campaigns/2020-emea-renewed-messaging/italian/patient-pathways.htmldaily1.0https://www.cepheid.com/en-CY/campaigns/2020-emea-renewed-messaging/portuguese/patient-pathways.htmldaily1.0https://www.cepheid.com/en-CY/campaigns/2020-emea-renewed-messaging/polish/patient-pathways.htmldaily1.0https://www.cepheid.com/en-CY/campaigns/india/cepheid-india.htmldaily1.0https://www.cepheid.com/en-CY/campaigns/india/india-submission.htmldaily1.0https://www.cepheid.com/en-CY/campaigns/india/cepheid-india-display.htmldaily1.0https://www.cepheid.com/en-CY/campaigns/india/cepheid-india-bangladesh.htmldaily1.0https://www.cepheid.com/en-CY/campaigns/pcr-plus.htmldaily1.0https://www.cepheid.com/en-CY/coronavirus-portfolio.htmldaily1.0https://www.cepheid.com/en-CZ.htmldaily1.0https://www.cepheid.com/en-CZ/tests.htmldaily1.0https://www.cepheid.com/en-CZ/tests/respiratory.htmldaily1.0https://www.cepheid.com/en-CZ/tests/respiratory/xpert-xpress-strep-a.htmldaily1.0https://www.cepheid.com/en-CZ/tests/respiratory/xpert-xpress-cov-2-plus.htmldaily1.0https://www.cepheid.com/en-CZ/tests/respiratory/xpert-xpress-flu-rsv.htmldaily1.0https://www.cepheid.com/en-CZ/tests/respiratory/xpert-xpress-cov-2-flu-rsv-plus.htmldaily1.0https://www.cepheid.com/en-CZ/tests/hai-other-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-CZ/tests/hai-other-infectious-diseases/xpert-sa-nasal-complete.htmldaily1.0https://www.cepheid.com/en-CZ/tests/hai-other-infectious-diseases/xpert-mrsa-sa-ssti.htmldaily1.0https://www.cepheid.com/en-CZ/tests/hai-other-infectious-diseases/xpert-c-difficile-bt.htmldaily1.0https://www.cepheid.com/en-CZ/tests/hai-other-infectious-diseases/xpert-norovirus.htmldaily1.0https://www.cepheid.com/en-CZ/tests/hai-other-infectious-diseases/xpert-mrsa-sa-blood-culture.htmldaily1.0https://www.cepheid.com/en-CZ/tests/hai-other-infectious-diseases/xpert-vana-vanb.htmldaily1.0https://www.cepheid.com/en-CZ/tests/hai-other-infectious-diseases/xpert-mrsa-nxg.htmldaily1.0https://www.cepheid.com/en-CZ/tests/hai-other-infectious-diseases/xpert-carba-r.htmldaily1.0https://www.cepheid.com/en-CZ/tests/blood-virology-womens-health-sexual-health.htmldaily1.0https://www.cepheid.com/en-CZ/tests/blood-virology-womens-health-sexual-health/xpert-hbv-viral-load.htmldaily1.0https://www.cepheid.com/en-CZ/tests/blood-virology-womens-health-sexual-health/resistanceplusmg-flexible.htmldaily1.0https://www.cepheid.com/en-CZ/tests/blood-virology-womens-health-sexual-health/xpert-xpress-gbs.htmldaily1.0https://www.cepheid.com/en-CZ/tests/blood-virology-womens-health-sexual-health/xpert-ct-ng.htmldaily1.0https://www.cepheid.com/en-CZ/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-qual-xc.htmldaily1.0https://www.cepheid.com/en-CZ/tests/blood-virology-womens-health-sexual-health/xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-CZ/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-viral-load-xc.htmldaily1.0https://www.cepheid.com/en-CZ/tests/blood-virology-womens-health-sexual-health/xpert-tv.htmldaily1.0https://www.cepheid.com/en-CZ/tests/blood-virology-womens-health-sexual-health/xpert-hpv-v2.htmldaily1.0https://www.cepheid.com/en-CZ/tests/blood-virology-womens-health-sexual-health/xpert-hcv-viral-load.htmldaily1.0https://www.cepheid.com/en-CZ/tests/tb-emerging-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-CZ/tests/tb-emerging-infectious-diseases/xpert-mtb-xdr.htmldaily1.0https://www.cepheid.com/en-CZ/tests/tb-emerging-infectious-diseases/xpert-mtb-rif-ultra.htmldaily1.0https://www.cepheid.com/en-CZ/tests/oncology-human-genetics.htmldaily1.0https://www.cepheid.com/en-CZ/tests/oncology-human-genetics/expert-bladder-cancer-monitor.htmldaily1.0https://www.cepheid.com/en-CZ/tests/oncology-human-genetics/xpert-fii-fv.htmldaily1.0https://www.cepheid.com/en-CZ/tests/oncology-human-genetics/xpert-bcr-abl-ultra-p190.htmldaily1.0https://www.cepheid.com/en-CZ/tests/oncology-human-genetics/xpert-breast-cancer-strat4.htmldaily1.0https://www.cepheid.com/en-CZ/tests/oncology-human-genetics/xpert-bladder-cancer-detection.htmldaily1.0https://www.cepheid.com/en-CZ/tests/oncology-human-genetics/xpert-bcr-abl-ultra.htmldaily1.0https://www.cepheid.com/en-CZ/tests/oncology-human-genetics/xpert-npm1-mutation.htmldaily1.0https://www.cepheid.com/en-CZ/systems.htmldaily1.0https://www.cepheid.com/en-CZ/systems/genexpert-family-of-systems.htmldaily1.0https://www.cepheid.com/en-CZ/systems/genexpert-family-of-systems/genexpert-system.htmldaily1.0https://www.cepheid.com/en-CZ/systems/genexpert-family-of-systems/genexpert-infinity.htmldaily1.0https://www.cepheid.com/en-CZ/systems/genexpert-software.htmldaily1.0https://www.cepheid.com/en-CZ/systems/genexpert-software/gx-software.htmldaily1.0https://www.cepheid.com/en-CZ/systems/genexpert-software/xpertise-software.htmldaily1.0https://www.cepheid.com/en-CZ/systems/connectivity.htmldaily1.0https://www.cepheid.com/en-CZ/systems/connectivity/cepheid-c360.htmldaily1.0https://www.cepheid.com/en-CZ/systems/connectivity/interface-capabilities.htmldaily1.0https://www.cepheid.com/en-CZ/systems/data-processing-agreement.htmldaily1.0https://www.cepheid.com/en-CZ/systems/partner-communities.htmldaily1.0https://www.cepheid.com/en-CZ/systems/business-associates-agreement.htmldaily1.0https://www.cepheid.com/en-CZ/solutions.htmldaily1.0https://www.cepheid.com/en-CZ/solutions/global-access.htmldaily1.0https://www.cepheid.com/en-CZ/solutions/global-access/eligibility-and-pricing.htmldaily1.0https://www.cepheid.com/en-CZ/solutions/testing-everywhere.htmldaily1.0https://www.cepheid.com/en-CZ/solutions/antibiotic-stewardship.htmldaily1.0https://www.cepheid.com/en-CZ/solutions/oncology-diagnostics.htmldaily1.0https://www.cepheid.com/en-CZ/solutions/customized-testing-institution.htmldaily1.0https://www.cepheid.com/en-CZ/solutions/knowing-more-matters.htmldaily1.0https://www.cepheid.com/en-CZ/solutions/knowing-more-matters/pcr-vs-antigen.htmldaily1.0https://www.cepheid.com/en-CZ/solutions/knowing-more-matters/covid-flu-rsv.htmldaily1.0https://www.cepheid.com/en-CZ/insights.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/all-posts.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/respiratory-health.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/respiratory-health/2024/09/proactive-surveillance-to-ensure-broad-flu-strain-detection.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/respiratory-health/2024/09/emerging-evolving-respiratory-viruses-test-design-matters.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/respiratory-health/2024/09/the-genexpert-xpress-system-can-change-your-pediatric-practice.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/respiratory-health/2024/09/Norwegian-ED-improves-Resource-Management-with-Rapid-PCR-Testing.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/respiratory-health/2024/09/key-steps-pandemic-preparedness.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/respiratory-health/2025/01/what-does-it-mean-to-have-a-pandemic-ready-pcr-test.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like-ilnesses.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/respiratory-health/2025/03/in-house-pcr-testing-clinical-leaders-explore-the-ripple-effect.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/respiratory-health/2025/04/real-world-clinical-impact-of-in-house-pcr-testing.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/respiratory-health/2025/04/what-is-the-difference-between-pcr-and-antigen-testing.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/respiratory-health/2025/05/a-quick-primer-on-the-adlm-guidance-on-respiratory-virus-testing.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/respiratory-health/2025/09/revolutionizing-respiratory-care-the-power-of-rapid-molecular-testing.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/respiratory-health/2025/09/antigen-testing-vs-pcr-less-haste-more-speed-please.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/respiratory-health/2025/09/the-time-for-widespread-adoption-of-mdx-testing-for-gas-pharyngi.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/respiratory-health/2025/11/why-test-type-matters-pcr-vs-antigen-in-outpatient-respiratory-care.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/respiratory-health/2025/11/transforming-respiratory-tnfection-diagnosis-embracing-molecular-innovation-clinical-practice1.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/respiratory-health/2026/01/staying-ahead-of-influenza.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/respiratory-health/2026/02/revolutionizing-rheumatic-heart-disease-prevention.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2024/09/accelerating-the-pace-for-hep-c-elimination-in-the-us.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2024/09/can-molecular-tests-revolutionize-tuberculosis-control.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2024/09/near-patient-testing-for-hep-c-xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2024/09/danish-hcv-testing-program-improves-patient-management-and-access.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2024/09/faster-prison-testing-for-hcv-drastically-improves-treatment-in-the-uk.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2024/09/innovative-POC-testing-shortens-time-between-testing-and-treatment.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2024/09/finnish-hospital-improves-care-for-expectant-mothers-with-gbs-pcr-screening.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2024/09/a-not-for-profit-in-vietnam-fights-to-end-tuberculosis.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2024/09/cepheid-expands-in-india-to-support-global-efforts-to-fight-tb.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2024/09/covid-19-and-tuberculosis-testing-in-south-africa.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2024/09/cepheid-supports-the-international-mpox-emergency-declared-august-2024.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2024/10/hpv-testing-south-african-clinic-may-prevent-cervical-cancer.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2024/12/strides-toward-early-infant-diagnosis-for-hiv-elimination-in-sou.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2025/02/common-misconceptions-about-vaginitis.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2025/05/revisiting-bacterial-vaginosis-evidence-for-sexual-transmission.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2025/05/a-breakthrough-in-hcv-elimination--how-hcv-point-of-care-rna-tes.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2025/05/decentralising-diagnostics-bringing-patient-centred-testing-closer-to-communities.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2025/05/integration-of-poc-viral-diagnostics-with-substance-use-disorder-treatment-to-improve-hepatitis-c-nfection-outcomes.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2025/04/tuberculosis-staying-one-step-ahead.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2025/04/how-three-countries-are-fighting-back-against-tuberculosis.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2025/04/a-mdr-tb-survivor-in-india-shares-her-remarkable-story.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2025/06/womens-health-testing-advantages-of-same-day-diagnosis-and-treatment.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2025/07/five-surprising-stats-that-reveal-the-hidden-burden-of-vaginitis.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2025/07/5-ways-vaginitis-treatment-goes-wrong-and-how-better-testing-can-fix-It.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2025/03/the-fight-to-end-tuberculosis-in-pakistan.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2025/03/devasena-gnanashanmugam-discusses-cepheids-global-access-program.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2025/03/desmond-tutu-foundation-reduces-impact-of-hiv-and-tb.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2025/03/tuberculosis-care-and-treatment-in-the-republic-of-indonesia.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2025/03/finding-missing-tuberculosis-tb-cases-philippines-need-for-speed.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2025/03/a-decade-of-health-and-economic-benefits-infographic.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2025/03/state-tb-in-us-overlooked-opportunity-better-results.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2025/03/fighting-tb-everything-10-years-of-impact-in-south-africa.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2025/09/in-memory-of-john-bishop-a-visionary-leader-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2025/12/wecare-humanitarian-medical-mission.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2025/08/kentucky-viral-hepatitis-treatment-projects-mission-to-eradicate-hcv.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2025/08/the-state-of-vaginitis-testing-in-the-us.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2025/08/improving-vaginitis-care-through-better-diagnostics.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2025/10/time-to-act-stopping-group-b-strep-infections-in-newborn-babies.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2025/10/real-user-experiences-with-xpert-xpress-mvp-oint-of-care-test.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2026/02/advancing-pandemic-preparedness-through-public-private-collaboration.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/community-and-global-health/2026/02/hepatitis-c-elimination-in-the-us-is-within-reach-experts-report.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/tech-disease-trends.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/tech-disease-trends/2024/09/candida-auris--rising-threat-and-future-implications.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/tech-disease-trends/2024/09/discussing-pharma-clinical-trials-utilizing-poc-diagnostics.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/tech-disease-trends/2024/09/poc-testing-increases-the-efficiency-of-patient-management-in-the-ed.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/tech-disease-trends/2024/10/dave-persing-legacy-and-leadership-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/tech-disease-trends/2024/11/invasive-group-streptococcal-disease.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/tech-disease-trends/2024/11/what-is-pcr--understanding-the-magic.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/tech-disease-trends/2024/11/decentralized-pcr-testing-and-the-quadruple-aim-insights-for-health-systems.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/tech-disease-trends/2025/01/how-a-cepheid-molecular-test-is-made.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/tech-disease-trends/2025/04/standardization-of-pcr-testing-across-healthcare-testing-sites.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/tech-disease-trends/2025/06/innovation-in-times-of-need-cepheids-legacy-of-outbreak-response.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/tech-disease-trends/2025/07/celebrating-the-cepheid-bike-where-art-meets-innovation.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/tech-disease-trends/2025/09/cepheid-advances-innovation-and-reach-with-key-partnerships.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/tech-disease-trends/2025/10/learn-about-cepheid-system-innovation.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/tech-disease-trends/2025/11/multiplex-with-meaning--cepheid-s-smart-approach-to-molecular-di.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/antimicrobial-stewardship.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/antimicrobial-stewardship/2024/09/a-public-health-dialogue-on-antibiotic-resistance-surveillance.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/antimicrobial-stewardship/2024/09/mortality-associated-with-carbapenem-resistant-gram-negative-infections.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/antimicrobial-stewardship/2024/09/decentralized-testing-for-the-surveillance-of-hospital-acquired-infections.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/antimicrobial-stewardship/2024/09/rapid-mrsa-screening-of-ortho-trauma-patients-improves-experience.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/antimicrobial-stewardship/2024/09/pcr-screening-at-a-british-hospital-enables-timely-infection-control.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/antimicrobial-stewardship/2024/10/fleming-initiative-cepheid-announce-partnership-tackle-amr.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/antimicrobial-stewardship/2024/10/link-between-colonization-multi-drug-resistant-infection.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/antimicrobial-stewardship/2024/12/point-of-care-testing-emergency-department-faster-decision-making-halle.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-schulz.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/antimicrobial-stewardship/2025/05/antimicrobial-and-diagnostic-stewardship-frost-and-sullivan-visual-whitepaper.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/antimicrobial-stewardship/2025/08/industry-voices-time-to-rethink-our-approach-to-using-modern-medicine.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/antimicrobial-stewardship/2025/09/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/antimicrobial-stewardship/2025/10/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/antimicrobial-stewardship/2025/11/vanessa-carter-s-journey--inspiring-action-against-amr.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/antimicrobial-stewardship/2025/11/advancing-antimicrobial-stewardship-in-small-and-rural-hospital.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/expert-spotlight.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/expert-spotlight/2025/10/expert-spotlight--michael-loeffelholz.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--devasena-gnanashanmugam-vice-president--me.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--jennifer-rakeman-cagno-senior-director--sc.htmldaily1.0https://www.cepheid.com/en-CZ/insights/insight-hub/expert-spotlight/2026/02/expert-spotlight-jordan-chase.htmldaily1.0https://www.cepheid.com/en-CZ/insights/webinars.htmldaily1.0https://www.cepheid.com/en-CZ/insights/resources.htmldaily1.0https://www.cepheid.com/en-CZ/support.htmldaily1.0https://www.cepheid.com/en-CZ/support/ivdr-update.htmldaily1.0https://www.cepheid.com/en-CZ/support/contact-us.htmldaily1.0https://www.cepheid.com/en-CZ/about.htmldaily1.0https://www.cepheid.com/en-CZ/about/mission-history.htmldaily1.0https://www.cepheid.com/en-CZ/about/leadership.htmldaily1.0https://www.cepheid.com/en-CZ/about/leadership/vitor-rocha.htmldaily1.0https://www.cepheid.com/en-CZ/about/leadership/laurent-bellon.htmldaily1.0https://www.cepheid.com/en-CZ/about/leadership/anette-engelhardt.htmldaily1.0https://www.cepheid.com/en-CZ/about/leadership/peter-farrell.htmldaily1.0https://www.cepheid.com/en-CZ/about/leadership/deborah-gonyea.htmldaily1.0https://www.cepheid.com/en-CZ/about/leadership/nichole-halsey.htmldaily1.0https://www.cepheid.com/en-CZ/about/leadership/luben-li.htmldaily1.0https://www.cepheid.com/en-CZ/about/leadership/luke-maitland.htmldaily1.0https://www.cepheid.com/en-CZ/about/leadership/david-h-persing.htmldaily1.0https://www.cepheid.com/en-CZ/about/leadership/ammar-qadan.htmldaily1.0https://www.cepheid.com/en-CZ/about/leadership/charles-mwangi.htmldaily1.0https://www.cepheid.com/en-CZ/about/leadership/samson-wu.htmldaily1.0https://www.cepheid.com/en-CZ/about/leadership/anupama-mokkapati.htmldaily1.0https://www.cepheid.com/en-CZ/about/leadership/traci-wicks.htmldaily1.0https://www.cepheid.com/en-CZ/about/leadership/scott-campbell.htmldaily1.0https://www.cepheid.com/en-CZ/about/leadership/anne-beauburn.htmldaily1.0https://www.cepheid.com/en-CZ/about/leadership/patrick-harkins.htmldaily1.0https://www.cepheid.com/en-CZ/about/leadership/ephraim-tsalik.htmldaily1.0https://www.cepheid.com/en-CZ/about/leadership/somesh-lalithraj.htmldaily1.0https://www.cepheid.com/en-CZ/about/leadership/connie-savor.htmldaily1.0https://www.cepheid.com/en-CZ/about/sustainability.htmldaily1.0https://www.cepheid.com/en-CZ/about/sustainability/environmental-sustainability.htmldaily1.0https://www.cepheid.com/en-CZ/about/sustainability/product-stewardship.htmldaily1.0https://www.cepheid.com/en-CZ/about/sustainability/conflict-materials.htmldaily1.0https://www.cepheid.com/en-CZ/about/policies-reports.htmldaily1.0https://www.cepheid.com/en-CZ/about/business-development-opportunities.htmldaily1.0https://www.cepheid.com/en-CZ/about/events.htmldaily1.0https://www.cepheid.com/en-CZ/about/innovation-form.htmldaily1.0https://www.cepheid.com/en-CZ/about/innovation-form/unsolicited-submission-agreement.htmldaily1.0https://www.cepheid.com/en-CZ/about/sars-cov-2-test-development-information.htmldaily1.0https://www.cepheid.com/en-CZ/about/sars-cov-2-product-resources.htmldaily1.0https://www.cepheid.com/en-CZ/contact/select-info-path.htmldaily1.0https://www.cepheid.com/en-CZ/contact/messages/thank-you.htmldaily1.0https://www.cepheid.com/en-CZ/contact/messages/thank-you-patient-pathways.htmldaily1.0https://www.cepheid.com/en-CZ/contact/messages/thank-you-patient-pathways-fr.htmldaily1.0https://www.cepheid.com/en-CZ/contact/messages/thank-you-patient-pathways-de.htmldaily1.0https://www.cepheid.com/en-CZ/contact/messages/thank-you-patient-pathways-it.htmldaily1.0https://www.cepheid.com/en-CZ/contact/messages/thank-you-patient-pathways-sp.htmldaily1.0https://www.cepheid.com/en-CZ/contact/messages/thank-you-patient-pathways-pl.htmldaily1.0https://www.cepheid.com/en-CZ/contact/messages/thank-you-patient-pathways-pt.htmldaily1.0https://www.cepheid.com/en-CZ/contact/request-cd-international.htmldaily1.0https://www.cepheid.com/en-CZ/personas/laboratory-professionals.htmldaily1.0https://www.cepheid.com/en-CZ/personas/healthcare-professsional.htmldaily1.0https://www.cepheid.com/en-CZ/personas/health-system-administrators.htmldaily1.0https://www.cepheid.com/en-CZ/legal/privacy.htmldaily1.0https://www.cepheid.com/en-CZ/legal/terms-of-use.htmldaily1.0https://www.cepheid.com/en-CZ/legal/product-security-updates.htmldaily1.0https://www.cepheid.com/en-CZ/legal/terms-of-sale.htmldaily1.0https://www.cepheid.com/en-CZ/legal/trademarks.htmldaily1.0https://www.cepheid.com/en-CZ/legal/cookies-notice.htmldaily1.0https://www.cepheid.com/en-CZ/campaigns/2020-emea-renewed-messaging/french/patient-pathways.htmldaily1.0https://www.cepheid.com/en-CZ/campaigns/2020-emea-renewed-messaging/german/patient-pathways.htmldaily1.0https://www.cepheid.com/en-CZ/campaigns/2020-emea-renewed-messaging/italian/patient-pathways.htmldaily1.0https://www.cepheid.com/en-CZ/campaigns/2020-emea-renewed-messaging/portuguese/patient-pathways.htmldaily1.0https://www.cepheid.com/en-CZ/campaigns/2020-emea-renewed-messaging/polish/patient-pathways.htmldaily1.0https://www.cepheid.com/en-CZ/campaigns/india/cepheid-india.htmldaily1.0https://www.cepheid.com/en-CZ/campaigns/india/india-submission.htmldaily1.0https://www.cepheid.com/en-CZ/campaigns/india/cepheid-india-display.htmldaily1.0https://www.cepheid.com/en-CZ/campaigns/india/cepheid-india-bangladesh.htmldaily1.0https://www.cepheid.com/en-CZ/campaigns/pcr-plus.htmldaily1.0https://www.cepheid.com/en-CZ/coronavirus-portfolio.htmldaily1.0https://www.cepheid.com/en-DK.htmldaily1.0https://www.cepheid.com/en-DK/tests.htmldaily1.0https://www.cepheid.com/en-DK/tests/respiratory.htmldaily1.0https://www.cepheid.com/en-DK/tests/respiratory/xpert-xpress-strep-a.htmldaily1.0https://www.cepheid.com/en-DK/tests/respiratory/xpert-xpress-cov-2-plus.htmldaily1.0https://www.cepheid.com/en-DK/tests/respiratory/xpert-xpress-flu-rsv.htmldaily1.0https://www.cepheid.com/en-DK/tests/respiratory/xpert-xpress-cov-2-flu-rsv-plus.htmldaily1.0https://www.cepheid.com/en-DK/tests/hai-other-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-DK/tests/hai-other-infectious-diseases/xpert-sa-nasal-complete.htmldaily1.0https://www.cepheid.com/en-DK/tests/hai-other-infectious-diseases/xpert-mrsa-sa-ssti.htmldaily1.0https://www.cepheid.com/en-DK/tests/hai-other-infectious-diseases/xpert-c-difficile-bt.htmldaily1.0https://www.cepheid.com/en-DK/tests/hai-other-infectious-diseases/xpert-norovirus.htmldaily1.0https://www.cepheid.com/en-DK/tests/hai-other-infectious-diseases/xpert-mrsa-sa-blood-culture.htmldaily1.0https://www.cepheid.com/en-DK/tests/hai-other-infectious-diseases/xpert-vana-vanb.htmldaily1.0https://www.cepheid.com/en-DK/tests/hai-other-infectious-diseases/xpert-mrsa-nxg.htmldaily1.0https://www.cepheid.com/en-DK/tests/hai-other-infectious-diseases/xpert-carba-r.htmldaily1.0https://www.cepheid.com/en-DK/tests/blood-virology-womens-health-sexual-health.htmldaily1.0https://www.cepheid.com/en-DK/tests/blood-virology-womens-health-sexual-health/xpert-hbv-viral-load.htmldaily1.0https://www.cepheid.com/en-DK/tests/blood-virology-womens-health-sexual-health/resistanceplusmg-flexible.htmldaily1.0https://www.cepheid.com/en-DK/tests/blood-virology-womens-health-sexual-health/xpert-xpress-gbs.htmldaily1.0https://www.cepheid.com/en-DK/tests/blood-virology-womens-health-sexual-health/xpert-ct-ng.htmldaily1.0https://www.cepheid.com/en-DK/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-qual-xc.htmldaily1.0https://www.cepheid.com/en-DK/tests/blood-virology-womens-health-sexual-health/xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-DK/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-viral-load-xc.htmldaily1.0https://www.cepheid.com/en-DK/tests/blood-virology-womens-health-sexual-health/xpert-tv.htmldaily1.0https://www.cepheid.com/en-DK/tests/blood-virology-womens-health-sexual-health/xpert-hpv-v2.htmldaily1.0https://www.cepheid.com/en-DK/tests/blood-virology-womens-health-sexual-health/xpert-hcv-viral-load.htmldaily1.0https://www.cepheid.com/en-DK/tests/tb-emerging-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-DK/tests/tb-emerging-infectious-diseases/xpert-mtb-xdr.htmldaily1.0https://www.cepheid.com/en-DK/tests/tb-emerging-infectious-diseases/xpert-mtb-rif-ultra.htmldaily1.0https://www.cepheid.com/en-DK/tests/oncology-human-genetics.htmldaily1.0https://www.cepheid.com/en-DK/tests/oncology-human-genetics/expert-bladder-cancer-monitor.htmldaily1.0https://www.cepheid.com/en-DK/tests/oncology-human-genetics/xpert-fii-fv.htmldaily1.0https://www.cepheid.com/en-DK/tests/oncology-human-genetics/xpert-bcr-abl-ultra-p190.htmldaily1.0https://www.cepheid.com/en-DK/tests/oncology-human-genetics/xpert-bladder-cancer-detection.htmldaily1.0https://www.cepheid.com/en-DK/tests/oncology-human-genetics/xpert-bcr-abl-ultra.htmldaily1.0https://www.cepheid.com/en-DK/tests/oncology-human-genetics/xpert-npm1-mutation.htmldaily1.0https://www.cepheid.com/en-DK/systems.htmldaily1.0https://www.cepheid.com/en-DK/systems/genexpert-family-of-systems.htmldaily1.0https://www.cepheid.com/en-DK/systems/genexpert-family-of-systems/genexpert-system.htmldaily1.0https://www.cepheid.com/en-DK/systems/genexpert-family-of-systems/genexpert-infinity.htmldaily1.0https://www.cepheid.com/en-DK/systems/genexpert-software.htmldaily1.0https://www.cepheid.com/en-DK/systems/genexpert-software/gx-software.htmldaily1.0https://www.cepheid.com/en-DK/systems/genexpert-software/xpertise-software.htmldaily1.0https://www.cepheid.com/en-DK/systems/connectivity.htmldaily1.0https://www.cepheid.com/en-DK/systems/connectivity/cepheid-c360.htmldaily1.0https://www.cepheid.com/en-DK/systems/connectivity/interface-capabilities.htmldaily1.0https://www.cepheid.com/en-DK/systems/data-processing-agreement.htmldaily1.0https://www.cepheid.com/en-DK/systems/partner-communities.htmldaily1.0https://www.cepheid.com/en-DK/systems/business-associates-agreement.htmldaily1.0https://www.cepheid.com/en-DK/solutions.htmldaily1.0https://www.cepheid.com/en-DK/solutions/global-access.htmldaily1.0https://www.cepheid.com/en-DK/solutions/global-access/eligibility-and-pricing.htmldaily1.0https://www.cepheid.com/en-DK/solutions/testing-everywhere.htmldaily1.0https://www.cepheid.com/en-DK/solutions/antibiotic-stewardship.htmldaily1.0https://www.cepheid.com/en-DK/solutions/customized-testing-institution.htmldaily1.0https://www.cepheid.com/en-DK/solutions/knowing-more-matters.htmldaily1.0https://www.cepheid.com/en-DK/solutions/knowing-more-matters/pcr-vs-antigen.htmldaily1.0https://www.cepheid.com/en-DK/solutions/knowing-more-matters/covid-flu-rsv.htmldaily1.0https://www.cepheid.com/en-DK/insights.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/all-posts.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/respiratory-health.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/respiratory-health/2024/09/proactive-surveillance-to-ensure-broad-flu-strain-detection.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/respiratory-health/2024/09/emerging-evolving-respiratory-viruses-test-design-matters.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/respiratory-health/2024/09/the-genexpert-xpress-system-can-change-your-pediatric-practice.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/respiratory-health/2024/09/Norwegian-ED-improves-Resource-Management-with-Rapid-PCR-Testing.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/respiratory-health/2024/09/key-steps-pandemic-preparedness.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/respiratory-health/2025/01/what-does-it-mean-to-have-a--pandemic-ready--pcr-test-.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/respiratory-health/2025/01/what-does-it-mean-to-have-a-pandemic-ready-pcr-test.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like-ilnesses.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/respiratory-health/2025/03/in-house-pcr-testing-clinical-leaders-explore-the-ripple-effect.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/respiratory-health/2025/04/real-world-clinical-impact-of-in-house-pcr-testing.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/respiratory-health/2025/04/what-is-the-difference-between-pcr-and-antigen-testing.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/respiratory-health/2025/05/a-quick-primer-on-the-adlm-guidance-on-respiratory-virus-testing.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/respiratory-health/2025/09/revolutionizing-respiratory-care-the-power-of-rapid-molecular-testing.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/respiratory-health/2025/09/antigen-testing-vs-pcr-less-haste-more-speed-please.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/respiratory-health/2025/09/the-time-for-widespread-adoption-of-mdx-testing-for-gas-pharyngi.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/respiratory-health/2025/11/why-test-type-matters-pcr-vs-antigen-in-outpatient-respiratory-care.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/respiratory-health/2025/11/transforming-respiratory-tnfection-diagnosis-embracing-molecular-innovation-clinical-practice1.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/respiratory-health/2026/01/staying-ahead-of-influenza.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/respiratory-health/2026/02/revolutionizing-rheumatic-heart-disease-prevention.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2024/09/accelerating-the-pace-for-hep-c-elimination-in-the-us.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2024/09/can-molecular-tests-revolutionize-tuberculosis-control.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2024/09/near-patient-testing-for-hep-c-xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2024/09/danish-hcv-testing-program-improves-patient-management-and-access.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2024/09/faster-prison-testing-for-hcv-drastically-improves-treatment-in-the-uk.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2024/09/innovative-POC-testing-shortens-time-between-testing-and-treatment.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2024/09/finnish-hospital-improves-care-for-expectant-mothers-with-gbs-pcr-screening.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2024/09/a-not-for-profit-in-vietnam-fights-to-end-tuberculosis.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2024/09/cepheid-expands-in-india-to-support-global-efforts-to-fight-tb.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2024/09/covid-19-and-tuberculosis-testing-in-south-africa.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2024/09/cepheid-supports-the-international-mpox-emergency-declared-august-2024.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2024/10/hpv-testing-south-african-clinic-may-prevent-cervical-cancer.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2024/12/strides-toward-early-infant-diagnosis-for-hiv-elimination-in-sou.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2025/02/common-misconceptions-about-vaginitis.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2025/05/revisiting-bacterial-vaginosis-evidence-for-sexual-transmission.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2025/05/a-breakthrough-in-hcv-elimination--how-hcv-point-of-care-rna-tes.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2025/05/decentralising-diagnostics-bringing-patient-centred-testing-closer-to-communities.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2025/05/integration-of-poc-viral-diagnostics-with-substance-use-disorder-treatment-to-improve-hepatitis-c-nfection-outcomes.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2025/06/womens-health-testing-advantages-of-same-day-diagnosis-and-treatment.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2025/04/tuberculosis-staying-one-step-ahead.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2025/04/how-three-countries-are-fighting-back-against-tuberculosis.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2025/04/a-mdr-tb-survivor-in-india-shares-her-remarkable-story.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2025/07/five-surprising-stats-that-reveal-the-hidden-burden-of-vaginitis.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2025/07/5-ways-vaginitis-treatment-goes-wrong-and-how-better-testing-can-fix-It.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2025/03/the-fight-to-end-tuberculosis-in-pakistan.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2025/03/devasena-gnanashanmugam-discusses-cepheids-global-access-program.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2025/03/desmond-tutu-foundation-reduces-impact-of-hiv-and-tb.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2025/03/tuberculosis-care-and-treatment-in-the-republic-of-indonesia.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2025/03/finding-missing-tuberculosis-tb-cases-philippines-need-for-speed.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2025/03/a-decade-of-health-and-economic-benefits-infographic.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2025/03/state-tb-in-us-overlooked-opportunity-better-results.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2025/03/fighting-tb-everything-10-years-of-impact-in-south-africa.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2025/09/in-memory-of-john-bishop-a-visionary-leader-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2025/08/kentucky-viral-hepatitis-treatment-projects-mission-to-eradicate-hcv.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2025/08/the-state-of-vaginitis-testing-in-the-us.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2025/08/improving-vaginitis-care-through-better-diagnostics.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2025/12/wecare-humanitarian-medical-mission.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2025/10/time-to-act-stopping-group-b-strep-infections-in-newborn-babies.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2025/10/real-user-experiences-with-xpert-xpress-mvp-oint-of-care-test.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2026/02/advancing-pandemic-preparedness-through-public-private-collaboration.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/community-and-global-health/2026/02/hepatitis-c-elimination-in-the-us-is-within-reach-experts-report.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/tech-disease-trends.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/tech-disease-trends/2024/09/candida-auris--rising-threat-and-future-implications.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/tech-disease-trends/2024/09/discussing-pharma-clinical-trials-utilizing-poc-diagnostics.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/tech-disease-trends/2024/09/poc-testing-increases-the-efficiency-of-patient-management-in-the-ed.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/tech-disease-trends/2024/10/dave-persing-legacy-and-leadership-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/tech-disease-trends/2024/11/invasive-group-streptococcal-disease.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/tech-disease-trends/2024/11/what-is-pcr--understanding-the-magic.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/tech-disease-trends/2024/11/decentralized-pcr-testing-and-the-quadruple-aim-insights-for-health-systems.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/tech-disease-trends/2025/01/how-a-cepheid-molecular-test-is-made.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/tech-disease-trends/2025/04/standardization-of-pcr-testing-across-healthcare-testing-sites.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/tech-disease-trends/2025/06/innovation-in-times-of-need-cepheids-legacy-of-outbreak-response.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/tech-disease-trends/2025/07/celebrating-the-cepheid-bike-where-art-meets-innovation.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/tech-disease-trends/2025/09/cepheid-advances-innovation-and-reach-with-key-partnerships.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/tech-disease-trends/2025/10/learn-about-cepheid-system-innovation.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/tech-disease-trends/2025/11/multiplex-with-meaning--cepheid-s-smart-approach-to-molecular-di.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/antimicrobial-stewardship.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/antimicrobial-stewardship/2024/09/a-public-health-dialogue-on-antibiotic-resistance-surveillance.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/antimicrobial-stewardship/2024/09/mortality-associated-with-carbapenem-resistant-gram-negative-infections.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/antimicrobial-stewardship/2024/09/decentralized-testing-for-the-surveillance-of-hospital-acquired-infections.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/antimicrobial-stewardship/2024/09/rapid-mrsa-screening-of-ortho-trauma-patients-improves-experience.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/antimicrobial-stewardship/2024/09/pcr-screening-at-a-british-hospital-enables-timely-infection-control.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/antimicrobial-stewardship/2024/10/fleming-initiative-cepheid-announce-partnership-tackle-amr.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/antimicrobial-stewardship/2024/10/link-between-colonization-multi-drug-resistant-infection.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/antimicrobial-stewardship/2024/12/point-of-care-testing-emergency-department-faster-decision-making-halle.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-schulz.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/antimicrobial-stewardship/2025/05/antimicrobial-and-diagnostic-stewardship-frost-and-sullivan-visual-whitepaper.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/antimicrobial-stewardship/2025/08/industry-voices-time-to-rethink-our-approach-to-using-modern-medicine.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/antimicrobial-stewardship/2025/09/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/antimicrobial-stewardship/2025/10/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/antimicrobial-stewardship/2025/11/vanessa-carter-s-journey--inspiring-action-against-amr.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/antimicrobial-stewardship/2025/11/advancing-antimicrobial-stewardship-in-small-and-rural-hospital.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/expert-spotlight.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/expert-spotlight/2025/10/expert-spotlight--michael-loeffelholz.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--devasena-gnanashanmugam-vice-president--me.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--jennifer-rakeman-cagno-senior-director--sc.htmldaily1.0https://www.cepheid.com/en-DK/insights/insight-hub/expert-spotlight/2026/02/expert-spotlight-jordan-chase.htmldaily1.0https://www.cepheid.com/en-DK/insights/webinars.htmldaily1.0https://www.cepheid.com/en-DK/insights/resources.htmldaily1.0https://www.cepheid.com/en-DK/support.htmldaily1.0https://www.cepheid.com/en-DK/support/ivdr-update.htmldaily1.0https://www.cepheid.com/en-DK/support/contact-us.htmldaily1.0https://www.cepheid.com/en-DK/about.htmldaily1.0https://www.cepheid.com/en-DK/about/mission-history.htmldaily1.0https://www.cepheid.com/en-DK/about/leadership.htmldaily1.0https://www.cepheid.com/en-DK/about/leadership/vitor-rocha.htmldaily1.0https://www.cepheid.com/en-DK/about/leadership/laurent-bellon.htmldaily1.0https://www.cepheid.com/en-DK/about/leadership/anette-engelhardt.htmldaily1.0https://www.cepheid.com/en-DK/about/leadership/peter-farrell.htmldaily1.0https://www.cepheid.com/en-DK/about/leadership/deborah-gonyea.htmldaily1.0https://www.cepheid.com/en-DK/about/leadership/nichole-halsey.htmldaily1.0https://www.cepheid.com/en-DK/about/leadership/luben-li.htmldaily1.0https://www.cepheid.com/en-DK/about/leadership/luke-maitland.htmldaily1.0https://www.cepheid.com/en-DK/about/leadership/david-h-persing.htmldaily1.0https://www.cepheid.com/en-DK/about/leadership/ammar-qadan.htmldaily1.0https://www.cepheid.com/en-DK/about/leadership/charles-mwangi.htmldaily1.0https://www.cepheid.com/en-DK/about/leadership/samson-wu.htmldaily1.0https://www.cepheid.com/en-DK/about/leadership/anupama-mokkapati.htmldaily1.0https://www.cepheid.com/en-DK/about/leadership/traci-wicks.htmldaily1.0https://www.cepheid.com/en-DK/about/leadership/scott-campbell.htmldaily1.0https://www.cepheid.com/en-DK/about/leadership/anne-beauburn.htmldaily1.0https://www.cepheid.com/en-DK/about/leadership/patrick-harkins.htmldaily1.0https://www.cepheid.com/en-DK/about/leadership/ephraim-tsalik.htmldaily1.0https://www.cepheid.com/en-DK/about/leadership/somesh-lalithraj.htmldaily1.0https://www.cepheid.com/en-DK/about/leadership/connie-savor.htmldaily1.0https://www.cepheid.com/en-DK/about/sustainability.htmldaily1.0https://www.cepheid.com/en-DK/about/sustainability/environmental-sustainability.htmldaily1.0https://www.cepheid.com/en-DK/about/sustainability/product-stewardship.htmldaily1.0https://www.cepheid.com/en-DK/about/sustainability/conflict-materials.htmldaily1.0https://www.cepheid.com/en-DK/about/policies-reports.htmldaily1.0https://www.cepheid.com/en-DK/about/business-development-opportunities.htmldaily1.0https://www.cepheid.com/en-DK/about/events.htmldaily1.0https://www.cepheid.com/en-DK/about/innovation-form.htmldaily1.0https://www.cepheid.com/en-DK/about/innovation-form/unsolicited-submission-agreement.htmldaily1.0https://www.cepheid.com/en-DK/about/sars-cov-2-test-development-information.htmldaily1.0https://www.cepheid.com/en-DK/about/sars-cov-2-product-resources.htmldaily1.0https://www.cepheid.com/en-DK/contact/select-info-path.htmldaily1.0https://www.cepheid.com/en-DK/contact/messages/thank-you.htmldaily1.0https://www.cepheid.com/en-DK/contact/messages/thank-you-patient-pathways.htmldaily1.0https://www.cepheid.com/en-DK/contact/messages/thank-you-patient-pathways-fr.htmldaily1.0https://www.cepheid.com/en-DK/contact/messages/thank-you-patient-pathways-de.htmldaily1.0https://www.cepheid.com/en-DK/contact/messages/thank-you-patient-pathways-it.htmldaily1.0https://www.cepheid.com/en-DK/contact/messages/thank-you-patient-pathways-sp.htmldaily1.0https://www.cepheid.com/en-DK/contact/messages/thank-you-patient-pathways-pl.htmldaily1.0https://www.cepheid.com/en-DK/contact/messages/thank-you-patient-pathways-pt.htmldaily1.0https://www.cepheid.com/en-DK/contact/request-cd-international.htmldaily1.0https://www.cepheid.com/en-DK/personas/laboratory-professionals.htmldaily1.0https://www.cepheid.com/en-DK/personas/healthcare-professsional.htmldaily1.0https://www.cepheid.com/en-DK/personas/health-system-administrators.htmldaily1.0https://www.cepheid.com/en-DK/legal/privacy.htmldaily1.0https://www.cepheid.com/en-DK/legal/terms-of-use.htmldaily1.0https://www.cepheid.com/en-DK/legal/product-security-updates.htmldaily1.0https://www.cepheid.com/en-DK/legal/terms-of-sale.htmldaily1.0https://www.cepheid.com/en-DK/legal/trademarks.htmldaily1.0https://www.cepheid.com/en-DK/legal/cookies-notice.htmldaily1.0https://www.cepheid.com/en-DK/campaigns/2020-emea-renewed-messaging/french/patient-pathways.htmldaily1.0https://www.cepheid.com/en-DK/campaigns/2020-emea-renewed-messaging/german/patient-pathways.htmldaily1.0https://www.cepheid.com/en-DK/campaigns/2020-emea-renewed-messaging/italian/patient-pathways.htmldaily1.0https://www.cepheid.com/en-DK/campaigns/2020-emea-renewed-messaging/portuguese/patient-pathways.htmldaily1.0https://www.cepheid.com/en-DK/campaigns/2020-emea-renewed-messaging/polish/patient-pathways.htmldaily1.0https://www.cepheid.com/en-DK/campaigns/india/cepheid-india.htmldaily1.0https://www.cepheid.com/en-DK/campaigns/india/india-submission.htmldaily1.0https://www.cepheid.com/en-DK/campaigns/india/cepheid-india-display.htmldaily1.0https://www.cepheid.com/en-DK/campaigns/india/cepheid-india-bangladesh.htmldaily1.0https://www.cepheid.com/en-DK/campaigns/pcr-plus.htmldaily1.0https://www.cepheid.com/en-DK/coronavirus-portfolio.htmldaily1.0https://www.cepheid.com/en-EE.htmldaily1.0https://www.cepheid.com/en-EE/tests.htmldaily1.0https://www.cepheid.com/en-EE/tests/respiratory.htmldaily1.0https://www.cepheid.com/en-EE/tests/respiratory/xpert-xpress-strep-a.htmldaily1.0https://www.cepheid.com/en-EE/tests/respiratory/xpert-xpress-cov-2-plus.htmldaily1.0https://www.cepheid.com/en-EE/tests/respiratory/xpert-xpress-flu-rsv.htmldaily1.0https://www.cepheid.com/en-EE/tests/respiratory/xpert-xpress-cov-2-flu-rsv-plus.htmldaily1.0https://www.cepheid.com/en-EE/tests/hai-other-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-EE/tests/hai-other-infectious-diseases/xpert-sa-nasal-complete.htmldaily1.0https://www.cepheid.com/en-EE/tests/hai-other-infectious-diseases/xpert-mrsa-sa-ssti.htmldaily1.0https://www.cepheid.com/en-EE/tests/hai-other-infectious-diseases/xpert-c-difficile-bt.htmldaily1.0https://www.cepheid.com/en-EE/tests/hai-other-infectious-diseases/xpert-norovirus.htmldaily1.0https://www.cepheid.com/en-EE/tests/hai-other-infectious-diseases/xpert-mrsa-sa-blood-culture.htmldaily1.0https://www.cepheid.com/en-EE/tests/hai-other-infectious-diseases/xpert-vana-vanb.htmldaily1.0https://www.cepheid.com/en-EE/tests/hai-other-infectious-diseases/xpert-mrsa-nxg.htmldaily1.0https://www.cepheid.com/en-EE/tests/hai-other-infectious-diseases/xpert-carba-r.htmldaily1.0https://www.cepheid.com/en-EE/tests/blood-virology-womens-health-sexual-health.htmldaily1.0https://www.cepheid.com/en-EE/tests/blood-virology-womens-health-sexual-health/xpert-hbv-viral-load.htmldaily1.0https://www.cepheid.com/en-EE/tests/blood-virology-womens-health-sexual-health/resistanceplusmg-flexible.htmldaily1.0https://www.cepheid.com/en-EE/tests/blood-virology-womens-health-sexual-health/xpert-xpress-gbs.htmldaily1.0https://www.cepheid.com/en-EE/tests/blood-virology-womens-health-sexual-health/xpert-ct-ng.htmldaily1.0https://www.cepheid.com/en-EE/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-qual-xc.htmldaily1.0https://www.cepheid.com/en-EE/tests/blood-virology-womens-health-sexual-health/xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-EE/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-viral-load-xc.htmldaily1.0https://www.cepheid.com/en-EE/tests/blood-virology-womens-health-sexual-health/xpert-tv.htmldaily1.0https://www.cepheid.com/en-EE/tests/blood-virology-womens-health-sexual-health/xpert-hpv-v2.htmldaily1.0https://www.cepheid.com/en-EE/tests/blood-virology-womens-health-sexual-health/xpert-hcv-viral-load.htmldaily1.0https://www.cepheid.com/en-EE/tests/tb-emerging-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-EE/tests/tb-emerging-infectious-diseases/xpert-mtb-xdr.htmldaily1.0https://www.cepheid.com/en-EE/tests/tb-emerging-infectious-diseases/xpert-mtb-rif-ultra.htmldaily1.0https://www.cepheid.com/en-EE/tests/oncology-human-genetics.htmldaily1.0https://www.cepheid.com/en-EE/tests/oncology-human-genetics/expert-bladder-cancer-monitor.htmldaily1.0https://www.cepheid.com/en-EE/tests/oncology-human-genetics/xpert-fii-fv.htmldaily1.0https://www.cepheid.com/en-EE/tests/oncology-human-genetics/xpert-bcr-abl-ultra-p190.htmldaily1.0https://www.cepheid.com/en-EE/tests/oncology-human-genetics/xpert-breast-cancer-strat4.htmldaily1.0https://www.cepheid.com/en-EE/tests/oncology-human-genetics/xpert-bladder-cancer-detection.htmldaily1.0https://www.cepheid.com/en-EE/tests/oncology-human-genetics/xpert-bcr-abl-ultra.htmldaily1.0https://www.cepheid.com/en-EE/tests/oncology-human-genetics/xpert-npm1-mutation.htmldaily1.0https://www.cepheid.com/en-EE/systems.htmldaily1.0https://www.cepheid.com/en-EE/systems/genexpert-family-of-systems.htmldaily1.0https://www.cepheid.com/en-EE/systems/genexpert-family-of-systems/genexpert-system.htmldaily1.0https://www.cepheid.com/en-EE/systems/genexpert-family-of-systems/genexpert-infinity.htmldaily1.0https://www.cepheid.com/en-EE/systems/genexpert-software.htmldaily1.0https://www.cepheid.com/en-EE/systems/genexpert-software/gx-software.htmldaily1.0https://www.cepheid.com/en-EE/systems/genexpert-software/xpertise-software.htmldaily1.0https://www.cepheid.com/en-EE/systems/connectivity.htmldaily1.0https://www.cepheid.com/en-EE/systems/connectivity/cepheid-c360.htmldaily1.0https://www.cepheid.com/en-EE/systems/connectivity/interface-capabilities.htmldaily1.0https://www.cepheid.com/en-EE/systems/data-processing-agreement.htmldaily1.0https://www.cepheid.com/en-EE/systems/partner-communities.htmldaily1.0https://www.cepheid.com/en-EE/systems/business-associates-agreement.htmldaily1.0https://www.cepheid.com/en-EE/solutions.htmldaily1.0https://www.cepheid.com/en-EE/solutions/global-access.htmldaily1.0https://www.cepheid.com/en-EE/solutions/global-access/eligibility-and-pricing.htmldaily1.0https://www.cepheid.com/en-EE/solutions/testing-everywhere.htmldaily1.0https://www.cepheid.com/en-EE/solutions/antibiotic-stewardship.htmldaily1.0https://www.cepheid.com/en-EE/solutions/customized-testing-institution.htmldaily1.0https://www.cepheid.com/en-EE/solutions/knowing-more-matters.htmldaily1.0https://www.cepheid.com/en-EE/solutions/knowing-more-matters/pcr-vs-antigen.htmldaily1.0https://www.cepheid.com/en-EE/solutions/knowing-more-matters/covid-flu-rsv.htmldaily1.0https://www.cepheid.com/en-EE/insights.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/all-posts.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/respiratory-health.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/respiratory-health/2024/09/proactive-surveillance-to-ensure-broad-flu-strain-detection.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/respiratory-health/2024/09/emerging-evolving-respiratory-viruses-test-design-matters.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/respiratory-health/2024/09/the-genexpert-xpress-system-can-change-your-pediatric-practice.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/respiratory-health/2024/09/Norwegian-ED-improves-Resource-Management-with-Rapid-PCR-Testing.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/respiratory-health/2024/09/key-steps-pandemic-preparedness.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/respiratory-health/2025/01/what-does-it-mean-to-have-a-pandemic-ready-pcr-test.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like-ilnesses.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/respiratory-health/2025/03/in-house-pcr-testing-clinical-leaders-explore-the-ripple-effect.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/respiratory-health/2025/04/real-world-clinical-impact-of-in-house-pcr-testing.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/respiratory-health/2025/04/what-is-the-difference-between-pcr-and-antigen-testing.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/respiratory-health/2025/05/a-quick-primer-on-the-adlm-guidance-on-respiratory-virus-testing.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/respiratory-health/2025/09/revolutionizing-respiratory-care-the-power-of-rapid-molecular-testing.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/respiratory-health/2025/09/antigen-testing-vs-pcr-less-haste-more-speed-please.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/respiratory-health/2025/09/the-time-for-widespread-adoption-of-mdx-testing-for-gas-pharyngi.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/respiratory-health/2025/11/why-test-type-matters-pcr-vs-antigen-in-outpatient-respiratory-care.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/respiratory-health/2025/11/transforming-respiratory-tnfection-diagnosis-embracing-molecular-innovation-clinical-practice1.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/respiratory-health/2026/01/staying-ahead-of-influenza.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/respiratory-health/2026/02/revolutionizing-rheumatic-heart-disease-prevention.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2024/09/accelerating-the-pace-for-hep-c-elimination-in-the-us.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2024/09/can-molecular-tests-revolutionize-tuberculosis-control.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2024/09/near-patient-testing-for-hep-c-xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2024/09/danish-hcv-testing-program-improves-patient-management-and-access.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2024/09/faster-prison-testing-for-hcv-drastically-improves-treatment-in-the-uk.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2024/09/innovative-POC-testing-shortens-time-between-testing-and-treatment.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2024/09/finnish-hospital-improves-care-for-expectant-mothers-with-gbs-pcr-screening.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2024/09/a-not-for-profit-in-vietnam-fights-to-end-tuberculosis.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2024/09/cepheid-expands-in-india-to-support-global-efforts-to-fight-tb.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2024/09/covid-19-and-tuberculosis-testing-in-south-africa.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2024/09/cepheid-supports-the-international-mpox-emergency-declared-august-2024.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2024/10/hpv-testing-south-african-clinic-may-prevent-cervical-cancer.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2024/12/strides-toward-early-infant-diagnosis-for-hiv-elimination-in-sou.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2025/02/common-misconceptions-about-vaginitis.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2025/05/revisiting-bacterial-vaginosis-evidence-for-sexual-transmission.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2025/05/a-breakthrough-in-hcv-elimination--how-hcv-point-of-care-rna-tes.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2025/05/decentralising-diagnostics-bringing-patient-centred-testing-closer-to-communities.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2025/05/integration-of-poc-viral-diagnostics-with-substance-use-disorder-treatment-to-improve-hepatitis-c-nfection-outcomes.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2025/06/womens-health-testing-advantages-of-same-day-diagnosis-and-treatment.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2025/04/tuberculosis-staying-one-step-ahead.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2025/04/how-three-countries-are-fighting-back-against-tuberculosis.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2025/04/a-mdr-tb-survivor-in-india-shares-her-remarkable-story.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2025/07/five-surprising-stats-that-reveal-the-hidden-burden-of-vaginitis.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2025/07/5-ways-vaginitis-treatment-goes-wrong-and-how-better-testing-can-fix-It.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2025/03/the-fight-to-end-tuberculosis-in-pakistan.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2025/03/devasena-gnanashanmugam-discusses-cepheids-global-access-program.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2025/03/desmond-tutu-foundation-reduces-impact-of-hiv-and-tb.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2025/03/tuberculosis-care-and-treatment-in-the-republic-of-indonesia.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2025/03/finding-missing-tuberculosis-tb-cases-philippines-need-for-speed.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2025/03/a-decade-of-health-and-economic-benefits-infographic.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2025/03/state-tb-in-us-overlooked-opportunity-better-results.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2025/03/fighting-tb-everything-10-years-of-impact-in-south-africa.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2025/09/in-memory-of-john-bishop-a-visionary-leader-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2025/08/kentucky-viral-hepatitis-treatment-projects-mission-to-eradicate-hcv.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2025/08/the-state-of-vaginitis-testing-in-the-us.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2025/08/improving-vaginitis-care-through-better-diagnostics.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2025/12/wecare-humanitarian-medical-mission.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2025/10/time-to-act-stopping-group-b-strep-infections-in-newborn-babies.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2025/10/real-user-experiences-with-xpert-xpress-mvp-oint-of-care-test.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2026/02/advancing-pandemic-preparedness-through-public-private-collaboration.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/community-and-global-health/2026/02/hepatitis-c-elimination-in-the-us-is-within-reach-experts-report.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/tech-disease-trends.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/tech-disease-trends/2024/09/candida-auris--rising-threat-and-future-implications.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/tech-disease-trends/2024/09/discussing-pharma-clinical-trials-utilizing-poc-diagnostics.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/tech-disease-trends/2024/09/poc-testing-increases-the-efficiency-of-patient-management-in-the-ed.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/tech-disease-trends/2024/10/dave-persing-legacy-and-leadership-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/tech-disease-trends/2024/11/invasive-group-streptococcal-disease.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/tech-disease-trends/2024/11/what-is-pcr--understanding-the-magic.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/tech-disease-trends/2024/11/decentralized-pcr-testing-and-the-quadruple-aim-insights-for-health-systems.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/tech-disease-trends/2025/01/how-a-cepheid-molecular-test-is-made.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct-.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/tech-disease-trends/2025/04/standardization-of-pcr-testing-across-healthcare-testing-sites.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/tech-disease-trends/2025/06/innovation-in-times-of-need-cepheids-legacy-of-outbreak-response.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/tech-disease-trends/2025/07/celebrating-the-cepheid-bike-where-art-meets-innovation.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/tech-disease-trends/2025/09/cepheid-advances-innovation-and-reach-with-key-partnerships.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/tech-disease-trends/2025/10/learn-about-cepheid-system-innovation.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/tech-disease-trends/2025/11/multiplex-with-meaning--cepheid-s-smart-approach-to-molecular-di.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/antimicrobial-stewardship.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/antimicrobial-stewardship/2024/09/a-public-health-dialogue-on-antibiotic-resistance-surveillance.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/antimicrobial-stewardship/2024/09/mortality-associated-with-carbapenem-resistant-gram-negative-infections.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/antimicrobial-stewardship/2024/09/decentralized-testing-for-the-surveillance-of-hospital-acquired-infections.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/antimicrobial-stewardship/2024/09/rapid-mrsa-screening-of-ortho-trauma-patients-improves-experience.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/antimicrobial-stewardship/2024/09/pcr-screening-at-a-british-hospital-enables-timely-infection-control.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/antimicrobial-stewardship/2024/10/fleming-initiative-cepheid-announce-partnership-tackle-amr.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/antimicrobial-stewardship/2024/10/link-between-colonization-multi-drug-resistant-infection.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/antimicrobial-stewardship/2024/12/point-of-care-testing-emergency-department-faster-decision-making-halle.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-shulz.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-schulz.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/antimicrobial-stewardship/2025/05/antimicrobial-and-diagnostic-stewardship-frost-and-sullivan-visual-whitepaper.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/antimicrobial-stewardship/2025/08/industry-voices-time-to-rethink-our-approach-to-using-modern-medicine.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/antimicrobial-stewardship/2025/09/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/antimicrobial-stewardship/2025/10/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/antimicrobial-stewardship/2025/11/vanessa-carter-s-journey--inspiring-action-against-amr.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/antimicrobial-stewardship/2025/11/advancing-antimicrobial-stewardship-in-small-and-rural-hospital.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/expert-spotlight.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/expert-spotlight/2025/10/expert-spotlight--michael-loeffelholz.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--devasena-gnanashanmugam-vice-president--me.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--jennifer-rakeman-cagno-senior-director--sc.htmldaily1.0https://www.cepheid.com/en-EE/insights/insight-hub/expert-spotlight/2026/02/expert-spotlight-jordan-chase.htmldaily1.0https://www.cepheid.com/en-EE/insights/webinars.htmldaily1.0https://www.cepheid.com/en-EE/insights/resources.htmldaily1.0https://www.cepheid.com/en-EE/support.htmldaily1.0https://www.cepheid.com/en-EE/support/ivdr-update.htmldaily1.0https://www.cepheid.com/en-EE/support/contact-us.htmldaily1.0https://www.cepheid.com/en-EE/about.htmldaily1.0https://www.cepheid.com/en-EE/about/mission-history.htmldaily1.0https://www.cepheid.com/en-EE/about/leadership.htmldaily1.0https://www.cepheid.com/en-EE/about/leadership/vitor-rocha.htmldaily1.0https://www.cepheid.com/en-EE/about/leadership/laurent-bellon.htmldaily1.0https://www.cepheid.com/en-EE/about/leadership/anette-engelhardt.htmldaily1.0https://www.cepheid.com/en-EE/about/leadership/peter-farrell.htmldaily1.0https://www.cepheid.com/en-EE/about/leadership/deborah-gonyea.htmldaily1.0https://www.cepheid.com/en-EE/about/leadership/nichole-halsey.htmldaily1.0https://www.cepheid.com/en-EE/about/leadership/luben-li.htmldaily1.0https://www.cepheid.com/en-EE/about/leadership/luke-maitland.htmldaily1.0https://www.cepheid.com/en-EE/about/leadership/david-h-persing.htmldaily1.0https://www.cepheid.com/en-EE/about/leadership/ammar-qadan.htmldaily1.0https://www.cepheid.com/en-EE/about/leadership/charles-mwangi.htmldaily1.0https://www.cepheid.com/en-EE/about/leadership/samson-wu.htmldaily1.0https://www.cepheid.com/en-EE/about/leadership/anupama-mokkapati.htmldaily1.0https://www.cepheid.com/en-EE/about/leadership/traci-wicks.htmldaily1.0https://www.cepheid.com/en-EE/about/leadership/scott-campbell.htmldaily1.0https://www.cepheid.com/en-EE/about/leadership/anne-beauburn.htmldaily1.0https://www.cepheid.com/en-EE/about/leadership/patrick-harkins.htmldaily1.0https://www.cepheid.com/en-EE/about/leadership/ephraim-tsalik.htmldaily1.0https://www.cepheid.com/en-EE/about/leadership/somesh-lalithraj.htmldaily1.0https://www.cepheid.com/en-EE/about/leadership/connie-savor.htmldaily1.0https://www.cepheid.com/en-EE/about/sustainability.htmldaily1.0https://www.cepheid.com/en-EE/about/sustainability/environmental-sustainability.htmldaily1.0https://www.cepheid.com/en-EE/about/sustainability/product-stewardship.htmldaily1.0https://www.cepheid.com/en-EE/about/sustainability/conflict-materials.htmldaily1.0https://www.cepheid.com/en-EE/about/policies-reports.htmldaily1.0https://www.cepheid.com/en-EE/about/business-development-opportunities.htmldaily1.0https://www.cepheid.com/en-EE/about/events.htmldaily1.0https://www.cepheid.com/en-EE/about/innovation-form.htmldaily1.0https://www.cepheid.com/en-EE/about/innovation-form/unsolicited-submission-agreement.htmldaily1.0https://www.cepheid.com/en-EE/about/sars-cov-2-test-development-information.htmldaily1.0https://www.cepheid.com/en-EE/about/sars-cov-2-product-resources.htmldaily1.0https://www.cepheid.com/en-EE/contact/select-info-path.htmldaily1.0https://www.cepheid.com/en-EE/contact/messages/thank-you.htmldaily1.0https://www.cepheid.com/en-EE/contact/messages/thank-you-patient-pathways.htmldaily1.0https://www.cepheid.com/en-EE/contact/messages/thank-you-patient-pathways-fr.htmldaily1.0https://www.cepheid.com/en-EE/contact/messages/thank-you-patient-pathways-de.htmldaily1.0https://www.cepheid.com/en-EE/contact/messages/thank-you-patient-pathways-it.htmldaily1.0https://www.cepheid.com/en-EE/contact/messages/thank-you-patient-pathways-sp.htmldaily1.0https://www.cepheid.com/en-EE/contact/messages/thank-you-patient-pathways-pl.htmldaily1.0https://www.cepheid.com/en-EE/contact/messages/thank-you-patient-pathways-pt.htmldaily1.0https://www.cepheid.com/en-EE/contact/request-cd-international.htmldaily1.0https://www.cepheid.com/en-EE/personas/laboratory-professionals.htmldaily1.0https://www.cepheid.com/en-EE/personas/healthcare-professsional.htmldaily1.0https://www.cepheid.com/en-EE/personas/health-system-administrators.htmldaily1.0https://www.cepheid.com/en-EE/legal/privacy.htmldaily1.0https://www.cepheid.com/en-EE/legal/terms-of-use.htmldaily1.0https://www.cepheid.com/en-EE/legal/product-security-updates.htmldaily1.0https://www.cepheid.com/en-EE/legal/terms-of-sale.htmldaily1.0https://www.cepheid.com/en-EE/legal/trademarks.htmldaily1.0https://www.cepheid.com/en-EE/legal/cookies-notice.htmldaily1.0https://www.cepheid.com/en-EE/campaigns/2020-emea-renewed-messaging/french/patient-pathways.htmldaily1.0https://www.cepheid.com/en-EE/campaigns/2020-emea-renewed-messaging/german/patient-pathways.htmldaily1.0https://www.cepheid.com/en-EE/campaigns/2020-emea-renewed-messaging/italian/patient-pathways.htmldaily1.0https://www.cepheid.com/en-EE/campaigns/2020-emea-renewed-messaging/portuguese/patient-pathways.htmldaily1.0https://www.cepheid.com/en-EE/campaigns/2020-emea-renewed-messaging/polish/patient-pathways.htmldaily1.0https://www.cepheid.com/en-EE/campaigns/india/cepheid-india.htmldaily1.0https://www.cepheid.com/en-EE/campaigns/india/india-submission.htmldaily1.0https://www.cepheid.com/en-EE/campaigns/india/cepheid-india-display.htmldaily1.0https://www.cepheid.com/en-EE/campaigns/india/cepheid-india-bangladesh.htmldaily1.0https://www.cepheid.com/en-EE/campaigns/pcr-plus.htmldaily1.0https://www.cepheid.com/en-EE/coronavirus-portfolio.htmldaily1.0https://www.cepheid.com/en-GR.htmldaily1.0https://www.cepheid.com/en-GR/tests.htmldaily1.0https://www.cepheid.com/en-GR/tests/respiratory.htmldaily1.0https://www.cepheid.com/en-GR/tests/respiratory/xpert-xpress-strep-a.htmldaily1.0https://www.cepheid.com/en-GR/tests/respiratory/xpert-xpress-cov-2-plus.htmldaily1.0https://www.cepheid.com/en-GR/tests/respiratory/xpert-xpress-flu-rsv.htmldaily1.0https://www.cepheid.com/en-GR/tests/respiratory/xpert-xpress-cov-2-flu-rsv-plus.htmldaily1.0https://www.cepheid.com/en-GR/tests/hai-other-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-GR/tests/hai-other-infectious-diseases/xpert-sa-nasal-complete.htmldaily1.0https://www.cepheid.com/en-GR/tests/hai-other-infectious-diseases/xpert-mrsa-sa-ssti.htmldaily1.0https://www.cepheid.com/en-GR/tests/hai-other-infectious-diseases/xpert-c-difficile-bt.htmldaily1.0https://www.cepheid.com/en-GR/tests/hai-other-infectious-diseases/xpert-norovirus.htmldaily1.0https://www.cepheid.com/en-GR/tests/hai-other-infectious-diseases/xpert-mrsa-sa-blood-culture.htmldaily1.0https://www.cepheid.com/en-GR/tests/hai-other-infectious-diseases/xpert-vana-vanb.htmldaily1.0https://www.cepheid.com/en-GR/tests/hai-other-infectious-diseases/xpert-mrsa-nxg.htmldaily1.0https://www.cepheid.com/en-GR/tests/hai-other-infectious-diseases/xpert-carba-r.htmldaily1.0https://www.cepheid.com/en-GR/tests/blood-virology-womens-health-sexual-health.htmldaily1.0https://www.cepheid.com/en-GR/tests/blood-virology-womens-health-sexual-health/xpert-hbv-viral-load.htmldaily1.0https://www.cepheid.com/en-GR/tests/blood-virology-womens-health-sexual-health/resistanceplusmg-flexible.htmldaily1.0https://www.cepheid.com/en-GR/tests/blood-virology-womens-health-sexual-health/xpert-xpress-gbs.htmldaily1.0https://www.cepheid.com/en-GR/tests/blood-virology-womens-health-sexual-health/xpert-ct-ng.htmldaily1.0https://www.cepheid.com/en-GR/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-qual-xc.htmldaily1.0https://www.cepheid.com/en-GR/tests/blood-virology-womens-health-sexual-health/xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-GR/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-viral-load-xc.htmldaily1.0https://www.cepheid.com/en-GR/tests/blood-virology-womens-health-sexual-health/xpert-tv.htmldaily1.0https://www.cepheid.com/en-GR/tests/blood-virology-womens-health-sexual-health/xpert-hpv-v2.htmldaily1.0https://www.cepheid.com/en-GR/tests/blood-virology-womens-health-sexual-health/xpert-hcv-viral-load.htmldaily1.0https://www.cepheid.com/en-GR/tests/tb-emerging-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-GR/tests/tb-emerging-infectious-diseases/xpert-mtb-xdr.htmldaily1.0https://www.cepheid.com/en-GR/tests/tb-emerging-infectious-diseases/xpert-mtb-rif-ultra.htmldaily1.0https://www.cepheid.com/en-GR/tests/oncology-human-genetics.htmldaily1.0https://www.cepheid.com/en-GR/tests/oncology-human-genetics/expert-bladder-cancer-monitor.htmldaily1.0https://www.cepheid.com/en-GR/tests/oncology-human-genetics/xpert-fii-fv.htmldaily1.0https://www.cepheid.com/en-GR/tests/oncology-human-genetics/xpert-bcr-abl-ultra-p190.htmldaily1.0https://www.cepheid.com/en-GR/tests/oncology-human-genetics/xpert-breast-cancer-strat4.htmldaily1.0https://www.cepheid.com/en-GR/tests/oncology-human-genetics/xpert-bladder-cancer-detection.htmldaily1.0https://www.cepheid.com/en-GR/tests/oncology-human-genetics/xpert-bcr-abl-ultra.htmldaily1.0https://www.cepheid.com/en-GR/tests/oncology-human-genetics/xpert-npm1-mutation.htmldaily1.0https://www.cepheid.com/en-GR/systems.htmldaily1.0https://www.cepheid.com/en-GR/systems/genexpert-family-of-systems.htmldaily1.0https://www.cepheid.com/en-GR/systems/genexpert-family-of-systems/genexpert-system.htmldaily1.0https://www.cepheid.com/en-GR/systems/genexpert-family-of-systems/genexpert-infinity.htmldaily1.0https://www.cepheid.com/en-GR/systems/genexpert-software.htmldaily1.0https://www.cepheid.com/en-GR/systems/genexpert-software/gx-software.htmldaily1.0https://www.cepheid.com/en-GR/systems/genexpert-software/xpertise-software.htmldaily1.0https://www.cepheid.com/en-GR/systems/connectivity.htmldaily1.0https://www.cepheid.com/en-GR/systems/connectivity/cepheid-c360.htmldaily1.0https://www.cepheid.com/en-GR/systems/connectivity/interface-capabilities.htmldaily1.0https://www.cepheid.com/en-GR/systems/data-processing-agreement.htmldaily1.0https://www.cepheid.com/en-GR/systems/partner-communities.htmldaily1.0https://www.cepheid.com/en-GR/systems/business-associates-agreement.htmldaily1.0https://www.cepheid.com/en-GR/solutions.htmldaily1.0https://www.cepheid.com/en-GR/solutions/global-access.htmldaily1.0https://www.cepheid.com/en-GR/solutions/global-access/eligibility-and-pricing.htmldaily1.0https://www.cepheid.com/en-GR/solutions/testing-everywhere.htmldaily1.0https://www.cepheid.com/en-GR/solutions/antibiotic-stewardship.htmldaily1.0https://www.cepheid.com/en-GR/solutions/customized-testing-institution.htmldaily1.0https://www.cepheid.com/en-GR/solutions/knowing-more-matters.htmldaily1.0https://www.cepheid.com/en-GR/solutions/knowing-more-matters/pcr-vs-antigen.htmldaily1.0https://www.cepheid.com/en-GR/solutions/knowing-more-matters/covid-flu-rsv.htmldaily1.0https://www.cepheid.com/en-GR/insights.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/all-posts.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/respiratory-health.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/respiratory-health/2024/09/proactive-surveillance-to-ensure-broad-flu-strain-detection.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/respiratory-health/2024/09/emerging-evolving-respiratory-viruses-test-design-matters.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/respiratory-health/2024/09/the-genexpert-xpress-system-can-change-your-pediatric-practice.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/respiratory-health/2024/09/Norwegian-ED-improves-Resource-Management-with-Rapid-PCR-Testing.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/respiratory-health/2024/09/key-steps-pandemic-preparedness.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/respiratory-health/2025/01/what-does-it-mean-to-have-a-pandemic-ready-pcr-test.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like-ilnesses.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/respiratory-health/2025/03/in-house-pcr-testing-clinical-leaders-explore-the-ripple-effect.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/respiratory-health/2025/04/real-world-clinical-impact-of-in-house-pcr-testing.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/respiratory-health/2025/04/what-is-the-difference-between-pcr-and-antigen-testing.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/respiratory-health/2025/05/a-quick-primer-on-the-adlm-guidance-on-respiratory-virus-testing.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/respiratory-health/2025/09/revolutionizing-respiratory-care-the-power-of-rapid-molecular-testing.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/respiratory-health/2025/09/antigen-testing-vs-pcr-less-haste-more-speed-please.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/respiratory-health/2025/09/the-time-for-widespread-adoption-of-mdx-testing-for-gas-pharyngi.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/respiratory-health/2025/11/why-test-type-matters-pcr-vs-antigen-in-outpatient-respiratory-care.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/respiratory-health/2025/11/transforming-respiratory-tnfection-diagnosis-embracing-molecular-innovation-clinical-practice1.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/respiratory-health/2026/01/staying-ahead-of-influenza.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/respiratory-health/2026/02/revolutionizing-rheumatic-heart-disease-prevention.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2024/09/accelerating-the-pace-for-hep-c-elimination-in-the-us.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2024/09/can-molecular-tests-revolutionize-tuberculosis-control.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2024/09/near-patient-testing-for-hep-c-xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2024/09/danish-hcv-testing-program-improves-patient-management-and-access.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2024/09/faster-prison-testing-for-hcv-drastically-improves-treatment-in-the-uk.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2024/09/innovative-POC-testing-shortens-time-between-testing-and-treatment.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2024/09/finnish-hospital-improves-care-for-expectant-mothers-with-gbs-pcr-screening.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2024/09/a-not-for-profit-in-vietnam-fights-to-end-tuberculosis.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2024/09/cepheid-expands-in-india-to-support-global-efforts-to-fight-tb.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2024/09/covid-19-and-tuberculosis-testing-in-south-africa.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2024/09/cepheid-supports-the-international-mpox-emergency-declared-august-2024.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2024/10/hpv-testing-south-african-clinic-may-prevent-cervical-cancer.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2024/12/strides-toward-early-infant-diagnosis-for-hiv-elimination-in-sou.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2025/02/common-misconceptions-about-vaginitis.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2025/05/revisiting-bacterial-vaginosis-evidence-for-sexual-transmission.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2025/05/a-breakthrough-in-hcv-elimination--how-hcv-point-of-care-rna-tes.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2025/05/decentralising-diagnostics-bringing-patient-centred-testing-closer-to-communities.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2025/05/integration-of-poc-viral-diagnostics-with-substance-use-disorder-treatment-to-improve-hepatitis-c-nfection-outcomes.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2025/06/womens-health-testing-advantages-of-same-day-diagnosis-and-treatment.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2025/04/tuberculosis-staying-one-step-ahead.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2025/04/how-three-countries-are-fighting-back-against-tuberculosis.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2025/04/a-mdr-tb-survivor-in-india-shares-her-remarkable-story.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2025/07/five-surprising-stats-that-reveal-the-hidden-burden-of-vaginitis.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2025/07/5-ways-vaginitis-treatment-goes-wrong-and-how-better-testing-can-fix-It.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2025/03/the-fight-to-end-tuberculosis-in-pakistan.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2025/03/devasena-gnanashanmugam-discusses-cepheids-global-access-program.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2025/03/desmond-tutu-foundation-reduces-impact-of-hiv-and-tb.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2025/03/tuberculosis-care-and-treatment-in-the-republic-of-indonesia.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2025/03/finding-missing-tuberculosis-tb-cases-philippines-need-for-speed.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2025/03/a-decade-of-health-and-economic-benefits-infographic.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2025/03/state-tb-in-us-overlooked-opportunity-better-results.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2025/03/fighting-tb-everything-10-years-of-impact-in-south-africa.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2025/09/in-memory-of-john-bishop-a-visionary-leader-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2025/10/time-to-act-stopping-group-b-strep-infections-in-newborn-babies.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2025/10/real-user-experiences-with-xpert-xpress-mvp-oint-of-care-test.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2025/12/wecare-humanitarian-medical-mission.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2025/08/kentucky-viral-hepatitis-treatment-projects-mission-to-eradicate-hcv.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2025/08/the-state-of-vaginitis-testing-in-the-us.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2025/08/improving-vaginitis-care-through-better-diagnostics.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2026/02/advancing-pandemic-preparedness-through-public-private-collaboration.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/community-and-global-health/2026/02/hepatitis-c-elimination-in-the-us-is-within-reach-experts-report.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/tech-disease-trends.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/tech-disease-trends/2024/09/candida-auris--rising-threat-and-future-implications.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/tech-disease-trends/2024/09/discussing-pharma-clinical-trials-utilizing-poc-diagnostics.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/tech-disease-trends/2024/09/poc-testing-increases-the-efficiency-of-patient-management-in-the-ed.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/tech-disease-trends/2024/10/dave-persing-legacy-and-leadership-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/tech-disease-trends/2024/11/invasive-group-streptococcal-disease.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/tech-disease-trends/2024/11/what-is-pcr--understanding-the-magic.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/tech-disease-trends/2024/11/decentralized-pcr-testing-and-the-quadruple-aim-insights-for-health-systems.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/tech-disease-trends/2025/01/how-a-cepheid-molecular-test-is-made.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct-.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/tech-disease-trends/2025/04/standardization-of-pcr-testing-across-healthcare-testing-sites.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/tech-disease-trends/2025/06/innovation-in-times-of-need-cepheids-legacy-of-outbreak-response.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/tech-disease-trends/2025/07/celebrating-the-cepheid-bike-where-art-meets-innovation.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/tech-disease-trends/2025/09/cepheid-advances-innovation-and-reach-with-key-partnerships.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/tech-disease-trends/2025/10/learn-about-cepheid-system-innovation.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/tech-disease-trends/2025/11/multiplex-with-meaning--cepheid-s-smart-approach-to-molecular-di.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/antimicrobial-stewardship.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/antimicrobial-stewardship/2024/09/a-public-health-dialogue-on-antibiotic-resistance-surveillance.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/antimicrobial-stewardship/2024/09/mortality-associated-with-carbapenem-resistant-gram-negative-infections.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/antimicrobial-stewardship/2024/09/decentralized-testing-for-the-surveillance-of-hospital-acquired-infections.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/antimicrobial-stewardship/2024/09/rapid-mrsa-screening-of-ortho-trauma-patients-improves-experience.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/antimicrobial-stewardship/2024/09/pcr-screening-at-a-british-hospital-enables-timely-infection-control.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/antimicrobial-stewardship/2024/10/fleming-initiative-cepheid-announce-partnership-tackle-amr.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/antimicrobial-stewardship/2024/10/link-between-colonization-multi-drug-resistant-infection.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/antimicrobial-stewardship/2024/12/point-of-care-testing-emergency-department-faster-decision-making-halle.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-shulz.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-schulz.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/antimicrobial-stewardship/2025/05/antimicrobial-and-diagnostic-stewardship-frost-and-sullivan-visual-whitepaper.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/antimicrobial-stewardship/2025/08/industry-voices-time-to-rethink-our-approach-to-using-modern-medicine.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/antimicrobial-stewardship/2025/09/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/antimicrobial-stewardship/2025/10/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/antimicrobial-stewardship/2025/11/vanessa-carter-s-journey--inspiring-action-against-amr.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/antimicrobial-stewardship/2025/11/advancing-antimicrobial-stewardship-in-small-and-rural-hospital.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/expert-spotlight.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/expert-spotlight/2025/10/expert-spotlight--michael-loeffelholz.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--devasena-gnanashanmugam-vice-president--me.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--jennifer-rakeman-cagno-senior-director--sc.htmldaily1.0https://www.cepheid.com/en-GR/insights/insight-hub/expert-spotlight/2026/02/expert-spotlight-jordan-chase.htmldaily1.0https://www.cepheid.com/en-GR/insights/webinars.htmldaily1.0https://www.cepheid.com/en-GR/insights/resources.htmldaily1.0https://www.cepheid.com/en-GR/support.htmldaily1.0https://www.cepheid.com/en-GR/support/ivdr-update.htmldaily1.0https://www.cepheid.com/en-GR/support/contact-us.htmldaily1.0https://www.cepheid.com/en-GR/about.htmldaily1.0https://www.cepheid.com/en-GR/about/mission-history.htmldaily1.0https://www.cepheid.com/en-GR/about/leadership.htmldaily1.0https://www.cepheid.com/en-GR/about/leadership/vitor-rocha.htmldaily1.0https://www.cepheid.com/en-GR/about/leadership/laurent-bellon.htmldaily1.0https://www.cepheid.com/en-GR/about/leadership/anette-engelhardt.htmldaily1.0https://www.cepheid.com/en-GR/about/leadership/peter-farrell.htmldaily1.0https://www.cepheid.com/en-GR/about/leadership/deborah-gonyea.htmldaily1.0https://www.cepheid.com/en-GR/about/leadership/nichole-halsey.htmldaily1.0https://www.cepheid.com/en-GR/about/leadership/luben-li.htmldaily1.0https://www.cepheid.com/en-GR/about/leadership/luke-maitland.htmldaily1.0https://www.cepheid.com/en-GR/about/leadership/david-h-persing.htmldaily1.0https://www.cepheid.com/en-GR/about/leadership/ammar-qadan.htmldaily1.0https://www.cepheid.com/en-GR/about/leadership/charles-mwangi.htmldaily1.0https://www.cepheid.com/en-GR/about/leadership/samson-wu.htmldaily1.0https://www.cepheid.com/en-GR/about/leadership/anupama-mokkapati.htmldaily1.0https://www.cepheid.com/en-GR/about/leadership/traci-wicks.htmldaily1.0https://www.cepheid.com/en-GR/about/leadership/scott-campbell.htmldaily1.0https://www.cepheid.com/en-GR/about/leadership/anne-beauburn.htmldaily1.0https://www.cepheid.com/en-GR/about/leadership/patrick-harkins.htmldaily1.0https://www.cepheid.com/en-GR/about/leadership/ephraim-tsalik.htmldaily1.0https://www.cepheid.com/en-GR/about/leadership/somesh-lalithraj.htmldaily1.0https://www.cepheid.com/en-GR/about/leadership/connie-savor.htmldaily1.0https://www.cepheid.com/en-GR/about/sustainability.htmldaily1.0https://www.cepheid.com/en-GR/about/sustainability/environmental-sustainability.htmldaily1.0https://www.cepheid.com/en-GR/about/sustainability/product-stewardship.htmldaily1.0https://www.cepheid.com/en-GR/about/sustainability/conflict-materials.htmldaily1.0https://www.cepheid.com/en-GR/about/policies-reports.htmldaily1.0https://www.cepheid.com/en-GR/about/business-development-opportunities.htmldaily1.0https://www.cepheid.com/en-GR/about/events.htmldaily1.0https://www.cepheid.com/en-GR/about/innovation-form.htmldaily1.0https://www.cepheid.com/en-GR/about/innovation-form/unsolicited-submission-agreement.htmldaily1.0https://www.cepheid.com/en-GR/about/sars-cov-2-test-development-information.htmldaily1.0https://www.cepheid.com/en-GR/about/sars-cov-2-product-resources.htmldaily1.0https://www.cepheid.com/en-GR/contact/select-info-path.htmldaily1.0https://www.cepheid.com/en-GR/contact/messages/thank-you.htmldaily1.0https://www.cepheid.com/en-GR/contact/messages/thank-you-patient-pathways.htmldaily1.0https://www.cepheid.com/en-GR/contact/messages/thank-you-patient-pathways-fr.htmldaily1.0https://www.cepheid.com/en-GR/contact/messages/thank-you-patient-pathways-de.htmldaily1.0https://www.cepheid.com/en-GR/contact/messages/thank-you-patient-pathways-it.htmldaily1.0https://www.cepheid.com/en-GR/contact/messages/thank-you-patient-pathways-sp.htmldaily1.0https://www.cepheid.com/en-GR/contact/messages/thank-you-patient-pathways-pl.htmldaily1.0https://www.cepheid.com/en-GR/contact/messages/thank-you-patient-pathways-pt.htmldaily1.0https://www.cepheid.com/en-GR/contact/request-cd-international.htmldaily1.0https://www.cepheid.com/en-GR/personas/laboratory-professionals.htmldaily1.0https://www.cepheid.com/en-GR/personas/healthcare-professsional.htmldaily1.0https://www.cepheid.com/en-GR/personas/health-system-administrators.htmldaily1.0https://www.cepheid.com/en-GR/legal/privacy.htmldaily1.0https://www.cepheid.com/en-GR/legal/terms-of-use.htmldaily1.0https://www.cepheid.com/en-GR/legal/product-security-updates.htmldaily1.0https://www.cepheid.com/en-GR/legal/terms-of-sale.htmldaily1.0https://www.cepheid.com/en-GR/legal/trademarks.htmldaily1.0https://www.cepheid.com/en-GR/legal/cookies-notice.htmldaily1.0https://www.cepheid.com/en-GR/campaigns/2020-emea-renewed-messaging/french/patient-pathways.htmldaily1.0https://www.cepheid.com/en-GR/campaigns/2020-emea-renewed-messaging/german/patient-pathways.htmldaily1.0https://www.cepheid.com/en-GR/campaigns/2020-emea-renewed-messaging/italian/patient-pathways.htmldaily1.0https://www.cepheid.com/en-GR/campaigns/2020-emea-renewed-messaging/portuguese/patient-pathways.htmldaily1.0https://www.cepheid.com/en-GR/campaigns/2020-emea-renewed-messaging/polish/patient-pathways.htmldaily1.0https://www.cepheid.com/en-GR/campaigns/india/cepheid-india.htmldaily1.0https://www.cepheid.com/en-GR/campaigns/india/india-submission.htmldaily1.0https://www.cepheid.com/en-GR/campaigns/india/cepheid-india-display.htmldaily1.0https://www.cepheid.com/en-GR/campaigns/india/cepheid-india-bangladesh.htmldaily1.0https://www.cepheid.com/en-GR/campaigns/pcr-plus.htmldaily1.0https://www.cepheid.com/en-GR/coronavirus-portfolio.htmldaily1.0https://www.cepheid.com/en-IE.htmldaily1.0https://www.cepheid.com/en-IE/tests.htmldaily1.0https://www.cepheid.com/en-IE/tests/respiratory.htmldaily1.0https://www.cepheid.com/en-IE/tests/respiratory/xpert-xpress-strep-a.htmldaily1.0https://www.cepheid.com/en-IE/tests/respiratory/xpert-xpress-cov-2-plus.htmldaily1.0https://www.cepheid.com/en-IE/tests/respiratory/xpert-xpress-flu-rsv.htmldaily1.0https://www.cepheid.com/en-IE/tests/respiratory/xpert-xpress-cov-2-flu-rsv-plus.htmldaily1.0https://www.cepheid.com/en-IE/tests/hai-other-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-IE/tests/hai-other-infectious-diseases/xpert-sa-nasal-complete.htmldaily1.0https://www.cepheid.com/en-IE/tests/hai-other-infectious-diseases/xpert-mrsa-sa-ssti.htmldaily1.0https://www.cepheid.com/en-IE/tests/hai-other-infectious-diseases/xpert-c-difficile-bt.htmldaily1.0https://www.cepheid.com/en-IE/tests/hai-other-infectious-diseases/xpert-norovirus.htmldaily1.0https://www.cepheid.com/en-IE/tests/hai-other-infectious-diseases/xpert-mrsa-sa-blood-culture.htmldaily1.0https://www.cepheid.com/en-IE/tests/hai-other-infectious-diseases/xpert-vana-vanb.htmldaily1.0https://www.cepheid.com/en-IE/tests/hai-other-infectious-diseases/xpert-mrsa-nxg.htmldaily1.0https://www.cepheid.com/en-IE/tests/hai-other-infectious-diseases/xpert-carba-r.htmldaily1.0https://www.cepheid.com/en-IE/tests/blood-virology-womens-health-sexual-health.htmldaily1.0https://www.cepheid.com/en-IE/tests/blood-virology-womens-health-sexual-health/xpert-hbv-viral-load.htmldaily1.0https://www.cepheid.com/en-IE/tests/blood-virology-womens-health-sexual-health/resistanceplusmg-flexible.htmldaily1.0https://www.cepheid.com/en-IE/tests/blood-virology-womens-health-sexual-health/xpert-xpress-gbs.htmldaily1.0https://www.cepheid.com/en-IE/tests/blood-virology-womens-health-sexual-health/xpert-ct-ng.htmldaily1.0https://www.cepheid.com/en-IE/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-qual-xc.htmldaily1.0https://www.cepheid.com/en-IE/tests/blood-virology-womens-health-sexual-health/xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-IE/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-viral-load-xc.htmldaily1.0https://www.cepheid.com/en-IE/tests/blood-virology-womens-health-sexual-health/xpert-tv.htmldaily1.0https://www.cepheid.com/en-IE/tests/blood-virology-womens-health-sexual-health/xpert-hpv-v2.htmldaily1.0https://www.cepheid.com/en-IE/tests/blood-virology-womens-health-sexual-health/xpert-hcv-viral-load.htmldaily1.0https://www.cepheid.com/en-IE/tests/tb-emerging-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-IE/tests/tb-emerging-infectious-diseases/xpert-mtb-xdr.htmldaily1.0https://www.cepheid.com/en-IE/tests/tb-emerging-infectious-diseases/xpert-mtb-rif-ultra.htmldaily1.0https://www.cepheid.com/en-IE/tests/oncology-human-genetics.htmldaily1.0https://www.cepheid.com/en-IE/tests/oncology-human-genetics/expert-bladder-cancer-monitor.htmldaily1.0https://www.cepheid.com/en-IE/tests/oncology-human-genetics/xpert-fii-fv.htmldaily1.0https://www.cepheid.com/en-IE/tests/oncology-human-genetics/xpert-bcr-abl-ultra-p190.htmldaily1.0https://www.cepheid.com/en-IE/tests/oncology-human-genetics/xpert-breast-cancer-strat4.htmldaily1.0https://www.cepheid.com/en-IE/tests/oncology-human-genetics/xpert-bladder-cancer-detection.htmldaily1.0https://www.cepheid.com/en-IE/tests/oncology-human-genetics/xpert-bcr-abl-ultra.htmldaily1.0https://www.cepheid.com/en-IE/tests/oncology-human-genetics/xpert-npm1-mutation.htmldaily1.0https://www.cepheid.com/en-IE/systems.htmldaily1.0https://www.cepheid.com/en-IE/systems/genexpert-family-of-systems.htmldaily1.0https://www.cepheid.com/en-IE/systems/genexpert-family-of-systems/genexpert-system.htmldaily1.0https://www.cepheid.com/en-IE/systems/genexpert-family-of-systems/genexpert-infinity.htmldaily1.0https://www.cepheid.com/en-IE/systems/genexpert-software.htmldaily1.0https://www.cepheid.com/en-IE/systems/genexpert-software/gx-software.htmldaily1.0https://www.cepheid.com/en-IE/systems/genexpert-software/xpertise-software.htmldaily1.0https://www.cepheid.com/en-IE/systems/connectivity.htmldaily1.0https://www.cepheid.com/en-IE/systems/connectivity/cepheid-c360.htmldaily1.0https://www.cepheid.com/en-IE/systems/connectivity/interface-capabilities.htmldaily1.0https://www.cepheid.com/en-IE/systems/data-processing-agreement.htmldaily1.0https://www.cepheid.com/en-IE/systems/partner-communities.htmldaily1.0https://www.cepheid.com/en-IE/systems/business-associates-agreement.htmldaily1.0https://www.cepheid.com/en-IE/solutions.htmldaily1.0https://www.cepheid.com/en-IE/solutions/global-access.htmldaily1.0https://www.cepheid.com/en-IE/solutions/global-access/eligibility-and-pricing.htmldaily1.0https://www.cepheid.com/en-IE/solutions/testing-everywhere.htmldaily1.0https://www.cepheid.com/en-IE/solutions/antibiotic-stewardship.htmldaily1.0https://www.cepheid.com/en-IE/solutions/oncology-diagnostics.htmldaily1.0https://www.cepheid.com/en-IE/solutions/customized-testing-institution.htmldaily1.0https://www.cepheid.com/en-IE/solutions/knowing-more-matters.htmldaily1.0https://www.cepheid.com/en-IE/solutions/knowing-more-matters/pcr-vs-antigen.htmldaily1.0https://www.cepheid.com/en-IE/solutions/knowing-more-matters/covid-flu-rsv.htmldaily1.0https://www.cepheid.com/en-IE/insights.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/all-posts.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/respiratory-health.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/respiratory-health/2024/09/proactive-surveillance-to-ensure-broad-flu-strain-detection.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/respiratory-health/2024/09/emerging-evolving-respiratory-viruses-test-design-matters.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/respiratory-health/2024/09/the-genexpert-xpress-system-can-change-your-pediatric-practice.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/respiratory-health/2024/09/Norwegian-ED-improves-Resource-Management-with-Rapid-PCR-Testing.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/respiratory-health/2024/09/key-steps-pandemic-preparedness.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/respiratory-health/2025/01/what-does-it-mean-to-have-a-pandemic-ready-pcr-test.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like-ilnesses.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/respiratory-health/2025/03/in-house-pcr-testing-clinical-leaders-explore-the-ripple-effect.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/respiratory-health/2025/04/real-world-clinical-impact-of-in-house-pcr-testing.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/respiratory-health/2025/04/what-is-the-difference-between-pcr-and-antigen-testing.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/respiratory-health/2025/05/a-quick-primer-on-the-adlm-guidance-on-respiratory-virus-testing.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/respiratory-health/2025/09/revolutionizing-respiratory-care-the-power-of-rapid-molecular-testing.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/respiratory-health/2025/09/antigen-testing-vs-pcr-less-haste-more-speed-please.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/respiratory-health/2025/09/the-time-for-widespread-adoption-of-mdx-testing-for-gas-pharyngi.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/respiratory-health/2025/11/why-test-type-matters-pcr-vs-antigen-in-outpatient-respiratory-care.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/respiratory-health/2025/11/transforming-respiratory-tnfection-diagnosis-embracing-molecular-innovation-clinical-practice1.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/respiratory-health/2026/01/staying-ahead-of-influenza.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/respiratory-health/2026/02/revolutionizing-rheumatic-heart-disease-prevention.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2024/09/accelerating-the-pace-for-hep-c-elimination-in-the-us.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2024/09/can-molecular-tests-revolutionize-tuberculosis-control.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2024/09/near-patient-testing-for-hep-c-xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2024/09/danish-hcv-testing-program-improves-patient-management-and-access.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2024/09/faster-prison-testing-for-hcv-drastically-improves-treatment-in-the-uk.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2024/09/innovative-POC-testing-shortens-time-between-testing-and-treatment.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2024/09/finnish-hospital-improves-care-for-expectant-mothers-with-gbs-pcr-screening.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2024/09/a-not-for-profit-in-vietnam-fights-to-end-tuberculosis.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2024/09/cepheid-expands-in-india-to-support-global-efforts-to-fight-tb.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2024/09/covid-19-and-tuberculosis-testing-in-south-africa.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2024/09/cepheid-supports-the-international-mpox-emergency-declared-august-2024.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2024/10/hpv-testing-south-african-clinic-may-prevent-cervical-cancer.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2024/12/strides-toward-early-infant-diagnosis-for-hiv-elimination-in-sou.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2025/02/common-misconceptions-about-vaginitis.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2025/04/tuberculosis-staying-one-step-ahead.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2025/04/how-three-countries-are-fighting-back-against-tuberculosis.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2025/04/a-mdr-tb-survivor-in-india-shares-her-remarkable-story.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2025/05/revisiting-bacterial-vaginosis-evidence-for-sexual-transmission.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2025/05/a-breakthrough-in-hcv-elimination--how-hcv-point-of-care-rna-tes.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2025/05/decentralising-diagnostics-bringing-patient-centred-testing-closer-to-communities.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2025/05/integration-of-poc-viral-diagnostics-with-substance-use-disorder-treatment-to-improve-hepatitis-c-nfection-outcomes.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2025/06/womens-health-testing-advantages-of-same-day-diagnosis-and-treatment.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2025/07/five-surprising-stats-that-reveal-the-hidden-burden-of-vaginitis.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2025/07/5-ways-vaginitis-treatment-goes-wrong-and-how-better-testing-can-fix-It.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2025/03/the-fight-to-end-tuberculosis-in-pakistan.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2025/03/devasena-gnanashanmugam-discusses-cepheids-global-access-program.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2025/03/desmond-tutu-foundation-reduces-impact-of-hiv-and-tb.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2025/03/tuberculosis-care-and-treatment-in-the-republic-of-indonesia.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2025/03/finding-missing-tuberculosis-tb-cases-philippines-need-for-speed.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2025/03/a-decade-of-health-and-economic-benefits-infographic.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2025/03/state-tb-in-us-overlooked-opportunity-better-results.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2025/03/fighting-tb-everything-10-years-of-impact-in-south-africa.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2025/09/in-memory-of-john-bishop-a-visionary-leader-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2025/08/kentucky-viral-hepatitis-treatment-projects-mission-to-eradicate-hcv.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2025/08/the-state-of-vaginitis-testing-in-the-us.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2025/08/improving-vaginitis-care-through-better-diagnostics.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2025/10/time-to-act-stopping-group-b-strep-infections-in-newborn-babies.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2025/10/real-user-experiences-with-xpert-xpress-mvp-oint-of-care-test.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2025/12/wecare-humanitarian-medical-mission.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2026/02/advancing-pandemic-preparedness-through-public-private-collaboration.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/community-and-global-health/2026/02/hepatitis-c-elimination-in-the-us-is-within-reach-experts-report.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/tech-disease-trends.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/tech-disease-trends/2024/09/candida-auris--rising-threat-and-future-implications.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/tech-disease-trends/2024/09/discussing-pharma-clinical-trials-utilizing-poc-diagnostics.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/tech-disease-trends/2024/09/poc-testing-increases-the-efficiency-of-patient-management-in-the-ed.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/tech-disease-trends/2024/10/dave-persing-legacy-and-leadership-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/tech-disease-trends/2024/11/invasive-group-streptococcal-disease.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/tech-disease-trends/2024/11/what-is-pcr--understanding-the-magic.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/tech-disease-trends/2024/11/decentralized-pcr-testing-and-the-quadruple-aim-insights-for-health-systems.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/tech-disease-trends/2025/01/how-a-cepheid-molecular-test-is-made.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/tech-disease-trends/2025/04/standardization-of-pcr-testing-across-healthcare-testing-sites.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/tech-disease-trends/2025/06/innovation-in-times-of-need-cepheids-legacy-of-outbreak-response.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/tech-disease-trends/2025/07/celebrating-the-cepheid-bike-where-art-meets-innovation.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/tech-disease-trends/2025/09/cepheid-advances-innovation-and-reach-with-key-partnerships.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/tech-disease-trends/2025/10/learn-about-cepheid-system-innovation.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/tech-disease-trends/2025/11/multiplex-with-meaning--cepheid-s-smart-approach-to-molecular-di.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/antimicrobial-stewardship.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/antimicrobial-stewardship/2024/09/a-public-health-dialogue-on-antibiotic-resistance-surveillance.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/antimicrobial-stewardship/2024/09/mortality-associated-with-carbapenem-resistant-gram-negative-infections.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/antimicrobial-stewardship/2024/09/decentralized-testing-for-the-surveillance-of-hospital-acquired-infections.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/antimicrobial-stewardship/2024/09/rapid-mrsa-screening-of-ortho-trauma-patients-improves-experience.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/antimicrobial-stewardship/2024/09/pcr-screening-at-a-british-hospital-enables-timely-infection-control.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/antimicrobial-stewardship/2024/10/fleming-initiative-cepheid-announce-partnership-tackle-amr.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/antimicrobial-stewardship/2024/10/link-between-colonization-multi-drug-resistant-infection.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/antimicrobial-stewardship/2024/12/point-of-care-testing-emergency-department-faster-decision-making-halle.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-schulz.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/antimicrobial-stewardship/2025/05/antimicrobial-and-diagnostic-stewardship-frost-and-sullivan-visual-whitepaper.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/antimicrobial-stewardship/2025/08/industry-voices-time-to-rethink-our-approach-to-using-modern-medicine.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/antimicrobial-stewardship/2025/09/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/antimicrobial-stewardship/2025/10/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/antimicrobial-stewardship/2025/11/vanessa-carter-s-journey--inspiring-action-against-amr.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/antimicrobial-stewardship/2025/11/advancing-antimicrobial-stewardship-in-small-and-rural-hospital.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/expert-spotlight.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/expert-spotlight/2025/10/expert-spotlight--michael-loeffelholz.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--devasena-gnanashanmugam-vice-president--me.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--jennifer-rakeman-cagno-senior-director--sc.htmldaily1.0https://www.cepheid.com/en-IE/insights/insight-hub/expert-spotlight/2026/02/expert-spotlight-jordan-chase.htmldaily1.0https://www.cepheid.com/en-IE/insights/webinars.htmldaily1.0https://www.cepheid.com/en-IE/insights/resources.htmldaily1.0https://www.cepheid.com/en-IE/support.htmldaily1.0https://www.cepheid.com/en-IE/support/ivdr-update.htmldaily1.0https://www.cepheid.com/en-IE/support/contact-us.htmldaily1.0https://www.cepheid.com/en-IE/about.htmldaily1.0https://www.cepheid.com/en-IE/about/mission-history.htmldaily1.0https://www.cepheid.com/en-IE/about/leadership.htmldaily1.0https://www.cepheid.com/en-IE/about/leadership/vitor-rocha.htmldaily1.0https://www.cepheid.com/en-IE/about/leadership/laurent-bellon.htmldaily1.0https://www.cepheid.com/en-IE/about/leadership/anette-engelhardt.htmldaily1.0https://www.cepheid.com/en-IE/about/leadership/peter-farrell.htmldaily1.0https://www.cepheid.com/en-IE/about/leadership/deborah-gonyea.htmldaily1.0https://www.cepheid.com/en-IE/about/leadership/nichole-halsey.htmldaily1.0https://www.cepheid.com/en-IE/about/leadership/luben-li.htmldaily1.0https://www.cepheid.com/en-IE/about/leadership/luke-maitland.htmldaily1.0https://www.cepheid.com/en-IE/about/leadership/david-h-persing.htmldaily1.0https://www.cepheid.com/en-IE/about/leadership/ammar-qadan.htmldaily1.0https://www.cepheid.com/en-IE/about/leadership/charles-mwangi.htmldaily1.0https://www.cepheid.com/en-IE/about/leadership/samson-wu.htmldaily1.0https://www.cepheid.com/en-IE/about/leadership/anupama-mokkapati.htmldaily1.0https://www.cepheid.com/en-IE/about/leadership/traci-wicks.htmldaily1.0https://www.cepheid.com/en-IE/about/leadership/scott-campbell.htmldaily1.0https://www.cepheid.com/en-IE/about/leadership/anne-beauburn.htmldaily1.0https://www.cepheid.com/en-IE/about/leadership/patrick-harkins.htmldaily1.0https://www.cepheid.com/en-IE/about/leadership/ephraim-tsalik.htmldaily1.0https://www.cepheid.com/en-IE/about/leadership/somesh-lalithraj.htmldaily1.0https://www.cepheid.com/en-IE/about/leadership/connie-savor.htmldaily1.0https://www.cepheid.com/en-IE/about/sustainability.htmldaily1.0https://www.cepheid.com/en-IE/about/sustainability/environmental-sustainability.htmldaily1.0https://www.cepheid.com/en-IE/about/sustainability/product-stewardship.htmldaily1.0https://www.cepheid.com/en-IE/about/sustainability/conflict-materials.htmldaily1.0https://www.cepheid.com/en-IE/about/policies-reports.htmldaily1.0https://www.cepheid.com/en-IE/about/business-development-opportunities.htmldaily1.0https://www.cepheid.com/en-IE/about/events.htmldaily1.0https://www.cepheid.com/en-IE/about/innovation-form.htmldaily1.0https://www.cepheid.com/en-IE/about/innovation-form/unsolicited-submission-agreement.htmldaily1.0https://www.cepheid.com/en-IE/about/sars-cov-2-test-development-information.htmldaily1.0https://www.cepheid.com/en-IE/about/sars-cov-2-product-resources.htmldaily1.0https://www.cepheid.com/en-IE/contact/select-info-path.htmldaily1.0https://www.cepheid.com/en-IE/contact/messages/thank-you.htmldaily1.0https://www.cepheid.com/en-IE/contact/messages/thank-you-patient-pathways.htmldaily1.0https://www.cepheid.com/en-IE/contact/messages/thank-you-patient-pathways-fr.htmldaily1.0https://www.cepheid.com/en-IE/contact/messages/thank-you-patient-pathways-de.htmldaily1.0https://www.cepheid.com/en-IE/contact/messages/thank-you-patient-pathways-it.htmldaily1.0https://www.cepheid.com/en-IE/contact/messages/thank-you-patient-pathways-sp.htmldaily1.0https://www.cepheid.com/en-IE/contact/messages/thank-you-patient-pathways-pl.htmldaily1.0https://www.cepheid.com/en-IE/contact/messages/thank-you-patient-pathways-pt.htmldaily1.0https://www.cepheid.com/en-IE/contact/request-cd-international.htmldaily1.0https://www.cepheid.com/en-IE/personas/laboratory-professionals.htmldaily1.0https://www.cepheid.com/en-IE/personas/healthcare-professsional.htmldaily1.0https://www.cepheid.com/en-IE/personas/health-system-administrators.htmldaily1.0https://www.cepheid.com/en-IE/legal/privacy.htmldaily1.0https://www.cepheid.com/en-IE/legal/terms-of-use.htmldaily1.0https://www.cepheid.com/en-IE/legal/product-security-updates.htmldaily1.0https://www.cepheid.com/en-IE/legal/terms-of-sale.htmldaily1.0https://www.cepheid.com/en-IE/legal/trademarks.htmldaily1.0https://www.cepheid.com/en-IE/legal/cookies-notice.htmldaily1.0https://www.cepheid.com/en-IE/campaigns/2020-emea-renewed-messaging/french/patient-pathways.htmldaily1.0https://www.cepheid.com/en-IE/campaigns/2020-emea-renewed-messaging/german/patient-pathways.htmldaily1.0https://www.cepheid.com/en-IE/campaigns/2020-emea-renewed-messaging/italian/patient-pathways.htmldaily1.0https://www.cepheid.com/en-IE/campaigns/2020-emea-renewed-messaging/portuguese/patient-pathways.htmldaily1.0https://www.cepheid.com/en-IE/campaigns/2020-emea-renewed-messaging/polish/patient-pathways.htmldaily1.0https://www.cepheid.com/en-IE/campaigns/india/cepheid-india.htmldaily1.0https://www.cepheid.com/en-IE/campaigns/india/india-submission.htmldaily1.0https://www.cepheid.com/en-IE/campaigns/india/cepheid-india-display.htmldaily1.0https://www.cepheid.com/en-IE/campaigns/india/cepheid-india-bangladesh.htmldaily1.0https://www.cepheid.com/en-IE/campaigns/pcr-plus.htmldaily1.0https://www.cepheid.com/en-IE/coronavirus-portfolio.htmldaily1.0https://www.cepheid.com/en-IL.htmldaily1.0https://www.cepheid.com/en-IL/tests.htmldaily1.0https://www.cepheid.com/en-IL/tests/respiratory.htmldaily1.0https://www.cepheid.com/en-IL/tests/respiratory/xpert-xpress-cov-2-plus.htmldaily1.0https://www.cepheid.com/en-IL/tests/respiratory/xpert-xpress-flu-rsv.htmldaily1.0https://www.cepheid.com/en-IL/tests/respiratory/xpert-xpress-cov-2-flu-rsv-plus.htmldaily1.0https://www.cepheid.com/en-IL/tests/hai-other-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-IL/tests/hai-other-infectious-diseases/xpert-mrsa-sa-ssti.htmldaily1.0https://www.cepheid.com/en-IL/tests/hai-other-infectious-diseases/xpert-norovirus.htmldaily1.0https://www.cepheid.com/en-IL/tests/hai-other-infectious-diseases/xpert-mrsa-sa-blood-culture.htmldaily1.0https://www.cepheid.com/en-IL/tests/hai-other-infectious-diseases/xpert-vana-vanb.htmldaily1.0https://www.cepheid.com/en-IL/tests/hai-other-infectious-diseases/xpert-mrsa-nxg.htmldaily1.0https://www.cepheid.com/en-IL/tests/blood-virology-womens-health-sexual-health.htmldaily1.0https://www.cepheid.com/en-IL/tests/blood-virology-womens-health-sexual-health/xpert-gbs.htmldaily1.0https://www.cepheid.com/en-IL/tests/blood-virology-womens-health-sexual-health/xpert-hbv-viral-load.htmldaily1.0https://www.cepheid.com/en-IL/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-qual-xc.htmldaily1.0https://www.cepheid.com/en-IL/tests/blood-virology-womens-health-sexual-health/xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-IL/tests/blood-virology-womens-health-sexual-health/xpert-tv.htmldaily1.0https://www.cepheid.com/en-IL/tests/blood-virology-womens-health-sexual-health/xpert-hpv-v2.htmldaily1.0https://www.cepheid.com/en-IL/tests/blood-virology-womens-health-sexual-health/xpert-hcv-viral-load.htmldaily1.0https://www.cepheid.com/en-IL/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-viral-load-xc.htmldaily1.0https://www.cepheid.com/en-IL/tests/tb-emerging-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-IL/tests/tb-emerging-infectious-diseases/xpert-mtb-xdr.htmldaily1.0https://www.cepheid.com/en-IL/tests/tb-emerging-infectious-diseases/xpert-mtb-rif-ultra.htmldaily1.0https://www.cepheid.com/en-IL/tests/oncology-human-genetics.htmldaily1.0https://www.cepheid.com/en-IL/tests/oncology-human-genetics/xpert-fii-fv.htmldaily1.0https://www.cepheid.com/en-IL/tests/oncology-human-genetics/xpert-bcr-abl-ultra.htmldaily1.0https://www.cepheid.com/en-IL/systems.htmldaily1.0https://www.cepheid.com/en-IL/systems/genexpert-family-of-systems.htmldaily1.0https://www.cepheid.com/en-IL/systems/genexpert-family-of-systems/genexpert-system.htmldaily1.0https://www.cepheid.com/en-IL/systems/genexpert-family-of-systems/genexpert-infinity.htmldaily1.0https://www.cepheid.com/en-IL/systems/genexpert-software.htmldaily1.0https://www.cepheid.com/en-IL/systems/genexpert-software/gx-software.htmldaily1.0https://www.cepheid.com/en-IL/systems/genexpert-software/xpertise-software.htmldaily1.0https://www.cepheid.com/en-IL/systems/connectivity.htmldaily1.0https://www.cepheid.com/en-IL/systems/connectivity/cepheid-c360.htmldaily1.0https://www.cepheid.com/en-IL/systems/connectivity/interface-capabilities.htmldaily1.0https://www.cepheid.com/en-IL/systems/data-processing-agreement.htmldaily1.0https://www.cepheid.com/en-IL/systems/partner-communities.htmldaily1.0https://www.cepheid.com/en-IL/systems/business-associates-agreement.htmldaily1.0https://www.cepheid.com/en-IL/solutions.htmldaily1.0https://www.cepheid.com/en-IL/solutions/global-access.htmldaily1.0https://www.cepheid.com/en-IL/solutions/global-access/eligibility-and-pricing.htmldaily1.0https://www.cepheid.com/en-IL/solutions/testing-everywhere.htmldaily1.0https://www.cepheid.com/en-IL/solutions/antibiotic-stewardship.htmldaily1.0https://www.cepheid.com/en-IL/solutions/oncology-diagnostics.htmldaily1.0https://www.cepheid.com/en-IL/solutions/customized-testing-institution.htmldaily1.0https://www.cepheid.com/en-IL/solutions/knowing-more-matters.htmldaily1.0https://www.cepheid.com/en-IL/solutions/knowing-more-matters/pcr-vs-antigen.htmldaily1.0https://www.cepheid.com/en-IL/solutions/knowing-more-matters/covid-flu-rsv.htmldaily1.0https://www.cepheid.com/en-IL/insights.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/all-posts.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/respiratory-health.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/respiratory-health/2024/09/proactive-surveillance-to-ensure-broad-flu-strain-detection.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/respiratory-health/2024/09/emerging-evolving-respiratory-viruses-test-design-matters.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/respiratory-health/2024/09/the-genexpert-xpress-system-can-change-your-pediatric-practice.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/respiratory-health/2024/09/Norwegian-ED-improves-Resource-Management-with-Rapid-PCR-Testing.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/respiratory-health/2024/09/key-steps-pandemic-preparedness.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/respiratory-health/2025/01/what-does-it-mean-to-have-a-pandemic-ready-pcr-test.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like-ilnesses.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/respiratory-health/2025/03/in-house-pcr-testing-clinical-leaders-explore-the-ripple-effect.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/respiratory-health/2025/04/real-world-clinical-impact-of-in-house-pcr-testing.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/respiratory-health/2025/04/what-is-the-difference-between-pcr-and-antigen-testing.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/respiratory-health/2025/05/a-quick-primer-on-the-adlm-guidance-on-respiratory-virus-testing.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/respiratory-health/2025/09/revolutionizing-respiratory-care-the-power-of-rapid-molecular-testing.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/respiratory-health/2025/09/antigen-testing-vs-pcr-less-haste-more-speed-please.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/respiratory-health/2025/09/the-time-for-widespread-adoption-of-mdx-testing-for-gas-pharyngi.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/respiratory-health/2025/11/why-test-type-matters-pcr-vs-antigen-in-outpatient-respiratory-care.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/respiratory-health/2025/11/transforming-respiratory-tnfection-diagnosis-embracing-molecular-innovation-clinical-practice1.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/respiratory-health/2026/01/staying-ahead-of-influenza.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/respiratory-health/2026/02/revolutionizing-rheumatic-heart-disease-prevention.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2024/09/accelerating-the-pace-for-hep-c-elimination-in-the-us.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2024/09/can-molecular-tests-revolutionize-tuberculosis-control.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2024/09/near-patient-testing-for-hep-c-xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2024/09/danish-hcv-testing-program-improves-patient-management-and-access.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2024/09/faster-prison-testing-for-hcv-drastically-improves-treatment-in-the-uk.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2024/09/innovative-POC-testing-shortens-time-between-testing-and-treatment.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2024/09/finnish-hospital-improves-care-for-expectant-mothers-with-gbs-pcr-screening.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2024/09/a-not-for-profit-in-vietnam-fights-to-end-tuberculosis.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2024/09/cepheid-expands-in-india-to-support-global-efforts-to-fight-tb.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2024/09/covid-19-and-tuberculosis-testing-in-south-africa.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2024/09/cepheid-supports-the-international-mpox-emergency-declared-august-2024.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2024/10/hpv-testing-south-african-clinic-may-prevent-cervical-cancer.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2024/12/strides-toward-early-infant-diagnosis-for-hiv-elimination-in-sou.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2025/02/common-misconceptions-about-vaginitis.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2025/05/revisiting-bacterial-vaginosis-evidence-for-sexual-transmission.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2025/05/a-breakthrough-in-hcv-elimination--how-hcv-point-of-care-rna-tes.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2025/05/decentralising-diagnostics-bringing-patient-centred-testing-closer-to-communities.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2025/05/integration-of-poc-viral-diagnostics-with-substance-use-disorder-treatment-to-improve-hepatitis-c-nfection-outcomes.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2025/06/womens-health-testing-advantages-of-same-day-diagnosis-and-treatment.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2025/04/tuberculosis-staying-one-step-ahead.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2025/04/how-three-countries-are-fighting-back-against-tuberculosis.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2025/04/a-mdr-tb-survivor-in-india-shares-her-remarkable-story.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2025/07/five-surprising-stats-that-reveal-the-hidden-burden-of-vaginitis.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2025/07/5-ways-vaginitis-treatment-goes-wrong-and-how-better-testing-can-fix-It.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2025/03/the-fight-to-end-tuberculosis-in-pakistan.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2025/03/devasena-gnanashanmugam-discusses-cepheids-global-access-program.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2025/03/desmond-tutu-foundation-reduces-impact-of-hiv-and-tb.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2025/03/tuberculosis-care-and-treatment-in-the-republic-of-indonesia.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2025/03/finding-missing-tuberculosis-tb-cases-philippines-need-for-speed.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2025/03/a-decade-of-health-and-economic-benefits-infographic.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2025/03/state-tb-in-us-overlooked-opportunity-better-results.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2025/03/fighting-tb-everything-10-years-of-impact-in-south-africa.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2025/09/in-memory-of-john-bishop-a-visionary-leader-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2025/12/wecare-humanitarian-medical-mission.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2025/10/time-to-act-stopping-group-b-strep-infections-in-newborn-babies.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2025/10/real-user-experiences-with-xpert-xpress-mvp-oint-of-care-test.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2025/08/kentucky-viral-hepatitis-treatment-projects-mission-to-eradicate-hcv.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2025/08/the-state-of-vaginitis-testing-in-the-us.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2025/08/improving-vaginitis-care-through-better-diagnostics.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2026/02/advancing-pandemic-preparedness-through-public-private-collaboration.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/community-and-global-health/2026/02/hepatitis-c-elimination-in-the-us-is-within-reach-experts-report.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/tech-disease-trends.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/tech-disease-trends/2024/09/candida-auris--rising-threat-and-future-implications.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/tech-disease-trends/2024/09/discussing-pharma-clinical-trials-utilizing-poc-diagnostics.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/tech-disease-trends/2024/09/poc-testing-increases-the-efficiency-of-patient-management-in-the-ed.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/tech-disease-trends/2024/10/dave-persing-legacy-and-leadership-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/tech-disease-trends/2024/11/invasive-group-streptococcal-disease.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/tech-disease-trends/2024/11/what-is-pcr--understanding-the-magic.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/tech-disease-trends/2024/11/decentralized-pcr-testing-and-the-quadruple-aim-insights-for-health-systems.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/tech-disease-trends/2025/01/how-a-cepheid-molecular-test-is-made.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct-.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/tech-disease-trends/2025/04/standardization-of-pcr-testing-across-healthcare-testing-sites.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/tech-disease-trends/2025/06/innovation-in-times-of-need-cepheids-legacy-of-outbreak-response.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/tech-disease-trends/2025/07/celebrating-the-cepheid-bike-where-art-meets-innovation.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/tech-disease-trends/2025/09/cepheid-advances-innovation-and-reach-with-key-partnerships.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/tech-disease-trends/2025/10/learn-about-cepheid-system-innovation.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/tech-disease-trends/2025/11/multiplex-with-meaning--cepheid-s-smart-approach-to-molecular-di.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/antimicrobial-stewardship.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/antimicrobial-stewardship/2024/09/a-public-health-dialogue-on-antibiotic-resistance-surveillance.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/antimicrobial-stewardship/2024/09/mortality-associated-with-carbapenem-resistant-gram-negative-infections.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/antimicrobial-stewardship/2024/09/decentralized-testing-for-the-surveillance-of-hospital-acquired-infections.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/antimicrobial-stewardship/2024/09/rapid-mrsa-screening-of-ortho-trauma-patients-improves-experience.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/antimicrobial-stewardship/2024/09/pcr-screening-at-a-british-hospital-enables-timely-infection-control.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/antimicrobial-stewardship/2024/10/fleming-initiative-cepheid-announce-partnership-tackle-amr.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/antimicrobial-stewardship/2024/10/link-between-colonization-multi-drug-resistant-infection.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/antimicrobial-stewardship/2024/12/point-of-care-testing-emergency-department-faster-decision-making-halle.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-shulz.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-schulz.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/antimicrobial-stewardship/2025/05/antimicrobial-and-diagnostic-stewardship-frost-and-sullivan-visual-whitepaper.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/antimicrobial-stewardship/2025/08/industry-voices-time-to-rethink-our-approach-to-using-modern-medicine.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/antimicrobial-stewardship/2025/09/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/antimicrobial-stewardship/2025/10/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/antimicrobial-stewardship/2025/11/vanessa-carter-s-journey--inspiring-action-against-amr.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/antimicrobial-stewardship/2025/11/advancing-antimicrobial-stewardship-in-small-and-rural-hospital.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/expert-spotlight.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/expert-spotlight/2025/10/expert-spotlight--michael-loeffelholz.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--devasena-gnanashanmugam-vice-president--me.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--jennifer-rakeman-cagno-senior-director--sc.htmldaily1.0https://www.cepheid.com/en-IL/insights/insight-hub/expert-spotlight/2026/02/expert-spotlight-jordan-chase.htmldaily1.0https://www.cepheid.com/en-IL/insights/webinars.htmldaily1.0https://www.cepheid.com/en-IL/insights/resources.htmldaily1.0https://www.cepheid.com/en-IL/support.htmldaily1.0https://www.cepheid.com/en-IL/support/ivdr-update.htmldaily1.0https://www.cepheid.com/en-IL/support/contact-us.htmldaily1.0https://www.cepheid.com/en-IL/about.htmldaily1.0https://www.cepheid.com/en-IL/about/mission-history.htmldaily1.0https://www.cepheid.com/en-IL/about/leadership.htmldaily1.0https://www.cepheid.com/en-IL/about/leadership/vitor-rocha.htmldaily1.0https://www.cepheid.com/en-IL/about/leadership/laurent-bellon.htmldaily1.0https://www.cepheid.com/en-IL/about/leadership/anette-engelhardt.htmldaily1.0https://www.cepheid.com/en-IL/about/leadership/peter-farrell.htmldaily1.0https://www.cepheid.com/en-IL/about/leadership/deborah-gonyea.htmldaily1.0https://www.cepheid.com/en-IL/about/leadership/nichole-halsey.htmldaily1.0https://www.cepheid.com/en-IL/about/leadership/luben-li.htmldaily1.0https://www.cepheid.com/en-IL/about/leadership/luke-maitland.htmldaily1.0https://www.cepheid.com/en-IL/about/leadership/david-h-persing.htmldaily1.0https://www.cepheid.com/en-IL/about/leadership/ammar-qadan.htmldaily1.0https://www.cepheid.com/en-IL/about/leadership/charles-mwangi.htmldaily1.0https://www.cepheid.com/en-IL/about/leadership/samson-wu.htmldaily1.0https://www.cepheid.com/en-IL/about/leadership/anupama-mokkapati.htmldaily1.0https://www.cepheid.com/en-IL/about/leadership/traci-wicks.htmldaily1.0https://www.cepheid.com/en-IL/about/leadership/scott-campbell.htmldaily1.0https://www.cepheid.com/en-IL/about/leadership/anne-beauburn.htmldaily1.0https://www.cepheid.com/en-IL/about/leadership/patrick-harkins.htmldaily1.0https://www.cepheid.com/en-IL/about/leadership/ephraim-tsalik.htmldaily1.0https://www.cepheid.com/en-IL/about/leadership/somesh-lalithraj.htmldaily1.0https://www.cepheid.com/en-IL/about/leadership/connie-savor.htmldaily1.0https://www.cepheid.com/en-IL/about/sustainability.htmldaily1.0https://www.cepheid.com/en-IL/about/sustainability/environmental-sustainability.htmldaily1.0https://www.cepheid.com/en-IL/about/sustainability/product-stewardship.htmldaily1.0https://www.cepheid.com/en-IL/about/sustainability/conflict-materials.htmldaily1.0https://www.cepheid.com/en-IL/about/policies-reports.htmldaily1.0https://www.cepheid.com/en-IL/about/business-development-opportunities.htmldaily1.0https://www.cepheid.com/en-IL/about/events.htmldaily1.0https://www.cepheid.com/en-IL/about/innovation-form.htmldaily1.0https://www.cepheid.com/en-IL/about/innovation-form/unsolicited-submission-agreement.htmldaily1.0https://www.cepheid.com/en-IL/about/sars-cov-2-test-development-information.htmldaily1.0https://www.cepheid.com/en-IL/about/sars-cov-2-product-resources.htmldaily1.0https://www.cepheid.com/en-IL/contact/select-info-path.htmldaily1.0https://www.cepheid.com/en-IL/contact/messages/thank-you.htmldaily1.0https://www.cepheid.com/en-IL/contact/messages/thank-you-patient-pathways.htmldaily1.0https://www.cepheid.com/en-IL/contact/messages/thank-you-patient-pathways-fr.htmldaily1.0https://www.cepheid.com/en-IL/contact/messages/thank-you-patient-pathways-de.htmldaily1.0https://www.cepheid.com/en-IL/contact/messages/thank-you-patient-pathways-it.htmldaily1.0https://www.cepheid.com/en-IL/contact/messages/thank-you-patient-pathways-sp.htmldaily1.0https://www.cepheid.com/en-IL/contact/messages/thank-you-patient-pathways-pl.htmldaily1.0https://www.cepheid.com/en-IL/contact/messages/thank-you-patient-pathways-pt.htmldaily1.0https://www.cepheid.com/en-IL/contact/request-cd-international.htmldaily1.0https://www.cepheid.com/en-IL/personas/laboratory-professionals.htmldaily1.0https://www.cepheid.com/en-IL/personas/healthcare-professsional.htmldaily1.0https://www.cepheid.com/en-IL/personas/health-system-administrators.htmldaily1.0https://www.cepheid.com/en-IL/legal/privacy.htmldaily1.0https://www.cepheid.com/en-IL/legal/terms-of-use.htmldaily1.0https://www.cepheid.com/en-IL/legal/product-security-updates.htmldaily1.0https://www.cepheid.com/en-IL/legal/terms-of-sale.htmldaily1.0https://www.cepheid.com/en-IL/legal/trademarks.htmldaily1.0https://www.cepheid.com/en-IL/legal/cookies-notice.htmldaily1.0https://www.cepheid.com/en-IL/campaigns/2020-emea-renewed-messaging/french/patient-pathways.htmldaily1.0https://www.cepheid.com/en-IL/campaigns/2020-emea-renewed-messaging/german/patient-pathways.htmldaily1.0https://www.cepheid.com/en-IL/campaigns/2020-emea-renewed-messaging/italian/patient-pathways.htmldaily1.0https://www.cepheid.com/en-IL/campaigns/2020-emea-renewed-messaging/portuguese/patient-pathways.htmldaily1.0https://www.cepheid.com/en-IL/campaigns/2020-emea-renewed-messaging/polish/patient-pathways.htmldaily1.0https://www.cepheid.com/en-IL/campaigns/india/cepheid-india.htmldaily1.0https://www.cepheid.com/en-IL/campaigns/india/india-submission.htmldaily1.0https://www.cepheid.com/en-IL/campaigns/india/cepheid-india-display.htmldaily1.0https://www.cepheid.com/en-IL/campaigns/india/cepheid-india-bangladesh.htmldaily1.0https://www.cepheid.com/en-IL/campaigns/pcr-plus.htmldaily1.0https://www.cepheid.com/en-IL/coronavirus-portfolio.htmldaily1.0https://www.cepheid.com/en-LT.htmldaily1.0https://www.cepheid.com/en-LT/tests.htmldaily1.0https://www.cepheid.com/en-LT/tests/respiratory.htmldaily1.0https://www.cepheid.com/en-LT/tests/respiratory/xpert-xpress-strep-a.htmldaily1.0https://www.cepheid.com/en-LT/tests/respiratory/xpert-xpress-cov-2-plus.htmldaily1.0https://www.cepheid.com/en-LT/tests/respiratory/xpert-xpress-flu-rsv.htmldaily1.0https://www.cepheid.com/en-LT/tests/respiratory/xpert-xpress-cov-2-flu-rsv-plus.htmldaily1.0https://www.cepheid.com/en-LT/tests/hai-other-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-LT/tests/hai-other-infectious-diseases/xpert-sa-nasal-complete.htmldaily1.0https://www.cepheid.com/en-LT/tests/hai-other-infectious-diseases/xpert-mrsa-sa-ssti.htmldaily1.0https://www.cepheid.com/en-LT/tests/hai-other-infectious-diseases/xpert-c-difficile-bt.htmldaily1.0https://www.cepheid.com/en-LT/tests/hai-other-infectious-diseases/xpert-norovirus.htmldaily1.0https://www.cepheid.com/en-LT/tests/hai-other-infectious-diseases/xpert-mrsa-sa-blood-culture.htmldaily1.0https://www.cepheid.com/en-LT/tests/hai-other-infectious-diseases/xpert-vana-vanb.htmldaily1.0https://www.cepheid.com/en-LT/tests/hai-other-infectious-diseases/xpert-mrsa-nxg.htmldaily1.0https://www.cepheid.com/en-LT/tests/hai-other-infectious-diseases/xpert-carba-r.htmldaily1.0https://www.cepheid.com/en-LT/tests/blood-virology-womens-health-sexual-health.htmldaily1.0https://www.cepheid.com/en-LT/tests/blood-virology-womens-health-sexual-health/xpert-hbv-viral-load.htmldaily1.0https://www.cepheid.com/en-LT/tests/blood-virology-womens-health-sexual-health/resistanceplusmg-flexible.htmldaily1.0https://www.cepheid.com/en-LT/tests/blood-virology-womens-health-sexual-health/xpert-xpress-gbs.htmldaily1.0https://www.cepheid.com/en-LT/tests/blood-virology-womens-health-sexual-health/xpert-ct-ng.htmldaily1.0https://www.cepheid.com/en-LT/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-qual-xc.htmldaily1.0https://www.cepheid.com/en-LT/tests/blood-virology-womens-health-sexual-health/xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-LT/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-viral-load-xc.htmldaily1.0https://www.cepheid.com/en-LT/tests/blood-virology-womens-health-sexual-health/xpert-tv.htmldaily1.0https://www.cepheid.com/en-LT/tests/blood-virology-womens-health-sexual-health/xpert-hpv-v2.htmldaily1.0https://www.cepheid.com/en-LT/tests/blood-virology-womens-health-sexual-health/xpert-hcv-viral-load.htmldaily1.0https://www.cepheid.com/en-LT/tests/tb-emerging-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-LT/tests/tb-emerging-infectious-diseases/xpert-mtb-xdr.htmldaily1.0https://www.cepheid.com/en-LT/tests/tb-emerging-infectious-diseases/xpert-mtb-rif-ultra.htmldaily1.0https://www.cepheid.com/en-LT/tests/oncology-human-genetics.htmldaily1.0https://www.cepheid.com/en-LT/tests/oncology-human-genetics/expert-bladder-cancer-monitor.htmldaily1.0https://www.cepheid.com/en-LT/tests/oncology-human-genetics/xpert-fii-fv.htmldaily1.0https://www.cepheid.com/en-LT/tests/oncology-human-genetics/xpert-bcr-abl-ultra-p190.htmldaily1.0https://www.cepheid.com/en-LT/tests/oncology-human-genetics/xpert-breast-cancer-strat4.htmldaily1.0https://www.cepheid.com/en-LT/tests/oncology-human-genetics/xpert-bladder-cancer-detection.htmldaily1.0https://www.cepheid.com/en-LT/tests/oncology-human-genetics/xpert-bcr-abl-ultra.htmldaily1.0https://www.cepheid.com/en-LT/tests/oncology-human-genetics/xpert-npm1-mutation.htmldaily1.0https://www.cepheid.com/en-LT/systems.htmldaily1.0https://www.cepheid.com/en-LT/systems/genexpert-family-of-systems.htmldaily1.0https://www.cepheid.com/en-LT/systems/genexpert-family-of-systems/genexpert-system.htmldaily1.0https://www.cepheid.com/en-LT/systems/genexpert-family-of-systems/genexpert-infinity.htmldaily1.0https://www.cepheid.com/en-LT/systems/genexpert-software.htmldaily1.0https://www.cepheid.com/en-LT/systems/genexpert-software/gx-software.htmldaily1.0https://www.cepheid.com/en-LT/systems/genexpert-software/xpertise-software.htmldaily1.0https://www.cepheid.com/en-LT/systems/connectivity.htmldaily1.0https://www.cepheid.com/en-LT/systems/connectivity/cepheid-c360.htmldaily1.0https://www.cepheid.com/en-LT/systems/connectivity/interface-capabilities.htmldaily1.0https://www.cepheid.com/en-LT/systems/data-processing-agreement.htmldaily1.0https://www.cepheid.com/en-LT/systems/partner-communities.htmldaily1.0https://www.cepheid.com/en-LT/systems/business-associates-agreement.htmldaily1.0https://www.cepheid.com/en-LT/solutions.htmldaily1.0https://www.cepheid.com/en-LT/solutions/global-access.htmldaily1.0https://www.cepheid.com/en-LT/solutions/global-access/eligibility-and-pricing.htmldaily1.0https://www.cepheid.com/en-LT/solutions/global-access/everything-about-our-fight-against-tb.htmldaily1.0https://www.cepheid.com/en-LT/solutions/testing-everywhere.htmldaily1.0https://www.cepheid.com/en-LT/solutions/antibiotic-stewardship.htmldaily1.0https://www.cepheid.com/en-LT/solutions/customized-testing-institution.htmldaily1.0https://www.cepheid.com/en-LT/solutions/knowing-more-matters.htmldaily1.0https://www.cepheid.com/en-LT/solutions/knowing-more-matters/pcr-vs-antigen.htmldaily1.0https://www.cepheid.com/en-LT/solutions/knowing-more-matters/covid-flu-rsv.htmldaily1.0https://www.cepheid.com/en-LT/insights.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/all-posts.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/respiratory-health.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/respiratory-health/2024/09/proactive-surveillance-to-ensure-broad-flu-strain-detection.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/respiratory-health/2024/09/emerging-evolving-respiratory-viruses-test-design-matters.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/respiratory-health/2024/09/the-genexpert-xpress-system-can-change-your-pediatric-practice.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/respiratory-health/2024/09/Norwegian-ED-improves-Resource-Management-with-Rapid-PCR-Testing.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/respiratory-health/2024/09/key-steps-pandemic-preparedness.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/respiratory-health/2025/01/what-does-it-mean-to-have-a-pandemic-ready-pcr-test.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like-ilnesses.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/respiratory-health/2025/03/in-house-pcr-testing-clinical-leaders-explore-the-ripple-effect.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/respiratory-health/2025/04/real-world-clinical-impact-of-in-house-pcr-testing.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/respiratory-health/2025/04/what-is-the-difference-between-pcr-and-antigen-testing.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/respiratory-health/2025/05/a-quick-primer-on-the-adlm-guidance-on-respiratory-virus-testing.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/respiratory-health/2025/09/revolutionizing-respiratory-care-the-power-of-rapid-molecular-testing.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/respiratory-health/2025/09/antigen-testing-vs-pcr-less-haste-more-speed-please.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/respiratory-health/2025/09/the-time-for-widespread-adoption-of-mdx-testing-for-gas-pharyngi.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/respiratory-health/2025/11/why-test-type-matters-pcr-vs-antigen-in-outpatient-respiratory-care.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/respiratory-health/2025/11/transforming-respiratory-tnfection-diagnosis-embracing-molecular-innovation-clinical-practice1.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/respiratory-health/2026/01/staying-ahead-of-influenza.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/respiratory-health/2026/02/revolutionizing-rheumatic-heart-disease-prevention.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2024/09/accelerating-the-pace-for-hep-c-elimination-in-the-us.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2024/09/can-molecular-tests-revolutionize-tuberculosis-control.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2024/09/near-patient-testing-for-hep-c-xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2024/09/danish-hcv-testing-program-improves-patient-management-and-access.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2024/09/faster-prison-testing-for-hcv-drastically-improves-treatment-in-the-uk.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2024/09/innovative-POC-testing-shortens-time-between-testing-and-treatment.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2024/09/finnish-hospital-improves-care-for-expectant-mothers-with-gbs-pcr-screening.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2024/09/a-not-for-profit-in-vietnam-fights-to-end-tuberculosis.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2024/09/cepheid-expands-in-india-to-support-global-efforts-to-fight-tb.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2024/09/covid-19-and-tuberculosis-testing-in-south-africa.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2024/09/cepheid-supports-the-international-mpox-emergency-declared-august-2024.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2024/10/hpv-testing-south-african-clinic-may-prevent-cervical-cancer.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2024/12/strides-toward-early-infant-diagnosis-for-hiv-elimination-in-sou.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2025/02/common-misconceptions-about-vaginitis.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2025/05/revisiting-bacterial-vaginosis-evidence-for-sexual-transmission.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2025/05/a-breakthrough-in-hcv-elimination--how-hcv-point-of-care-rna-tes.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2025/05/decentralising-diagnostics-bringing-patient-centred-testing-closer-to-communities.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2025/05/integration-of-poc-viral-diagnostics-with-substance-use-disorder-treatment-to-improve-hepatitis-c-nfection-outcomes.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2025/04/tuberculosis-staying-one-step-ahead.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2025/04/how-three-countries-are-fighting-back-against-tuberculosis.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2025/04/a-mdr-tb-survivor-in-india-shares-her-remarkable-story.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2025/06/womens-health-testing-advantages-of-same-day-diagnosis-and-treatment.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2025/07/five-surprising-stats-that-reveal-the-hidden-burden-of-vaginitis.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2025/07/5-ways-vaginitis-treatment-goes-wrong-and-how-better-testing-can-fix-It.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2025/03/the-fight-to-end-tuberculosis-in-pakistan.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2025/03/devasena-gnanashanmugam-discusses-cepheids-global-access-program.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2025/03/desmond-tutu-foundation-reduces-impact-of-hiv-and-tb.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2025/03/tuberculosis-care-and-treatment-in-the-republic-of-indonesia.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2025/03/finding-missing-tuberculosis-tb-cases-philippines-need-for-speed.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2025/03/a-decade-of-health-and-economic-benefits-infographic.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2025/03/state-tb-in-us-overlooked-opportunity-better-results.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2025/03/fighting-tb-everything-10-years-of-impact-in-south-africa.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2025/09/in-memory-of-john-bishop-a-visionary-leader-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2025/08/kentucky-viral-hepatitis-treatment-projects-mission-to-eradicate-hcv.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2025/08/the-state-of-vaginitis-testing-in-the-us.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2025/08/improving-vaginitis-care-through-better-diagnostics.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2025/12/wecare-humanitarian-medical-mission.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2025/10/time-to-act-stopping-group-b-strep-infections-in-newborn-babies.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2025/10/real-user-experiences-with-xpert-xpress-mvp-oint-of-care-test.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2026/02/advancing-pandemic-preparedness-through-public-private-collaboration.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/community-and-global-health/2026/02/hepatitis-c-elimination-in-the-us-is-within-reach-experts-report.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/tech-disease-trends.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/tech-disease-trends/2024/09/candida-auris--rising-threat-and-future-implications.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/tech-disease-trends/2024/09/discussing-pharma-clinical-trials-utilizing-poc-diagnostics.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/tech-disease-trends/2024/09/poc-testing-increases-the-efficiency-of-patient-management-in-the-ed.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/tech-disease-trends/2024/10/dave-persing-legacy-and-leadership-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/tech-disease-trends/2024/11/invasive-group-streptococcal-disease.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/tech-disease-trends/2024/11/what-is-pcr--understanding-the-magic.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/tech-disease-trends/2024/11/decentralized-pcr-testing-and-the-quadruple-aim-insights-for-health-systems.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/tech-disease-trends/2025/01/how-a-cepheid-molecular-test-is-made.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/tech-disease-trends/2025/04/standardization-of-pcr-testing-across-healthcare-testing-sites.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/tech-disease-trends/2025/06/innovation-in-times-of-need-cepheids-legacy-of-outbreak-response.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/tech-disease-trends/2025/07/celebrating-the-cepheid-bike-where-art-meets-innovation.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/tech-disease-trends/2025/09/cepheid-advances-innovation-and-reach-with-key-partnerships.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/tech-disease-trends/2025/10/learn-about-cepheid-system-innovation.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/tech-disease-trends/2025/11/multiplex-with-meaning--cepheid-s-smart-approach-to-molecular-di.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/antimicrobial-stewardship.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/antimicrobial-stewardship/2024/09/a-public-health-dialogue-on-antibiotic-resistance-surveillance.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/antimicrobial-stewardship/2024/09/mortality-associated-with-carbapenem-resistant-gram-negative-infections.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/antimicrobial-stewardship/2024/09/decentralized-testing-for-the-surveillance-of-hospital-acquired-infections.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/antimicrobial-stewardship/2024/09/rapid-mrsa-screening-of-ortho-trauma-patients-improves-experience.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/antimicrobial-stewardship/2024/09/pcr-screening-at-a-british-hospital-enables-timely-infection-control.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/antimicrobial-stewardship/2024/10/fleming-initiative-cepheid-announce-partnership-tackle-amr.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/antimicrobial-stewardship/2024/10/link-between-colonization-multi-drug-resistant-infection.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/antimicrobial-stewardship/2024/12/point-of-care-testing-emergency-department-faster-decision-making-halle.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-schulz.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/antimicrobial-stewardship/2025/05/antimicrobial-and-diagnostic-stewardship-frost-and-sullivan-visual-whitepaper.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/antimicrobial-stewardship/2025/08/industry-voices-time-to-rethink-our-approach-to-using-modern-medicine.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/antimicrobial-stewardship/2025/09/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/antimicrobial-stewardship/2025/10/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/antimicrobial-stewardship/2025/11/vanessa-carter-s-journey--inspiring-action-against-amr.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/antimicrobial-stewardship/2025/11/advancing-antimicrobial-stewardship-in-small-and-rural-hospital.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/expert-spotlight.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/expert-spotlight/2025/10/expert-spotlight--michael-loeffelholz.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--devasena-gnanashanmugam-vice-president--me.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--jennifer-rakeman-cagno-senior-director--sc.htmldaily1.0https://www.cepheid.com/en-LT/insights/insight-hub/expert-spotlight/2026/02/expert-spotlight-jordan-chase.htmldaily1.0https://www.cepheid.com/en-LT/insights/webinars.htmldaily1.0https://www.cepheid.com/en-LT/insights/resources.htmldaily1.0https://www.cepheid.com/en-LT/support.htmldaily1.0https://www.cepheid.com/en-LT/support/ivdr-update.htmldaily1.0https://www.cepheid.com/en-LT/support/contact-us.htmldaily1.0https://www.cepheid.com/en-LT/about.htmldaily1.0https://www.cepheid.com/en-LT/about/mission-history.htmldaily1.0https://www.cepheid.com/en-LT/about/leadership.htmldaily1.0https://www.cepheid.com/en-LT/about/leadership/vitor-rocha.htmldaily1.0https://www.cepheid.com/en-LT/about/leadership/laurent-bellon.htmldaily1.0https://www.cepheid.com/en-LT/about/leadership/anette-engelhardt.htmldaily1.0https://www.cepheid.com/en-LT/about/leadership/peter-farrell.htmldaily1.0https://www.cepheid.com/en-LT/about/leadership/deborah-gonyea.htmldaily1.0https://www.cepheid.com/en-LT/about/leadership/nichole-halsey.htmldaily1.0https://www.cepheid.com/en-LT/about/leadership/luben-li.htmldaily1.0https://www.cepheid.com/en-LT/about/leadership/luke-maitland.htmldaily1.0https://www.cepheid.com/en-LT/about/leadership/david-h-persing.htmldaily1.0https://www.cepheid.com/en-LT/about/leadership/ammar-qadan.htmldaily1.0https://www.cepheid.com/en-LT/about/leadership/charles-mwangi.htmldaily1.0https://www.cepheid.com/en-LT/about/leadership/samson-wu.htmldaily1.0https://www.cepheid.com/en-LT/about/leadership/anupama-mokkapati.htmldaily1.0https://www.cepheid.com/en-LT/about/leadership/traci-wicks.htmldaily1.0https://www.cepheid.com/en-LT/about/leadership/scott-campbell.htmldaily1.0https://www.cepheid.com/en-LT/about/leadership/anne-beauburn.htmldaily1.0https://www.cepheid.com/en-LT/about/leadership/patrick-harkins.htmldaily1.0https://www.cepheid.com/en-LT/about/leadership/ephraim-tsalik.htmldaily1.0https://www.cepheid.com/en-LT/about/leadership/somesh-lalithraj.htmldaily1.0https://www.cepheid.com/en-LT/about/leadership/connie-savor.htmldaily1.0https://www.cepheid.com/en-LT/about/sustainability.htmldaily1.0https://www.cepheid.com/en-LT/about/sustainability/environmental-sustainability.htmldaily1.0https://www.cepheid.com/en-LT/about/sustainability/product-stewardship.htmldaily1.0https://www.cepheid.com/en-LT/about/sustainability/conflict-materials.htmldaily1.0https://www.cepheid.com/en-LT/about/policies-reports.htmldaily1.0https://www.cepheid.com/en-LT/about/business-development-opportunities.htmldaily1.0https://www.cepheid.com/en-LT/about/events.htmldaily1.0https://www.cepheid.com/en-LT/about/innovation-form.htmldaily1.0https://www.cepheid.com/en-LT/about/innovation-form/unsolicited-submission-agreement.htmldaily1.0https://www.cepheid.com/en-LT/about/sars-cov-2-test-development-information.htmldaily1.0https://www.cepheid.com/en-LT/about/sars-cov-2-product-resources.htmldaily1.0https://www.cepheid.com/en-LT/contact/select-info-path.htmldaily1.0https://www.cepheid.com/en-LT/contact/messages/thank-you.htmldaily1.0https://www.cepheid.com/en-LT/contact/messages/thank-you-patient-pathways.htmldaily1.0https://www.cepheid.com/en-LT/contact/messages/thank-you-patient-pathways-fr.htmldaily1.0https://www.cepheid.com/en-LT/contact/messages/thank-you-patient-pathways-de.htmldaily1.0https://www.cepheid.com/en-LT/contact/messages/thank-you-patient-pathways-it.htmldaily1.0https://www.cepheid.com/en-LT/contact/messages/thank-you-patient-pathways-sp.htmldaily1.0https://www.cepheid.com/en-LT/contact/messages/thank-you-patient-pathways-pl.htmldaily1.0https://www.cepheid.com/en-LT/contact/messages/thank-you-patient-pathways-pt.htmldaily1.0https://www.cepheid.com/en-LT/contact/request-cd-international.htmldaily1.0https://www.cepheid.com/en-LT/personas/laboratory-professionals.htmldaily1.0https://www.cepheid.com/en-LT/personas/healthcare-professsional.htmldaily1.0https://www.cepheid.com/en-LT/personas/health-system-administrators.htmldaily1.0https://www.cepheid.com/en-LT/legal/privacy.htmldaily1.0https://www.cepheid.com/en-LT/legal/terms-of-use.htmldaily1.0https://www.cepheid.com/en-LT/legal/product-security-updates.htmldaily1.0https://www.cepheid.com/en-LT/legal/terms-of-sale.htmldaily1.0https://www.cepheid.com/en-LT/legal/trademarks.htmldaily1.0https://www.cepheid.com/en-LT/legal/cookies-notice.htmldaily1.0https://www.cepheid.com/en-LT/campaigns/2020-emea-renewed-messaging/french/patient-pathways.htmldaily1.0https://www.cepheid.com/en-LT/campaigns/2020-emea-renewed-messaging/german/patient-pathways.htmldaily1.0https://www.cepheid.com/en-LT/campaigns/2020-emea-renewed-messaging/italian/patient-pathways.htmldaily1.0https://www.cepheid.com/en-LT/campaigns/2020-emea-renewed-messaging/portuguese/patient-pathways.htmldaily1.0https://www.cepheid.com/en-LT/campaigns/2020-emea-renewed-messaging/polish/patient-pathways.htmldaily1.0https://www.cepheid.com/en-LT/campaigns/india/cepheid-india.htmldaily1.0https://www.cepheid.com/en-LT/campaigns/india/india-submission.htmldaily1.0https://www.cepheid.com/en-LT/campaigns/india/cepheid-india-display.htmldaily1.0https://www.cepheid.com/en-LT/campaigns/india/cepheid-india-bangladesh.htmldaily1.0https://www.cepheid.com/en-LT/campaigns/pcr-plus.htmldaily1.0https://www.cepheid.com/en-LT/coronavirus-portfolio.htmldaily1.0https://www.cepheid.com/en-LU.htmldaily1.0https://www.cepheid.com/en-LU/tests.htmldaily1.0https://www.cepheid.com/en-LU/tests/respiratory.htmldaily1.0https://www.cepheid.com/en-LU/tests/respiratory/xpert-xpress-strep-a.htmldaily1.0https://www.cepheid.com/en-LU/tests/respiratory/xpert-xpress-cov-2-plus.htmldaily1.0https://www.cepheid.com/en-LU/tests/respiratory/xpert-xpress-flu-rsv.htmldaily1.0https://www.cepheid.com/en-LU/tests/respiratory/xpert-xpress-cov-2-flu-rsv-plus.htmldaily1.0https://www.cepheid.com/en-LU/tests/hai-other-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-LU/tests/hai-other-infectious-diseases/xpert-sa-nasal-complete.htmldaily1.0https://www.cepheid.com/en-LU/tests/hai-other-infectious-diseases/xpert-mrsa-sa-ssti.htmldaily1.0https://www.cepheid.com/en-LU/tests/hai-other-infectious-diseases/xpert-c-difficile-bt.htmldaily1.0https://www.cepheid.com/en-LU/tests/hai-other-infectious-diseases/xpert-norovirus.htmldaily1.0https://www.cepheid.com/en-LU/tests/hai-other-infectious-diseases/xpert-mrsa-sa-blood-culture.htmldaily1.0https://www.cepheid.com/en-LU/tests/hai-other-infectious-diseases/xpert-vana-vanb.htmldaily1.0https://www.cepheid.com/en-LU/tests/hai-other-infectious-diseases/xpert-mrsa-nxg.htmldaily1.0https://www.cepheid.com/en-LU/tests/hai-other-infectious-diseases/xpert-carba-r.htmldaily1.0https://www.cepheid.com/en-LU/tests/blood-virology-womens-health-sexual-health.htmldaily1.0https://www.cepheid.com/en-LU/tests/blood-virology-womens-health-sexual-health/xpert-hbv-viral-load.htmldaily1.0https://www.cepheid.com/en-LU/tests/blood-virology-womens-health-sexual-health/resistanceplusmg-flexible.htmldaily1.0https://www.cepheid.com/en-LU/tests/blood-virology-womens-health-sexual-health/xpert-xpress-gbs.htmldaily1.0https://www.cepheid.com/en-LU/tests/blood-virology-womens-health-sexual-health/xpert-ct-ng.htmldaily1.0https://www.cepheid.com/en-LU/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-qual-xc.htmldaily1.0https://www.cepheid.com/en-LU/tests/blood-virology-womens-health-sexual-health/xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-LU/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-viral-load-xc.htmldaily1.0https://www.cepheid.com/en-LU/tests/blood-virology-womens-health-sexual-health/xpert-tv.htmldaily1.0https://www.cepheid.com/en-LU/tests/blood-virology-womens-health-sexual-health/xpert-hpv-v2.htmldaily1.0https://www.cepheid.com/en-LU/tests/blood-virology-womens-health-sexual-health/xpert-hcv-viral-load.htmldaily1.0https://www.cepheid.com/en-LU/tests/tb-emerging-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-LU/tests/tb-emerging-infectious-diseases/xpert-mtb-xdr.htmldaily1.0https://www.cepheid.com/en-LU/tests/tb-emerging-infectious-diseases/xpert-mtb-rif-ultra.htmldaily1.0https://www.cepheid.com/en-LU/tests/oncology-human-genetics.htmldaily1.0https://www.cepheid.com/en-LU/tests/oncology-human-genetics/expert-bladder-cancer-monitor.htmldaily1.0https://www.cepheid.com/en-LU/tests/oncology-human-genetics/xpert-fii-fv.htmldaily1.0https://www.cepheid.com/en-LU/tests/oncology-human-genetics/xpert-bcr-abl-ultra-p190.htmldaily1.0https://www.cepheid.com/en-LU/tests/oncology-human-genetics/xpert-breast-cancer-strat4.htmldaily1.0https://www.cepheid.com/en-LU/tests/oncology-human-genetics/xpert-bladder-cancer-detection.htmldaily1.0https://www.cepheid.com/en-LU/tests/oncology-human-genetics/xpert-bcr-abl-ultra.htmldaily1.0https://www.cepheid.com/en-LU/tests/oncology-human-genetics/xpert-npm1-mutation.htmldaily1.0https://www.cepheid.com/en-LU/systems.htmldaily1.0https://www.cepheid.com/en-LU/systems/genexpert-family-of-systems.htmldaily1.0https://www.cepheid.com/en-LU/systems/genexpert-family-of-systems/genexpert-system.htmldaily1.0https://www.cepheid.com/en-LU/systems/genexpert-family-of-systems/genexpert-infinity.htmldaily1.0https://www.cepheid.com/en-LU/systems/genexpert-software.htmldaily1.0https://www.cepheid.com/en-LU/systems/genexpert-software/gx-software.htmldaily1.0https://www.cepheid.com/en-LU/systems/genexpert-software/xpertise-software.htmldaily1.0https://www.cepheid.com/en-LU/systems/connectivity.htmldaily1.0https://www.cepheid.com/en-LU/systems/connectivity/cepheid-c360.htmldaily1.0https://www.cepheid.com/en-LU/systems/connectivity/interface-capabilities.htmldaily1.0https://www.cepheid.com/en-LU/systems/data-processing-agreement.htmldaily1.0https://www.cepheid.com/en-LU/systems/partner-communities.htmldaily1.0https://www.cepheid.com/en-LU/systems/business-associates-agreement.htmldaily1.0https://www.cepheid.com/en-LU/solutions.htmldaily1.0https://www.cepheid.com/en-LU/solutions/global-access.htmldaily1.0https://www.cepheid.com/en-LU/solutions/global-access/eligibility-and-pricing.htmldaily1.0https://www.cepheid.com/en-LU/solutions/testing-everywhere.htmldaily1.0https://www.cepheid.com/en-LU/solutions/antibiotic-stewardship.htmldaily1.0https://www.cepheid.com/en-LU/solutions/oncology-diagnostics.htmldaily1.0https://www.cepheid.com/en-LU/solutions/customized-testing-institution.htmldaily1.0https://www.cepheid.com/en-LU/solutions/knowing-more-matters.htmldaily1.0https://www.cepheid.com/en-LU/solutions/knowing-more-matters/pcr-vs-antigen.htmldaily1.0https://www.cepheid.com/en-LU/solutions/knowing-more-matters/covid-flu-rsv.htmldaily1.0https://www.cepheid.com/en-LU/insights.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/all-posts.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/respiratory-health.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/respiratory-health/2024/09/proactive-surveillance-to-ensure-broad-flu-strain-detection.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/respiratory-health/2024/09/emerging-evolving-respiratory-viruses-test-design-matters.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/respiratory-health/2024/09/the-genexpert-xpress-system-can-change-your-pediatric-practice.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/respiratory-health/2024/09/Norwegian-ED-improves-Resource-Management-with-Rapid-PCR-Testing.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/respiratory-health/2024/09/key-steps-pandemic-preparedness.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/respiratory-health/2025/01/what-does-it-mean-to-have-a--pandemic-ready--pcr-test-.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/respiratory-health/2025/01/what-does-it-mean-to-have-a-pandemic-ready-pcr-test.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like-ilnesses.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/respiratory-health/2025/03/in-house-pcr-testing-clinical-leaders-explore-the-ripple-effect.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/respiratory-health/2025/04/real-world-clinical-impact-of-in-house-pcr-testing.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/respiratory-health/2025/04/what-is-the-difference-between-pcr-and-antigen-testing.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/respiratory-health/2025/05/a-quick-primer-on-the-adlm-guidance-on-respiratory-virus-testing.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/respiratory-health/2025/09/revolutionizing-respiratory-care-the-power-of-rapid-molecular-testing.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/respiratory-health/2025/09/antigen-testing-vs-pcr-less-haste-more-speed-please.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/respiratory-health/2025/09/the-time-for-widespread-adoption-of-mdx-testing-for-gas-pharyngi.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/respiratory-health/2025/11/why-test-type-matters-pcr-vs-antigen-in-outpatient-respiratory-care.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/respiratory-health/2025/11/transforming-respiratory-tnfection-diagnosis-embracing-molecular-innovation-clinical-practice1.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/respiratory-health/2026/01/staying-ahead-of-influenza.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/respiratory-health/2026/02/revolutionizing-rheumatic-heart-disease-prevention.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2024/09/accelerating-the-pace-for-hep-c-elimination-in-the-us.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2024/09/can-molecular-tests-revolutionize-tuberculosis-control.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2024/09/near-patient-testing-for-hep-c-xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2024/09/danish-hcv-testing-program-improves-patient-management-and-access.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2024/09/faster-prison-testing-for-hcv-drastically-improves-treatment-in-the-uk.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2024/09/innovative-POC-testing-shortens-time-between-testing-and-treatment.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2024/09/finnish-hospital-improves-care-for-expectant-mothers-with-gbs-pcr-screening.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2024/09/a-not-for-profit-in-vietnam-fights-to-end-tuberculosis.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2024/09/cepheid-expands-in-india-to-support-global-efforts-to-fight-tb.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2024/09/covid-19-and-tuberculosis-testing-in-south-africa.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2024/09/cepheid-supports-the-international-mpox-emergency-declared-august-2024.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2024/10/hpv-testing-south-african-clinic-may-prevent-cervical-cancer.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2024/12/strides-toward-early-infant-diagnosis-for-hiv-elimination-in-sou.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2025/02/common-misconceptions-about-vaginitis.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2025/06/womens-health-testing-advantages-of-same-day-diagnosis-and-treatment.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2025/04/tuberculosis-staying-one-step-ahead.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2025/04/how-three-countries-are-fighting-back-against-tuberculosis.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2025/04/a-mdr-tb-survivor-in-india-shares-her-remarkable-story.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2025/05/revisiting-bacterial-vaginosis-evidence-for-sexual-transmission.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2025/05/a-breakthrough-in-hcv-elimination--how-hcv-point-of-care-rna-tes.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2025/05/decentralising-diagnostics-bringing-patient-centred-testing-closer-to-communities.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2025/05/integration-of-poc-viral-diagnostics-with-substance-use-disorder-treatment-to-improve-hepatitis-c-nfection-outcomes.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2025/07/five-surprising-stats-that-reveal-the-hidden-burden-of-vaginitis.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2025/07/5-ways-vaginitis-treatment-goes-wrong-and-how-better-testing-can-fix-It.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2025/03/the-fight-to-end-tuberculosis-in-pakistan.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2025/03/devasena-gnanashanmugam-discusses-cepheids-global-access-program.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2025/03/desmond-tutu-foundation-reduces-impact-of-hiv-and-tb.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2025/03/tuberculosis-care-and-treatment-in-the-republic-of-indonesia.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2025/03/finding-missing-tuberculosis-tb-cases-philippines-need-for-speed.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2025/03/a-decade-of-health-and-economic-benefits-infographic.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2025/03/state-tb-in-us-overlooked-opportunity-better-results.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2025/03/fighting-tb-everything-10-years-of-impact-in-south-africa.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2025/09/in-memory-of-john-bishop-a-visionary-leader-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2025/08/kentucky-viral-hepatitis-treatment-projects-mission-to-eradicate-hcv.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2025/08/the-state-of-vaginitis-testing-in-the-us.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2025/08/improving-vaginitis-care-through-better-diagnostics.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2025/10/time-to-act-stopping-group-b-strep-infections-in-newborn-babies.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2025/10/real-user-experiences-with-xpert-xpress-mvp-oint-of-care-test.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2025/12/wecare-humanitarian-medical-mission.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2026/02/advancing-pandemic-preparedness-through-public-private-collaboration.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/community-and-global-health/2026/02/hepatitis-c-elimination-in-the-us-is-within-reach-experts-report.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/tech-disease-trends.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/tech-disease-trends/2024/09/candida-auris--rising-threat-and-future-implications.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/tech-disease-trends/2024/09/discussing-pharma-clinical-trials-utilizing-poc-diagnostics.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/tech-disease-trends/2024/09/poc-testing-increases-the-efficiency-of-patient-management-in-the-ed.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/tech-disease-trends/2024/10/dave-persing-legacy-and-leadership-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/tech-disease-trends/2024/11/invasive-group-streptococcal-disease.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/tech-disease-trends/2024/11/what-is-pcr--understanding-the-magic.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/tech-disease-trends/2024/11/decentralized-pcr-testing-and-the-quadruple-aim-insights-for-health-systems.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/tech-disease-trends/2025/01/how-a-cepheid-molecular-test-is-made.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/tech-disease-trends/2025/04/standardization-of-pcr-testing-across-healthcare-testing-sites.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/tech-disease-trends/2025/06/innovation-in-times-of-need-cepheids-legacy-of-outbreak-response.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/tech-disease-trends/2025/07/celebrating-the-cepheid-bike-where-art-meets-innovation.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/tech-disease-trends/2025/09/cepheid-advances-innovation-and-reach-with-key-partnerships.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/tech-disease-trends/2025/10/learn-about-cepheid-system-innovation.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/tech-disease-trends/2025/11/multiplex-with-meaning--cepheid-s-smart-approach-to-molecular-di.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/antimicrobial-stewardship.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/antimicrobial-stewardship/2024/09/a-public-health-dialogue-on-antibiotic-resistance-surveillance.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/antimicrobial-stewardship/2024/09/mortality-associated-with-carbapenem-resistant-gram-negative-infections.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/antimicrobial-stewardship/2024/09/decentralized-testing-for-the-surveillance-of-hospital-acquired-infections.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/antimicrobial-stewardship/2024/09/rapid-mrsa-screening-of-ortho-trauma-patients-improves-experience.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/antimicrobial-stewardship/2024/09/pcr-screening-at-a-british-hospital-enables-timely-infection-control.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/antimicrobial-stewardship/2024/10/fleming-initiative-cepheid-announce-partnership-tackle-amr.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/antimicrobial-stewardship/2024/10/link-between-colonization-multi-drug-resistant-infection.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/antimicrobial-stewardship/2024/12/point-of-care-testing-emergency-department-faster-decision-making-halle.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-schulz.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/antimicrobial-stewardship/2025/05/antimicrobial-and-diagnostic-stewardship-frost-and-sullivan-visual-whitepaper.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/antimicrobial-stewardship/2025/08/industry-voices-time-to-rethink-our-approach-to-using-modern-medicine.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/antimicrobial-stewardship/2025/09/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/antimicrobial-stewardship/2025/10/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/antimicrobial-stewardship/2025/11/vanessa-carter-s-journey--inspiring-action-against-amr.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/antimicrobial-stewardship/2025/11/advancing-antimicrobial-stewardship-in-small-and-rural-hospital.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/expert-spotlight.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/expert-spotlight/2025/10/expert-spotlight--michael-loeffelholz.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--devasena-gnanashanmugam-vice-president--me.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--jennifer-rakeman-cagno-senior-director--sc.htmldaily1.0https://www.cepheid.com/en-LU/insights/insight-hub/expert-spotlight/2026/02/expert-spotlight-jordan-chase.htmldaily1.0https://www.cepheid.com/en-LU/insights/webinars.htmldaily1.0https://www.cepheid.com/en-LU/insights/resources.htmldaily1.0https://www.cepheid.com/en-LU/support.htmldaily1.0https://www.cepheid.com/en-LU/support/ivdr-update.htmldaily1.0https://www.cepheid.com/en-LU/support/contact-us.htmldaily1.0https://www.cepheid.com/en-LU/about.htmldaily1.0https://www.cepheid.com/en-LU/about/mission-history.htmldaily1.0https://www.cepheid.com/en-LU/about/leadership.htmldaily1.0https://www.cepheid.com/en-LU/about/leadership/vitor-rocha.htmldaily1.0https://www.cepheid.com/en-LU/about/leadership/laurent-bellon.htmldaily1.0https://www.cepheid.com/en-LU/about/leadership/anette-engelhardt.htmldaily1.0https://www.cepheid.com/en-LU/about/leadership/peter-farrell.htmldaily1.0https://www.cepheid.com/en-LU/about/leadership/deborah-gonyea.htmldaily1.0https://www.cepheid.com/en-LU/about/leadership/nichole-halsey.htmldaily1.0https://www.cepheid.com/en-LU/about/leadership/luben-li.htmldaily1.0https://www.cepheid.com/en-LU/about/leadership/luke-maitland.htmldaily1.0https://www.cepheid.com/en-LU/about/leadership/david-h-persing.htmldaily1.0https://www.cepheid.com/en-LU/about/leadership/ammar-qadan.htmldaily1.0https://www.cepheid.com/en-LU/about/leadership/charles-mwangi.htmldaily1.0https://www.cepheid.com/en-LU/about/leadership/samson-wu.htmldaily1.0https://www.cepheid.com/en-LU/about/leadership/anupama-mokkapati.htmldaily1.0https://www.cepheid.com/en-LU/about/leadership/traci-wicks.htmldaily1.0https://www.cepheid.com/en-LU/about/leadership/scott-campbell.htmldaily1.0https://www.cepheid.com/en-LU/about/leadership/anne-beauburn.htmldaily1.0https://www.cepheid.com/en-LU/about/leadership/patrick-harkins.htmldaily1.0https://www.cepheid.com/en-LU/about/leadership/ephraim-tsalik.htmldaily1.0https://www.cepheid.com/en-LU/about/leadership/somesh-lalithraj.htmldaily1.0https://www.cepheid.com/en-LU/about/leadership/connie-savor.htmldaily1.0https://www.cepheid.com/en-LU/about/sustainability.htmldaily1.0https://www.cepheid.com/en-LU/about/sustainability/environmental-sustainability.htmldaily1.0https://www.cepheid.com/en-LU/about/sustainability/product-stewardship.htmldaily1.0https://www.cepheid.com/en-LU/about/sustainability/conflict-materials.htmldaily1.0https://www.cepheid.com/en-LU/about/policies-reports.htmldaily1.0https://www.cepheid.com/en-LU/about/business-development-opportunities.htmldaily1.0https://www.cepheid.com/en-LU/about/events.htmldaily1.0https://www.cepheid.com/en-LU/about/innovation-form.htmldaily1.0https://www.cepheid.com/en-LU/about/innovation-form/unsolicited-submission-agreement.htmldaily1.0https://www.cepheid.com/en-LU/about/sars-cov-2-test-development-information.htmldaily1.0https://www.cepheid.com/en-LU/about/sars-cov-2-product-resources.htmldaily1.0https://www.cepheid.com/en-LU/contact/select-info-path.htmldaily1.0https://www.cepheid.com/en-LU/contact/messages/thank-you.htmldaily1.0https://www.cepheid.com/en-LU/contact/messages/thank-you-patient-pathways.htmldaily1.0https://www.cepheid.com/en-LU/contact/messages/thank-you-patient-pathways-fr.htmldaily1.0https://www.cepheid.com/en-LU/contact/messages/thank-you-patient-pathways-de.htmldaily1.0https://www.cepheid.com/en-LU/contact/messages/thank-you-patient-pathways-it.htmldaily1.0https://www.cepheid.com/en-LU/contact/messages/thank-you-patient-pathways-sp.htmldaily1.0https://www.cepheid.com/en-LU/contact/messages/thank-you-patient-pathways-pl.htmldaily1.0https://www.cepheid.com/en-LU/contact/messages/thank-you-patient-pathways-pt.htmldaily1.0https://www.cepheid.com/en-LU/contact/request-cd-international.htmldaily1.0https://www.cepheid.com/en-LU/personas/laboratory-professionals.htmldaily1.0https://www.cepheid.com/en-LU/personas/healthcare-professsional.htmldaily1.0https://www.cepheid.com/en-LU/personas/health-system-administrators.htmldaily1.0https://www.cepheid.com/en-LU/legal/privacy.htmldaily1.0https://www.cepheid.com/en-LU/legal/terms-of-use.htmldaily1.0https://www.cepheid.com/en-LU/legal/product-security-updates.htmldaily1.0https://www.cepheid.com/en-LU/legal/terms-of-sale.htmldaily1.0https://www.cepheid.com/en-LU/legal/trademarks.htmldaily1.0https://www.cepheid.com/en-LU/legal/cookies-notice.htmldaily1.0https://www.cepheid.com/en-LU/campaigns/2020-emea-renewed-messaging/french/patient-pathways.htmldaily1.0https://www.cepheid.com/en-LU/campaigns/2020-emea-renewed-messaging/german/patient-pathways.htmldaily1.0https://www.cepheid.com/en-LU/campaigns/2020-emea-renewed-messaging/italian/patient-pathways.htmldaily1.0https://www.cepheid.com/en-LU/campaigns/2020-emea-renewed-messaging/portuguese/patient-pathways.htmldaily1.0https://www.cepheid.com/en-LU/campaigns/2020-emea-renewed-messaging/polish/patient-pathways.htmldaily1.0https://www.cepheid.com/en-LU/campaigns/india/cepheid-india.htmldaily1.0https://www.cepheid.com/en-LU/campaigns/india/india-submission.htmldaily1.0https://www.cepheid.com/en-LU/campaigns/india/cepheid-india-display.htmldaily1.0https://www.cepheid.com/en-LU/campaigns/india/cepheid-india-bangladesh.htmldaily1.0https://www.cepheid.com/en-LU/campaigns/pcr-plus.htmldaily1.0https://www.cepheid.com/en-LU/coronavirus-portfolio.htmldaily1.0https://www.cepheid.com/en-LV.htmldaily1.0https://www.cepheid.com/en-LV/tests.htmldaily1.0https://www.cepheid.com/en-LV/tests/respiratory.htmldaily1.0https://www.cepheid.com/en-LV/tests/respiratory/xpert-xpress-strep-a.htmldaily1.0https://www.cepheid.com/en-LV/tests/respiratory/xpert-xpress-cov-2-plus.htmldaily1.0https://www.cepheid.com/en-LV/tests/respiratory/xpert-xpress-flu-rsv.htmldaily1.0https://www.cepheid.com/en-LV/tests/respiratory/xpert-xpress-cov-2-flu-rsv-plus.htmldaily1.0https://www.cepheid.com/en-LV/tests/hai-other-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-LV/tests/hai-other-infectious-diseases/xpert-sa-nasal-complete.htmldaily1.0https://www.cepheid.com/en-LV/tests/hai-other-infectious-diseases/xpert-mrsa-sa-ssti.htmldaily1.0https://www.cepheid.com/en-LV/tests/hai-other-infectious-diseases/xpert-c-difficile-bt.htmldaily1.0https://www.cepheid.com/en-LV/tests/hai-other-infectious-diseases/xpert-norovirus.htmldaily1.0https://www.cepheid.com/en-LV/tests/hai-other-infectious-diseases/xpert-mrsa-sa-blood-culture.htmldaily1.0https://www.cepheid.com/en-LV/tests/hai-other-infectious-diseases/xpert-vana-vanb.htmldaily1.0https://www.cepheid.com/en-LV/tests/hai-other-infectious-diseases/xpert-mrsa-nxg.htmldaily1.0https://www.cepheid.com/en-LV/tests/hai-other-infectious-diseases/xpert-carba-r.htmldaily1.0https://www.cepheid.com/en-LV/tests/blood-virology-womens-health-sexual-health.htmldaily1.0https://www.cepheid.com/en-LV/tests/blood-virology-womens-health-sexual-health/xpert-hbv-viral-load.htmldaily1.0https://www.cepheid.com/en-LV/tests/blood-virology-womens-health-sexual-health/resistanceplusmg-flexible.htmldaily1.0https://www.cepheid.com/en-LV/tests/blood-virology-womens-health-sexual-health/xpert-xpress-gbs.htmldaily1.0https://www.cepheid.com/en-LV/tests/blood-virology-womens-health-sexual-health/xpert-ct-ng.htmldaily1.0https://www.cepheid.com/en-LV/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-qual-xc.htmldaily1.0https://www.cepheid.com/en-LV/tests/blood-virology-womens-health-sexual-health/xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-LV/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-viral-load-xc.htmldaily1.0https://www.cepheid.com/en-LV/tests/blood-virology-womens-health-sexual-health/xpert-tv.htmldaily1.0https://www.cepheid.com/en-LV/tests/blood-virology-womens-health-sexual-health/xpert-hpv-v2.htmldaily1.0https://www.cepheid.com/en-LV/tests/blood-virology-womens-health-sexual-health/xpert-hcv-viral-load.htmldaily1.0https://www.cepheid.com/en-LV/tests/tb-emerging-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-LV/tests/tb-emerging-infectious-diseases/xpert-mtb-xdr.htmldaily1.0https://www.cepheid.com/en-LV/tests/tb-emerging-infectious-diseases/xpert-mtb-rif-ultra.htmldaily1.0https://www.cepheid.com/en-LV/tests/oncology-human-genetics.htmldaily1.0https://www.cepheid.com/en-LV/tests/oncology-human-genetics/xpert-fii-fv.htmldaily1.0https://www.cepheid.com/en-LV/tests/oncology-human-genetics/xpert-bcr-abl-ultra-p190.htmldaily1.0https://www.cepheid.com/en-LV/tests/oncology-human-genetics/xpert-breast-cancer-strat4.htmldaily1.0https://www.cepheid.com/en-LV/tests/oncology-human-genetics/xpert-bcr-abl-ultra.htmldaily1.0https://www.cepheid.com/en-LV/tests/oncology-human-genetics/xpert-npm1-mutation.htmldaily1.0https://www.cepheid.com/en-LV/systems.htmldaily1.0https://www.cepheid.com/en-LV/systems/genexpert-family-of-systems.htmldaily1.0https://www.cepheid.com/en-LV/systems/genexpert-family-of-systems/genexpert-system.htmldaily1.0https://www.cepheid.com/en-LV/systems/genexpert-family-of-systems/genexpert-infinity.htmldaily1.0https://www.cepheid.com/en-LV/systems/genexpert-software.htmldaily1.0https://www.cepheid.com/en-LV/systems/genexpert-software/gx-software.htmldaily1.0https://www.cepheid.com/en-LV/systems/genexpert-software/xpertise-software.htmldaily1.0https://www.cepheid.com/en-LV/systems/connectivity.htmldaily1.0https://www.cepheid.com/en-LV/systems/connectivity/cepheid-c360.htmldaily1.0https://www.cepheid.com/en-LV/systems/connectivity/interface-capabilities.htmldaily1.0https://www.cepheid.com/en-LV/systems/data-processing-agreement.htmldaily1.0https://www.cepheid.com/en-LV/systems/partner-communities.htmldaily1.0https://www.cepheid.com/en-LV/systems/business-associates-agreement.htmldaily1.0https://www.cepheid.com/en-LV/solutions.htmldaily1.0https://www.cepheid.com/en-LV/solutions/global-access.htmldaily1.0https://www.cepheid.com/en-LV/solutions/global-access/eligibility-and-pricing.htmldaily1.0https://www.cepheid.com/en-LV/solutions/testing-everywhere.htmldaily1.0https://www.cepheid.com/en-LV/solutions/antibiotic-stewardship.htmldaily1.0https://www.cepheid.com/en-LV/solutions/oncology-diagnostics.htmldaily1.0https://www.cepheid.com/en-LV/solutions/customized-testing-institution.htmldaily1.0https://www.cepheid.com/en-LV/solutions/knowing-more-matters.htmldaily1.0https://www.cepheid.com/en-LV/solutions/knowing-more-matters/pcr-vs-antigen.htmldaily1.0https://www.cepheid.com/en-LV/solutions/knowing-more-matters/covid-flu-rsv.htmldaily1.0https://www.cepheid.com/en-LV/insights.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/all-posts.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/respiratory-health.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/respiratory-health/2024/09/proactive-surveillance-to-ensure-broad-flu-strain-detection.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/respiratory-health/2024/09/emerging-evolving-respiratory-viruses-test-design-matters.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/respiratory-health/2024/09/the-genexpert-xpress-system-can-change-your-pediatric-practice.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/respiratory-health/2024/09/Norwegian-ED-improves-Resource-Management-with-Rapid-PCR-Testing.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/respiratory-health/2024/09/key-steps-pandemic-preparedness.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/respiratory-health/2025/01/what-does-it-mean-to-have-a--pandemic-ready--pcr-test-.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/respiratory-health/2025/01/what-does-it-mean-to-have-a-pandemic-ready-pcr-test.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like-ilnesses.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/respiratory-health/2025/03/in-house-pcr-testing-clinical-leaders-explore-the-ripple-effect.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/respiratory-health/2025/04/real-world-clinical-impact-of-in-house-pcr-testing.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/respiratory-health/2025/04/what-is-the-difference-between-pcr-and-antigen-testing.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/respiratory-health/2025/05/a-quick-primer-on-the-adlm-guidance-on-respiratory-virus-testing.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/respiratory-health/2025/09/revolutionizing-respiratory-care-the-power-of-rapid-molecular-testing.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/respiratory-health/2025/09/antigen-testing-vs-pcr-less-haste-more-speed-please.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/respiratory-health/2025/09/the-time-for-widespread-adoption-of-mdx-testing-for-gas-pharyngi.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/respiratory-health/2025/11/why-test-type-matters-pcr-vs-antigen-in-outpatient-respiratory-care.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/respiratory-health/2025/11/transforming-respiratory-tnfection-diagnosis-embracing-molecular-innovation-clinical-practice1.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/respiratory-health/2026/01/staying-ahead-of-influenza.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/respiratory-health/2026/02/revolutionizing-rheumatic-heart-disease-prevention.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2024/09/accelerating-the-pace-for-hep-c-elimination-in-the-us.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2024/09/can-molecular-tests-revolutionize-tuberculosis-control.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2024/09/near-patient-testing-for-hep-c-xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2024/09/danish-hcv-testing-program-improves-patient-management-and-access.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2024/09/faster-prison-testing-for-hcv-drastically-improves-treatment-in-the-uk.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2024/09/innovative-POC-testing-shortens-time-between-testing-and-treatment.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2024/09/finnish-hospital-improves-care-for-expectant-mothers-with-gbs-pcr-screening.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2024/09/a-not-for-profit-in-vietnam-fights-to-end-tuberculosis.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2024/09/cepheid-expands-in-india-to-support-global-efforts-to-fight-tb.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2024/09/covid-19-and-tuberculosis-testing-in-south-africa.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2024/09/cepheid-supports-the-international-mpox-emergency-declared-august-2024.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2024/10/hpv-testing-south-african-clinic-may-prevent-cervical-cancer.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2024/12/strides-toward-early-infant-diagnosis-for-hiv-elimination-in-sou.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2025/02/common-misconceptions-about-vaginitis.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2025/05/revisiting-bacterial-vaginosis-evidence-for-sexual-transmission.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2025/05/a-breakthrough-in-hcv-elimination--how-hcv-point-of-care-rna-tes.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2025/05/decentralising-diagnostics-bringing-patient-centred-testing-closer-to-communities.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2025/05/integration-of-poc-viral-diagnostics-with-substance-use-disorder-treatment-to-improve-hepatitis-c-nfection-outcomes.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2025/06/womens-health-testing-advantages-of-same-day-diagnosis-and-treatment.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2025/04/tuberculosis-staying-one-step-ahead.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2025/04/how-three-countries-are-fighting-back-against-tuberculosis.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2025/04/a-mdr-tb-survivor-in-india-shares-her-remarkable-story.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2025/07/five-surprising-stats-that-reveal-the-hidden-burden-of-vaginitis.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2025/07/5-ways-vaginitis-treatment-goes-wrong-and-how-better-testing-can-fix-It.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2025/03/the-fight-to-end-tuberculosis-in-pakistan.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2025/03/devasena-gnanashanmugam-discusses-cepheids-global-access-program.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2025/03/desmond-tutu-foundation-reduces-impact-of-hiv-and-tb.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2025/03/tuberculosis-care-and-treatment-in-the-republic-of-indonesia.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2025/03/finding-missing-tuberculosis-tb-cases-philippines-need-for-speed.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2025/03/a-decade-of-health-and-economic-benefits-infographic.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2025/03/state-tb-in-us-overlooked-opportunity-better-results.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2025/03/fighting-tb-everything-10-years-of-impact-in-south-africa.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2025/09/in-memory-of-john-bishop-a-visionary-leader-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2025/08/kentucky-viral-hepatitis-treatment-projects-mission-to-eradicate-hcv.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2025/08/the-state-of-vaginitis-testing-in-the-us.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2025/08/improving-vaginitis-care-through-better-diagnostics.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2025/10/time-to-act-stopping-group-b-strep-infections-in-newborn-babies.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2025/10/real-user-experiences-with-xpert-xpress-mvp-oint-of-care-test.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2025/12/wecare-humanitarian-medical-mission.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2026/02/advancing-pandemic-preparedness-through-public-private-collaboration.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/community-and-global-health/2026/02/hepatitis-c-elimination-in-the-us-is-within-reach-experts-report.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/tech-disease-trends.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/tech-disease-trends/2024/09/candida-auris--rising-threat-and-future-implications.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/tech-disease-trends/2024/09/discussing-pharma-clinical-trials-utilizing-poc-diagnostics.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/tech-disease-trends/2024/09/poc-testing-increases-the-efficiency-of-patient-management-in-the-ed.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/tech-disease-trends/2024/10/dave-persing-legacy-and-leadership-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/tech-disease-trends/2024/11/invasive-group-streptococcal-disease.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/tech-disease-trends/2024/11/what-is-pcr--understanding-the-magic.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/tech-disease-trends/2024/11/decentralized-pcr-testing-and-the-quadruple-aim-insights-for-health-systems.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/tech-disease-trends/2025/01/how-a-cepheid-molecular-test-is-made.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/tech-disease-trends/2025/04/standardization-of-pcr-testing-across-healthcare-testing-sites.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/tech-disease-trends/2025/06/innovation-in-times-of-need-cepheids-legacy-of-outbreak-response.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/tech-disease-trends/2025/07/celebrating-the-cepheid-bike-where-art-meets-innovation.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/tech-disease-trends/2025/09/cepheid-advances-innovation-and-reach-with-key-partnerships.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/tech-disease-trends/2025/10/learn-about-cepheid-system-innovation.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/tech-disease-trends/2025/11/multiplex-with-meaning--cepheid-s-smart-approach-to-molecular-di.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/antimicrobial-stewardship.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/antimicrobial-stewardship/2024/09/a-public-health-dialogue-on-antibiotic-resistance-surveillance.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/antimicrobial-stewardship/2024/09/mortality-associated-with-carbapenem-resistant-gram-negative-infections.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/antimicrobial-stewardship/2024/09/decentralized-testing-for-the-surveillance-of-hospital-acquired-infections.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/antimicrobial-stewardship/2024/09/rapid-mrsa-screening-of-ortho-trauma-patients-improves-experience.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/antimicrobial-stewardship/2024/09/pcr-screening-at-a-british-hospital-enables-timely-infection-control.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/antimicrobial-stewardship/2024/10/fleming-initiative-cepheid-announce-partnership-tackle-amr.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/antimicrobial-stewardship/2024/10/link-between-colonization-multi-drug-resistant-infection.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/antimicrobial-stewardship/2024/12/point-of-care-testing-emergency-department-faster-decision-making-halle.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-schulz.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/antimicrobial-stewardship/2025/05/antimicrobial-and-diagnostic-stewardship-frost-and-sullivan-visual-whitepaper.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/antimicrobial-stewardship/2025/08/industry-voices-time-to-rethink-our-approach-to-using-modern-medicine.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/antimicrobial-stewardship/2025/09/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/antimicrobial-stewardship/2025/10/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/antimicrobial-stewardship/2025/11/vanessa-carter-s-journey--inspiring-action-against-amr.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/antimicrobial-stewardship/2025/11/advancing-antimicrobial-stewardship-in-small-and-rural-hospital.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/expert-spotlight.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/expert-spotlight/2025/10/expert-spotlight--michael-loeffelholz.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--devasena-gnanashanmugam-vice-president--me.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--jennifer-rakeman-cagno-senior-director--sc.htmldaily1.0https://www.cepheid.com/en-LV/insights/insight-hub/expert-spotlight/2026/02/expert-spotlight-jordan-chase.htmldaily1.0https://www.cepheid.com/en-LV/insights/webinars.htmldaily1.0https://www.cepheid.com/en-LV/insights/resources.htmldaily1.0https://www.cepheid.com/en-LV/support.htmldaily1.0https://www.cepheid.com/en-LV/support/ivdr-update.htmldaily1.0https://www.cepheid.com/en-LV/support/contact-us.htmldaily1.0https://www.cepheid.com/en-LV/about.htmldaily1.0https://www.cepheid.com/en-LV/about/mission-history.htmldaily1.0https://www.cepheid.com/en-LV/about/leadership.htmldaily1.0https://www.cepheid.com/en-LV/about/leadership/vitor-rocha.htmldaily1.0https://www.cepheid.com/en-LV/about/leadership/laurent-bellon.htmldaily1.0https://www.cepheid.com/en-LV/about/leadership/anette-engelhardt.htmldaily1.0https://www.cepheid.com/en-LV/about/leadership/peter-farrell.htmldaily1.0https://www.cepheid.com/en-LV/about/leadership/deborah-gonyea.htmldaily1.0https://www.cepheid.com/en-LV/about/leadership/nichole-halsey.htmldaily1.0https://www.cepheid.com/en-LV/about/leadership/luben-li.htmldaily1.0https://www.cepheid.com/en-LV/about/leadership/luke-maitland.htmldaily1.0https://www.cepheid.com/en-LV/about/leadership/david-h-persing.htmldaily1.0https://www.cepheid.com/en-LV/about/leadership/ammar-qadan.htmldaily1.0https://www.cepheid.com/en-LV/about/leadership/charles-mwangi.htmldaily1.0https://www.cepheid.com/en-LV/about/leadership/samson-wu.htmldaily1.0https://www.cepheid.com/en-LV/about/leadership/anupama-mokkapati.htmldaily1.0https://www.cepheid.com/en-LV/about/leadership/traci-wicks.htmldaily1.0https://www.cepheid.com/en-LV/about/leadership/scott-campbell.htmldaily1.0https://www.cepheid.com/en-LV/about/leadership/anne-beauburn.htmldaily1.0https://www.cepheid.com/en-LV/about/leadership/patrick-harkins.htmldaily1.0https://www.cepheid.com/en-LV/about/leadership/ephraim-tsalik.htmldaily1.0https://www.cepheid.com/en-LV/about/leadership/somesh-lalithraj.htmldaily1.0https://www.cepheid.com/en-LV/about/leadership/connie-savor.htmldaily1.0https://www.cepheid.com/en-LV/about/sustainability.htmldaily1.0https://www.cepheid.com/en-LV/about/sustainability/environmental-sustainability.htmldaily1.0https://www.cepheid.com/en-LV/about/sustainability/product-stewardship.htmldaily1.0https://www.cepheid.com/en-LV/about/sustainability/conflict-materials.htmldaily1.0https://www.cepheid.com/en-LV/about/policies-reports.htmldaily1.0https://www.cepheid.com/en-LV/about/business-development-opportunities.htmldaily1.0https://www.cepheid.com/en-LV/about/events.htmldaily1.0https://www.cepheid.com/en-LV/about/innovation-form.htmldaily1.0https://www.cepheid.com/en-LV/about/innovation-form/unsolicited-submission-agreement.htmldaily1.0https://www.cepheid.com/en-LV/about/sars-cov-2-test-development-information.htmldaily1.0https://www.cepheid.com/en-LV/about/sars-cov-2-product-resources.htmldaily1.0https://www.cepheid.com/en-LV/contact/select-info-path.htmldaily1.0https://www.cepheid.com/en-LV/contact/messages/thank-you.htmldaily1.0https://www.cepheid.com/en-LV/contact/messages/thank-you-patient-pathways.htmldaily1.0https://www.cepheid.com/en-LV/contact/messages/thank-you-patient-pathways-fr.htmldaily1.0https://www.cepheid.com/en-LV/contact/messages/thank-you-patient-pathways-de.htmldaily1.0https://www.cepheid.com/en-LV/contact/messages/thank-you-patient-pathways-it.htmldaily1.0https://www.cepheid.com/en-LV/contact/messages/thank-you-patient-pathways-sp.htmldaily1.0https://www.cepheid.com/en-LV/contact/messages/thank-you-patient-pathways-pl.htmldaily1.0https://www.cepheid.com/en-LV/contact/messages/thank-you-patient-pathways-pt.htmldaily1.0https://www.cepheid.com/en-LV/contact/request-cd-international.htmldaily1.0https://www.cepheid.com/en-LV/personas/laboratory-professionals.htmldaily1.0https://www.cepheid.com/en-LV/personas/healthcare-professsional.htmldaily1.0https://www.cepheid.com/en-LV/personas/health-system-administrators.htmldaily1.0https://www.cepheid.com/en-LV/legal/privacy.htmldaily1.0https://www.cepheid.com/en-LV/legal/terms-of-use.htmldaily1.0https://www.cepheid.com/en-LV/legal/product-security-updates.htmldaily1.0https://www.cepheid.com/en-LV/legal/terms-of-sale.htmldaily1.0https://www.cepheid.com/en-LV/legal/trademarks.htmldaily1.0https://www.cepheid.com/en-LV/legal/cookies-notice.htmldaily1.0https://www.cepheid.com/en-LV/campaigns/2020-emea-renewed-messaging/french/patient-pathways.htmldaily1.0https://www.cepheid.com/en-LV/campaigns/2020-emea-renewed-messaging/german/patient-pathways.htmldaily1.0https://www.cepheid.com/en-LV/campaigns/2020-emea-renewed-messaging/italian/patient-pathways.htmldaily1.0https://www.cepheid.com/en-LV/campaigns/2020-emea-renewed-messaging/portuguese/patient-pathways.htmldaily1.0https://www.cepheid.com/en-LV/campaigns/2020-emea-renewed-messaging/polish/patient-pathways.htmldaily1.0https://www.cepheid.com/en-LV/campaigns/india/cepheid-india.htmldaily1.0https://www.cepheid.com/en-LV/campaigns/india/india-submission.htmldaily1.0https://www.cepheid.com/en-LV/campaigns/india/cepheid-india-display.htmldaily1.0https://www.cepheid.com/en-LV/campaigns/india/cepheid-india-bangladesh.htmldaily1.0https://www.cepheid.com/en-LV/campaigns/pcr-plus.htmldaily1.0https://www.cepheid.com/en-LV/coronavirus-portfolio.htmldaily1.0https://www.cepheid.com/en-NL.htmldaily1.0https://www.cepheid.com/en-NL/tests.htmldaily1.0https://www.cepheid.com/en-NL/tests/respiratory.htmldaily1.0https://www.cepheid.com/en-NL/tests/respiratory/xpert-xpress-strep-a.htmldaily1.0https://www.cepheid.com/en-NL/tests/respiratory/xpert-xpress-cov-2-plus.htmldaily1.0https://www.cepheid.com/en-NL/tests/respiratory/xpert-xpress-sars-cov-2.htmldaily1.0https://www.cepheid.com/en-NL/tests/respiratory/xpert-xpress-flu-rsv.htmldaily1.0https://www.cepheid.com/en-NL/tests/respiratory/xpert-xpress-cov-2-flu-rsv-plus.htmldaily1.0https://www.cepheid.com/en-NL/tests/hai-other-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-NL/tests/hai-other-infectious-diseases/xpert-sa-nasal-complete.htmldaily1.0https://www.cepheid.com/en-NL/tests/hai-other-infectious-diseases/xpert-mrsa-sa-ssti.htmldaily1.0https://www.cepheid.com/en-NL/tests/hai-other-infectious-diseases/xpert-c-difficile-bt.htmldaily1.0https://www.cepheid.com/en-NL/tests/hai-other-infectious-diseases/xpert-norovirus.htmldaily1.0https://www.cepheid.com/en-NL/tests/hai-other-infectious-diseases/xpert-mrsa-sa-blood-culture.htmldaily1.0https://www.cepheid.com/en-NL/tests/hai-other-infectious-diseases/xpert-vana-vanb.htmldaily1.0https://www.cepheid.com/en-NL/tests/hai-other-infectious-diseases/xpert-mrsa-nxg.htmldaily1.0https://www.cepheid.com/en-NL/tests/hai-other-infectious-diseases/xpert-carba-r.htmldaily1.0https://www.cepheid.com/en-NL/tests/blood-virology-womens-health-sexual-health.htmldaily1.0https://www.cepheid.com/en-NL/tests/blood-virology-womens-health-sexual-health/xpert-hbv-viral-load.htmldaily1.0https://www.cepheid.com/en-NL/tests/blood-virology-womens-health-sexual-health/resistanceplusmg-flexible.htmldaily1.0https://www.cepheid.com/en-NL/tests/blood-virology-womens-health-sexual-health/xpert-xpress-gbs.htmldaily1.0https://www.cepheid.com/en-NL/tests/blood-virology-womens-health-sexual-health/xpert-ct-ng.htmldaily1.0https://www.cepheid.com/en-NL/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-qual-xc.htmldaily1.0https://www.cepheid.com/en-NL/tests/blood-virology-womens-health-sexual-health/xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-NL/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-viral-load-xc.htmldaily1.0https://www.cepheid.com/en-NL/tests/blood-virology-womens-health-sexual-health/xpert-tv.htmldaily1.0https://www.cepheid.com/en-NL/tests/blood-virology-womens-health-sexual-health/xpert-hpv-v2.htmldaily1.0https://www.cepheid.com/en-NL/tests/blood-virology-womens-health-sexual-health/xpert-hcv-viral-load.htmldaily1.0https://www.cepheid.com/en-NL/tests/tb-emerging-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-NL/tests/tb-emerging-infectious-diseases/xpert-mtb-xdr.htmldaily1.0https://www.cepheid.com/en-NL/tests/tb-emerging-infectious-diseases/xpert-mtb-rif-ultra.htmldaily1.0https://www.cepheid.com/en-NL/tests/oncology-human-genetics.htmldaily1.0https://www.cepheid.com/en-NL/tests/oncology-human-genetics/expert-bladder-cancer-monitor.htmldaily1.0https://www.cepheid.com/en-NL/tests/oncology-human-genetics/xpert-fii-fv.htmldaily1.0https://www.cepheid.com/en-NL/tests/oncology-human-genetics/xpert-bcr-abl-ultra-p190.htmldaily1.0https://www.cepheid.com/en-NL/tests/oncology-human-genetics/xpert-breast-cancer-strat4.htmldaily1.0https://www.cepheid.com/en-NL/tests/oncology-human-genetics/xpert-bladder-cancer-detection.htmldaily1.0https://www.cepheid.com/en-NL/tests/oncology-human-genetics/xpert-bcr-abl-ultra.htmldaily1.0https://www.cepheid.com/en-NL/tests/oncology-human-genetics/xpert-npm1-mutation.htmldaily1.0https://www.cepheid.com/en-NL/systems.htmldaily1.0https://www.cepheid.com/en-NL/systems/genexpert-family-of-systems.htmldaily1.0https://www.cepheid.com/en-NL/systems/genexpert-family-of-systems/genexpert-system.htmldaily1.0https://www.cepheid.com/en-NL/systems/genexpert-family-of-systems/genexpert-infinity.htmldaily1.0https://www.cepheid.com/en-NL/systems/genexpert-software.htmldaily1.0https://www.cepheid.com/en-NL/systems/genexpert-software/gx-software.htmldaily1.0https://www.cepheid.com/en-NL/systems/genexpert-software/xpertise-software.htmldaily1.0https://www.cepheid.com/en-NL/systems/connectivity.htmldaily1.0https://www.cepheid.com/en-NL/systems/connectivity/cepheid-c360.htmldaily1.0https://www.cepheid.com/en-NL/systems/connectivity/interface-capabilities.htmldaily1.0https://www.cepheid.com/en-NL/systems/data-processing-agreement.htmldaily1.0https://www.cepheid.com/en-NL/systems/partner-communities.htmldaily1.0https://www.cepheid.com/en-NL/systems/business-associates-agreement.htmldaily1.0https://www.cepheid.com/en-NL/solutions.htmldaily1.0https://www.cepheid.com/en-NL/solutions/global-access.htmldaily1.0https://www.cepheid.com/en-NL/solutions/global-access/eligibility-and-pricing.htmldaily1.0https://www.cepheid.com/en-NL/solutions/testing-everywhere.htmldaily1.0https://www.cepheid.com/en-NL/solutions/antibiotic-stewardship.htmldaily1.0https://www.cepheid.com/en-NL/solutions/oncology-diagnostics.htmldaily1.0https://www.cepheid.com/en-NL/solutions/customized-testing-institution.htmldaily1.0https://www.cepheid.com/en-NL/solutions/knowing-more-matters.htmldaily1.0https://www.cepheid.com/en-NL/solutions/knowing-more-matters/pcr-vs-antigen.htmldaily1.0https://www.cepheid.com/en-NL/solutions/knowing-more-matters/covid-flu-rsv.htmldaily1.0https://www.cepheid.com/en-NL/insights.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/all-posts.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/respiratory-health.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/respiratory-health/2024/09/proactive-surveillance-to-ensure-broad-flu-strain-detection.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/respiratory-health/2024/09/emerging-evolving-respiratory-viruses-test-design-matters.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/respiratory-health/2024/09/the-genexpert-xpress-system-can-change-your-pediatric-practice.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/respiratory-health/2024/09/Norwegian-ED-improves-Resource-Management-with-Rapid-PCR-Testing.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/respiratory-health/2024/09/key-steps-pandemic-preparedness.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/respiratory-health/2025/01/what-does-it-mean-to-have-a-pandemic-ready-pcr-test.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like-ilnesses.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/respiratory-health/2025/03/in-house-pcr-testing-clinical-leaders-explore-the-ripple-effect.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/respiratory-health/2025/04/real-world-clinical-impact-of-in-house-pcr-testing.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/respiratory-health/2025/04/what-is-the-difference-between-pcr-and-antigen-testing.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/respiratory-health/2025/05/a-quick-primer-on-the-adlm-guidance-on-respiratory-virus-testing.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/respiratory-health/2025/09/revolutionizing-respiratory-care-the-power-of-rapid-molecular-testing.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/respiratory-health/2025/09/antigen-testing-vs-pcr-less-haste-more-speed-please.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/respiratory-health/2025/09/the-time-for-widespread-adoption-of-mdx-testing-for-gas-pharyngi.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/respiratory-health/2025/11/why-test-type-matters-pcr-vs-antigen-in-outpatient-respiratory-care.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/respiratory-health/2025/11/transforming-respiratory-tnfection-diagnosis-embracing-molecular-innovation-clinical-practice1.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/respiratory-health/2026/01/staying-ahead-of-influenza.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/respiratory-health/2026/02/revolutionizing-rheumatic-heart-disease-prevention.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2024/09/accelerating-the-pace-for-hep-c-elimination-in-the-us.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2024/09/can-molecular-tests-revolutionize-tuberculosis-control.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2024/09/near-patient-testing-for-hep-c-xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2024/09/danish-hcv-testing-program-improves-patient-management-and-access.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2024/09/faster-prison-testing-for-hcv-drastically-improves-treatment-in-the-uk.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2024/09/innovative-POC-testing-shortens-time-between-testing-and-treatment.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2024/09/finnish-hospital-improves-care-for-expectant-mothers-with-gbs-pcr-screening.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2024/09/a-not-for-profit-in-vietnam-fights-to-end-tuberculosis.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2024/09/cepheid-expands-in-india-to-support-global-efforts-to-fight-tb.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2024/09/covid-19-and-tuberculosis-testing-in-south-africa.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2024/09/cepheid-supports-the-international-mpox-emergency-declared-august-2024.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2024/10/hpv-testing-south-african-clinic-may-prevent-cervical-cancer.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2024/12/strides-toward-early-infant-diagnosis-for-hiv-elimination-in-sou.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2025/02/common-misconceptions-about-vaginitis.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2025/06/womens-health-testing-advantages-of-same-day-diagnosis-and-treatment.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2025/04/tuberculosis-staying-one-step-ahead.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2025/04/how-three-countries-are-fighting-back-against-tuberculosis.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2025/04/a-mdr-tb-survivor-in-india-shares-her-remarkable-story.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2025/05/revisiting-bacterial-vaginosis-evidence-for-sexual-transmission.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2025/05/a-breakthrough-in-hcv-elimination--how-hcv-point-of-care-rna-tes.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2025/05/decentralising-diagnostics-bringing-patient-centred-testing-closer-to-communities.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2025/05/integration-of-poc-viral-diagnostics-with-substance-use-disorder-treatment-to-improve-hepatitis-c-nfection-outcomes.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2025/07/five-surprising-stats-that-reveal-the-hidden-burden-of-vaginitis.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2025/07/5-ways-vaginitis-treatment-goes-wrong-and-how-better-testing-can-fix-It.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2025/03/the-fight-to-end-tuberculosis-in-pakistan.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2025/03/devasena-gnanashanmugam-discusses-cepheids-global-access-program.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2025/03/desmond-tutu-foundation-reduces-impact-of-hiv-and-tb.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2025/03/tuberculosis-care-and-treatment-in-the-republic-of-indonesia.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2025/03/finding-missing-tuberculosis-tb-cases-philippines-need-for-speed.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2025/03/a-decade-of-health-and-economic-benefits-infographic.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2025/03/state-tb-in-us-overlooked-opportunity-better-results.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2025/03/fighting-tb-everything-10-years-of-impact-in-south-africa.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2025/09/in-memory-of-john-bishop-a-visionary-leader-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2025/10/time-to-act-stopping-group-b-strep-infections-in-newborn-babies.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2025/10/real-user-experiences-with-xpert-xpress-mvp-oint-of-care-test.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2025/12/wecare-humanitarian-medical-mission.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2025/08/kentucky-viral-hepatitis-treatment-projects-mission-to-eradicate-hcv.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2025/08/the-state-of-vaginitis-testing-in-the-us.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2025/08/improving-vaginitis-care-through-better-diagnostics.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2026/02/advancing-pandemic-preparedness-through-public-private-collaboration.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/community-and-global-health/2026/02/hepatitis-c-elimination-in-the-us-is-within-reach-experts-report.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/tech-disease-trends.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/tech-disease-trends/2024/09/candida-auris--rising-threat-and-future-implications.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/tech-disease-trends/2024/09/discussing-pharma-clinical-trials-utilizing-poc-diagnostics.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/tech-disease-trends/2024/09/poc-testing-increases-the-efficiency-of-patient-management-in-the-ed.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/tech-disease-trends/2024/10/dave-persing-legacy-and-leadership-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/tech-disease-trends/2024/11/invasive-group-streptococcal-disease.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/tech-disease-trends/2024/11/what-is-pcr--understanding-the-magic.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/tech-disease-trends/2024/11/decentralized-pcr-testing-and-the-quadruple-aim-insights-for-health-systems.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/tech-disease-trends/2025/01/how-a-cepheid-molecular-test-is-made.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct-.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/tech-disease-trends/2025/04/standardization-of-pcr-testing-across-healthcare-testing-sites.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/tech-disease-trends/2025/06/innovation-in-times-of-need-cepheids-legacy-of-outbreak-response.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/tech-disease-trends/2025/07/celebrating-the-cepheid-bike-where-art-meets-innovation.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/tech-disease-trends/2025/09/cepheid-advances-innovation-and-reach-with-key-partnerships.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/tech-disease-trends/2025/10/learn-about-cepheid-system-innovation.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/tech-disease-trends/2025/11/multiplex-with-meaning--cepheid-s-smart-approach-to-molecular-di.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/antimicrobial-stewardship.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/antimicrobial-stewardship/2024/09/a-public-health-dialogue-on-antibiotic-resistance-surveillance.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/antimicrobial-stewardship/2024/09/mortality-associated-with-carbapenem-resistant-gram-negative-infections.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/antimicrobial-stewardship/2024/09/decentralized-testing-for-the-surveillance-of-hospital-acquired-infections.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/antimicrobial-stewardship/2024/09/rapid-mrsa-screening-of-ortho-trauma-patients-improves-experience.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/antimicrobial-stewardship/2024/09/pcr-screening-at-a-british-hospital-enables-timely-infection-control.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/antimicrobial-stewardship/2024/10/fleming-initiative-cepheid-announce-partnership-tackle-amr.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/antimicrobial-stewardship/2024/10/link-between-colonization-multi-drug-resistant-infection.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/antimicrobial-stewardship/2024/12/point-of-care-testing-emergency-department-faster-decision-making-halle.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-shulz.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-schulz.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/antimicrobial-stewardship/2025/05/antimicrobial-and-diagnostic-stewardship-frost-and-sullivan-visual-whitepaper.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/antimicrobial-stewardship/2025/08/industry-voices-time-to-rethink-our-approach-to-using-modern-medicine.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/antimicrobial-stewardship/2025/09/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/antimicrobial-stewardship/2025/10/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/antimicrobial-stewardship/2025/11/vanessa-carter-s-journey--inspiring-action-against-amr.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/antimicrobial-stewardship/2025/11/advancing-antimicrobial-stewardship-in-small-and-rural-hospital.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/expert-spotlight.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/expert-spotlight/2025/10/expert-spotlight--michael-loeffelholz.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--devasena-gnanashanmugam-vice-president--me.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--jennifer-rakeman-cagno-senior-director--sc.htmldaily1.0https://www.cepheid.com/en-NL/insights/insight-hub/expert-spotlight/2026/02/expert-spotlight-jordan-chase.htmldaily1.0https://www.cepheid.com/en-NL/insights/webinars.htmldaily1.0https://www.cepheid.com/en-NL/insights/resources.htmldaily1.0https://www.cepheid.com/en-NL/support.htmldaily1.0https://www.cepheid.com/en-NL/support/ivdr-update.htmldaily1.0https://www.cepheid.com/en-NL/support/contact-us.htmldaily1.0https://www.cepheid.com/en-NL/about.htmldaily1.0https://www.cepheid.com/en-NL/about/mission-history.htmldaily1.0https://www.cepheid.com/en-NL/about/leadership.htmldaily1.0https://www.cepheid.com/en-NL/about/leadership/vitor-rocha.htmldaily1.0https://www.cepheid.com/en-NL/about/leadership/laurent-bellon.htmldaily1.0https://www.cepheid.com/en-NL/about/leadership/anette-engelhardt.htmldaily1.0https://www.cepheid.com/en-NL/about/leadership/peter-farrell.htmldaily1.0https://www.cepheid.com/en-NL/about/leadership/deborah-gonyea.htmldaily1.0https://www.cepheid.com/en-NL/about/leadership/nichole-halsey.htmldaily1.0https://www.cepheid.com/en-NL/about/leadership/luben-li.htmldaily1.0https://www.cepheid.com/en-NL/about/leadership/luke-maitland.htmldaily1.0https://www.cepheid.com/en-NL/about/leadership/david-h-persing.htmldaily1.0https://www.cepheid.com/en-NL/about/leadership/ammar-qadan.htmldaily1.0https://www.cepheid.com/en-NL/about/leadership/charles-mwangi.htmldaily1.0https://www.cepheid.com/en-NL/about/leadership/samson-wu.htmldaily1.0https://www.cepheid.com/en-NL/about/leadership/anupama-mokkapati.htmldaily1.0https://www.cepheid.com/en-NL/about/leadership/traci-wicks.htmldaily1.0https://www.cepheid.com/en-NL/about/leadership/scott-campbell.htmldaily1.0https://www.cepheid.com/en-NL/about/leadership/anne-beauburn.htmldaily1.0https://www.cepheid.com/en-NL/about/leadership/patrick-harkins.htmldaily1.0https://www.cepheid.com/en-NL/about/leadership/ephraim-tsalik.htmldaily1.0https://www.cepheid.com/en-NL/about/leadership/somesh-lalithraj.htmldaily1.0https://www.cepheid.com/en-NL/about/leadership/connie-savor.htmldaily1.0https://www.cepheid.com/en-NL/about/sustainability.htmldaily1.0https://www.cepheid.com/en-NL/about/sustainability/environmental-sustainability.htmldaily1.0https://www.cepheid.com/en-NL/about/sustainability/product-stewardship.htmldaily1.0https://www.cepheid.com/en-NL/about/sustainability/conflict-materials.htmldaily1.0https://www.cepheid.com/en-NL/about/policies-reports.htmldaily1.0https://www.cepheid.com/en-NL/about/business-development-opportunities.htmldaily1.0https://www.cepheid.com/en-NL/about/events.htmldaily1.0https://www.cepheid.com/en-NL/about/innovation-form.htmldaily1.0https://www.cepheid.com/en-NL/about/innovation-form/unsolicited-submission-agreement.htmldaily1.0https://www.cepheid.com/en-NL/about/sars-cov-2-test-development-information.htmldaily1.0https://www.cepheid.com/en-NL/about/sars-cov-2-product-resources.htmldaily1.0https://www.cepheid.com/en-NL/contact/select-info-path.htmldaily1.0https://www.cepheid.com/en-NL/contact/messages/thank-you.htmldaily1.0https://www.cepheid.com/en-NL/contact/messages/thank-you-patient-pathways.htmldaily1.0https://www.cepheid.com/en-NL/contact/messages/thank-you-patient-pathways-fr.htmldaily1.0https://www.cepheid.com/en-NL/contact/messages/thank-you-patient-pathways-de.htmldaily1.0https://www.cepheid.com/en-NL/contact/messages/thank-you-patient-pathways-it.htmldaily1.0https://www.cepheid.com/en-NL/contact/messages/thank-you-patient-pathways-sp.htmldaily1.0https://www.cepheid.com/en-NL/contact/messages/thank-you-patient-pathways-pl.htmldaily1.0https://www.cepheid.com/en-NL/contact/messages/thank-you-patient-pathways-pt.htmldaily1.0https://www.cepheid.com/en-NL/contact/request-cd-international.htmldaily1.0https://www.cepheid.com/en-NL/personas/laboratory-professionals.htmldaily1.0https://www.cepheid.com/en-NL/personas/healthcare-professsional.htmldaily1.0https://www.cepheid.com/en-NL/personas/health-system-administrators.htmldaily1.0https://www.cepheid.com/en-NL/legal/privacy.htmldaily1.0https://www.cepheid.com/en-NL/legal/terms-of-use.htmldaily1.0https://www.cepheid.com/en-NL/legal/product-security-updates.htmldaily1.0https://www.cepheid.com/en-NL/legal/terms-of-sale.htmldaily1.0https://www.cepheid.com/en-NL/legal/trademarks.htmldaily1.0https://www.cepheid.com/en-NL/legal/cookies-notice.htmldaily1.0https://www.cepheid.com/en-NL/campaigns/2020-emea-renewed-messaging/french/patient-pathways.htmldaily1.0https://www.cepheid.com/en-NL/campaigns/2020-emea-renewed-messaging/german/patient-pathways.htmldaily1.0https://www.cepheid.com/en-NL/campaigns/2020-emea-renewed-messaging/italian/patient-pathways.htmldaily1.0https://www.cepheid.com/en-NL/campaigns/2020-emea-renewed-messaging/portuguese/patient-pathways.htmldaily1.0https://www.cepheid.com/en-NL/campaigns/2020-emea-renewed-messaging/polish/patient-pathways.htmldaily1.0https://www.cepheid.com/en-NL/campaigns/india/cepheid-india.htmldaily1.0https://www.cepheid.com/en-NL/campaigns/india/india-submission.htmldaily1.0https://www.cepheid.com/en-NL/campaigns/india/cepheid-india-display.htmldaily1.0https://www.cepheid.com/en-NL/campaigns/india/cepheid-india-bangladesh.htmldaily1.0https://www.cepheid.com/en-NL/campaigns/pcr-plus.htmldaily1.0https://www.cepheid.com/en-NL/coronavirus-portfolio.htmldaily1.0https://www.cepheid.com/en-NO.htmldaily1.0https://www.cepheid.com/en-NO/tests.htmldaily1.0https://www.cepheid.com/en-NO/tests/respiratory.htmldaily1.0https://www.cepheid.com/en-NO/tests/respiratory/xpert-xpress-strep-a.htmldaily1.0https://www.cepheid.com/en-NO/tests/respiratory/xpert-xpress-cov-2-plus.htmldaily1.0https://www.cepheid.com/en-NO/tests/respiratory/xpert-xpress-flu-rsv.htmldaily1.0https://www.cepheid.com/en-NO/tests/respiratory/xpert-xpress-cov-2-flu-rsv-plus.htmldaily1.0https://www.cepheid.com/en-NO/tests/hai-other-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-NO/tests/hai-other-infectious-diseases/xpert-sa-nasal-complete.htmldaily1.0https://www.cepheid.com/en-NO/tests/hai-other-infectious-diseases/xpert-mrsa-sa-ssti.htmldaily1.0https://www.cepheid.com/en-NO/tests/hai-other-infectious-diseases/xpert-c-difficile-bt.htmldaily1.0https://www.cepheid.com/en-NO/tests/hai-other-infectious-diseases/xpert-norovirus.htmldaily1.0https://www.cepheid.com/en-NO/tests/hai-other-infectious-diseases/xpert-mrsa-sa-blood-culture.htmldaily1.0https://www.cepheid.com/en-NO/tests/hai-other-infectious-diseases/xpert-vana-vanb.htmldaily1.0https://www.cepheid.com/en-NO/tests/hai-other-infectious-diseases/xpert-mrsa-nxg.htmldaily1.0https://www.cepheid.com/en-NO/tests/hai-other-infectious-diseases/xpert-carba-r.htmldaily1.0https://www.cepheid.com/en-NO/tests/blood-virology-womens-health-sexual-health.htmldaily1.0https://www.cepheid.com/en-NO/tests/blood-virology-womens-health-sexual-health/xpert-gbs.htmldaily1.0https://www.cepheid.com/en-NO/tests/blood-virology-womens-health-sexual-health/xpert-hbv-viral-load.htmldaily1.0https://www.cepheid.com/en-NO/tests/blood-virology-womens-health-sexual-health/resistanceplusmg-flexible.htmldaily1.0https://www.cepheid.com/en-NO/tests/blood-virology-womens-health-sexual-health/xpert-xpress-gbs.htmldaily1.0https://www.cepheid.com/en-NO/tests/blood-virology-womens-health-sexual-health/xpert-ct-ng.htmldaily1.0https://www.cepheid.com/en-NO/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-qual-xc.htmldaily1.0https://www.cepheid.com/en-NO/tests/blood-virology-womens-health-sexual-health/xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-NO/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-viral-load-xc.htmldaily1.0https://www.cepheid.com/en-NO/tests/blood-virology-womens-health-sexual-health/xpert-tv.htmldaily1.0https://www.cepheid.com/en-NO/tests/blood-virology-womens-health-sexual-health/xpert-hpv-v2.htmldaily1.0https://www.cepheid.com/en-NO/tests/blood-virology-womens-health-sexual-health/xpert-hcv-viral-load.htmldaily1.0https://www.cepheid.com/en-NO/tests/tb-emerging-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-NO/tests/tb-emerging-infectious-diseases/xpert-mtb-xdr.htmldaily1.0https://www.cepheid.com/en-NO/tests/tb-emerging-infectious-diseases/xpert-mtb-rif-ultra.htmldaily1.0https://www.cepheid.com/en-NO/tests/oncology-human-genetics.htmldaily1.0https://www.cepheid.com/en-NO/tests/oncology-human-genetics/expert-bladder-cancer-monitor.htmldaily1.0https://www.cepheid.com/en-NO/tests/oncology-human-genetics/xpert-fii-fv.htmldaily1.0https://www.cepheid.com/en-NO/tests/oncology-human-genetics/xpert-bcr-abl-ultra-p190.htmldaily1.0https://www.cepheid.com/en-NO/tests/oncology-human-genetics/xpert-bladder-cancer-detection.htmldaily1.0https://www.cepheid.com/en-NO/tests/oncology-human-genetics/xpert-bcr-abl-ultra.htmldaily1.0https://www.cepheid.com/en-NO/systems.htmldaily1.0https://www.cepheid.com/en-NO/systems/genexpert-family-of-systems.htmldaily1.0https://www.cepheid.com/en-NO/systems/genexpert-family-of-systems/genexpert-system.htmldaily1.0https://www.cepheid.com/en-NO/systems/genexpert-family-of-systems/genexpert-infinity.htmldaily1.0https://www.cepheid.com/en-NO/systems/genexpert-software.htmldaily1.0https://www.cepheid.com/en-NO/systems/genexpert-software/gx-software.htmldaily1.0https://www.cepheid.com/en-NO/systems/genexpert-software/xpertise-software.htmldaily1.0https://www.cepheid.com/en-NO/systems/connectivity.htmldaily1.0https://www.cepheid.com/en-NO/systems/connectivity/cepheid-c360.htmldaily1.0https://www.cepheid.com/en-NO/systems/connectivity/interface-capabilities.htmldaily1.0https://www.cepheid.com/en-NO/systems/data-processing-agreement.htmldaily1.0https://www.cepheid.com/en-NO/systems/partner-communities.htmldaily1.0https://www.cepheid.com/en-NO/systems/business-associates-agreement.htmldaily1.0https://www.cepheid.com/en-NO/solutions.htmldaily1.0https://www.cepheid.com/en-NO/solutions/global-access.htmldaily1.0https://www.cepheid.com/en-NO/solutions/global-access/eligibility-and-pricing.htmldaily1.0https://www.cepheid.com/en-NO/solutions/testing-everywhere.htmldaily1.0https://www.cepheid.com/en-NO/solutions/antibiotic-stewardship.htmldaily1.0https://www.cepheid.com/en-NO/solutions/oncology-diagnostics.htmldaily1.0https://www.cepheid.com/en-NO/solutions/customized-testing-institution.htmldaily1.0https://www.cepheid.com/en-NO/solutions/knowing-more-matters.htmldaily1.0https://www.cepheid.com/en-NO/solutions/knowing-more-matters/pcr-vs-antigen.htmldaily1.0https://www.cepheid.com/en-NO/solutions/knowing-more-matters/covid-flu-rsv.htmldaily1.0https://www.cepheid.com/en-NO/insights.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/all-posts.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/respiratory-health.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/respiratory-health/2024/09/proactive-surveillance-to-ensure-broad-flu-strain-detection.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/respiratory-health/2024/09/emerging-evolving-respiratory-viruses-test-design-matters.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/respiratory-health/2024/09/the-genexpert-xpress-system-can-change-your-pediatric-practice.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/respiratory-health/2024/09/Norwegian-ED-improves-Resource-Management-with-Rapid-PCR-Testing.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/respiratory-health/2024/09/key-steps-pandemic-preparedness.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/respiratory-health/2025/01/what-does-it-mean-to-have-a-pandemic-ready-pcr-test.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like-ilnesses.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/respiratory-health/2025/03/in-house-pcr-testing-clinical-leaders-explore-the-ripple-effect.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/respiratory-health/2025/04/real-world-clinical-impact-of-in-house-pcr-testing.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/respiratory-health/2025/04/what-is-the-difference-between-pcr-and-antigen-testing.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/respiratory-health/2025/05/a-quick-primer-on-the-adlm-guidance-on-respiratory-virus-testing.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/respiratory-health/2025/09/revolutionizing-respiratory-care-the-power-of-rapid-molecular-testing.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/respiratory-health/2025/09/antigen-testing-vs-pcr-less-haste-more-speed-please.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/respiratory-health/2025/09/the-time-for-widespread-adoption-of-mdx-testing-for-gas-pharyngi.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/respiratory-health/2025/11/why-test-type-matters-pcr-vs-antigen-in-outpatient-respiratory-care.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/respiratory-health/2025/11/transforming-respiratory-tnfection-diagnosis-embracing-molecular-innovation-clinical-practice1.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/respiratory-health/2026/01/staying-ahead-of-influenza.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/respiratory-health/2026/02/revolutionizing-rheumatic-heart-disease-prevention.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2024/09/accelerating-the-pace-for-hep-c-elimination-in-the-us.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2024/09/can-molecular-tests-revolutionize-tuberculosis-control.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2024/09/near-patient-testing-for-hep-c-xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2024/09/danish-hcv-testing-program-improves-patient-management-and-access.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2024/09/faster-prison-testing-for-hcv-drastically-improves-treatment-in-the-uk.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2024/09/innovative-POC-testing-shortens-time-between-testing-and-treatment.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2024/09/finnish-hospital-improves-care-for-expectant-mothers-with-gbs-pcr-screening.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2024/09/a-not-for-profit-in-vietnam-fights-to-end-tuberculosis.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2024/09/cepheid-expands-in-india-to-support-global-efforts-to-fight-tb.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2024/09/covid-19-and-tuberculosis-testing-in-south-africa.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2024/09/cepheid-supports-the-international-mpox-emergency-declared-august-2024.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2024/10/hpv-testing-south-african-clinic-may-prevent-cervical-cancer.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2024/12/strides-toward-early-infant-diagnosis-for-hiv-elimination-in-sou.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2025/02/common-misconceptions-about-vaginitis.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2025/07/five-surprising-stats-that-reveal-the-hidden-burden-of-vaginitis.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2025/07/5-ways-vaginitis-treatment-goes-wrong-and-how-better-testing-can-fix-It.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2025/03/the-fight-to-end-tuberculosis-in-pakistan.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2025/03/devasena-gnanashanmugam-discusses-cepheids-global-access-program.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2025/03/desmond-tutu-foundation-reduces-impact-of-hiv-and-tb.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2025/03/tuberculosis-care-and-treatment-in-the-republic-of-indonesia.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2025/03/finding-missing-tuberculosis-tb-cases-philippines-need-for-speed.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2025/03/a-decade-of-health-and-economic-benefits-infographic.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2025/03/state-tb-in-us-overlooked-opportunity-better-results.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2025/03/fighting-tb-everything-10-years-of-impact-in-south-africa.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2025/04/tuberculosis-staying-one-step-ahead.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2025/04/how-three-countries-are-fighting-back-against-tuberculosis.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2025/04/a-mdr-tb-survivor-in-india-shares-her-remarkable-story.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2025/06/womens-health-testing-advantages-of-same-day-diagnosis-and-treatment.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2025/05/revisiting-bacterial-vaginosis-evidence-for-sexual-transmission.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2025/05/a-breakthrough-in-hcv-elimination--how-hcv-point-of-care-rna-tes.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2025/05/decentralising-diagnostics-bringing-patient-centred-testing-closer-to-communities.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2025/05/integration-of-poc-viral-diagnostics-with-substance-use-disorder-treatment-to-improve-hepatitis-c-nfection-outcomes.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2025/09/in-memory-of-john-bishop-a-visionary-leader-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2025/12/wecare-humanitarian-medical-mission.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2025/10/time-to-act-stopping-group-b-strep-infections-in-newborn-babies.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2025/10/real-user-experiences-with-xpert-xpress-mvp-oint-of-care-test.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2025/08/kentucky-viral-hepatitis-treatment-projects-mission-to-eradicate-hcv.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2025/08/the-state-of-vaginitis-testing-in-the-us.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2025/08/improving-vaginitis-care-through-better-diagnostics.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2026/02/advancing-pandemic-preparedness-through-public-private-collaboration.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/community-and-global-health/2026/02/hepatitis-c-elimination-in-the-us-is-within-reach-experts-report.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/tech-disease-trends.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/tech-disease-trends/2024/09/candida-auris--rising-threat-and-future-implications.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/tech-disease-trends/2024/09/discussing-pharma-clinical-trials-utilizing-poc-diagnostics.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/tech-disease-trends/2024/09/poc-testing-increases-the-efficiency-of-patient-management-in-the-ed.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/tech-disease-trends/2024/10/dave-persing-legacy-and-leadership-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/tech-disease-trends/2024/11/invasive-group-streptococcal-disease.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/tech-disease-trends/2024/11/what-is-pcr--understanding-the-magic.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/tech-disease-trends/2024/11/decentralized-pcr-testing-and-the-quadruple-aim-insights-for-health-systems.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/tech-disease-trends/2025/01/how-a-cepheid-molecular-test-is-made.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct-.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/tech-disease-trends/2025/04/standardization-of-pcr-testing-across-healthcare-testing-sites.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/tech-disease-trends/2025/06/innovation-in-times-of-need-cepheids-legacy-of-outbreak-response.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/tech-disease-trends/2025/07/celebrating-the-cepheid-bike-where-art-meets-innovation.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/tech-disease-trends/2025/09/cepheid-advances-innovation-and-reach-with-key-partnerships.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/tech-disease-trends/2025/10/learn-about-cepheid-system-innovation.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/tech-disease-trends/2025/11/multiplex-with-meaning--cepheid-s-smart-approach-to-molecular-di.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/antimicrobial-stewardship.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/antimicrobial-stewardship/2024/09/a-public-health-dialogue-on-antibiotic-resistance-surveillance.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/antimicrobial-stewardship/2024/09/mortality-associated-with-carbapenem-resistant-gram-negative-infections.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/antimicrobial-stewardship/2024/09/decentralized-testing-for-the-surveillance-of-hospital-acquired-infections.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/antimicrobial-stewardship/2024/09/rapid-mrsa-screening-of-ortho-trauma-patients-improves-experience.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/antimicrobial-stewardship/2024/09/pcr-screening-at-a-british-hospital-enables-timely-infection-control.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/antimicrobial-stewardship/2024/10/fleming-initiative-cepheid-announce-partnership-tackle-amr.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/antimicrobial-stewardship/2024/10/link-between-colonization-multi-drug-resistant-infection.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/antimicrobial-stewardship/2024/12/point-of-care-testing-emergency-department-faster-decision-making-halle.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-shulz.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-schulz.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/antimicrobial-stewardship/2025/05/antimicrobial-and-diagnostic-stewardship-frost-and-sullivan-visual-whitepaper.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/antimicrobial-stewardship/2025/08/industry-voices-time-to-rethink-our-approach-to-using-modern-medicine.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/antimicrobial-stewardship/2025/09/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/antimicrobial-stewardship/2025/10/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/antimicrobial-stewardship/2025/11/vanessa-carter-s-journey--inspiring-action-against-amr.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/antimicrobial-stewardship/2025/11/advancing-antimicrobial-stewardship-in-small-and-rural-hospital.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/expert-spotlight.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/expert-spotlight/2025/10/expert-spotlight--michael-loeffelholz.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--devasena-gnanashanmugam-vice-president--me.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--jennifer-rakeman-cagno-senior-director--sc.htmldaily1.0https://www.cepheid.com/en-NO/insights/insight-hub/expert-spotlight/2026/02/expert-spotlight-jordan-chase.htmldaily1.0https://www.cepheid.com/en-NO/insights/webinars.htmldaily1.0https://www.cepheid.com/en-NO/insights/resources.htmldaily1.0https://www.cepheid.com/en-NO/support.htmldaily1.0https://www.cepheid.com/en-NO/support/ivdr-update.htmldaily1.0https://www.cepheid.com/en-NO/support/contact-us.htmldaily1.0https://www.cepheid.com/en-NO/about.htmldaily1.0https://www.cepheid.com/en-NO/about/mission-history.htmldaily1.0https://www.cepheid.com/en-NO/about/leadership.htmldaily1.0https://www.cepheid.com/en-NO/about/leadership/vitor-rocha.htmldaily1.0https://www.cepheid.com/en-NO/about/leadership/laurent-bellon.htmldaily1.0https://www.cepheid.com/en-NO/about/leadership/anette-engelhardt.htmldaily1.0https://www.cepheid.com/en-NO/about/leadership/peter-farrell.htmldaily1.0https://www.cepheid.com/en-NO/about/leadership/deborah-gonyea.htmldaily1.0https://www.cepheid.com/en-NO/about/leadership/nichole-halsey.htmldaily1.0https://www.cepheid.com/en-NO/about/leadership/luben-li.htmldaily1.0https://www.cepheid.com/en-NO/about/leadership/luke-maitland.htmldaily1.0https://www.cepheid.com/en-NO/about/leadership/david-h-persing.htmldaily1.0https://www.cepheid.com/en-NO/about/leadership/ammar-qadan.htmldaily1.0https://www.cepheid.com/en-NO/about/leadership/charles-mwangi.htmldaily1.0https://www.cepheid.com/en-NO/about/leadership/samson-wu.htmldaily1.0https://www.cepheid.com/en-NO/about/leadership/anupama-mokkapati.htmldaily1.0https://www.cepheid.com/en-NO/about/leadership/traci-wicks.htmldaily1.0https://www.cepheid.com/en-NO/about/leadership/scott-campbell.htmldaily1.0https://www.cepheid.com/en-NO/about/leadership/anne-beauburn.htmldaily1.0https://www.cepheid.com/en-NO/about/leadership/patrick-harkins.htmldaily1.0https://www.cepheid.com/en-NO/about/leadership/ephraim-tsalik.htmldaily1.0https://www.cepheid.com/en-NO/about/leadership/somesh-lalithraj.htmldaily1.0https://www.cepheid.com/en-NO/about/leadership/connie-savor.htmldaily1.0https://www.cepheid.com/en-NO/about/sustainability.htmldaily1.0https://www.cepheid.com/en-NO/about/sustainability/environmental-sustainability.htmldaily1.0https://www.cepheid.com/en-NO/about/sustainability/product-stewardship.htmldaily1.0https://www.cepheid.com/en-NO/about/sustainability/conflict-materials.htmldaily1.0https://www.cepheid.com/en-NO/about/policies-reports.htmldaily1.0https://www.cepheid.com/en-NO/about/business-development-opportunities.htmldaily1.0https://www.cepheid.com/en-NO/about/events.htmldaily1.0https://www.cepheid.com/en-NO/about/innovation-form.htmldaily1.0https://www.cepheid.com/en-NO/about/innovation-form/unsolicited-submission-agreement.htmldaily1.0https://www.cepheid.com/en-NO/about/sars-cov-2-test-development-information.htmldaily1.0https://www.cepheid.com/en-NO/about/sars-cov-2-product-resources.htmldaily1.0https://www.cepheid.com/en-NO/contact/select-info-path.htmldaily1.0https://www.cepheid.com/en-NO/contact/messages/thank-you.htmldaily1.0https://www.cepheid.com/en-NO/contact/messages/thank-you-patient-pathways.htmldaily1.0https://www.cepheid.com/en-NO/contact/messages/thank-you-patient-pathways-fr.htmldaily1.0https://www.cepheid.com/en-NO/contact/messages/thank-you-patient-pathways-de.htmldaily1.0https://www.cepheid.com/en-NO/contact/messages/thank-you-patient-pathways-it.htmldaily1.0https://www.cepheid.com/en-NO/contact/messages/thank-you-patient-pathways-sp.htmldaily1.0https://www.cepheid.com/en-NO/contact/messages/thank-you-patient-pathways-pl.htmldaily1.0https://www.cepheid.com/en-NO/contact/messages/thank-you-patient-pathways-pt.htmldaily1.0https://www.cepheid.com/en-NO/contact/request-cd-international.htmldaily1.0https://www.cepheid.com/en-NO/personas/laboratory-professionals.htmldaily1.0https://www.cepheid.com/en-NO/personas/healthcare-professsional.htmldaily1.0https://www.cepheid.com/en-NO/personas/health-system-administrators.htmldaily1.0https://www.cepheid.com/en-NO/legal/privacy.htmldaily1.0https://www.cepheid.com/en-NO/legal/terms-of-use.htmldaily1.0https://www.cepheid.com/en-NO/legal/product-security-updates.htmldaily1.0https://www.cepheid.com/en-NO/legal/terms-of-sale.htmldaily1.0https://www.cepheid.com/en-NO/legal/trademarks.htmldaily1.0https://www.cepheid.com/en-NO/legal/cookies-notice.htmldaily1.0https://www.cepheid.com/en-NO/campaigns/2020-emea-renewed-messaging/french/patient-pathways.htmldaily1.0https://www.cepheid.com/en-NO/campaigns/2020-emea-renewed-messaging/german/patient-pathways.htmldaily1.0https://www.cepheid.com/en-NO/campaigns/2020-emea-renewed-messaging/italian/patient-pathways.htmldaily1.0https://www.cepheid.com/en-NO/campaigns/2020-emea-renewed-messaging/portuguese/patient-pathways.htmldaily1.0https://www.cepheid.com/en-NO/campaigns/2020-emea-renewed-messaging/polish/patient-pathways.htmldaily1.0https://www.cepheid.com/en-NO/campaigns/india/cepheid-india.htmldaily1.0https://www.cepheid.com/en-NO/campaigns/india/india-submission.htmldaily1.0https://www.cepheid.com/en-NO/campaigns/india/cepheid-india-display.htmldaily1.0https://www.cepheid.com/en-NO/campaigns/india/cepheid-india-bangladesh.htmldaily1.0https://www.cepheid.com/en-NO/campaigns/pcr-plus.htmldaily1.0https://www.cepheid.com/en-NO/coronavirus-portfolio.htmldaily1.0https://www.cepheid.com/en-NZ.htmldaily1.0https://www.cepheid.com/en-NZ/tests.htmldaily1.0https://www.cepheid.com/en-NZ/tests/respiratory.htmldaily1.0https://www.cepheid.com/en-NZ/tests/respiratory/xpert-xpress-strep-a.htmldaily1.0https://www.cepheid.com/en-NZ/tests/respiratory/xpert-xpress-sars-cov-2.htmldaily1.0https://www.cepheid.com/en-NZ/tests/respiratory/xpert-xpress-flu-rsv.htmldaily1.0https://www.cepheid.com/en-NZ/tests/respiratory/xpert-xpress-cov-2-flu-rsv-plus.htmldaily1.0https://www.cepheid.com/en-NZ/tests/hai-other-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-NZ/tests/hai-other-infectious-diseases/xpert-sa-nasal-complete.htmldaily1.0https://www.cepheid.com/en-NZ/tests/hai-other-infectious-diseases/xpert-mrsa-sa-ssti.htmldaily1.0https://www.cepheid.com/en-NZ/tests/hai-other-infectious-diseases/xpert-c-difficile-bt.htmldaily1.0https://www.cepheid.com/en-NZ/tests/hai-other-infectious-diseases/xpert-norovirus.htmldaily1.0https://www.cepheid.com/en-NZ/tests/hai-other-infectious-diseases/xpert-vana-vanb.htmldaily1.0https://www.cepheid.com/en-NZ/tests/hai-other-infectious-diseases/xpert-mrsa-nxg.htmldaily1.0https://www.cepheid.com/en-NZ/tests/hai-other-infectious-diseases/xpert-carba-r.htmldaily1.0https://www.cepheid.com/en-NZ/tests/hai-other-infectious-diseases/xpert-mrsa-sa-blood-culture.htmldaily1.0https://www.cepheid.com/en-NZ/tests/blood-virology-womens-health-sexual-health.htmldaily1.0https://www.cepheid.com/en-NZ/tests/blood-virology-womens-health-sexual-health/xpert-gbs.htmldaily1.0https://www.cepheid.com/en-NZ/tests/blood-virology-womens-health-sexual-health/xpert-hbv-viral-load.htmldaily1.0https://www.cepheid.com/en-NZ/tests/blood-virology-womens-health-sexual-health/xpert-hpv.htmldaily1.0https://www.cepheid.com/en-NZ/tests/blood-virology-womens-health-sexual-health/xpert-ct-ng.htmldaily1.0https://www.cepheid.com/en-NZ/tests/blood-virology-womens-health-sexual-health/xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-NZ/tests/blood-virology-womens-health-sexual-health/xpert-tv.htmldaily1.0https://www.cepheid.com/en-NZ/tests/blood-virology-womens-health-sexual-health/xpert-hcv-viral-load.htmldaily1.0https://www.cepheid.com/en-NZ/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-qual-xc.htmldaily1.0https://www.cepheid.com/en-NZ/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-viral-load-xc.htmldaily1.0https://www.cepheid.com/en-NZ/tests/tb-emerging-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-NZ/tests/tb-emerging-infectious-diseases/xpert-mtb-rif-ultra.htmldaily1.0https://www.cepheid.com/en-NZ/tests/tb-emerging-infectious-diseases/xpert-mtb-rif.htmldaily1.0https://www.cepheid.com/en-NZ/tests/oncology-human-genetics.htmldaily1.0https://www.cepheid.com/en-NZ/tests/oncology-human-genetics/xpert-fii-fv.htmldaily1.0https://www.cepheid.com/en-NZ/tests/oncology-human-genetics/xpert-bcr-abl-ultra-p190.htmldaily1.0https://www.cepheid.com/en-NZ/tests/oncology-human-genetics/xpert-bcr-abl-ultra.htmldaily1.0https://www.cepheid.com/en-NZ/systems.htmldaily1.0https://www.cepheid.com/en-NZ/systems/genexpert-family-of-systems.htmldaily1.0https://www.cepheid.com/en-NZ/systems/genexpert-family-of-systems/genexpert-system.htmldaily1.0https://www.cepheid.com/en-NZ/systems/genexpert-family-of-systems/genexpert-infinity.htmldaily1.0https://www.cepheid.com/en-NZ/systems/genexpert-software.htmldaily1.0https://www.cepheid.com/en-NZ/systems/genexpert-software/gx-software.htmldaily1.0https://www.cepheid.com/en-NZ/systems/genexpert-software/xpertise-software.htmldaily1.0https://www.cepheid.com/en-NZ/systems/connectivity.htmldaily1.0https://www.cepheid.com/en-NZ/systems/connectivity/cepheid-c360.htmldaily1.0https://www.cepheid.com/en-NZ/systems/connectivity/interface-capabilities.htmldaily1.0https://www.cepheid.com/en-NZ/systems/data-processing-agreement.htmldaily1.0https://www.cepheid.com/en-NZ/systems/partner-communities.htmldaily1.0https://www.cepheid.com/en-NZ/systems/business-associates-agreement.htmldaily1.0https://www.cepheid.com/en-NZ/solutions.htmldaily1.0https://www.cepheid.com/en-NZ/solutions/global-access.htmldaily1.0https://www.cepheid.com/en-NZ/solutions/global-access/eligibility-and-pricing.htmldaily1.0https://www.cepheid.com/en-NZ/solutions/testing-everywhere.htmldaily1.0https://www.cepheid.com/en-NZ/solutions/antibiotic-stewardship.htmldaily1.0https://www.cepheid.com/en-NZ/solutions/oncology-diagnostics.htmldaily1.0https://www.cepheid.com/en-NZ/solutions/customized-testing-institution.htmldaily1.0https://www.cepheid.com/en-NZ/solutions/knowing-more-matters.htmldaily1.0https://www.cepheid.com/en-NZ/solutions/knowing-more-matters/pcr-vs-antigen.htmldaily1.0https://www.cepheid.com/en-NZ/solutions/knowing-more-matters/covid-flu-rsv.htmldaily1.0https://www.cepheid.com/en-NZ/insights.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/all-posts.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/respiratory-health.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/respiratory-health/2024/09/proactive-surveillance-to-ensure-broad-flu-strain-detection.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/respiratory-health/2024/09/emerging-evolving-respiratory-viruses-test-design-matters.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/respiratory-health/2024/09/the-genexpert-xpress-system-can-change-your-pediatric-practice.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/respiratory-health/2024/09/Norwegian-ED-improves-Resource-Management-with-Rapid-PCR-Testing.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/respiratory-health/2024/09/key-steps-pandemic-preparedness.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/respiratory-health/2025/01/what-does-it-mean-to-have-a-pandemic-ready-pcr-test.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like-ilnesses.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/respiratory-health/2025/03/in-house-pcr-testing-clinical-leaders-explore-the-ripple-effect.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/respiratory-health/2025/04/real-world-clinical-impact-of-in-house-pcr-testing.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/respiratory-health/2025/04/what-is-the-difference-between-pcr-and-antigen-testing.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/respiratory-health/2025/05/a-quick-primer-on-the-adlm-guidance-on-respiratory-virus-testing.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/respiratory-health/2025/09/revolutionizing-respiratory-care-the-power-of-rapid-molecular-testing.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/respiratory-health/2025/09/antigen-testing-vs-pcr-less-haste-more-speed-please.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/respiratory-health/2025/09/the-time-for-widespread-adoption-of-mdx-testing-for-gas-pharyngi.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/respiratory-health/2025/11/why-test-type-matters-pcr-vs-antigen-in-outpatient-respiratory-care.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/respiratory-health/2025/11/transforming-respiratory-tnfection-diagnosis-embracing-molecular-innovation-clinical-practice1.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/respiratory-health/2026/01/staying-ahead-of-influenza.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/respiratory-health/2026/02/revolutionizing-rheumatic-heart-disease-prevention.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2024/09/accelerating-the-pace-for-hep-c-elimination-in-the-us.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2024/09/can-molecular-tests-revolutionize-tuberculosis-control.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2024/09/near-patient-testing-for-hep-c-xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2024/09/danish-hcv-testing-program-improves-patient-management-and-access.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2024/09/faster-prison-testing-for-hcv-drastically-improves-treatment-in-the-uk.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2024/09/innovative-POC-testing-shortens-time-between-testing-and-treatment.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2024/09/finnish-hospital-improves-care-for-expectant-mothers-with-gbs-pcr-screening.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2024/09/a-not-for-profit-in-vietnam-fights-to-end-tuberculosis.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2024/09/cepheid-expands-in-india-to-support-global-efforts-to-fight-tb.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2024/09/covid-19-and-tuberculosis-testing-in-south-africa.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2024/09/cepheid-supports-the-international-mpox-emergency-declared-august-2024.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2024/10/hpv-testing-south-african-clinic-may-prevent-cervical-cancer.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2024/12/strides-toward-early-infant-diagnosis-for-hiv-elimination-in-sou.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2025/02/common-misconceptions-about-vaginitis.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2025/06/womens-health-testing-advantages-of-same-day-diagnosis-and-treatment.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2025/04/tuberculosis-staying-one-step-ahead.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2025/04/how-three-countries-are-fighting-back-against-tuberculosis.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2025/04/a-mdr-tb-survivor-in-india-shares-her-remarkable-story.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2025/05/revisiting-bacterial-vaginosis-evidence-for-sexual-transmission.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2025/05/a-breakthrough-in-hcv-elimination--how-hcv-point-of-care-rna-tes.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2025/05/decentralising-diagnostics-bringing-patient-centred-testing-closer-to-communities.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2025/05/integration-of-poc-viral-diagnostics-with-substance-use-disorder-treatment-to-improve-hepatitis-c-nfection-outcomes.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2025/07/five-surprising-stats-that-reveal-the-hidden-burden-of-vaginitis.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2025/07/5-ways-vaginitis-treatment-goes-wrong-and-how-better-testing-can-fix-It.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2025/03/the-fight-to-end-tuberculosis-in-pakistan.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2025/03/devasena-gnanashanmugam-discusses-cepheids-global-access-program.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2025/03/desmond-tutu-foundation-reduces-impact-of-hiv-and-tb.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2025/03/tuberculosis-care-and-treatment-in-the-republic-of-indonesia.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2025/03/finding-missing-tuberculosis-tb-cases-philippines-need-for-speed.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2025/03/a-decade-of-health-and-economic-benefits-infographic.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2025/03/state-tb-in-us-overlooked-opportunity-better-results.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2025/03/fighting-tb-everything-10-years-of-impact-in-south-africa.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2025/09/in-memory-of-john-bishop-a-visionary-leader-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2025/12/wecare-humanitarian-medical-mission.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2025/10/time-to-act-stopping-group-b-strep-infections-in-newborn-babies.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2025/10/real-user-experiences-with-xpert-xpress-mvp-oint-of-care-test.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2025/08/kentucky-viral-hepatitis-treatment-projects-mission-to-eradicate-hcv.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2025/08/the-state-of-vaginitis-testing-in-the-us.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2025/08/improving-vaginitis-care-through-better-diagnostics.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2026/02/advancing-pandemic-preparedness-through-public-private-collaboration.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/community-and-global-health/2026/02/hepatitis-c-elimination-in-the-us-is-within-reach-experts-report.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/tech-disease-trends.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/tech-disease-trends/2024/09/candida-auris--rising-threat-and-future-implications.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/tech-disease-trends/2024/09/discussing-pharma-clinical-trials-utilizing-poc-diagnostics.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/tech-disease-trends/2024/09/poc-testing-increases-the-efficiency-of-patient-management-in-the-ed.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/tech-disease-trends/2024/10/dave-persing-legacy-and-leadership-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/tech-disease-trends/2024/11/invasive-group-streptococcal-disease.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/tech-disease-trends/2024/11/what-is-pcr--understanding-the-magic.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/tech-disease-trends/2024/11/decentralized-pcr-testing-and-the-quadruple-aim-insights-for-health-systems.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/tech-disease-trends/2025/01/how-a-cepheid-molecular-test-is-made.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct-.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/tech-disease-trends/2025/04/standardization-of-pcr-testing-across-healthcare-testing-sites.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/tech-disease-trends/2025/06/innovation-in-times-of-need-cepheids-legacy-of-outbreak-response.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/tech-disease-trends/2025/07/celebrating-the-cepheid-bike-where-art-meets-innovation.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/tech-disease-trends/2025/09/cepheid-advances-innovation-and-reach-with-key-partnerships.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/tech-disease-trends/2025/10/learn-about-cepheid-system-innovation.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/tech-disease-trends/2025/11/multiplex-with-meaning--cepheid-s-smart-approach-to-molecular-di.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/antimicrobial-stewardship.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/antimicrobial-stewardship/2024/09/a-public-health-dialogue-on-antibiotic-resistance-surveillance.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/antimicrobial-stewardship/2024/09/mortality-associated-with-carbapenem-resistant-gram-negative-infections.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/antimicrobial-stewardship/2024/09/decentralized-testing-for-the-surveillance-of-hospital-acquired-infections.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/antimicrobial-stewardship/2024/09/rapid-mrsa-screening-of-ortho-trauma-patients-improves-experience.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/antimicrobial-stewardship/2024/09/pcr-screening-at-a-british-hospital-enables-timely-infection-control.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/antimicrobial-stewardship/2024/10/fleming-initiative-cepheid-announce-partnership-tackle-amr.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/antimicrobial-stewardship/2024/10/link-between-colonization-multi-drug-resistant-infection.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/antimicrobial-stewardship/2024/12/point-of-care-testing-emergency-department-faster-decision-making-halle.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-shulz.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-schulz.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/antimicrobial-stewardship/2025/05/antimicrobial-and-diagnostic-stewardship-frost-and-sullivan-visual-whitepaper.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/antimicrobial-stewardship/2025/08/industry-voices-time-to-rethink-our-approach-to-using-modern-medicine.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/antimicrobial-stewardship/2025/09/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/antimicrobial-stewardship/2025/10/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/antimicrobial-stewardship/2025/11/vanessa-carter-s-journey--inspiring-action-against-amr.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/antimicrobial-stewardship/2025/11/advancing-antimicrobial-stewardship-in-small-and-rural-hospital.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/expert-spotlight.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/expert-spotlight/2025/10/expert-spotlight--michael-loeffelholz.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--devasena-gnanashanmugam-vice-president--me.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--jennifer-rakeman-cagno-senior-director--sc.htmldaily1.0https://www.cepheid.com/en-NZ/insights/insight-hub/expert-spotlight/2026/02/expert-spotlight-jordan-chase.htmldaily1.0https://www.cepheid.com/en-NZ/insights/webinars.htmldaily1.0https://www.cepheid.com/en-NZ/insights/resources.htmldaily1.0https://www.cepheid.com/en-NZ/support.htmldaily1.0https://www.cepheid.com/en-NZ/support/ivdr-update.htmldaily1.0https://www.cepheid.com/en-NZ/support/contact-us.htmldaily1.0https://www.cepheid.com/en-NZ/about.htmldaily1.0https://www.cepheid.com/en-NZ/about/mission-history.htmldaily1.0https://www.cepheid.com/en-NZ/about/leadership.htmldaily1.0https://www.cepheid.com/en-NZ/about/leadership/vitor-rocha.htmldaily1.0https://www.cepheid.com/en-NZ/about/leadership/laurent-bellon.htmldaily1.0https://www.cepheid.com/en-NZ/about/leadership/anette-engelhardt.htmldaily1.0https://www.cepheid.com/en-NZ/about/leadership/peter-farrell.htmldaily1.0https://www.cepheid.com/en-NZ/about/leadership/deborah-gonyea.htmldaily1.0https://www.cepheid.com/en-NZ/about/leadership/nichole-halsey.htmldaily1.0https://www.cepheid.com/en-NZ/about/leadership/luben-li.htmldaily1.0https://www.cepheid.com/en-NZ/about/leadership/luke-maitland.htmldaily1.0https://www.cepheid.com/en-NZ/about/leadership/david-h-persing.htmldaily1.0https://www.cepheid.com/en-NZ/about/leadership/ammar-qadan.htmldaily1.0https://www.cepheid.com/en-NZ/about/leadership/charles-mwangi.htmldaily1.0https://www.cepheid.com/en-NZ/about/leadership/samson-wu.htmldaily1.0https://www.cepheid.com/en-NZ/about/leadership/anupama-mokkapati.htmldaily1.0https://www.cepheid.com/en-NZ/about/leadership/traci-wicks.htmldaily1.0https://www.cepheid.com/en-NZ/about/leadership/scott-campbell.htmldaily1.0https://www.cepheid.com/en-NZ/about/leadership/anne-beauburn.htmldaily1.0https://www.cepheid.com/en-NZ/about/leadership/patrick-harkins.htmldaily1.0https://www.cepheid.com/en-NZ/about/leadership/ephraim-tsalik.htmldaily1.0https://www.cepheid.com/en-NZ/about/leadership/somesh-lalithraj.htmldaily1.0https://www.cepheid.com/en-NZ/about/leadership/connie-savor.htmldaily1.0https://www.cepheid.com/en-NZ/about/sustainability.htmldaily1.0https://www.cepheid.com/en-NZ/about/sustainability/environmental-sustainability.htmldaily1.0https://www.cepheid.com/en-NZ/about/sustainability/product-stewardship.htmldaily1.0https://www.cepheid.com/en-NZ/about/sustainability/conflict-materials.htmldaily1.0https://www.cepheid.com/en-NZ/about/policies-reports.htmldaily1.0https://www.cepheid.com/en-NZ/about/business-development-opportunities.htmldaily1.0https://www.cepheid.com/en-NZ/about/events.htmldaily1.0https://www.cepheid.com/en-NZ/about/innovation-form.htmldaily1.0https://www.cepheid.com/en-NZ/about/innovation-form/unsolicited-submission-agreement.htmldaily1.0https://www.cepheid.com/en-NZ/about/sars-cov-2-test-development-information.htmldaily1.0https://www.cepheid.com/en-NZ/about/sars-cov-2-product-resources.htmldaily1.0https://www.cepheid.com/en-NZ/contact/select-info-path.htmldaily1.0https://www.cepheid.com/en-NZ/contact/messages/thank-you.htmldaily1.0https://www.cepheid.com/en-NZ/contact/messages/thank-you-patient-pathways.htmldaily1.0https://www.cepheid.com/en-NZ/contact/messages/thank-you-patient-pathways-fr.htmldaily1.0https://www.cepheid.com/en-NZ/contact/messages/thank-you-patient-pathways-de.htmldaily1.0https://www.cepheid.com/en-NZ/contact/messages/thank-you-patient-pathways-it.htmldaily1.0https://www.cepheid.com/en-NZ/contact/messages/thank-you-patient-pathways-sp.htmldaily1.0https://www.cepheid.com/en-NZ/contact/messages/thank-you-patient-pathways-pl.htmldaily1.0https://www.cepheid.com/en-NZ/contact/messages/thank-you-patient-pathways-pt.htmldaily1.0https://www.cepheid.com/en-NZ/contact/request-cd-international.htmldaily1.0https://www.cepheid.com/en-NZ/personas/laboratory-professionals.htmldaily1.0https://www.cepheid.com/en-NZ/personas/healthcare-professsional.htmldaily1.0https://www.cepheid.com/en-NZ/personas/health-system-administrators.htmldaily1.0https://www.cepheid.com/en-NZ/legal/privacy.htmldaily1.0https://www.cepheid.com/en-NZ/legal/terms-of-use.htmldaily1.0https://www.cepheid.com/en-NZ/legal/product-security-updates.htmldaily1.0https://www.cepheid.com/en-NZ/legal/terms-of-sale.htmldaily1.0https://www.cepheid.com/en-NZ/legal/trademarks.htmldaily1.0https://www.cepheid.com/en-NZ/legal/cookies-notice.htmldaily1.0https://www.cepheid.com/en-NZ/campaigns/2020-emea-renewed-messaging/french/patient-pathways.htmldaily1.0https://www.cepheid.com/en-NZ/campaigns/2020-emea-renewed-messaging/german/patient-pathways.htmldaily1.0https://www.cepheid.com/en-NZ/campaigns/2020-emea-renewed-messaging/italian/patient-pathways.htmldaily1.0https://www.cepheid.com/en-NZ/campaigns/2020-emea-renewed-messaging/portuguese/patient-pathways.htmldaily1.0https://www.cepheid.com/en-NZ/campaigns/2020-emea-renewed-messaging/polish/patient-pathways.htmldaily1.0https://www.cepheid.com/en-NZ/campaigns/india/cepheid-india.htmldaily1.0https://www.cepheid.com/en-NZ/campaigns/india/india-submission.htmldaily1.0https://www.cepheid.com/en-NZ/campaigns/india/cepheid-india-display.htmldaily1.0https://www.cepheid.com/en-NZ/campaigns/india/cepheid-india-bangladesh.htmldaily1.0https://www.cepheid.com/en-NZ/campaigns/pcr-plus.htmldaily1.0https://www.cepheid.com/en-NZ/coronavirus-portfolio.htmldaily1.0https://www.cepheid.com/en-SE.htmldaily1.0https://www.cepheid.com/en-SE/tests.htmldaily1.0https://www.cepheid.com/en-SE/tests/respiratory.htmldaily1.0https://www.cepheid.com/en-SE/tests/respiratory/xpert-xpress-strep-a.htmldaily1.0https://www.cepheid.com/en-SE/tests/respiratory/xpert-xpress-cov-2-plus.htmldaily1.0https://www.cepheid.com/en-SE/tests/respiratory/xpert-xpress-flu-rsv.htmldaily1.0https://www.cepheid.com/en-SE/tests/respiratory/xpert-xpress-cov-2-flu-rsv-plus.htmldaily1.0https://www.cepheid.com/en-SE/tests/hai-other-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-SE/tests/hai-other-infectious-diseases/xpert-sa-nasal-complete.htmldaily1.0https://www.cepheid.com/en-SE/tests/hai-other-infectious-diseases/xpert-mrsa-sa-ssti.htmldaily1.0https://www.cepheid.com/en-SE/tests/hai-other-infectious-diseases/xpert-c-difficile-bt.htmldaily1.0https://www.cepheid.com/en-SE/tests/hai-other-infectious-diseases/xpert-norovirus.htmldaily1.0https://www.cepheid.com/en-SE/tests/hai-other-infectious-diseases/xpert-mrsa-sa-blood-culture.htmldaily1.0https://www.cepheid.com/en-SE/tests/hai-other-infectious-diseases/xpert-vana-vanb.htmldaily1.0https://www.cepheid.com/en-SE/tests/hai-other-infectious-diseases/xpert-mrsa-nxg.htmldaily1.0https://www.cepheid.com/en-SE/tests/hai-other-infectious-diseases/xpert-carba-r.htmldaily1.0https://www.cepheid.com/en-SE/tests/blood-virology-womens-health-sexual-health.htmldaily1.0https://www.cepheid.com/en-SE/tests/blood-virology-womens-health-sexual-health/xpert-hbv-viral-load.htmldaily1.0https://www.cepheid.com/en-SE/tests/blood-virology-womens-health-sexual-health/resistanceplusmg-flexible.htmldaily1.0https://www.cepheid.com/en-SE/tests/blood-virology-womens-health-sexual-health/xpert-xpress-gbs.htmldaily1.0https://www.cepheid.com/en-SE/tests/blood-virology-womens-health-sexual-health/xpert-ct-ng.htmldaily1.0https://www.cepheid.com/en-SE/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-qual-xc.htmldaily1.0https://www.cepheid.com/en-SE/tests/blood-virology-womens-health-sexual-health/xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-SE/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-viral-load-xc.htmldaily1.0https://www.cepheid.com/en-SE/tests/blood-virology-womens-health-sexual-health/xpert-tv.htmldaily1.0https://www.cepheid.com/en-SE/tests/blood-virology-womens-health-sexual-health/xpert-hpv-v2.htmldaily1.0https://www.cepheid.com/en-SE/tests/blood-virology-womens-health-sexual-health/xpert-hcv-viral-load.htmldaily1.0https://www.cepheid.com/en-SE/tests/tb-emerging-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-SE/tests/tb-emerging-infectious-diseases/xpert-mtb-xdr.htmldaily1.0https://www.cepheid.com/en-SE/tests/tb-emerging-infectious-diseases/xpert-mtb-rif-ultra.htmldaily1.0https://www.cepheid.com/en-SE/tests/oncology-human-genetics.htmldaily1.0https://www.cepheid.com/en-SE/tests/oncology-human-genetics/expert-bladder-cancer-monitor.htmldaily1.0https://www.cepheid.com/en-SE/tests/oncology-human-genetics/xpert-fii-fv.htmldaily1.0https://www.cepheid.com/en-SE/tests/oncology-human-genetics/xpert-bcr-abl-ultra-p190.htmldaily1.0https://www.cepheid.com/en-SE/tests/oncology-human-genetics/xpert-bladder-cancer-detection.htmldaily1.0https://www.cepheid.com/en-SE/tests/oncology-human-genetics/xpert-bcr-abl-ultra.htmldaily1.0https://www.cepheid.com/en-SE/tests/oncology-human-genetics/xpert-npm1-mutation.htmldaily1.0https://www.cepheid.com/en-SE/systems.htmldaily1.0https://www.cepheid.com/en-SE/systems/genexpert-family-of-systems.htmldaily1.0https://www.cepheid.com/en-SE/systems/genexpert-family-of-systems/genexpert-system.htmldaily1.0https://www.cepheid.com/en-SE/systems/genexpert-family-of-systems/genexpert-infinity.htmldaily1.0https://www.cepheid.com/en-SE/systems/genexpert-software.htmldaily1.0https://www.cepheid.com/en-SE/systems/genexpert-software/gx-software.htmldaily1.0https://www.cepheid.com/en-SE/systems/genexpert-software/xpertise-software.htmldaily1.0https://www.cepheid.com/en-SE/systems/connectivity.htmldaily1.0https://www.cepheid.com/en-SE/systems/connectivity/cepheid-c360.htmldaily1.0https://www.cepheid.com/en-SE/systems/connectivity/interface-capabilities.htmldaily1.0https://www.cepheid.com/en-SE/systems/data-processing-agreement.htmldaily1.0https://www.cepheid.com/en-SE/systems/partner-communities.htmldaily1.0https://www.cepheid.com/en-SE/systems/business-associates-agreement.htmldaily1.0https://www.cepheid.com/en-SE/solutions.htmldaily1.0https://www.cepheid.com/en-SE/solutions/global-access.htmldaily1.0https://www.cepheid.com/en-SE/solutions/global-access/eligibility-and-pricing.htmldaily1.0https://www.cepheid.com/en-SE/solutions/testing-everywhere.htmldaily1.0https://www.cepheid.com/en-SE/solutions/antibiotic-stewardship.htmldaily1.0https://www.cepheid.com/en-SE/solutions/oncology-diagnostics.htmldaily1.0https://www.cepheid.com/en-SE/solutions/customized-testing-institution.htmldaily1.0https://www.cepheid.com/en-SE/solutions/knowing-more-matters.htmldaily1.0https://www.cepheid.com/en-SE/solutions/knowing-more-matters/pcr-vs-antigen.htmldaily1.0https://www.cepheid.com/en-SE/solutions/knowing-more-matters/covid-flu-rsv.htmldaily1.0https://www.cepheid.com/en-SE/insights.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/all-posts.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/respiratory-health.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/respiratory-health/2024/09/proactive-surveillance-to-ensure-broad-flu-strain-detection.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/respiratory-health/2024/09/emerging-evolving-respiratory-viruses-test-design-matters.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/respiratory-health/2024/09/the-genexpert-xpress-system-can-change-your-pediatric-practice.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/respiratory-health/2024/09/Norwegian-ED-improves-Resource-Management-with-Rapid-PCR-Testing.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/respiratory-health/2024/09/key-steps-pandemic-preparedness.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/respiratory-health/2025/01/what-does-it-mean-to-have-a-pandemic-ready-pcr-test.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like-ilnesses.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/respiratory-health/2025/03/in-house-pcr-testing-clinical-leaders-explore-the-ripple-effect.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/respiratory-health/2025/04/real-world-clinical-impact-of-in-house-pcr-testing.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/respiratory-health/2025/04/what-is-the-difference-between-pcr-and-antigen-testing.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/respiratory-health/2025/05/a-quick-primer-on-the-adlm-guidance-on-respiratory-virus-testing.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/respiratory-health/2025/09/revolutionizing-respiratory-care-the-power-of-rapid-molecular-testing.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/respiratory-health/2025/09/antigen-testing-vs-pcr-less-haste-more-speed-please.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/respiratory-health/2025/09/the-time-for-widespread-adoption-of-mdx-testing-for-gas-pharyngi.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/respiratory-health/2025/11/why-test-type-matters-pcr-vs-antigen-in-outpatient-respiratory-care.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/respiratory-health/2025/11/transforming-respiratory-tnfection-diagnosis-embracing-molecular-innovation-clinical-practice1.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/respiratory-health/2026/01/staying-ahead-of-influenza.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/respiratory-health/2026/02/revolutionizing-rheumatic-heart-disease-prevention.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2024/09/accelerating-the-pace-for-hep-c-elimination-in-the-us.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2024/09/can-molecular-tests-revolutionize-tuberculosis-control.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2024/09/near-patient-testing-for-hep-c-xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2024/09/danish-hcv-testing-program-improves-patient-management-and-access.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2024/09/faster-prison-testing-for-hcv-drastically-improves-treatment-in-the-uk.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2024/09/innovative-POC-testing-shortens-time-between-testing-and-treatment.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2024/09/finnish-hospital-improves-care-for-expectant-mothers-with-gbs-pcr-screening.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2024/09/a-not-for-profit-in-vietnam-fights-to-end-tuberculosis.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2024/09/cepheid-expands-in-india-to-support-global-efforts-to-fight-tb.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2024/09/covid-19-and-tuberculosis-testing-in-south-africa.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2024/09/cepheid-supports-the-international-mpox-emergency-declared-august-2024.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2024/10/hpv-testing-south-african-clinic-may-prevent-cervical-cancer.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2024/12/strides-toward-early-infant-diagnosis-for-hiv-elimination-in-sou.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2025/02/common-misconceptions-about-vaginitis.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2025/05/revisiting-bacterial-vaginosis-evidence-for-sexual-transmission.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2025/05/a-breakthrough-in-hcv-elimination--how-hcv-point-of-care-rna-tes.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2025/05/decentralising-diagnostics-bringing-patient-centred-testing-closer-to-communities.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2025/05/integration-of-poc-viral-diagnostics-with-substance-use-disorder-treatment-to-improve-hepatitis-c-nfection-outcomes.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2025/04/tuberculosis-staying-one-step-ahead.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2025/04/how-three-countries-are-fighting-back-against-tuberculosis.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2025/04/a-mdr-tb-survivor-in-india-shares-her-remarkable-story.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2025/06/womens-health-testing-advantages-of-same-day-diagnosis-and-treatment.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2025/07/five-surprising-stats-that-reveal-the-hidden-burden-of-vaginitis.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2025/07/5-ways-vaginitis-treatment-goes-wrong-and-how-better-testing-can-fix-It.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2025/03/the-fight-to-end-tuberculosis-in-pakistan.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2025/03/devasena-gnanashanmugam-discusses-cepheids-global-access-program.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2025/03/desmond-tutu-foundation-reduces-impact-of-hiv-and-tb.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2025/03/tuberculosis-care-and-treatment-in-the-republic-of-indonesia.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2025/03/finding-missing-tuberculosis-tb-cases-philippines-need-for-speed.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2025/03/a-decade-of-health-and-economic-benefits-infographic.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2025/03/state-tb-in-us-overlooked-opportunity-better-results.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2025/03/fighting-tb-everything-10-years-of-impact-in-south-africa.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2025/09/in-memory-of-john-bishop-a-visionary-leader-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2025/08/kentucky-viral-hepatitis-treatment-projects-mission-to-eradicate-hcv.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2025/08/the-state-of-vaginitis-testing-in-the-us.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2025/08/improving-vaginitis-care-through-better-diagnostics.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2025/12/wecare-humanitarian-medical-mission.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2025/10/time-to-act-stopping-group-b-strep-infections-in-newborn-babies.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2025/10/real-user-experiences-with-xpert-xpress-mvp-oint-of-care-test.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2026/02/advancing-pandemic-preparedness-through-public-private-collaboration.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/community-and-global-health/2026/02/hepatitis-c-elimination-in-the-us-is-within-reach-experts-report.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/tech-disease-trends.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/tech-disease-trends/2024/09/candida-auris--rising-threat-and-future-implications.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/tech-disease-trends/2024/09/discussing-pharma-clinical-trials-utilizing-poc-diagnostics.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/tech-disease-trends/2024/09/poc-testing-increases-the-efficiency-of-patient-management-in-the-ed.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/tech-disease-trends/2024/10/dave-persing-legacy-and-leadership-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/tech-disease-trends/2024/11/invasive-group-streptococcal-disease.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/tech-disease-trends/2024/11/what-is-pcr--understanding-the-magic.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/tech-disease-trends/2024/11/decentralized-pcr-testing-and-the-quadruple-aim-insights-for-health-systems.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/tech-disease-trends/2025/01/how-a-cepheid-molecular-test-is-made.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct-.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/tech-disease-trends/2025/04/standardization-of-pcr-testing-across-healthcare-testing-sites.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/tech-disease-trends/2025/06/innovation-in-times-of-need-cepheids-legacy-of-outbreak-response.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/tech-disease-trends/2025/07/celebrating-the-cepheid-bike-where-art-meets-innovation.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/tech-disease-trends/2025/09/cepheid-advances-innovation-and-reach-with-key-partnerships.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/tech-disease-trends/2025/10/learn-about-cepheid-system-innovation.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/tech-disease-trends/2025/11/multiplex-with-meaning--cepheid-s-smart-approach-to-molecular-di.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/antimicrobial-stewardship.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/antimicrobial-stewardship/2024/09/a-public-health-dialogue-on-antibiotic-resistance-surveillance.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/antimicrobial-stewardship/2024/09/mortality-associated-with-carbapenem-resistant-gram-negative-infections.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/antimicrobial-stewardship/2024/09/decentralized-testing-for-the-surveillance-of-hospital-acquired-infections.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/antimicrobial-stewardship/2024/09/rapid-mrsa-screening-of-ortho-trauma-patients-improves-experience.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/antimicrobial-stewardship/2024/09/pcr-screening-at-a-british-hospital-enables-timely-infection-control.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/antimicrobial-stewardship/2024/10/fleming-initiative-cepheid-announce-partnership-tackle-amr.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/antimicrobial-stewardship/2024/10/link-between-colonization-multi-drug-resistant-infection.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/antimicrobial-stewardship/2024/12/point-of-care-testing-emergency-department-faster-decision-making-halle.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-shulz.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-schulz.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/antimicrobial-stewardship/2025/05/antimicrobial-and-diagnostic-stewardship-frost-and-sullivan-visual-whitepaper.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/antimicrobial-stewardship/2025/08/industry-voices-time-to-rethink-our-approach-to-using-modern-medicine.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/antimicrobial-stewardship/2025/09/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/antimicrobial-stewardship/2025/10/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/antimicrobial-stewardship/2025/11/vanessa-carter-s-journey--inspiring-action-against-amr.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/antimicrobial-stewardship/2025/11/advancing-antimicrobial-stewardship-in-small-and-rural-hospital.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/expert-spotlight.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/expert-spotlight/2025/10/expert-spotlight--michael-loeffelholz.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--devasena-gnanashanmugam-vice-president--me.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--jennifer-rakeman-cagno-senior-director--sc.htmldaily1.0https://www.cepheid.com/en-SE/insights/insight-hub/expert-spotlight/2026/02/expert-spotlight-jordan-chase.htmldaily1.0https://www.cepheid.com/en-SE/insights/webinars.htmldaily1.0https://www.cepheid.com/en-SE/insights/resources.htmldaily1.0https://www.cepheid.com/en-SE/support.htmldaily1.0https://www.cepheid.com/en-SE/support/ivdr-update.htmldaily1.0https://www.cepheid.com/en-SE/support/contact-us.htmldaily1.0https://www.cepheid.com/en-SE/about.htmldaily1.0https://www.cepheid.com/en-SE/about/mission-history.htmldaily1.0https://www.cepheid.com/en-SE/about/leadership.htmldaily1.0https://www.cepheid.com/en-SE/about/leadership/vitor-rocha.htmldaily1.0https://www.cepheid.com/en-SE/about/leadership/laurent-bellon.htmldaily1.0https://www.cepheid.com/en-SE/about/leadership/anette-engelhardt.htmldaily1.0https://www.cepheid.com/en-SE/about/leadership/peter-farrell.htmldaily1.0https://www.cepheid.com/en-SE/about/leadership/deborah-gonyea.htmldaily1.0https://www.cepheid.com/en-SE/about/leadership/nichole-halsey.htmldaily1.0https://www.cepheid.com/en-SE/about/leadership/luben-li.htmldaily1.0https://www.cepheid.com/en-SE/about/leadership/luke-maitland.htmldaily1.0https://www.cepheid.com/en-SE/about/leadership/david-h-persing.htmldaily1.0https://www.cepheid.com/en-SE/about/leadership/ammar-qadan.htmldaily1.0https://www.cepheid.com/en-SE/about/leadership/charles-mwangi.htmldaily1.0https://www.cepheid.com/en-SE/about/leadership/samson-wu.htmldaily1.0https://www.cepheid.com/en-SE/about/leadership/anupama-mokkapati.htmldaily1.0https://www.cepheid.com/en-SE/about/leadership/traci-wicks.htmldaily1.0https://www.cepheid.com/en-SE/about/leadership/scott-campbell.htmldaily1.0https://www.cepheid.com/en-SE/about/leadership/anne-beauburn.htmldaily1.0https://www.cepheid.com/en-SE/about/leadership/patrick-harkins.htmldaily1.0https://www.cepheid.com/en-SE/about/leadership/ephraim-tsalik.htmldaily1.0https://www.cepheid.com/en-SE/about/leadership/somesh-lalithraj.htmldaily1.0https://www.cepheid.com/en-SE/about/leadership/connie-savor.htmldaily1.0https://www.cepheid.com/en-SE/about/sustainability.htmldaily1.0https://www.cepheid.com/en-SE/about/sustainability/environmental-sustainability.htmldaily1.0https://www.cepheid.com/en-SE/about/sustainability/product-stewardship.htmldaily1.0https://www.cepheid.com/en-SE/about/sustainability/conflict-materials.htmldaily1.0https://www.cepheid.com/en-SE/about/policies-reports.htmldaily1.0https://www.cepheid.com/en-SE/about/business-development-opportunities.htmldaily1.0https://www.cepheid.com/en-SE/about/events.htmldaily1.0https://www.cepheid.com/en-SE/about/innovation-form.htmldaily1.0https://www.cepheid.com/en-SE/about/innovation-form/unsolicited-submission-agreement.htmldaily1.0https://www.cepheid.com/en-SE/about/sars-cov-2-test-development-information.htmldaily1.0https://www.cepheid.com/en-SE/about/sars-cov-2-product-resources.htmldaily1.0https://www.cepheid.com/en-SE/contact/select-info-path.htmldaily1.0https://www.cepheid.com/en-SE/contact/messages/thank-you.htmldaily1.0https://www.cepheid.com/en-SE/contact/messages/thank-you-patient-pathways.htmldaily1.0https://www.cepheid.com/en-SE/contact/messages/thank-you-patient-pathways-fr.htmldaily1.0https://www.cepheid.com/en-SE/contact/messages/thank-you-patient-pathways-de.htmldaily1.0https://www.cepheid.com/en-SE/contact/messages/thank-you-patient-pathways-it.htmldaily1.0https://www.cepheid.com/en-SE/contact/messages/thank-you-patient-pathways-sp.htmldaily1.0https://www.cepheid.com/en-SE/contact/messages/thank-you-patient-pathways-pl.htmldaily1.0https://www.cepheid.com/en-SE/contact/messages/thank-you-patient-pathways-pt.htmldaily1.0https://www.cepheid.com/en-SE/contact/request-cd-international.htmldaily1.0https://www.cepheid.com/en-SE/personas/laboratory-professionals.htmldaily1.0https://www.cepheid.com/en-SE/personas/healthcare-professsional.htmldaily1.0https://www.cepheid.com/en-SE/personas/health-system-administrators.htmldaily1.0https://www.cepheid.com/en-SE/legal/privacy.htmldaily1.0https://www.cepheid.com/en-SE/legal/terms-of-use.htmldaily1.0https://www.cepheid.com/en-SE/legal/product-security-updates.htmldaily1.0https://www.cepheid.com/en-SE/legal/terms-of-sale.htmldaily1.0https://www.cepheid.com/en-SE/legal/trademarks.htmldaily1.0https://www.cepheid.com/en-SE/legal/cookies-notice.htmldaily1.0https://www.cepheid.com/en-SE/campaigns/2020-emea-renewed-messaging/french/patient-pathways.htmldaily1.0https://www.cepheid.com/en-SE/campaigns/2020-emea-renewed-messaging/german/patient-pathways.htmldaily1.0https://www.cepheid.com/en-SE/campaigns/2020-emea-renewed-messaging/italian/patient-pathways.htmldaily1.0https://www.cepheid.com/en-SE/campaigns/2020-emea-renewed-messaging/portuguese/patient-pathways.htmldaily1.0https://www.cepheid.com/en-SE/campaigns/2020-emea-renewed-messaging/polish/patient-pathways.htmldaily1.0https://www.cepheid.com/en-SE/campaigns/india/cepheid-india.htmldaily1.0https://www.cepheid.com/en-SE/campaigns/india/india-submission.htmldaily1.0https://www.cepheid.com/en-SE/campaigns/india/cepheid-india-display.htmldaily1.0https://www.cepheid.com/en-SE/campaigns/india/cepheid-india-bangladesh.htmldaily1.0https://www.cepheid.com/en-SE/campaigns/pcr-plus.htmldaily1.0https://www.cepheid.com/en-SE/coronavirus-portfolio.htmldaily1.0https://www.cepheid.com/fi-FI.htmldaily1.0https://www.cepheid.com/fi-FI/tests.htmldaily1.0https://www.cepheid.com/fi-FI/tests/respiratory.htmldaily1.0https://www.cepheid.com/fi-FI/tests/respiratory/xpert-xpress-strep-a.htmldaily1.0https://www.cepheid.com/fi-FI/tests/respiratory/xpert-xpress-cov-2-plus.htmldaily1.0https://www.cepheid.com/fi-FI/tests/respiratory/xpert-xpress-flu-rsv.htmldaily1.0https://www.cepheid.com/fi-FI/tests/respiratory/xpert-xpress-cov-2-flu-rsv-plus.htmldaily1.0https://www.cepheid.com/fi-FI/tests/hai-other-infectious-diseases.htmldaily1.0https://www.cepheid.com/fi-FI/tests/hai-other-infectious-diseases/xpert-sa-nasal-complete.htmldaily1.0https://www.cepheid.com/fi-FI/tests/hai-other-infectious-diseases/xpert-mrsa-sa-ssti.htmldaily1.0https://www.cepheid.com/fi-FI/tests/hai-other-infectious-diseases/xpert-c-difficile-bt.htmldaily1.0https://www.cepheid.com/fi-FI/tests/hai-other-infectious-diseases/xpert-norovirus.htmldaily1.0https://www.cepheid.com/fi-FI/tests/hai-other-infectious-diseases/xpert-mrsa-sa-blood-culture.htmldaily1.0https://www.cepheid.com/fi-FI/tests/hai-other-infectious-diseases/xpert-vana-vanb.htmldaily1.0https://www.cepheid.com/fi-FI/tests/hai-other-infectious-diseases/xpert-mrsa-nxg.htmldaily1.0https://www.cepheid.com/fi-FI/tests/hai-other-infectious-diseases/xpert-carba-r.htmldaily1.0https://www.cepheid.com/fi-FI/tests/blood-virology-womens-health-sexual-health.htmldaily1.0https://www.cepheid.com/fi-FI/tests/blood-virology-womens-health-sexual-health/xpert-hbv-viral-load.htmldaily1.0https://www.cepheid.com/fi-FI/tests/blood-virology-womens-health-sexual-health/resistanceplusmg-flexible.htmldaily1.0https://www.cepheid.com/fi-FI/tests/blood-virology-womens-health-sexual-health/xpert-xpress-gbs.htmldaily1.0https://www.cepheid.com/fi-FI/tests/blood-virology-womens-health-sexual-health/xpert-ct-ng.htmldaily1.0https://www.cepheid.com/fi-FI/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-qual-xc.htmldaily1.0https://www.cepheid.com/fi-FI/tests/blood-virology-womens-health-sexual-health/xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/fi-FI/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-viral-load-xc.htmldaily1.0https://www.cepheid.com/fi-FI/tests/blood-virology-womens-health-sexual-health/xpert-tv.htmldaily1.0https://www.cepheid.com/fi-FI/tests/blood-virology-womens-health-sexual-health/xpert-hpv-v2.htmldaily1.0https://www.cepheid.com/fi-FI/tests/blood-virology-womens-health-sexual-health/xpert-hcv-viral-load.htmldaily1.0https://www.cepheid.com/fi-FI/tests/tb-emerging-infectious-diseases.htmldaily1.0https://www.cepheid.com/fi-FI/tests/tb-emerging-infectious-diseases/xpert-mtb-xdr.htmldaily1.0https://www.cepheid.com/fi-FI/tests/tb-emerging-infectious-diseases/xpert-mtb-rif-ultra.htmldaily1.0https://www.cepheid.com/fi-FI/tests/oncology-human-genetics.htmldaily1.0https://www.cepheid.com/fi-FI/tests/oncology-human-genetics/expert-bladder-cancer-monitor.htmldaily1.0https://www.cepheid.com/fi-FI/tests/oncology-human-genetics/xpert-fii-fv.htmldaily1.0https://www.cepheid.com/fi-FI/tests/oncology-human-genetics/xpert-bcr-abl-ultra-p190.htmldaily1.0https://www.cepheid.com/fi-FI/tests/oncology-human-genetics/xpert-bladder-cancer-detection.htmldaily1.0https://www.cepheid.com/fi-FI/tests/oncology-human-genetics/xpert-bcr-abl-ultra.htmldaily1.0https://www.cepheid.com/fi-FI/tests/oncology-human-genetics/xpert-npm1-mutation.htmldaily1.0https://www.cepheid.com/fi-FI/systems.htmldaily1.0https://www.cepheid.com/fi-FI/systems/genexpert-family-of-systems.htmldaily1.0https://www.cepheid.com/fi-FI/systems/genexpert-family-of-systems/genexpert-system.htmldaily1.0https://www.cepheid.com/fi-FI/systems/genexpert-family-of-systems/genexpert-infinity.htmldaily1.0https://www.cepheid.com/fi-FI/systems/genexpert-software.htmldaily1.0https://www.cepheid.com/fi-FI/systems/genexpert-software/gx-software.htmldaily1.0https://www.cepheid.com/fi-FI/systems/genexpert-software/xpertise-software.htmldaily1.0https://www.cepheid.com/fi-FI/systems/connectivity.htmldaily1.0https://www.cepheid.com/fi-FI/systems/connectivity/cepheid-c360.htmldaily1.0https://www.cepheid.com/fi-FI/systems/connectivity/interface-capabilities.htmldaily1.0https://www.cepheid.com/fi-FI/systems/data-processing-agreement.htmldaily1.0https://www.cepheid.com/fi-FI/systems/partner-communities.htmldaily1.0https://www.cepheid.com/fi-FI/systems/business-associates-agreement.htmldaily1.0https://www.cepheid.com/fi-FI/solutions.htmldaily1.0https://www.cepheid.com/fi-FI/solutions/global-access.htmldaily1.0https://www.cepheid.com/fi-FI/solutions/global-access/eligibility-and-pricing.htmldaily1.0https://www.cepheid.com/fi-FI/solutions/testing-everywhere.htmldaily1.0https://www.cepheid.com/fi-FI/solutions/antibiotic-stewardship.htmldaily1.0https://www.cepheid.com/fi-FI/solutions/oncology-diagnostics.htmldaily1.0https://www.cepheid.com/fi-FI/solutions/customized-testing-institution.htmldaily1.0https://www.cepheid.com/fi-FI/solutions/knowing-more-matters.htmldaily1.0https://www.cepheid.com/fi-FI/solutions/knowing-more-matters/pcr-vs-antigen.htmldaily1.0https://www.cepheid.com/fi-FI/solutions/knowing-more-matters/covid-flu-rsv.htmldaily1.0https://www.cepheid.com/fi-FI/insights.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/all-posts.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/respiratory-health.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/respiratory-health/2024/09/proactive-surveillance-to-ensure-broad-flu-strain-detection.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/respiratory-health/2024/09/emerging-evolving-respiratory-viruses-test-design-matters.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/respiratory-health/2024/09/the-genexpert-xpress-system-can-change-your-pediatric-practice.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/respiratory-health/2024/09/Norwegian-ED-improves-Resource-Management-with-Rapid-PCR-Testing.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/respiratory-health/2024/09/key-steps-pandemic-preparedness.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/respiratory-health/2025/01/what-does-it-mean-to-have-a-pandemic-ready-pcr-test.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like-ilnesses.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/respiratory-health/2025/03/in-house-pcr-testing-clinical-leaders-explore-the-ripple-effect.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/respiratory-health/2025/04/real-world-clinical-impact-of-in-house-pcr-testing.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/respiratory-health/2025/04/what-is-the-difference-between-pcr-and-antigen-testing.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/respiratory-health/2025/05/a-quick-primer-on-the-adlm-guidance-on-respiratory-virus-testing.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/respiratory-health/2025/09/revolutionizing-respiratory-care-the-power-of-rapid-molecular-testing.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/respiratory-health/2025/09/antigen-testing-vs-pcr-less-haste-more-speed-please.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/respiratory-health/2025/09/the-time-for-widespread-adoption-of-mdx-testing-for-gas-pharyngi.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/respiratory-health/2025/11/why-test-type-matters-pcr-vs-antigen-in-outpatient-respiratory-care.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/respiratory-health/2025/11/transforming-respiratory-tnfection-diagnosis-embracing-molecular-innovation-clinical-practice1.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/respiratory-health/2026/01/staying-ahead-of-influenza.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/respiratory-health/2026/02/revolutionizing-rheumatic-heart-disease-prevention.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2024/09/accelerating-the-pace-for-hep-c-elimination-in-the-us.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2024/09/can-molecular-tests-revolutionize-tuberculosis-control.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2024/09/near-patient-testing-for-hep-c-xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2024/09/danish-hcv-testing-program-improves-patient-management-and-access.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2024/09/faster-prison-testing-for-hcv-drastically-improves-treatment-in-the-uk.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2024/09/innovative-POC-testing-shortens-time-between-testing-and-treatment.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2024/09/finnish-hospital-improves-care-for-expectant-mothers-with-gbs-pcr-screening.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2024/09/a-not-for-profit-in-vietnam-fights-to-end-tuberculosis.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2024/09/cepheid-expands-in-india-to-support-global-efforts-to-fight-tb.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2024/09/covid-19-and-tuberculosis-testing-in-south-africa.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2024/09/cepheid-supports-the-international-mpox-emergency-declared-august-2024.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2024/10/hpv-testing-south-african-clinic-may-prevent-cervical-cancer.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2024/12/strides-toward-early-infant-diagnosis-for-hiv-elimination-in-sou.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2025/02/common-misconceptions-about-vaginitis.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2025/06/womens-health-testing-advantages-of-same-day-diagnosis-and-treatment.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2025/04/tuberculosis-staying-one-step-ahead.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2025/04/how-three-countries-are-fighting-back-against-tuberculosis.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2025/04/a-mdr-tb-survivor-in-india-shares-her-remarkable-story.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2025/05/revisiting-bacterial-vaginosis-evidence-for-sexual-transmission.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2025/05/a-breakthrough-in-hcv-elimination--how-hcv-point-of-care-rna-tes.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2025/05/decentralising-diagnostics-bringing-patient-centred-testing-closer-to-communities.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2025/05/integration-of-poc-viral-diagnostics-with-substance-use-disorder-treatment-to-improve-hepatitis-c-nfection-outcomes.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2025/07/five-surprising-stats-that-reveal-the-hidden-burden-of-vaginitis.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2025/07/5-ways-vaginitis-treatment-goes-wrong-and-how-better-testing-can-fix-It.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2025/03/the-fight-to-end-tuberculosis-in-pakistan.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2025/03/devasena-gnanashanmugam-discusses-cepheids-global-access-program.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2025/03/desmond-tutu-foundation-reduces-impact-of-hiv-and-tb.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2025/03/tuberculosis-care-and-treatment-in-the-republic-of-indonesia.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2025/03/finding-missing-tuberculosis-tb-cases-philippines-need-for-speed.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2025/03/a-decade-of-health-and-economic-benefits-infographic.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2025/03/state-tb-in-us-overlooked-opportunity-better-results.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2025/03/fighting-tb-everything-10-years-of-impact-in-south-africa.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2025/09/in-memory-of-john-bishop-a-visionary-leader-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2025/10/time-to-act-stopping-group-b-strep-infections-in-newborn-babies.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2025/10/real-user-experiences-with-xpert-xpress-mvp-oint-of-care-test.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2025/12/wecare-humanitarian-medical-mission.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2025/08/kentucky-viral-hepatitis-treatment-projects-mission-to-eradicate-hcv.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2025/08/the-state-of-vaginitis-testing-in-the-us.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2025/08/improving-vaginitis-care-through-better-diagnostics.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2026/02/advancing-pandemic-preparedness-through-public-private-collaboration.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/community-and-global-health/2026/02/hepatitis-c-elimination-in-the-us-is-within-reach-experts-report.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/tech-disease-trends.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/tech-disease-trends/2024/09/candida-auris--rising-threat-and-future-implications.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/tech-disease-trends/2024/09/discussing-pharma-clinical-trials-utilizing-poc-diagnostics.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/tech-disease-trends/2024/09/poc-testing-increases-the-efficiency-of-patient-management-in-the-ed.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/tech-disease-trends/2024/10/dave-persing-legacy-and-leadership-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/tech-disease-trends/2024/11/invasive-group-streptococcal-disease.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/tech-disease-trends/2024/11/what-is-pcr--understanding-the-magic.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/tech-disease-trends/2024/11/decentralized-pcr-testing-and-the-quadruple-aim-insights-for-health-systems.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/tech-disease-trends/2025/01/how-a-cepheid-molecular-test-is-made.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct-.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/tech-disease-trends/2025/04/standardization-of-pcr-testing-across-healthcare-testing-sites.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/tech-disease-trends/2025/06/innovation-in-times-of-need-cepheids-legacy-of-outbreak-response.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/tech-disease-trends/2025/07/celebrating-the-cepheid-bike-where-art-meets-innovation.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/tech-disease-trends/2025/09/cepheid-advances-innovation-and-reach-with-key-partnerships.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/tech-disease-trends/2025/10/learn-about-cepheid-system-innovation.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/tech-disease-trends/2025/11/multiplex-with-meaning--cepheid-s-smart-approach-to-molecular-di.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/antimicrobial-stewardship.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/antimicrobial-stewardship/2024/09/a-public-health-dialogue-on-antibiotic-resistance-surveillance.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/antimicrobial-stewardship/2024/09/mortality-associated-with-carbapenem-resistant-gram-negative-infections.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/antimicrobial-stewardship/2024/09/decentralized-testing-for-the-surveillance-of-hospital-acquired-infections.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/antimicrobial-stewardship/2024/09/rapid-mrsa-screening-of-ortho-trauma-patients-improves-experience.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/antimicrobial-stewardship/2024/09/pcr-screening-at-a-british-hospital-enables-timely-infection-control.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/antimicrobial-stewardship/2024/10/fleming-initiative-cepheid-announce-partnership-tackle-amr.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/antimicrobial-stewardship/2024/10/link-between-colonization-multi-drug-resistant-infection.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/antimicrobial-stewardship/2024/12/point-of-care-testing-emergency-department-faster-decision-making-halle.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-shulz.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-schulz.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/antimicrobial-stewardship/2025/05/antimicrobial-and-diagnostic-stewardship-frost-and-sullivan-visual-whitepaper.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/antimicrobial-stewardship/2025/08/industry-voices-time-to-rethink-our-approach-to-using-modern-medicine.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/antimicrobial-stewardship/2025/09/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/antimicrobial-stewardship/2025/10/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/antimicrobial-stewardship/2025/11/vanessa-carter-s-journey--inspiring-action-against-amr.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/antimicrobial-stewardship/2025/11/advancing-antimicrobial-stewardship-in-small-and-rural-hospital.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/expert-spotlight.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/expert-spotlight/2025/10/expert-spotlight--michael-loeffelholz.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--devasena-gnanashanmugam-vice-president--me.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--jennifer-rakeman-cagno-senior-director--sc.htmldaily1.0https://www.cepheid.com/fi-FI/insights/insight-hub/expert-spotlight/2026/02/expert-spotlight-jordan-chase.htmldaily1.0https://www.cepheid.com/fi-FI/insights/webinars.htmldaily1.0https://www.cepheid.com/fi-FI/insights/resources.htmldaily1.0https://www.cepheid.com/fi-FI/support.htmldaily1.0https://www.cepheid.com/fi-FI/support/ivdr-update.htmldaily1.0https://www.cepheid.com/fi-FI/support/contact-us.htmldaily1.0https://www.cepheid.com/fi-FI/about.htmldaily1.0https://www.cepheid.com/fi-FI/about/mission-history.htmldaily1.0https://www.cepheid.com/fi-FI/about/leadership.htmldaily1.0https://www.cepheid.com/fi-FI/about/leadership/vitor-rocha.htmldaily1.0https://www.cepheid.com/fi-FI/about/leadership/laurent-bellon.htmldaily1.0https://www.cepheid.com/fi-FI/about/leadership/anette-engelhardt.htmldaily1.0https://www.cepheid.com/fi-FI/about/leadership/peter-farrell.htmldaily1.0https://www.cepheid.com/fi-FI/about/leadership/deborah-gonyea.htmldaily1.0https://www.cepheid.com/fi-FI/about/leadership/nichole-halsey.htmldaily1.0https://www.cepheid.com/fi-FI/about/leadership/luben-li.htmldaily1.0https://www.cepheid.com/fi-FI/about/leadership/luke-maitland.htmldaily1.0https://www.cepheid.com/fi-FI/about/leadership/david-h-persing.htmldaily1.0https://www.cepheid.com/fi-FI/about/leadership/ammar-qadan.htmldaily1.0https://www.cepheid.com/fi-FI/about/leadership/charles-mwangi.htmldaily1.0https://www.cepheid.com/fi-FI/about/leadership/samson-wu.htmldaily1.0https://www.cepheid.com/fi-FI/about/leadership/anupama-mokkapati.htmldaily1.0https://www.cepheid.com/fi-FI/about/leadership/traci-wicks.htmldaily1.0https://www.cepheid.com/fi-FI/about/leadership/scott-campbell.htmldaily1.0https://www.cepheid.com/fi-FI/about/leadership/anne-beauburn.htmldaily1.0https://www.cepheid.com/fi-FI/about/leadership/patrick-harkins.htmldaily1.0https://www.cepheid.com/fi-FI/about/leadership/ephraim-tsalik.htmldaily1.0https://www.cepheid.com/fi-FI/about/leadership/somesh-lalithraj.htmldaily1.0https://www.cepheid.com/fi-FI/about/leadership/connie-savor.htmldaily1.0https://www.cepheid.com/fi-FI/about/sustainability.htmldaily1.0https://www.cepheid.com/fi-FI/about/sustainability/environmental-sustainability.htmldaily1.0https://www.cepheid.com/fi-FI/about/sustainability/product-stewardship.htmldaily1.0https://www.cepheid.com/fi-FI/about/sustainability/conflict-materials.htmldaily1.0https://www.cepheid.com/fi-FI/about/policies-reports.htmldaily1.0https://www.cepheid.com/fi-FI/about/business-development-opportunities.htmldaily1.0https://www.cepheid.com/fi-FI/about/events.htmldaily1.0https://www.cepheid.com/fi-FI/about/innovation-form.htmldaily1.0https://www.cepheid.com/fi-FI/about/innovation-form/unsolicited-submission-agreement.htmldaily1.0https://www.cepheid.com/fi-FI/about/sars-cov-2-test-development-information.htmldaily1.0https://www.cepheid.com/fi-FI/about/sars-cov-2-product-resources.htmldaily1.0https://www.cepheid.com/fi-FI/contact/select-info-path.htmldaily1.0https://www.cepheid.com/fi-FI/contact/messages/thank-you.htmldaily1.0https://www.cepheid.com/fi-FI/contact/messages/thank-you-patient-pathways.htmldaily1.0https://www.cepheid.com/fi-FI/contact/messages/thank-you-patient-pathways-fr.htmldaily1.0https://www.cepheid.com/fi-FI/contact/messages/thank-you-patient-pathways-de.htmldaily1.0https://www.cepheid.com/fi-FI/contact/messages/thank-you-patient-pathways-it.htmldaily1.0https://www.cepheid.com/fi-FI/contact/messages/thank-you-patient-pathways-sp.htmldaily1.0https://www.cepheid.com/fi-FI/contact/messages/thank-you-patient-pathways-pl.htmldaily1.0https://www.cepheid.com/fi-FI/contact/messages/thank-you-patient-pathways-pt.htmldaily1.0https://www.cepheid.com/fi-FI/contact/request-cd-international.htmldaily1.0https://www.cepheid.com/fi-FI/personas/laboratory-professionals.htmldaily1.0https://www.cepheid.com/fi-FI/personas/healthcare-professsional.htmldaily1.0https://www.cepheid.com/fi-FI/personas/health-system-administrators.htmldaily1.0https://www.cepheid.com/fi-FI/legal/privacy.htmldaily1.0https://www.cepheid.com/fi-FI/legal/terms-of-use.htmldaily1.0https://www.cepheid.com/fi-FI/legal/product-security-updates.htmldaily1.0https://www.cepheid.com/fi-FI/legal/terms-of-sale.htmldaily1.0https://www.cepheid.com/fi-FI/legal/trademarks.htmldaily1.0https://www.cepheid.com/fi-FI/legal/cookies-notice.htmldaily1.0https://www.cepheid.com/fi-FI/campaigns/2020-emea-renewed-messaging/french/patient-pathways.htmldaily1.0https://www.cepheid.com/fi-FI/campaigns/2020-emea-renewed-messaging/german/patient-pathways.htmldaily1.0https://www.cepheid.com/fi-FI/campaigns/2020-emea-renewed-messaging/italian/patient-pathways.htmldaily1.0https://www.cepheid.com/fi-FI/campaigns/2020-emea-renewed-messaging/portuguese/patient-pathways.htmldaily1.0https://www.cepheid.com/fi-FI/campaigns/2020-emea-renewed-messaging/polish/patient-pathways.htmldaily1.0https://www.cepheid.com/fi-FI/campaigns/india/cepheid-india.htmldaily1.0https://www.cepheid.com/fi-FI/campaigns/india/india-submission.htmldaily1.0https://www.cepheid.com/fi-FI/campaigns/india/cepheid-india-display.htmldaily1.0https://www.cepheid.com/fi-FI/campaigns/india/cepheid-india-bangladesh.htmldaily1.0https://www.cepheid.com/fi-FI/campaigns/pcr-plus.htmldaily1.0https://www.cepheid.com/fi-FI/coronavirus-portfolio.htmldaily1.0https://www.cepheid.com/fr-CA.htmldaily1.0https://www.cepheid.com/fr-CA/tests.htmldaily1.0https://www.cepheid.com/fr-CA/tests/respiratory.htmldaily1.0https://www.cepheid.com/fr-CA/tests/respiratory/xpert-xpress-flu-rsv.htmldaily1.0https://www.cepheid.com/fr-CA/tests/respiratory/xpert-xpress-strep-a.htmldaily1.0https://www.cepheid.com/fr-CA/tests/respiratory/xpert-xpress-cov-2-plus.htmldaily1.0https://www.cepheid.com/fr-CA/tests/respiratory/xpert-xpress-cov-2-flu-rsv-plus.htmldaily1.0https://www.cepheid.com/fr-CA/tests/hai-other-infectious-diseases.htmldaily1.0https://www.cepheid.com/fr-CA/tests/hai-other-infectious-diseases/xpert-sa-nasal-complete.htmldaily1.0https://www.cepheid.com/fr-CA/tests/hai-other-infectious-diseases/xpert-mrsa-sa-ssti.htmldaily1.0https://www.cepheid.com/fr-CA/tests/hai-other-infectious-diseases/xpert-norovirus.htmldaily1.0https://www.cepheid.com/fr-CA/tests/hai-other-infectious-diseases/xpert-c-difficile-epi.htmldaily1.0https://www.cepheid.com/fr-CA/tests/hai-other-infectious-diseases/xpert-mrsa-sa-blood-culture.htmldaily1.0https://www.cepheid.com/fr-CA/tests/hai-other-infectious-diseases/xpert-mrsa-nxg.htmldaily1.0https://www.cepheid.com/fr-CA/tests/hai-other-infectious-diseases/xpert-vana.htmldaily1.0https://www.cepheid.com/fr-CA/tests/hai-other-infectious-diseases/xpert-vana-vanb.htmldaily1.0https://www.cepheid.com/fr-CA/tests/hai-other-infectious-diseases/xpert-carba-r.htmldaily1.0https://www.cepheid.com/fr-CA/tests/blood-virology-womens-health-sexual-health.htmldaily1.0https://www.cepheid.com/fr-CA/tests/blood-virology-womens-health-sexual-health/xpert-ct-ng.htmldaily1.0https://www.cepheid.com/fr-CA/tests/blood-virology-womens-health-sexual-health/xpert-tv.htmldaily1.0https://www.cepheid.com/fr-CA/tests/blood-virology-womens-health-sexual-health/xpert-hpv.htmldaily1.0https://www.cepheid.com/fr-CA/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-viral-load-xc.htmldaily1.0https://www.cepheid.com/fr-CA/tests/blood-virology-womens-health-sexual-health/xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/fr-CA/tests/tb-emerging-infectious-diseases.htmldaily1.0https://www.cepheid.com/fr-CA/tests/tb-emerging-infectious-diseases/xpert-mtb-rif-ultra.htmldaily1.0https://www.cepheid.com/fr-CA/tests/oncology-human-genetics.htmldaily1.0https://www.cepheid.com/fr-CA/tests/oncology-human-genetics/xpert-fii-fv.htmldaily1.0https://www.cepheid.com/fr-CA/tests/oncology-human-genetics/xpert-bcr-abl-ultra.htmldaily1.0https://www.cepheid.com/fr-CA/systems.htmldaily1.0https://www.cepheid.com/fr-CA/systems/genexpert-family-of-systems.htmldaily1.0https://www.cepheid.com/fr-CA/systems/genexpert-family-of-systems/genexpert-system.htmldaily1.0https://www.cepheid.com/fr-CA/systems/genexpert-family-of-systems/genexpert-infinity.htmldaily1.0https://www.cepheid.com/fr-CA/systems/genexpert-family-of-systems/genexpert-xpress.htmldaily1.0https://www.cepheid.com/fr-CA/systems/genexpert-software.htmldaily1.0https://www.cepheid.com/fr-CA/systems/genexpert-software/gx-software.htmldaily1.0https://www.cepheid.com/fr-CA/systems/genexpert-software/xpertise-software.htmldaily1.0https://www.cepheid.com/fr-CA/systems/connectivity.htmldaily1.0https://www.cepheid.com/fr-CA/systems/connectivity/cepheid-c360.htmldaily1.0https://www.cepheid.com/fr-CA/systems/connectivity/interface-capabilities.htmldaily1.0https://www.cepheid.com/fr-CA/systems/data-processing-agreement.htmldaily1.0https://www.cepheid.com/fr-CA/systems/partner-communities.htmldaily1.0https://www.cepheid.com/fr-CA/systems/business-associates-agreement.htmldaily1.0https://www.cepheid.com/fr-CA/solutions.htmldaily1.0https://www.cepheid.com/fr-CA/solutions/global-access.htmldaily1.0https://www.cepheid.com/fr-CA/solutions/global-access/everything-about-our-fight-against-tb.htmldaily1.0https://www.cepheid.com/fr-CA/solutions/global-access/eligibility-and-pricing.htmldaily1.0https://www.cepheid.com/fr-CA/solutions/enhanced-antibiotic-stewardship.htmldaily1.0https://www.cepheid.com/fr-CA/solutions/customized-menu-scalability.htmldaily1.0https://www.cepheid.com/fr-CA/solutions/better-testing-everywhere.htmldaily1.0https://www.cepheid.com/fr-CA/solutions/knowing-more-matters.htmldaily1.0https://www.cepheid.com/fr-CA/solutions/knowing-more-matters/campaign-resources.htmldaily1.0https://www.cepheid.com/fr-CA/solutions/knowing-more-matters/pcr-vs-antigen.htmldaily1.0https://www.cepheid.com/fr-CA/solutions/knowing-more-matters/covid-flu-rsv.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/all-posts.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/respiratory-health.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/respiratory-health/2024/09/proactive-surveillance-to-ensure-broad-flu-strain-detection.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/respiratory-health/2024/09/emerging-evolving-respiratory-viruses-test-design-matters.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/respiratory-health/2024/09/the-genexpert-xpress-system-can-change-your-pediatric-practice.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/respiratory-health/2024/09/Norwegian-ED-improves-Resource-Management-with-Rapid-PCR-Testing.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/respiratory-health/2024/09/key-steps-pandemic-preparedness.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/respiratory-health/2025/01/what-does-it-mean-to-have-a-pandemic-ready-pcr-test.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like-illnesses.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/respiratory-health/2025/03/in-house-pcr-testing-clinical-leaders-explore-the-ripple-effect.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/respiratory-health/2025/04/real-world-clinical-impact-of-in-house-pcr-testing.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/respiratory-health/2025/04/what-is-the-difference-between-pcr-and-antigen-testing.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/respiratory-health/2025/05/a-quick-primer-on-the-adlm-guidance-on-respiratory-virus-testing.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/respiratory-health/2025/09/revolutionizing-respiratory-care-the-power-of-rapid-molecular-testing.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/respiratory-health/2025/09/antigen-testing-vs-pcr-less-haste-more-speed-please.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/respiratory-health/2025/09/the-time-for-widespread-adoption-of-mdx-testing-for-gas-pharyngi.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/respiratory-health/2025/11/why-test-type-matters-pcr-vs-antigen-in-outpatient-respiratory-care.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/respiratory-health/2025/11/transforming-respiratory-tnfection-diagnosis-embracing-molecular-innovation-clinical-practice.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/respiratory-health/2026/01/staying-ahead-of-influenza.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2024/09/accelerating-the-pace-for-hep-c-elimination-in-the-us.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2024/09/can-molecular-tests-revolutionize-tuberculosis-control.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2024/09/near-patient-testing-for-hep-c-xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2024/09/danish-hcv-testing-program-improves-patient-management-and-access.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2024/09/faster-prison-testing-for-hcv-drastically-improves-treatment-in-the-uk.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2024/09/innovative-POC-testing-shortens-time-between-testing-and-treatment.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2024/09/finnish-hospital-improves-care-for-expectant-mothers-with-gbs-pcr-screening.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2024/09/a-not-for-profit-in-vietnam-fights-to-end-tuberculosis.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2024/09/cepheid-expands-in-india-to-support-global-efforts-to-fight-tb.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2024/09/covid-19-and-tuberculosis-testing-in-south-africa.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2024/09/cepheid-supports-the-international-mpox-emergency-declared-august-2024.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2024/10/hpv-testing-south-african-clinic-may-prevent-cervical-cancer.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2024/12/strides-toward-early-infant-diagnosis-for-hiv-elimination-in-sou.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2025/01/common-misconceptions-about-vaginitis.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2025/04/tuberculosis-staying-one-step-ahead.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2025/04/how-three-countries-are-fighting-back-against-tuberculosis.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2025/04/a-mdr-tb-survivor-in-india-shares-her-remarkable-story.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2025/07/five-surprising-stats-that-reveal-the-hidden-burden-of-vaginitis.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2025/07/5-ways-vaginitis-treatment-goes-wrong-and-how-better-testing-can-fix-It.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2025/03/the-fight-to-end-tuberculosis-in-pakistan.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2025/03/devasena-gnanashanmugam-discusses-cepheids-global-access-program.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2025/03/desmond-tutu-foundation-reduces-impact-of-hiv-and-tb.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2025/03/tuberculosis-care-and-treatment-in-the-republic-of-indonesia.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2025/03/finding-missing-tuberculosis-tb-cases-philippines-need-for-speed.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2025/03/a-decade-of-health-and-economic-benefits-infographic.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2025/03/state-tb-in-us-overlooked-opportunity-better-results.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2025/03/fighting-tb-everything-10-years-of-impact-in-south-africa.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2025/06/womens-health-testing-advantages-of-same-day-diagnosis-and-treatment.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2025/05/revisiting-bacterial-vaginosis-evidence-for-sexual-transmission.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2025/05/a-breakthrough-in-hcv-elimination--how-hcv-point-of-care-rna-tes.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2025/05/decentralising-diagnostics-bringing-patient-centred-testing-closer-to-communities.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2025/05/integration-of-poc-viral-diagnostics-with-substance-use-disorder-treatment-to-improve-hepatitis-c-nfection-outcomes.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2025/08/kentucky-viral-hepatitis-treatment-projects-mission-to-eradicate-hcv.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2025/08/the-state-of-vaginitis-testing-in-the-us.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2025/08/improving-vaginitis-care-through-better-diagnostics.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2025/10/time-to-act-stopping-group-b-strep-infections-in-newborn-babies.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2025/10/real-user-experiences-with-xpert-xpress-mvp-oint-of-care-test.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2025/12/wecare-humanitarian-medical-mission.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2025/09/in-memory-of-john-bishop-a-visionary-leader-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2026/02/advancing-pandemic-preparedness-through-public-private-collaboration.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/community-and-global-health/2026/02/hepatitis-c-elimination-in-the-us-is-within-reach-experts-report.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/tech-disease-trends.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/tech-disease-trends/2024/09/candida-auris--rising-threat-and-future-implications.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/tech-disease-trends/2024/09/discussing-pharma-clinical-trials-utilizing-poc-diagnostics.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/tech-disease-trends/2024/09/poc-testing-increases-the-efficiency-of-patient-management-in-the-ed.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/tech-disease-trends/2024/10/dave-persing-legacy-and-leadership-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/tech-disease-trends/2024/11/invasive-group-streptococcal-disease.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/tech-disease-trends/2024/11/what-is-pcr--understanding-the-magic.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/tech-disease-trends/2024/11/decentralized-pcr-testing-and-the-quadruple-aim-insights-for-health-systems.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/tech-disease-trends/2025/01/how-a-cepheid-molecular-test-is-made.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/tech-disease-trends/2025/04/standardization-of-pcr-testing-across-healthcare-testing-sites.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/tech-disease-trends/2025/06/innovation-in-times-of-need-cepheids-legacy-of-outbreak-response.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/tech-disease-trends/2025/07/celebrating-the-cepheid-bike-where-art-meets-innovation.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/tech-disease-trends/2025/09/cepheid-advances-innovation-and-reach-with-key-partnerships.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/tech-disease-trends/2025/10/learn-about-cepheid-system-innovation.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/tech-disease-trends/2025/11/multiplex-with-meaning--cepheid-s-smart-approach-to-molecular-di.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/tech-disease-trends/2026/01/innovation-in-era-of-dxex.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/antimicrobial-stewardship.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/antimicrobial-stewardship/2024/09/a-public-health-dialogue-on-antibiotic-resistance-surveillance.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/antimicrobial-stewardship/2024/09/mortality-associated-with-carbapenem-resistant-gram-negative-infections.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/antimicrobial-stewardship/2024/09/decentralized-testing-for-the-surveillance-of-hospital-acquired-infections.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/antimicrobial-stewardship/2024/09/rapid-mrsa-screening-of-ortho-trauma-patients-improves-experience.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/antimicrobial-stewardship/2024/09/pcr-screening-at-a-british-hospital-enables-timely-infection-control.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/antimicrobial-stewardship/2024/10/fleming-initiative-cepheid-announce-partnership-tackle-amr.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/antimicrobial-stewardship/2024/10/link-between-colonization-multi-drug-resistant-infection.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/antimicrobial-stewardship/2024/12/point-of-care-testing-emergency-department-faster-decision-making-halle.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-schulz.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/antimicrobial-stewardship/2025/05/antimicrobial-and-diagnostic-stewardship-frost-and-sullivan-visual-whitepaper.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/antimicrobial-stewardship/2025/08/industry-voices-time-to-rethink-our-approach-to-using-modern-medicine.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/antimicrobial-stewardship/2025/10/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/antimicrobial-stewardship/2025/11/vanessa-carter-s-journey--inspiring-action-against-amr.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/antimicrobial-stewardship/2025/11/advancing-antimicrobial-stewardship-in-small-and-rural-hospital.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/expert-spotlight.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/expert-spotlight/2025/10/expert-spotlight--michael-loeffelholz.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--devasena-gnanashanmugam-vice-president--me.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--jennifer-rakeman-cagno-senior-director--sc.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/expert-spotlight/2026/02/expert-spotlight-jordan-chase.htmldaily1.0https://www.cepheid.com/fr-CA/insights/insight-hub/expert-spotlight/2026/02/expert-spotlight-juan-cruz-cuevas.htmldaily1.0https://www.cepheid.com/fr-CA/insights/webinars.htmldaily1.0https://www.cepheid.com/fr-CA/insights/webinars/featured-webinars.htmldaily1.0https://www.cepheid.com/fr-CA/support.htmldaily1.0https://www.cepheid.com/fr-CA/support/order-management.htmldaily1.0https://www.cepheid.com/fr-CA/support/contact-us.htmldaily1.0https://www.cepheid.com/fr-CA/about.htmldaily1.0https://www.cepheid.com/fr-CA/about/mission-history.htmldaily1.0https://www.cepheid.com/fr-CA/about/leadership.htmldaily1.0https://www.cepheid.com/fr-CA/about/leadership/vitor-rocha.htmldaily1.0https://www.cepheid.com/fr-CA/about/leadership/laurent-bellon.htmldaily1.0https://www.cepheid.com/fr-CA/about/leadership/anette-engelhardt.htmldaily1.0https://www.cepheid.com/fr-CA/about/leadership/peter-farrell.htmldaily1.0https://www.cepheid.com/fr-CA/about/leadership/deborah-gonyea.htmldaily1.0https://www.cepheid.com/fr-CA/about/leadership/nichole-halsey.htmldaily1.0https://www.cepheid.com/fr-CA/about/leadership/luben-li.htmldaily1.0https://www.cepheid.com/fr-CA/about/leadership/luke-maitland.htmldaily1.0https://www.cepheid.com/fr-CA/about/leadership/david-h-persing.htmldaily1.0https://www.cepheid.com/fr-CA/about/leadership/ammar-qadan.htmldaily1.0https://www.cepheid.com/fr-CA/about/leadership/charles-mwangi.htmldaily1.0https://www.cepheid.com/fr-CA/about/leadership/samson-wu.htmldaily1.0https://www.cepheid.com/fr-CA/about/leadership/anupama-mokkapati.htmldaily1.0https://www.cepheid.com/fr-CA/about/leadership/scott-campbell.htmldaily1.0https://www.cepheid.com/fr-CA/about/leadership/traci-wicks.htmldaily1.0https://www.cepheid.com/fr-CA/about/leadership/ephraim-tsalik.htmldaily1.0https://www.cepheid.com/fr-CA/about/leadership/patrick-harkins.htmldaily1.0https://www.cepheid.com/fr-CA/about/leadership/anne-beauburn.htmldaily1.0https://www.cepheid.com/fr-CA/about/leadership/somesh-lalithraj.htmldaily1.0https://www.cepheid.com/fr-CA/about/leadership/connie-savor.htmldaily1.0https://www.cepheid.com/fr-CA/about/reimbursement-support.htmldaily1.0https://www.cepheid.com/fr-CA/about/business-development-opportunities.htmldaily1.0https://www.cepheid.com/fr-CA/about/innovation-form.htmldaily1.0https://www.cepheid.com/fr-CA/about/innovation-form/unsolicited-submission-agreement.htmldaily1.0https://www.cepheid.com/fr-CA/about/events.htmldaily1.0https://www.cepheid.com/fr-CA/about/sustainability.htmldaily1.0https://www.cepheid.com/fr-CA/about/sustainability/environmental-sustainability.htmldaily1.0https://www.cepheid.com/fr-CA/about/sustainability/product-stewardship.htmldaily1.0https://www.cepheid.com/fr-CA/about/sustainability/conflict-minerals.htmldaily1.0https://www.cepheid.com/fr-CA/about/careers/internship-opportunities.htmldaily1.0https://www.cepheid.com/fr-CA/about/careers/join-the-team.htmldaily1.0https://www.cepheid.com/fr-CA/about/policies-reports.htmldaily1.0https://www.cepheid.com/fr-CA/about/sars-cov-2-test-development-information.htmldaily1.0https://www.cepheid.com/fr-CA/about/sars-cov-2-product-resources.htmldaily1.0https://www.cepheid.com/fr-CA/legal/privacy.htmldaily1.0https://www.cepheid.com/fr-CA/legal/terms-of-use.htmldaily1.0https://www.cepheid.com/fr-CA/legal/california-consumer-privacy-act.htmldaily1.0https://www.cepheid.com/fr-CA/legal/trademarks.htmldaily1.0https://www.cepheid.com/fr-CA/legal/product-security.htmldaily1.0https://www.cepheid.com/fr-CA/legal/product-security/product-security-updates.htmldaily1.0https://www.cepheid.com/fr-CA/legal/cookies-notice.htmldaily1.0https://www.cepheid.com/fr-CA/personas/laboratory-professionals.htmldaily1.0https://www.cepheid.com/fr-CA/personas/healthcare-providers.htmldaily1.0https://www.cepheid.com/fr-CA/personas/health-system-administrators.htmldaily1.0https://www.cepheid.com/fr-CA/contact/messages/thank-you.htmldaily1.0https://www.cepheid.com/fr-CA/contact/request-cd.htmldaily1.0https://www.cepheid.com/fr-CA/contact/request-express-hub.htmldaily1.0https://www.cepheid.com/fr-CA/contact/select-info-path.htmldaily1.0https://www.cepheid.com/fr-CA/contact/thank-you.htmldaily1.0https://www.cepheid.com/fr-CA/campaigns/pcr-plus.htmldaily1.0https://www.cepheid.com/fr-CA/coronavirus-portfolio.htmldaily1.0https://www.cepheid.com/fr-CH.htmldaily1.0https://www.cepheid.com/fr-CH/tests.htmldaily1.0https://www.cepheid.com/fr-CH/tests/respiratory.htmldaily1.0https://www.cepheid.com/fr-CH/tests/respiratory/xpert-xpress-strep-a.htmldaily1.0https://www.cepheid.com/fr-CH/tests/respiratory/xpert-xpress-cov-2-plus.htmldaily1.0https://www.cepheid.com/fr-CH/tests/respiratory/xpert-xpress-sars-cov-2.htmldaily1.0https://www.cepheid.com/fr-CH/tests/respiratory/xpert-xpress-flu-rsv.htmldaily1.0https://www.cepheid.com/fr-CH/tests/respiratory/xpert-xpress-cov-2-flu-rsv-plus.htmldaily1.0https://www.cepheid.com/fr-CH/tests/hai-other-infectious-diseases.htmldaily1.0https://www.cepheid.com/fr-CH/tests/hai-other-infectious-diseases/xpert-sa-nasal-complete.htmldaily1.0https://www.cepheid.com/fr-CH/tests/hai-other-infectious-diseases/xpert-mrsa-sa-ssti.htmldaily1.0https://www.cepheid.com/fr-CH/tests/hai-other-infectious-diseases/xpert-c-difficile-bt.htmldaily1.0https://www.cepheid.com/fr-CH/tests/hai-other-infectious-diseases/xpert-norovirus.htmldaily1.0https://www.cepheid.com/fr-CH/tests/hai-other-infectious-diseases/xpert-mrsa-sa-blood-culture.htmldaily1.0https://www.cepheid.com/fr-CH/tests/hai-other-infectious-diseases/xpert-vana-vanb.htmldaily1.0https://www.cepheid.com/fr-CH/tests/hai-other-infectious-diseases/xpert-mrsa-nxg.htmldaily1.0https://www.cepheid.com/fr-CH/tests/hai-other-infectious-diseases/xpert-carba-r.htmldaily1.0https://www.cepheid.com/fr-CH/tests/blood-virology-womens-health-sexual-health.htmldaily1.0https://www.cepheid.com/fr-CH/tests/blood-virology-womens-health-sexual-health/xpert-gbs.htmldaily1.0https://www.cepheid.com/fr-CH/tests/blood-virology-womens-health-sexual-health/xpert-hbv-viral-load.htmldaily1.0https://www.cepheid.com/fr-CH/tests/blood-virology-womens-health-sexual-health/resistanceplusmg-flexible.htmldaily1.0https://www.cepheid.com/fr-CH/tests/blood-virology-womens-health-sexual-health/xpert-xpress-gbs.htmldaily1.0https://www.cepheid.com/fr-CH/tests/blood-virology-womens-health-sexual-health/xpert-ct-ng.htmldaily1.0https://www.cepheid.com/fr-CH/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-qual-xc.htmldaily1.0https://www.cepheid.com/fr-CH/tests/blood-virology-womens-health-sexual-health/xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/fr-CH/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-viral-load-xc.htmldaily1.0https://www.cepheid.com/fr-CH/tests/blood-virology-womens-health-sexual-health/xpert-tv.htmldaily1.0https://www.cepheid.com/fr-CH/tests/blood-virology-womens-health-sexual-health/xpert-hpv-v2.htmldaily1.0https://www.cepheid.com/fr-CH/tests/blood-virology-womens-health-sexual-health/xpert-hcv-viral-load.htmldaily1.0https://www.cepheid.com/fr-CH/tests/tb-emerging-infectious-diseases.htmldaily1.0https://www.cepheid.com/fr-CH/tests/tb-emerging-infectious-diseases/xpert-mtb-xdr.htmldaily1.0https://www.cepheid.com/fr-CH/tests/tb-emerging-infectious-diseases/xpert-mtb-rif-ultra.htmldaily1.0https://www.cepheid.com/fr-CH/tests/oncology-human-genetics.htmldaily1.0https://www.cepheid.com/fr-CH/tests/oncology-human-genetics/expert-bladder-cancer-monitor.htmldaily1.0https://www.cepheid.com/fr-CH/tests/oncology-human-genetics/xpert-fii-fv.htmldaily1.0https://www.cepheid.com/fr-CH/tests/oncology-human-genetics/xpert-bcr-abl-ultra-p190.htmldaily1.0https://www.cepheid.com/fr-CH/tests/oncology-human-genetics/xpert-breast-cancer-strat4.htmldaily1.0https://www.cepheid.com/fr-CH/tests/oncology-human-genetics/xpert-bladder-cancer-detection.htmldaily1.0https://www.cepheid.com/fr-CH/tests/oncology-human-genetics/xpert-bcr-abl-ultra.htmldaily1.0https://www.cepheid.com/fr-CH/systems.htmldaily1.0https://www.cepheid.com/fr-CH/systems/genexpert-family-of-systems.htmldaily1.0https://www.cepheid.com/fr-CH/systems/genexpert-family-of-systems/genexpert-system.htmldaily1.0https://www.cepheid.com/fr-CH/systems/genexpert-family-of-systems/genexpert-infinity.htmldaily1.0https://www.cepheid.com/fr-CH/systems/genexpert-software.htmldaily1.0https://www.cepheid.com/fr-CH/systems/genexpert-software/gx-software.htmldaily1.0https://www.cepheid.com/fr-CH/systems/genexpert-software/xpertise-software.htmldaily1.0https://www.cepheid.com/fr-CH/systems/connectivity.htmldaily1.0https://www.cepheid.com/fr-CH/systems/connectivity/cepheid-c360.htmldaily1.0https://www.cepheid.com/fr-CH/systems/connectivity/interface-capabilities.htmldaily1.0https://www.cepheid.com/fr-CH/systems/data-processing-agreement.htmldaily1.0https://www.cepheid.com/fr-CH/systems/partner-communities.htmldaily1.0https://www.cepheid.com/fr-CH/systems/business-associates-agreement.htmldaily1.0https://www.cepheid.com/fr-CH/solutions.htmldaily1.0https://www.cepheid.com/fr-CH/solutions/global-access.htmldaily1.0https://www.cepheid.com/fr-CH/solutions/global-access/eligibility-and-pricing.htmldaily1.0https://www.cepheid.com/fr-CH/solutions/testing-everywhere.htmldaily1.0https://www.cepheid.com/fr-CH/solutions/oncology-diagnostics.htmldaily1.0https://www.cepheid.com/fr-CH/solutions/antibiotic-stewardship.htmldaily1.0https://www.cepheid.com/fr-CH/solutions/customized-testing-institution.htmldaily1.0https://www.cepheid.com/fr-CH/solutions/knowing-more-matters.htmldaily1.0https://www.cepheid.com/fr-CH/solutions/knowing-more-matters/pcr-vs-antigen.htmldaily1.0https://www.cepheid.com/fr-CH/solutions/knowing-more-matters/covid-flu-rsv.htmldaily1.0https://www.cepheid.com/fr-CH/insights.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/all-posts.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/respiratory-health.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/respiratory-health/2024/09/proactive-surveillance-to-ensure-broad-flu-strain-detection.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/respiratory-health/2024/09/emerging-evolving-respiratory-viruses-test-design-matters.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/respiratory-health/2024/09/the-genexpert-xpress-system-can-change-your-pediatric-practice.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/respiratory-health/2024/09/Norwegian-ED-improves-Resource-Management-with-Rapid-PCR-Testing.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/respiratory-health/2024/09/key-steps-pandemic-preparedness.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/respiratory-health/2025/01/what-does-it-mean-to-have-a-pandemic-ready-pcr-test.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like-ilnesses.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/respiratory-health/2025/03/in-house-pcr-testing-clinical-leaders-explore-the-ripple-effect.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/respiratory-health/2025/04/real-world-clinical-impact-of-in-house-pcr-testing.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/respiratory-health/2025/04/what-is-the-difference-between-pcr-and-antigen-testing.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/respiratory-health/2025/05/a-quick-primer-on-the-adlm-guidance-on-respiratory-virus-testing.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/respiratory-health/2025/09/revolutionizing-respiratory-care-the-power-of-rapid-molecular-testing.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/respiratory-health/2025/09/antigen-testing-vs-pcr-less-haste-more-speed-please.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/respiratory-health/2025/09/the-time-for-widespread-adoption-of-mdx-testing-for-gas-pharyngi.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/respiratory-health/2025/11/why-test-type-matters-pcr-vs-antigen-in-outpatient-respiratory-care.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/respiratory-health/2025/11/transforming-respiratory-tnfection-diagnosis-embracing-molecular-innovation-clinical-practice1.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/respiratory-health/2026/01/staying-ahead-of-influenza.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/respiratory-health/2026/02/revolutionizing-rheumatic-heart-disease-prevention.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2024/09/accelerating-the-pace-for-hep-c-elimination-in-the-us.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2024/09/can-molecular-tests-revolutionize-tuberculosis-control.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2024/09/near-patient-testing-for-hep-c-xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2024/09/danish-hcv-testing-program-improves-patient-management-and-access.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2024/09/faster-prison-testing-for-hcv-drastically-improves-treatment-in-the-uk.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2024/09/innovative-POC-testing-shortens-time-between-testing-and-treatment.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2024/09/finnish-hospital-improves-care-for-expectant-mothers-with-gbs-pcr-screening.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2024/09/a-not-for-profit-in-vietnam-fights-to-end-tuberculosis.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2024/09/cepheid-expands-in-india-to-support-global-efforts-to-fight-tb.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2024/09/covid-19-and-tuberculosis-testing-in-south-africa.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2024/09/cepheid-supports-the-international-mpox-emergency-declared-august-2024.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2024/10/hpv-testing-south-african-clinic-may-prevent-cervical-cancer.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2024/12/strides-toward-early-infant-diagnosis-for-hiv-elimination-in-sou.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2025/02/common-misconceptions-about-vaginitis.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2025/05/revisiting-bacterial-vaginosis-evidence-for-sexual-transmission.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2025/05/a-breakthrough-in-hcv-elimination--how-hcv-point-of-care-rna-tes.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2025/05/decentralising-diagnostics-bringing-patient-centred-testing-closer-to-communities.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2025/05/integration-of-poc-viral-diagnostics-with-substance-use-disorder-treatment-to-improve-hepatitis-c-nfection-outcomes.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2025/04/tuberculosis-staying-one-step-ahead.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2025/04/how-three-countries-are-fighting-back-against-tuberculosis.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2025/04/a-mdr-tb-survivor-in-india-shares-her-remarkable-story.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2025/06/womens-health-testing-advantages-of-same-day-diagnosis-and-treatment.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2025/07/five-surprising-stats-that-reveal-the-hidden-burden-of-vaginitis.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2025/07/5-ways-vaginitis-treatment-goes-wrong-and-how-better-testing-can-fix-It.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2025/03/the-fight-to-end-tuberculosis-in-pakistan.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2025/03/devasena-gnanashanmugam-discusses-cepheids-global-access-program.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2025/03/desmond-tutu-foundation-reduces-impact-of-hiv-and-tb.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2025/03/tuberculosis-care-and-treatment-in-the-republic-of-indonesia.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2025/03/finding-missing-tuberculosis-tb-cases-philippines-need-for-speed.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2025/03/a-decade-of-health-and-economic-benefits-infographic.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2025/03/state-tb-in-us-overlooked-opportunity-better-results.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2025/03/fighting-tb-everything-10-years-of-impact-in-south-africa.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2025/09/in-memory-of-john-bishop-a-visionary-leader-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2025/12/wecare-humanitarian-medical-mission.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2025/10/time-to-act-stopping-group-b-strep-infections-in-newborn-babies.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2025/10/real-user-experiences-with-xpert-xpress-mvp-oint-of-care-test.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2025/08/kentucky-viral-hepatitis-treatment-projects-mission-to-eradicate-hcv.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2025/08/the-state-of-vaginitis-testing-in-the-us.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2025/08/improving-vaginitis-care-through-better-diagnostics.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2026/02/advancing-pandemic-preparedness-through-public-private-collaboration.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/community-and-global-health/2026/02/hepatitis-c-elimination-in-the-us-is-within-reach-experts-report.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/tech-disease-trends.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/tech-disease-trends/2024/09/candida-auris--rising-threat-and-future-implications.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/tech-disease-trends/2024/09/discussing-pharma-clinical-trials-utilizing-poc-diagnostics.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/tech-disease-trends/2024/09/poc-testing-increases-the-efficiency-of-patient-management-in-the-ed.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/tech-disease-trends/2024/10/dave-persing-legacy-and-leadership-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/tech-disease-trends/2024/11/invasive-group-streptococcal-disease.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/tech-disease-trends/2024/11/what-is-pcr--understanding-the-magic.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/tech-disease-trends/2024/11/decentralized-pcr-testing-and-the-quadruple-aim-insights-for-health-systems.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/tech-disease-trends/2025/01/how-a-cepheid-molecular-test-is-made.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct-.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/tech-disease-trends/2025/04/standardization-of-pcr-testing-across-healthcare-testing-sites.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/tech-disease-trends/2025/06/innovation-in-times-of-need-cepheids-legacy-of-outbreak-response.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/tech-disease-trends/2025/07/celebrating-the-cepheid-bike-where-art-meets-innovation.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/tech-disease-trends/2025/09/cepheid-advances-innovation-and-reach-with-key-partnerships.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/tech-disease-trends/2025/10/learn-about-cepheid-system-innovation.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/tech-disease-trends/2025/11/multiplex-with-meaning--cepheid-s-smart-approach-to-molecular-di.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/antimicrobial-stewardship.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/antimicrobial-stewardship/2024/09/a-public-health-dialogue-on-antibiotic-resistance-surveillance.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/antimicrobial-stewardship/2024/09/mortality-associated-with-carbapenem-resistant-gram-negative-infections.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/antimicrobial-stewardship/2024/09/decentralized-testing-for-the-surveillance-of-hospital-acquired-infections.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/antimicrobial-stewardship/2024/09/rapid-mrsa-screening-of-ortho-trauma-patients-improves-experience.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/antimicrobial-stewardship/2024/09/pcr-screening-at-a-british-hospital-enables-timely-infection-control.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/antimicrobial-stewardship/2024/10/fleming-initiative-cepheid-announce-partnership-tackle-amr.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/antimicrobial-stewardship/2024/10/link-between-colonization-multi-drug-resistant-infection.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/antimicrobial-stewardship/2024/12/point-of-care-testing-emergency-department-faster-decision-making-halle.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-shulz.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-schulz.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/antimicrobial-stewardship/2025/05/antimicrobial-and-diagnostic-stewardship-frost-and-sullivan-visual-whitepaper.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/antimicrobial-stewardship/2025/08/industry-voices-time-to-rethink-our-approach-to-using-modern-medicine.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/antimicrobial-stewardship/2025/09/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/antimicrobial-stewardship/2025/10/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/antimicrobial-stewardship/2025/11/vanessa-carter-s-journey--inspiring-action-against-amr.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/antimicrobial-stewardship/2025/11/advancing-antimicrobial-stewardship-in-small-and-rural-hospital.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/expert-spotlight.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/expert-spotlight/2025/10/expert-spotlight--michael-loeffelholz.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--devasena-gnanashanmugam-vice-president--me.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--jennifer-rakeman-cagno-senior-director--sc.htmldaily1.0https://www.cepheid.com/fr-CH/insights/insight-hub/expert-spotlight/2026/02/expert-spotlight-jordan-chase.htmldaily1.0https://www.cepheid.com/fr-CH/insights/webinars.htmldaily1.0https://www.cepheid.com/fr-CH/insights/resources.htmldaily1.0https://www.cepheid.com/fr-CH/support.htmldaily1.0https://www.cepheid.com/fr-CH/support/ivdr-update.htmldaily1.0https://www.cepheid.com/fr-CH/support/contact-us.htmldaily1.0https://www.cepheid.com/fr-CH/about.htmldaily1.0https://www.cepheid.com/fr-CH/about/mission-history.htmldaily1.0https://www.cepheid.com/fr-CH/about/leadership.htmldaily1.0https://www.cepheid.com/fr-CH/about/leadership/vitor-rocha.htmldaily1.0https://www.cepheid.com/fr-CH/about/leadership/laurent-bellon.htmldaily1.0https://www.cepheid.com/fr-CH/about/leadership/anette-engelhardt.htmldaily1.0https://www.cepheid.com/fr-CH/about/leadership/peter-farrell.htmldaily1.0https://www.cepheid.com/fr-CH/about/leadership/deborah-gonyea.htmldaily1.0https://www.cepheid.com/fr-CH/about/leadership/nichole-halsey.htmldaily1.0https://www.cepheid.com/fr-CH/about/leadership/luben-li.htmldaily1.0https://www.cepheid.com/fr-CH/about/leadership/luke-maitland.htmldaily1.0https://www.cepheid.com/fr-CH/about/leadership/david-h-persing.htmldaily1.0https://www.cepheid.com/fr-CH/about/leadership/ammar-qadan.htmldaily1.0https://www.cepheid.com/fr-CH/about/leadership/charles-mwangi.htmldaily1.0https://www.cepheid.com/fr-CH/about/leadership/samson-wu.htmldaily1.0https://www.cepheid.com/fr-CH/about/leadership/anupama-mokkapati.htmldaily1.0https://www.cepheid.com/fr-CH/about/leadership/traci-wicks.htmldaily1.0https://www.cepheid.com/fr-CH/about/leadership/scott-campbell.htmldaily1.0https://www.cepheid.com/fr-CH/about/leadership/anne-beauburn.htmldaily1.0https://www.cepheid.com/fr-CH/about/leadership/patrick-harkins.htmldaily1.0https://www.cepheid.com/fr-CH/about/leadership/ephraim-tsalik.htmldaily1.0https://www.cepheid.com/fr-CH/about/leadership/somesh-lalithraj.htmldaily1.0https://www.cepheid.com/fr-CH/about/leadership/connie-savor.htmldaily1.0https://www.cepheid.com/fr-CH/about/sustainability.htmldaily1.0https://www.cepheid.com/fr-CH/about/sustainability/environmental-sustainability.htmldaily1.0https://www.cepheid.com/fr-CH/about/sustainability/product-stewardship.htmldaily1.0https://www.cepheid.com/fr-CH/about/sustainability/conflict-materials.htmldaily1.0https://www.cepheid.com/fr-CH/about/policies-reports.htmldaily1.0https://www.cepheid.com/fr-CH/about/business-development-opportunities.htmldaily1.0https://www.cepheid.com/fr-CH/about/events.htmldaily1.0https://www.cepheid.com/fr-CH/about/innovation-form.htmldaily1.0https://www.cepheid.com/fr-CH/about/innovation-form/unsolicited-submission-agreement.htmldaily1.0https://www.cepheid.com/fr-CH/about/sars-cov-2-test-development-information.htmldaily1.0https://www.cepheid.com/fr-CH/about/sars-cov-2-product-resources.htmldaily1.0https://www.cepheid.com/fr-CH/contact/select-info-path.htmldaily1.0https://www.cepheid.com/fr-CH/contact/messages/thank-you.htmldaily1.0https://www.cepheid.com/fr-CH/contact/messages/thank-you-patient-pathways.htmldaily1.0https://www.cepheid.com/fr-CH/contact/messages/thank-you-patient-pathways-fr.htmldaily1.0https://www.cepheid.com/fr-CH/contact/messages/thank-you-patient-pathways-de.htmldaily1.0https://www.cepheid.com/fr-CH/contact/messages/thank-you-patient-pathways-it.htmldaily1.0https://www.cepheid.com/fr-CH/contact/messages/thank-you-patient-pathways-sp.htmldaily1.0https://www.cepheid.com/fr-CH/contact/messages/thank-you-patient-pathways-pl.htmldaily1.0https://www.cepheid.com/fr-CH/contact/messages/thank-you-patient-pathways-pt.htmldaily1.0https://www.cepheid.com/fr-CH/contact/request-cd-international.htmldaily1.0https://www.cepheid.com/fr-CH/personas/laboratory-professionals.htmldaily1.0https://www.cepheid.com/fr-CH/personas/healthcare-professsional.htmldaily1.0https://www.cepheid.com/fr-CH/personas/health-system-administrators.htmldaily1.0https://www.cepheid.com/fr-CH/legal/privacy.htmldaily1.0https://www.cepheid.com/fr-CH/legal/terms-of-use.htmldaily1.0https://www.cepheid.com/fr-CH/legal/product-security-updates.htmldaily1.0https://www.cepheid.com/fr-CH/legal/terms-of-sale.htmldaily1.0https://www.cepheid.com/fr-CH/legal/trademarks.htmldaily1.0https://www.cepheid.com/fr-CH/legal/cookies-notice.htmldaily1.0https://www.cepheid.com/fr-CH/campaigns/2020-emea-renewed-messaging/french/patient-pathways.htmldaily1.0https://www.cepheid.com/fr-CH/campaigns/2020-emea-renewed-messaging/german/patient-pathways.htmldaily1.0https://www.cepheid.com/fr-CH/campaigns/2020-emea-renewed-messaging/italian/patient-pathways.htmldaily1.0https://www.cepheid.com/fr-CH/campaigns/2020-emea-renewed-messaging/portuguese/patient-pathways.htmldaily1.0https://www.cepheid.com/fr-CH/campaigns/2020-emea-renewed-messaging/polish/patient-pathways.htmldaily1.0https://www.cepheid.com/fr-CH/campaigns/india/cepheid-india.htmldaily1.0https://www.cepheid.com/fr-CH/campaigns/india/india-submission.htmldaily1.0https://www.cepheid.com/fr-CH/campaigns/india/cepheid-india-display.htmldaily1.0https://www.cepheid.com/fr-CH/campaigns/india/cepheid-india-bangladesh.htmldaily1.0https://www.cepheid.com/fr-CH/campaigns/pcr-plus.htmldaily1.0https://www.cepheid.com/fr-CH/coronavirus-portfolio.htmldaily1.0https://www.cepheid.com/fr-FR.htmldaily1.0https://www.cepheid.com/fr-FR/tests.htmldaily1.0https://www.cepheid.com/fr-FR/tests/respiratory.htmldaily1.0https://www.cepheid.com/fr-FR/tests/respiratory/xpert-xpress-strep-a.htmldaily1.0https://www.cepheid.com/fr-FR/tests/respiratory/xpert-xpress-cov-2-plus.htmldaily1.0https://www.cepheid.com/fr-FR/tests/respiratory/xpert-xpress-sars-cov-2.htmldaily1.0https://www.cepheid.com/fr-FR/tests/respiratory/xpert-xpress-flu-rsv.htmldaily1.0https://www.cepheid.com/fr-FR/tests/respiratory/xpert-xpress-cov-2-flu-rsv-plus.htmldaily1.0https://www.cepheid.com/fr-FR/tests/hai-other-infectious-diseases.htmldaily1.0https://www.cepheid.com/fr-FR/tests/hai-other-infectious-diseases/xpert-sa-nasal-complete.htmldaily1.0https://www.cepheid.com/fr-FR/tests/hai-other-infectious-diseases/xpert-mrsa-sa-ssti.htmldaily1.0https://www.cepheid.com/fr-FR/tests/hai-other-infectious-diseases/xpert-c-difficile-bt.htmldaily1.0https://www.cepheid.com/fr-FR/tests/hai-other-infectious-diseases/xpert-norovirus.htmldaily1.0https://www.cepheid.com/fr-FR/tests/hai-other-infectious-diseases/xpert-mrsa-sa-blood-culture.htmldaily1.0https://www.cepheid.com/fr-FR/tests/hai-other-infectious-diseases/xpert-vana-vanb.htmldaily1.0https://www.cepheid.com/fr-FR/tests/hai-other-infectious-diseases/xpert-mrsa-nxg.htmldaily1.0https://www.cepheid.com/fr-FR/tests/hai-other-infectious-diseases/xpert-carba-r.htmldaily1.0https://www.cepheid.com/fr-FR/tests/blood-virology-womens-health-sexual-health.htmldaily1.0https://www.cepheid.com/fr-FR/tests/blood-virology-womens-health-sexual-health/resistanceplusmg-flexible.htmldaily1.0https://www.cepheid.com/fr-FR/tests/blood-virology-womens-health-sexual-health/xpert-xpress-gbs.htmldaily1.0https://www.cepheid.com/fr-FR/tests/blood-virology-womens-health-sexual-health/xpert-ct-ng.htmldaily1.0https://www.cepheid.com/fr-FR/tests/blood-virology-womens-health-sexual-health/xpert-tv.htmldaily1.0https://www.cepheid.com/fr-FR/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-qual-xc.htmldaily1.0https://www.cepheid.com/fr-FR/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-viral-load-xc.htmldaily1.0https://www.cepheid.com/fr-FR/tests/tb-emerging-infectious-diseases.htmldaily1.0https://www.cepheid.com/fr-FR/tests/tb-emerging-infectious-diseases/xpert-mtb-xdr.htmldaily1.0https://www.cepheid.com/fr-FR/tests/tb-emerging-infectious-diseases/xpert-mtb-rif-ultra.htmldaily1.0https://www.cepheid.com/fr-FR/tests/oncology-human-genetics.htmldaily1.0https://www.cepheid.com/fr-FR/tests/oncology-human-genetics/expert-bladder-cancer-monitor.htmldaily1.0https://www.cepheid.com/fr-FR/tests/oncology-human-genetics/xpert-fii-fv.htmldaily1.0https://www.cepheid.com/fr-FR/tests/oncology-human-genetics/xpert-bcr-abl-ultra-p190.htmldaily1.0https://www.cepheid.com/fr-FR/tests/oncology-human-genetics/xpert-breast-cancer-strat4.htmldaily1.0https://www.cepheid.com/fr-FR/tests/oncology-human-genetics/xpert-bladder-cancer-detection.htmldaily1.0https://www.cepheid.com/fr-FR/tests/oncology-human-genetics/xpert-bcr-abl-ultra.htmldaily1.0https://www.cepheid.com/fr-FR/tests/oncology-human-genetics/xpert-npm1-mutation.htmldaily1.0https://www.cepheid.com/fr-FR/systems.htmldaily1.0https://www.cepheid.com/fr-FR/systems/genexpert-family-of-systems.htmldaily1.0https://www.cepheid.com/fr-FR/systems/genexpert-family-of-systems/genexpert-system.htmldaily1.0https://www.cepheid.com/fr-FR/systems/genexpert-family-of-systems/genexpert-infinity.htmldaily1.0https://www.cepheid.com/fr-FR/systems/genexpert-software.htmldaily1.0https://www.cepheid.com/fr-FR/systems/genexpert-software/gx-software.htmldaily1.0https://www.cepheid.com/fr-FR/systems/genexpert-software/xpertise-software.htmldaily1.0https://www.cepheid.com/fr-FR/systems/connectivity.htmldaily1.0https://www.cepheid.com/fr-FR/systems/connectivity/cepheid-c360.htmldaily1.0https://www.cepheid.com/fr-FR/systems/connectivity/interface-capabilities.htmldaily1.0https://www.cepheid.com/fr-FR/systems/data-processing-agreement.htmldaily1.0https://www.cepheid.com/fr-FR/systems/partner-communities.htmldaily1.0https://www.cepheid.com/fr-FR/systems/business-associates-agreement.htmldaily1.0https://www.cepheid.com/fr-FR/solutions.htmldaily1.0https://www.cepheid.com/fr-FR/solutions/global-access.htmldaily1.0https://www.cepheid.com/fr-FR/solutions/global-access/eligibility-and-pricing.htmldaily1.0https://www.cepheid.com/fr-FR/solutions/testing-everywhere.htmldaily1.0https://www.cepheid.com/fr-FR/solutions/oncology-diagnostics.htmldaily1.0https://www.cepheid.com/fr-FR/solutions/antibiotic-stewardship.htmldaily1.0https://www.cepheid.com/fr-FR/solutions/customized-testing-institution.htmldaily1.0https://www.cepheid.com/fr-FR/solutions/knowing-more-matters.htmldaily1.0https://www.cepheid.com/fr-FR/solutions/knowing-more-matters/pcr-vs-antigen.htmldaily1.0https://www.cepheid.com/fr-FR/solutions/knowing-more-matters/covid-flu-rsv.htmldaily1.0https://www.cepheid.com/fr-FR/insights.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/all-posts.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/respiratory-health.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/respiratory-health/2024/09/proactive-surveillance-to-ensure-broad-flu-strain-detection.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/respiratory-health/2024/09/emerging-evolving-respiratory-viruses-test-design-matters.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/respiratory-health/2024/09/the-genexpert-xpress-system-can-change-your-pediatric-practice.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/respiratory-health/2024/09/Norwegian-ED-improves-Resource-Management-with-Rapid-PCR-Testing.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/respiratory-health/2024/09/key-steps-pandemic-preparedness.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/respiratory-health/2025/01/what-does-it-mean-to-have-a-pandemic-ready-pcr-test.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like-ilnesses.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/respiratory-health/2025/03/in-house-pcr-testing-clinical-leaders-explore-the-ripple-effect.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/respiratory-health/2025/04/real-world-clinical-impact-of-in-house-pcr-testing.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/respiratory-health/2025/04/what-is-the-difference-between-pcr-and-antigen-testing.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/respiratory-health/2025/05/a-quick-primer-on-the-adlm-guidance-on-respiratory-virus-testing.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/respiratory-health/2025/09/revolutionizing-respiratory-care-the-power-of-rapid-molecular-testing.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/respiratory-health/2025/09/antigen-testing-vs-pcr-less-haste-more-speed-please.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/respiratory-health/2025/09/the-time-for-widespread-adoption-of-mdx-testing-for-gas-pharyngi.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/respiratory-health/2025/11/why-test-type-matters-pcr-vs-antigen-in-outpatient-respiratory-care.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/respiratory-health/2025/11/transforming-respiratory-tnfection-diagnosis-embracing-molecular-innovation-clinical-practice1.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/respiratory-health/2026/01/staying-ahead-of-influenza.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/respiratory-health/2026/02/revolutionizing-rheumatic-heart-disease-prevention.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2024/09/accelerating-the-pace-for-hep-c-elimination-in-the-us.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2024/09/can-molecular-tests-revolutionize-tuberculosis-control.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2024/09/near-patient-testing-for-hep-c-xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2024/09/danish-hcv-testing-program-improves-patient-management-and-access.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2024/09/faster-prison-testing-for-hcv-drastically-improves-treatment-in-the-uk.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2024/09/innovative-POC-testing-shortens-time-between-testing-and-treatment.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2024/09/finnish-hospital-improves-care-for-expectant-mothers-with-gbs-pcr-screening.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2024/09/a-not-for-profit-in-vietnam-fights-to-end-tuberculosis.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2024/09/cepheid-expands-in-india-to-support-global-efforts-to-fight-tb.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2024/09/covid-19-and-tuberculosis-testing-in-south-africa.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2024/09/cepheid-supports-the-international-mpox-emergency-declared-august-2024.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2024/10/hpv-testing-south-african-clinic-may-prevent-cervical-cancer.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2024/12/strides-toward-early-infant-diagnosis-for-hiv-elimination-in-sou.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2025/02/common-misconceptions-about-vaginitis.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2025/06/womens-health-testing-advantages-of-same-day-diagnosis-and-treatment.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2025/04/tuberculosis-staying-one-step-ahead.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2025/04/how-three-countries-are-fighting-back-against-tuberculosis.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2025/04/a-mdr-tb-survivor-in-india-shares-her-remarkable-story.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2025/05/revisiting-bacterial-vaginosis-evidence-for-sexual-transmission.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2025/05/a-breakthrough-in-hcv-elimination--how-hcv-point-of-care-rna-tes.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2025/05/decentralising-diagnostics-bringing-patient-centred-testing-closer-to-communities.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2025/05/integration-of-poc-viral-diagnostics-with-substance-use-disorder-treatment-to-improve-hepatitis-c-nfection-outcomes.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2025/03/the-fight-to-end-tuberculosis-in-pakistan.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2025/03/devasena-gnanashanmugam-discusses-cepheids-global-access-program.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2025/03/desmond-tutu-foundation-reduces-impact-of-hiv-and-tb.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2025/03/tuberculosis-care-and-treatment-in-the-republic-of-indonesia.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2025/03/finding-missing-tuberculosis-tb-cases-philippines-need-for-speed.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2025/03/a-decade-of-health-and-economic-benefits-infographic.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2025/03/state-tb-in-us-overlooked-opportunity-better-results.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2025/03/fighting-tb-everything-10-years-of-impact-in-south-africa.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2025/07/five-surprising-stats-that-reveal-the-hidden-burden-of-vaginitis.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2025/07/5-ways-vaginitis-treatment-goes-wrong-and-how-better-testing-can-fix-It.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2025/09/in-memory-of-john-bishop-a-visionary-leader-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2025/08/kentucky-viral-hepatitis-treatment-projects-mission-to-eradicate-hcv.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2025/08/the-state-of-vaginitis-testing-in-the-us.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2025/08/improving-vaginitis-care-through-better-diagnostics.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2025/10/time-to-act-stopping-group-b-strep-infections-in-newborn-babies.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2025/10/real-user-experiences-with-xpert-xpress-mvp-oint-of-care-test.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2025/12/wecare-humanitarian-medical-mission.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2026/02/advancing-pandemic-preparedness-through-public-private-collaboration.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/community-and-global-health/2026/02/hepatitis-c-elimination-in-the-us-is-within-reach-experts-report.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/tech-disease-trends.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/tech-disease-trends/2024/09/candida-auris--rising-threat-and-future-implications.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/tech-disease-trends/2024/09/discussing-pharma-clinical-trials-utilizing-poc-diagnostics.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/tech-disease-trends/2024/09/poc-testing-increases-the-efficiency-of-patient-management-in-the-ed.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/tech-disease-trends/2024/10/dave-persing-legacy-and-leadership-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/tech-disease-trends/2024/11/invasive-group-streptococcal-disease.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/tech-disease-trends/2024/11/what-is-pcr--understanding-the-magic.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/tech-disease-trends/2024/11/decentralized-pcr-testing-and-the-quadruple-aim-insights-for-health-systems.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/tech-disease-trends/2025/01/how-a-cepheid-molecular-test-is-made.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/tech-disease-trends/2025/04/standardization-of-pcr-testing-across-healthcare-testing-sites.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/tech-disease-trends/2025/06/innovation-in-times-of-need-cepheids-legacy-of-outbreak-response.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/tech-disease-trends/2025/07/celebrating-the-cepheid-bike-where-art-meets-innovation.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/tech-disease-trends/2025/09/cepheid-advances-innovation-and-reach-with-key-partnerships.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/tech-disease-trends/2025/10/learn-about-cepheid-system-innovation.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/tech-disease-trends/2025/11/multiplex-with-meaning--cepheid-s-smart-approach-to-molecular-di.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/antimicrobial-stewardship.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/antimicrobial-stewardship/2024/09/a-public-health-dialogue-on-antibiotic-resistance-surveillance.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/antimicrobial-stewardship/2024/09/mortality-associated-with-carbapenem-resistant-gram-negative-infections.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/antimicrobial-stewardship/2024/09/decentralized-testing-for-the-surveillance-of-hospital-acquired-infections.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/antimicrobial-stewardship/2024/09/rapid-mrsa-screening-of-ortho-trauma-patients-improves-experience.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/antimicrobial-stewardship/2024/09/pcr-screening-at-a-british-hospital-enables-timely-infection-control.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/antimicrobial-stewardship/2024/10/fleming-initiative-cepheid-announce-partnership-tackle-amr.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/antimicrobial-stewardship/2024/10/link-between-colonization-multi-drug-resistant-infection.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/antimicrobial-stewardship/2024/12/point-of-care-testing-emergency-department-faster-decision-making-halle.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-schulz.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/antimicrobial-stewardship/2025/05/antimicrobial-and-diagnostic-stewardship-frost-and-sullivan-visual-whitepaper.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/antimicrobial-stewardship/2025/08/industry-voices-time-to-rethink-our-approach-to-using-modern-medicine.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/antimicrobial-stewardship/2025/09/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/antimicrobial-stewardship/2025/10/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/antimicrobial-stewardship/2025/11/vanessa-carter-s-journey--inspiring-action-against-amr.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/antimicrobial-stewardship/2025/11/advancing-antimicrobial-stewardship-in-small-and-rural-hospital.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/expert-spotlight.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/expert-spotlight/2025/10/expert-spotlight--michael-loeffelholz.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--devasena-gnanashanmugam-vice-president--me.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--jennifer-rakeman-cagno-senior-director--sc.htmldaily1.0https://www.cepheid.com/fr-FR/insights/insight-hub/expert-spotlight/2026/02/expert-spotlight-jordan-chase.htmldaily1.0https://www.cepheid.com/fr-FR/insights/webinars.htmldaily1.0https://www.cepheid.com/fr-FR/insights/resources.htmldaily1.0https://www.cepheid.com/fr-FR/support.htmldaily1.0https://www.cepheid.com/fr-FR/support/ivdr-update.htmldaily1.0https://www.cepheid.com/fr-FR/support/contact-us.htmldaily1.0https://www.cepheid.com/fr-FR/about.htmldaily1.0https://www.cepheid.com/fr-FR/about/mission-history.htmldaily1.0https://www.cepheid.com/fr-FR/about/leadership.htmldaily1.0https://www.cepheid.com/fr-FR/about/leadership/vitor-rocha.htmldaily1.0https://www.cepheid.com/fr-FR/about/leadership/laurent-bellon.htmldaily1.0https://www.cepheid.com/fr-FR/about/leadership/anette-engelhardt.htmldaily1.0https://www.cepheid.com/fr-FR/about/leadership/peter-farrell.htmldaily1.0https://www.cepheid.com/fr-FR/about/leadership/deborah-gonyea.htmldaily1.0https://www.cepheid.com/fr-FR/about/leadership/nichole-halsey.htmldaily1.0https://www.cepheid.com/fr-FR/about/leadership/luben-li.htmldaily1.0https://www.cepheid.com/fr-FR/about/leadership/luke-maitland.htmldaily1.0https://www.cepheid.com/fr-FR/about/leadership/david-h-persing.htmldaily1.0https://www.cepheid.com/fr-FR/about/leadership/ammar-qadan.htmldaily1.0https://www.cepheid.com/fr-FR/about/leadership/charles-mwangi.htmldaily1.0https://www.cepheid.com/fr-FR/about/leadership/samson-wu.htmldaily1.0https://www.cepheid.com/fr-FR/about/leadership/anupama-mokkapati.htmldaily1.0https://www.cepheid.com/fr-FR/about/leadership/traci-wicks.htmldaily1.0https://www.cepheid.com/fr-FR/about/leadership/scott-campbell.htmldaily1.0https://www.cepheid.com/fr-FR/about/leadership/anne-beauburn.htmldaily1.0https://www.cepheid.com/fr-FR/about/leadership/patrick-harkins.htmldaily1.0https://www.cepheid.com/fr-FR/about/leadership/ephraim-tsalik.htmldaily1.0https://www.cepheid.com/fr-FR/about/leadership/somesh-lalithraj.htmldaily1.0https://www.cepheid.com/fr-FR/about/leadership/connie-savor.htmldaily1.0https://www.cepheid.com/fr-FR/about/sustainability.htmldaily1.0https://www.cepheid.com/fr-FR/about/sustainability/environmental-sustainability.htmldaily1.0https://www.cepheid.com/fr-FR/about/sustainability/product-stewardship.htmldaily1.0https://www.cepheid.com/fr-FR/about/sustainability/conflict-materials.htmldaily1.0https://www.cepheid.com/fr-FR/about/policies-reports.htmldaily1.0https://www.cepheid.com/fr-FR/about/business-development-opportunities.htmldaily1.0https://www.cepheid.com/fr-FR/about/events.htmldaily1.0https://www.cepheid.com/fr-FR/about/innovation-form.htmldaily1.0https://www.cepheid.com/fr-FR/about/innovation-form/unsolicited-submission-agreement.htmldaily1.0https://www.cepheid.com/fr-FR/about/careers/Index-egalite-professionnelle-femmes-hommes.htmldaily1.0https://www.cepheid.com/fr-FR/about/sars-cov-2-test-development-information.htmldaily1.0https://www.cepheid.com/fr-FR/about/sars-cov-2-product-resources.htmldaily1.0https://www.cepheid.com/fr-FR/contact/select-info-path.htmldaily1.0https://www.cepheid.com/fr-FR/contact/messages/thank-you.htmldaily1.0https://www.cepheid.com/fr-FR/contact/messages/thank-you-patient-pathways.htmldaily1.0https://www.cepheid.com/fr-FR/contact/messages/thank-you-patient-pathways-fr.htmldaily1.0https://www.cepheid.com/fr-FR/contact/messages/thank-you-patient-pathways-de.htmldaily1.0https://www.cepheid.com/fr-FR/contact/messages/thank-you-patient-pathways-it.htmldaily1.0https://www.cepheid.com/fr-FR/contact/messages/thank-you-patient-pathways-sp.htmldaily1.0https://www.cepheid.com/fr-FR/contact/messages/thank-you-patient-pathways-pl.htmldaily1.0https://www.cepheid.com/fr-FR/contact/messages/thank-you-patient-pathways-pt.htmldaily1.0https://www.cepheid.com/fr-FR/contact/request-cd-international.htmldaily1.0https://www.cepheid.com/fr-FR/personas/laboratory-professionals.htmldaily1.0https://www.cepheid.com/fr-FR/personas/healthcare-professsional.htmldaily1.0https://www.cepheid.com/fr-FR/personas/health-system-administrators.htmldaily1.0https://www.cepheid.com/fr-FR/legal/privacy.htmldaily1.0https://www.cepheid.com/fr-FR/legal/terms-of-use.htmldaily1.0https://www.cepheid.com/fr-FR/legal/product-security-updates.htmldaily1.0https://www.cepheid.com/fr-FR/legal/terms-of-sale.htmldaily1.0https://www.cepheid.com/fr-FR/legal/trademarks.htmldaily1.0https://www.cepheid.com/fr-FR/legal/cookies-notice.htmldaily1.0https://www.cepheid.com/fr-FR/campaigns/2020-emea-renewed-messaging/french/patient-pathways.htmldaily1.0https://www.cepheid.com/fr-FR/campaigns/2020-emea-renewed-messaging/german/patient-pathways.htmldaily1.0https://www.cepheid.com/fr-FR/campaigns/2020-emea-renewed-messaging/italian/patient-pathways.htmldaily1.0https://www.cepheid.com/fr-FR/campaigns/2020-emea-renewed-messaging/portuguese/patient-pathways.htmldaily1.0https://www.cepheid.com/fr-FR/campaigns/2020-emea-renewed-messaging/polish/patient-pathways.htmldaily1.0https://www.cepheid.com/fr-FR/campaigns/india/cepheid-india.htmldaily1.0https://www.cepheid.com/fr-FR/campaigns/india/india-submission.htmldaily1.0https://www.cepheid.com/fr-FR/campaigns/india/cepheid-india-display.htmldaily1.0https://www.cepheid.com/fr-FR/campaigns/india/cepheid-india-bangladesh.htmldaily1.0https://www.cepheid.com/fr-FR/campaigns/pcr-plus.htmldaily1.0https://www.cepheid.com/fr-FR/coronavirus-portfolio.htmldaily1.0https://www.cepheid.com/it-IT.htmldaily1.0https://www.cepheid.com/it-IT/tests.htmldaily1.0https://www.cepheid.com/it-IT/tests/respiratory.htmldaily1.0https://www.cepheid.com/it-IT/tests/respiratory/xpert-xpress-strep-a.htmldaily1.0https://www.cepheid.com/it-IT/tests/respiratory/xpert-xpress-cov-2-plus.htmldaily1.0https://www.cepheid.com/it-IT/tests/respiratory/xpert-xpress-sars-cov-2.htmldaily1.0https://www.cepheid.com/it-IT/tests/respiratory/xpert-xpress-flu-rsv.htmldaily1.0https://www.cepheid.com/it-IT/tests/respiratory/xpert-xpress-cov-2-flu-rsv-plus.htmldaily1.0https://www.cepheid.com/it-IT/tests/respiratory/xpert-xpress-sars-cov-2-flu-rsv.htmldaily1.0https://www.cepheid.com/it-IT/tests/hai-other-infectious-diseases.htmldaily1.0https://www.cepheid.com/it-IT/tests/hai-other-infectious-diseases/xpert-sa-nasal-complete.htmldaily1.0https://www.cepheid.com/it-IT/tests/hai-other-infectious-diseases/xpert-mrsa-sa-ssti.htmldaily1.0https://www.cepheid.com/it-IT/tests/hai-other-infectious-diseases/xpert-c-difficile-bt.htmldaily1.0https://www.cepheid.com/it-IT/tests/hai-other-infectious-diseases/xpert-norovirus.htmldaily1.0https://www.cepheid.com/it-IT/tests/hai-other-infectious-diseases/xpert-mrsa-sa-blood-culture.htmldaily1.0https://www.cepheid.com/it-IT/tests/hai-other-infectious-diseases/xpert-vana-vanb.htmldaily1.0https://www.cepheid.com/it-IT/tests/hai-other-infectious-diseases/xpert-mrsa-nxg.htmldaily1.0https://www.cepheid.com/it-IT/tests/hai-other-infectious-diseases/xpert-carba-r.htmldaily1.0https://www.cepheid.com/it-IT/tests/blood-virology-womens-health-sexual-health.htmldaily1.0https://www.cepheid.com/it-IT/tests/blood-virology-womens-health-sexual-health/xpert-hbv-viral-load.htmldaily1.0https://www.cepheid.com/it-IT/tests/blood-virology-womens-health-sexual-health/resistanceplusmg-flexible.htmldaily1.0https://www.cepheid.com/it-IT/tests/blood-virology-womens-health-sexual-health/xpert-xpress-gbs.htmldaily1.0https://www.cepheid.com/it-IT/tests/blood-virology-womens-health-sexual-health/xpert-ct-ng.htmldaily1.0https://www.cepheid.com/it-IT/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-qual-xc.htmldaily1.0https://www.cepheid.com/it-IT/tests/blood-virology-womens-health-sexual-health/xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/it-IT/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-viral-load-xc.htmldaily1.0https://www.cepheid.com/it-IT/tests/blood-virology-womens-health-sexual-health/xpert-tv.htmldaily1.0https://www.cepheid.com/it-IT/tests/blood-virology-womens-health-sexual-health/xpert-hpv-v2.htmldaily1.0https://www.cepheid.com/it-IT/tests/blood-virology-womens-health-sexual-health/xpert-hcv-viral-load.htmldaily1.0https://www.cepheid.com/it-IT/tests/tb-emerging-infectious-diseases.htmldaily1.0https://www.cepheid.com/it-IT/tests/tb-emerging-infectious-diseases/xpert-mtb-xdr.htmldaily1.0https://www.cepheid.com/it-IT/tests/tb-emerging-infectious-diseases/xpert-mtb-rif-ultra.htmldaily1.0https://www.cepheid.com/it-IT/tests/oncology-human-genetics.htmldaily1.0https://www.cepheid.com/it-IT/tests/oncology-human-genetics/expert-bladder-cancer-monitor.htmldaily1.0https://www.cepheid.com/it-IT/tests/oncology-human-genetics/xpert-fii-fv.htmldaily1.0https://www.cepheid.com/it-IT/tests/oncology-human-genetics/xpert-bcr-abl-ultra-p190.htmldaily1.0https://www.cepheid.com/it-IT/tests/oncology-human-genetics/xpert-breast-cancer-strat4.htmldaily1.0https://www.cepheid.com/it-IT/tests/oncology-human-genetics/xpert-bladder-cancer-detection.htmldaily1.0https://www.cepheid.com/it-IT/tests/oncology-human-genetics/xpert-bcr-abl-ultra.htmldaily1.0https://www.cepheid.com/it-IT/tests/oncology-human-genetics/xpert-npm1-mutation.htmldaily1.0https://www.cepheid.com/it-IT/systems.htmldaily1.0https://www.cepheid.com/it-IT/systems/genexpert-family-of-systems.htmldaily1.0https://www.cepheid.com/it-IT/systems/genexpert-family-of-systems/genexpert-system.htmldaily1.0https://www.cepheid.com/it-IT/systems/genexpert-family-of-systems/genexpert-infinity.htmldaily1.0https://www.cepheid.com/it-IT/systems/genexpert-software.htmldaily1.0https://www.cepheid.com/it-IT/systems/genexpert-software/gx-software.htmldaily1.0https://www.cepheid.com/it-IT/systems/genexpert-software/xpertise-software.htmldaily1.0https://www.cepheid.com/it-IT/systems/connectivity.htmldaily1.0https://www.cepheid.com/it-IT/systems/connectivity/cepheid-c360.htmldaily1.0https://www.cepheid.com/it-IT/systems/connectivity/interface-capabilities.htmldaily1.0https://www.cepheid.com/it-IT/systems/data-processing-agreement.htmldaily1.0https://www.cepheid.com/it-IT/systems/partner-communities.htmldaily1.0https://www.cepheid.com/it-IT/systems/business-associates-agreement.htmldaily1.0https://www.cepheid.com/it-IT/solutions.htmldaily1.0https://www.cepheid.com/it-IT/solutions/global-access.htmldaily1.0https://www.cepheid.com/it-IT/solutions/global-access/eligibility-and-pricing.htmldaily1.0https://www.cepheid.com/it-IT/solutions/testing-everywhere.htmldaily1.0https://www.cepheid.com/it-IT/solutions/antibiotic-stewardship.htmldaily1.0https://www.cepheid.com/it-IT/solutions/customized-testing-institution.htmldaily1.0https://www.cepheid.com/it-IT/solutions/knowing-more-matters.htmldaily1.0https://www.cepheid.com/it-IT/solutions/knowing-more-matters/pcr-vs-antigen.htmldaily1.0https://www.cepheid.com/it-IT/solutions/knowing-more-matters/covid-flu-rsv.htmldaily1.0https://www.cepheid.com/it-IT/impact/global-access/everything-about-our-fight-against-tb.htmldaily1.0https://www.cepheid.com/it-IT/impact/global-access/eligibility-and-pricing.htmldaily1.0https://www.cepheid.com/it-IT/impact/customized-testing-institution.htmldaily1.0https://www.cepheid.com/it-IT/impact/better-testing-everywhere.htmldaily1.0https://www.cepheid.com/it-IT/insights.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/all-posts.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/respiratory-health.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/respiratory-health/2024/09/proactive-surveillance-to-ensure-broad-flu-strain-detection.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/respiratory-health/2024/09/emerging-evolving-respiratory-viruses-test-design-matters.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/respiratory-health/2024/09/the-genexpert-xpress-system-can-change-your-pediatric-practice.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/respiratory-health/2024/09/Norwegian-ED-improves-Resource-Management-with-Rapid-PCR-Testing.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/respiratory-health/2024/09/key-steps-pandemic-preparedness.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/respiratory-health/2025/01/what-does-it-mean-to-have-a-pandemic-ready-pcr-test.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like-ilnesses.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/respiratory-health/2025/03/in-house-pcr-testing-clinical-leaders-explore-the-ripple-effect.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/respiratory-health/2025/04/real-world-clinical-impact-of-in-house-pcr-testing.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/respiratory-health/2025/04/what-is-the-difference-between-pcr-and-antigen-testing.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/respiratory-health/2025/05/a-quick-primer-on-the-adlm-guidance-on-respiratory-virus-testing.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/respiratory-health/2025/09/revolutionizing-respiratory-care-the-power-of-rapid-molecular-testing.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/respiratory-health/2025/09/antigen-testing-vs-pcr-less-haste-more-speed-please.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/respiratory-health/2025/09/the-time-for-widespread-adoption-of-mdx-testing-for-gas-pharyngi.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/respiratory-health/2025/11/why-test-type-matters-pcr-vs-antigen-in-outpatient-respiratory-care.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/respiratory-health/2025/11/transforming-respiratory-tnfection-diagnosis-embracing-molecular-innovation-clinical-practice1.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/respiratory-health/2026/01/staying-ahead-of-influenza.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/respiratory-health/2026/02/revolutionizing-rheumatic-heart-disease-prevention.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2024/09/accelerating-the-pace-for-hep-c-elimination-in-the-us.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2024/09/can-molecular-tests-revolutionize-tuberculosis-control.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2024/09/near-patient-testing-for-hep-c-xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2024/09/danish-hcv-testing-program-improves-patient-management-and-access.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2024/09/faster-prison-testing-for-hcv-drastically-improves-treatment-in-the-uk.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2024/09/innovative-POC-testing-shortens-time-between-testing-and-treatment.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2024/09/finnish-hospital-improves-care-for-expectant-mothers-with-gbs-pcr-screening.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2024/09/a-not-for-profit-in-vietnam-fights-to-end-tuberculosis.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2024/09/cepheid-expands-in-india-to-support-global-efforts-to-fight-tb.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2024/09/covid-19-and-tuberculosis-testing-in-south-africa.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2024/09/cepheid-supports-the-international-mpox-emergency-declared-august-2024.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2024/10/hpv-testing-south-african-clinic-may-prevent-cervical-cancer.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2024/12/strides-toward-early-infant-diagnosis-for-hiv-elimination-in-sou.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2025/02/common-misconceptions-about-vaginitis.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2025/05/revisiting-bacterial-vaginosis-evidence-for-sexual-transmission.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2025/05/a-breakthrough-in-hcv-elimination--how-hcv-point-of-care-rna-tes.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2025/05/decentralising-diagnostics-bringing-patient-centred-testing-closer-to-communities.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2025/05/integration-of-poc-viral-diagnostics-with-substance-use-disorder-treatment-to-improve-hepatitis-c-nfection-outcomes.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2025/06/womens-health-testing-advantages-of-same-day-diagnosis-and-treatment.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2025/04/tuberculosis-staying-one-step-ahead.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2025/04/how-three-countries-are-fighting-back-against-tuberculosis.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2025/04/a-mdr-tb-survivor-in-india-shares-her-remarkable-story.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2025/07/five-surprising-stats-that-reveal-the-hidden-burden-of-vaginitis.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2025/07/5-ways-vaginitis-treatment-goes-wrong-and-how-better-testing-can-fix-It.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2025/03/the-fight-to-end-tuberculosis-in-pakistan.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2025/03/devasena-gnanashanmugam-discusses-cepheids-global-access-program.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2025/03/desmond-tutu-foundation-reduces-impact-of-hiv-and-tb.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2025/03/tuberculosis-care-and-treatment-in-the-republic-of-indonesia.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2025/03/finding-missing-tuberculosis-tb-cases-philippines-need-for-speed.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2025/03/a-decade-of-health-and-economic-benefits-infographic.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2025/03/state-tb-in-us-overlooked-opportunity-better-results.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2025/03/fighting-tb-everything-10-years-of-impact-in-south-africa.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2025/09/in-memory-of-john-bishop-a-visionary-leader-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2025/08/kentucky-viral-hepatitis-treatment-projects-mission-to-eradicate-hcv.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2025/08/the-state-of-vaginitis-testing-in-the-us.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2025/08/improving-vaginitis-care-through-better-diagnostics.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2025/12/wecare-humanitarian-medical-mission.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2025/10/time-to-act-stopping-group-b-strep-infections-in-newborn-babies.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2025/10/real-user-experiences-with-xpert-xpress-mvp-oint-of-care-test.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2026/02/advancing-pandemic-preparedness-through-public-private-collaboration.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/community-and-global-health/2026/02/hepatitis-c-elimination-in-the-us-is-within-reach-experts-report.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/tech-disease-trends.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/tech-disease-trends/2024/09/candida-auris--rising-threat-and-future-implications.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/tech-disease-trends/2024/09/discussing-pharma-clinical-trials-utilizing-poc-diagnostics.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/tech-disease-trends/2024/09/poc-testing-increases-the-efficiency-of-patient-management-in-the-ed.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/tech-disease-trends/2024/10/dave-persing-legacy-and-leadership-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/tech-disease-trends/2024/11/invasive-group-streptococcal-disease.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/tech-disease-trends/2024/11/what-is-pcr--understanding-the-magic.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/tech-disease-trends/2024/11/decentralized-pcr-testing-and-the-quadruple-aim-insights-for-health-systems.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/tech-disease-trends/2025/01/how-a-cepheid-molecular-test-is-made.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/tech-disease-trends/2025/04/standardization-of-pcr-testing-across-healthcare-testing-sites.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/tech-disease-trends/2025/06/innovation-in-times-of-need-cepheids-legacy-of-outbreak-response.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/tech-disease-trends/2025/07/celebrating-the-cepheid-bike-where-art-meets-innovation.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/tech-disease-trends/2025/09/cepheid-advances-innovation-and-reach-with-key-partnerships.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/tech-disease-trends/2025/10/learn-about-cepheid-system-innovation.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/tech-disease-trends/2025/11/multiplex-with-meaning--cepheid-s-smart-approach-to-molecular-di.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/antimicrobial-stewardship.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/antimicrobial-stewardship/2024/09/a-public-health-dialogue-on-antibiotic-resistance-surveillance.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/antimicrobial-stewardship/2024/09/mortality-associated-with-carbapenem-resistant-gram-negative-infections.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/antimicrobial-stewardship/2024/09/decentralized-testing-for-the-surveillance-of-hospital-acquired-infections.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/antimicrobial-stewardship/2024/09/rapid-mrsa-screening-of-ortho-trauma-patients-improves-experience.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/antimicrobial-stewardship/2024/09/pcr-screening-at-a-british-hospital-enables-timely-infection-control.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/antimicrobial-stewardship/2024/10/fleming-initiative-cepheid-announce-partnership-tackle-amr.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/antimicrobial-stewardship/2024/10/link-between-colonization-multi-drug-resistant-infection.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/antimicrobial-stewardship/2024/12/point-of-care-testing-emergency-department-faster-decision-making-halle.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-schulz.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/antimicrobial-stewardship/2025/05/antimicrobial-and-diagnostic-stewardship-frost-and-sullivan-visual-whitepaper.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/antimicrobial-stewardship/2025/08/industry-voices-time-to-rethink-our-approach-to-using-modern-medicine.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/antimicrobial-stewardship/2025/09/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/antimicrobial-stewardship/2025/10/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/antimicrobial-stewardship/2025/11/vanessa-carter-s-journey--inspiring-action-against-amr.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/antimicrobial-stewardship/2025/11/advancing-antimicrobial-stewardship-in-small-and-rural-hospital.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/expert-spotlight.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/expert-spotlight/2025/10/expert-spotlight--michael-loeffelholz.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--devasena-gnanashanmugam-vice-president--me.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--jennifer-rakeman-cagno-senior-director--sc.htmldaily1.0https://www.cepheid.com/it-IT/insights/insight-hub/expert-spotlight/2026/02/expert-spotlight-jordan-chase.htmldaily1.0https://www.cepheid.com/it-IT/insights/webinars.htmldaily1.0https://www.cepheid.com/it-IT/insights/resources.htmldaily1.0https://www.cepheid.com/it-IT/support.htmldaily1.0https://www.cepheid.com/it-IT/support/ivdr-update.htmldaily1.0https://www.cepheid.com/it-IT/support/contact-us.htmldaily1.0https://www.cepheid.com/it-IT/about.htmldaily1.0https://www.cepheid.com/it-IT/about/mission-history.htmldaily1.0https://www.cepheid.com/it-IT/about/leadership.htmldaily1.0https://www.cepheid.com/it-IT/about/leadership/vitor-rocha.htmldaily1.0https://www.cepheid.com/it-IT/about/leadership/laurent-bellon.htmldaily1.0https://www.cepheid.com/it-IT/about/leadership/anette-engelhardt.htmldaily1.0https://www.cepheid.com/it-IT/about/leadership/peter-farrell.htmldaily1.0https://www.cepheid.com/it-IT/about/leadership/deborah-gonyea.htmldaily1.0https://www.cepheid.com/it-IT/about/leadership/nichole-halsey.htmldaily1.0https://www.cepheid.com/it-IT/about/leadership/luben-li.htmldaily1.0https://www.cepheid.com/it-IT/about/leadership/luke-maitland.htmldaily1.0https://www.cepheid.com/it-IT/about/leadership/david-h-persing.htmldaily1.0https://www.cepheid.com/it-IT/about/leadership/ammar-qadan.htmldaily1.0https://www.cepheid.com/it-IT/about/leadership/charles-mwangi.htmldaily1.0https://www.cepheid.com/it-IT/about/leadership/samson-wu.htmldaily1.0https://www.cepheid.com/it-IT/about/leadership/anupama-mokkapati.htmldaily1.0https://www.cepheid.com/it-IT/about/leadership/traci-wicks.htmldaily1.0https://www.cepheid.com/it-IT/about/leadership/scott-campbell.htmldaily1.0https://www.cepheid.com/it-IT/about/leadership/anne-beauburn.htmldaily1.0https://www.cepheid.com/it-IT/about/leadership/patrick-harkins.htmldaily1.0https://www.cepheid.com/it-IT/about/leadership/ephraim-tsalik.htmldaily1.0https://www.cepheid.com/it-IT/about/leadership/somesh-lalithraj.htmldaily1.0https://www.cepheid.com/it-IT/about/leadership/connie-savor.htmldaily1.0https://www.cepheid.com/it-IT/about/sustainability.htmldaily1.0https://www.cepheid.com/it-IT/about/sustainability/environmental-sustainability.htmldaily1.0https://www.cepheid.com/it-IT/about/sustainability/product-stewardship.htmldaily1.0https://www.cepheid.com/it-IT/about/sustainability/conflict-materials.htmldaily1.0https://www.cepheid.com/it-IT/about/policies-reports.htmldaily1.0https://www.cepheid.com/it-IT/about/policies-reports/italy-code-of-ethics.htmldaily1.0https://www.cepheid.com/it-IT/about/business-development-opportunities.htmldaily1.0https://www.cepheid.com/it-IT/about/events.htmldaily1.0https://www.cepheid.com/it-IT/about/innovation-form.htmldaily1.0https://www.cepheid.com/it-IT/about/innovation-form/unsolicited-submission-agreement.htmldaily1.0https://www.cepheid.com/it-IT/about/sars-cov-2-test-development-information.htmldaily1.0https://www.cepheid.com/it-IT/about/sars-cov-2-product-resources.htmldaily1.0https://www.cepheid.com/it-IT/contact/select-info-path.htmldaily1.0https://www.cepheid.com/it-IT/contact/messages/thank-you.htmldaily1.0https://www.cepheid.com/it-IT/contact/messages/thank-you-patient-pathways.htmldaily1.0https://www.cepheid.com/it-IT/contact/messages/thank-you-patient-pathways-fr.htmldaily1.0https://www.cepheid.com/it-IT/contact/messages/thank-you-patient-pathways-de.htmldaily1.0https://www.cepheid.com/it-IT/contact/messages/thank-you-patient-pathways-it.htmldaily1.0https://www.cepheid.com/it-IT/contact/messages/thank-you-patient-pathways-sp.htmldaily1.0https://www.cepheid.com/it-IT/contact/messages/thank-you-patient-pathways-pl.htmldaily1.0https://www.cepheid.com/it-IT/contact/messages/thank-you-patient-pathways-pt.htmldaily1.0https://www.cepheid.com/it-IT/contact/request-cd-international.htmldaily1.0https://www.cepheid.com/it-IT/personas/laboratory-professionals.htmldaily1.0https://www.cepheid.com/it-IT/personas/healthcare-professsional.htmldaily1.0https://www.cepheid.com/it-IT/personas/health-system-administrators.htmldaily1.0https://www.cepheid.com/it-IT/legal/privacy.htmldaily1.0https://www.cepheid.com/it-IT/legal/terms-of-use.htmldaily1.0https://www.cepheid.com/it-IT/legal/product-security-updates.htmldaily1.0https://www.cepheid.com/it-IT/legal/terms-of-sale.htmldaily1.0https://www.cepheid.com/it-IT/legal/trademarks.htmldaily1.0https://www.cepheid.com/it-IT/legal/cookies-notice.htmldaily1.0https://www.cepheid.com/it-IT/campaigns/2020-emea-renewed-messaging/french/patient-pathways.htmldaily1.0https://www.cepheid.com/it-IT/campaigns/2020-emea-renewed-messaging/german/patient-pathways.htmldaily1.0https://www.cepheid.com/it-IT/campaigns/2020-emea-renewed-messaging/italian/patient-pathways.htmldaily1.0https://www.cepheid.com/it-IT/campaigns/2020-emea-renewed-messaging/portuguese/patient-pathways.htmldaily1.0https://www.cepheid.com/it-IT/campaigns/2020-emea-renewed-messaging/polish/patient-pathways.htmldaily1.0https://www.cepheid.com/it-IT/campaigns/india/cepheid-india.htmldaily1.0https://www.cepheid.com/it-IT/campaigns/india/india-submission.htmldaily1.0https://www.cepheid.com/it-IT/campaigns/india/cepheid-india-display.htmldaily1.0https://www.cepheid.com/it-IT/campaigns/india/cepheid-india-bangladesh.htmldaily1.0https://www.cepheid.com/it-IT/campaigns/pcr-plus.htmldaily1.0https://www.cepheid.com/it-IT/coronavirus-portfolio.htmldaily1.0https://www.cepheid.com/pl-PL.htmldaily1.0https://www.cepheid.com/pl-PL/tests.htmldaily1.0https://www.cepheid.com/pl-PL/tests/respiratory.htmldaily1.0https://www.cepheid.com/pl-PL/tests/respiratory/xpert-xpress-strep-a.htmldaily1.0https://www.cepheid.com/pl-PL/tests/respiratory/xpert-xpress-cov-2-plus.htmldaily1.0https://www.cepheid.com/pl-PL/tests/respiratory/xpert-xpress-flu-rsv.htmldaily1.0https://www.cepheid.com/pl-PL/tests/respiratory/xpert-xpress-cov-2-flu-rsv-plus.htmldaily1.0https://www.cepheid.com/pl-PL/tests/hai-other-infectious-diseases.htmldaily1.0https://www.cepheid.com/pl-PL/tests/hai-other-infectious-diseases/xpert-sa-nasal-complete.htmldaily1.0https://www.cepheid.com/pl-PL/tests/hai-other-infectious-diseases/xpert-mrsa-sa-ssti.htmldaily1.0https://www.cepheid.com/pl-PL/tests/hai-other-infectious-diseases/xpert-c-difficile-bt.htmldaily1.0https://www.cepheid.com/pl-PL/tests/hai-other-infectious-diseases/xpert-norovirus.htmldaily1.0https://www.cepheid.com/pl-PL/tests/hai-other-infectious-diseases/xpert-mrsa-sa-blood-culture.htmldaily1.0https://www.cepheid.com/pl-PL/tests/hai-other-infectious-diseases/xpert-vana-vanb.htmldaily1.0https://www.cepheid.com/pl-PL/tests/hai-other-infectious-diseases/xpert-mrsa-nxg.htmldaily1.0https://www.cepheid.com/pl-PL/tests/hai-other-infectious-diseases/xpert-carba-r.htmldaily1.0https://www.cepheid.com/pl-PL/tests/blood-virology-womens-health-sexual-health.htmldaily1.0https://www.cepheid.com/pl-PL/tests/blood-virology-womens-health-sexual-health/xpert-hbv-viral-load.htmldaily1.0https://www.cepheid.com/pl-PL/tests/blood-virology-womens-health-sexual-health/resistanceplusmg-flexible.htmldaily1.0https://www.cepheid.com/pl-PL/tests/blood-virology-womens-health-sexual-health/xpert-xpress-gbs.htmldaily1.0https://www.cepheid.com/pl-PL/tests/blood-virology-womens-health-sexual-health/xpert-ct-ng.htmldaily1.0https://www.cepheid.com/pl-PL/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-qual-xc.htmldaily1.0https://www.cepheid.com/pl-PL/tests/blood-virology-womens-health-sexual-health/xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/pl-PL/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-viral-load-xc.htmldaily1.0https://www.cepheid.com/pl-PL/tests/blood-virology-womens-health-sexual-health/xpert-tv.htmldaily1.0https://www.cepheid.com/pl-PL/tests/blood-virology-womens-health-sexual-health/xpert-hpv-v2.htmldaily1.0https://www.cepheid.com/pl-PL/tests/blood-virology-womens-health-sexual-health/xpert-hcv-viral-load.htmldaily1.0https://www.cepheid.com/pl-PL/tests/tb-emerging-infectious-diseases.htmldaily1.0https://www.cepheid.com/pl-PL/tests/tb-emerging-infectious-diseases/xpert-mtb-xdr.htmldaily1.0https://www.cepheid.com/pl-PL/tests/tb-emerging-infectious-diseases/xpert-mtb-rif-ultra.htmldaily1.0https://www.cepheid.com/pl-PL/tests/oncology-human-genetics.htmldaily1.0https://www.cepheid.com/pl-PL/tests/oncology-human-genetics/expert-bladder-cancer-monitor.htmldaily1.0https://www.cepheid.com/pl-PL/tests/oncology-human-genetics/xpert-fii-fv.htmldaily1.0https://www.cepheid.com/pl-PL/tests/oncology-human-genetics/xpert-bcr-abl-ultra-p190.htmldaily1.0https://www.cepheid.com/pl-PL/tests/oncology-human-genetics/xpert-breast-cancer-strat4.htmldaily1.0https://www.cepheid.com/pl-PL/tests/oncology-human-genetics/xpert-bladder-cancer-detection.htmldaily1.0https://www.cepheid.com/pl-PL/tests/oncology-human-genetics/xpert-bcr-abl-ultra.htmldaily1.0https://www.cepheid.com/pl-PL/tests/oncology-human-genetics/xpert-npm1-mutation.htmldaily1.0https://www.cepheid.com/pl-PL/systems.htmldaily1.0https://www.cepheid.com/pl-PL/systems/genexpert-family-of-systems.htmldaily1.0https://www.cepheid.com/pl-PL/systems/genexpert-family-of-systems/genexpert-system.htmldaily1.0https://www.cepheid.com/pl-PL/systems/genexpert-family-of-systems/genexpert-infinity.htmldaily1.0https://www.cepheid.com/pl-PL/systems/genexpert-software.htmldaily1.0https://www.cepheid.com/pl-PL/systems/genexpert-software/gx-software.htmldaily1.0https://www.cepheid.com/pl-PL/systems/genexpert-software/xpertise-software.htmldaily1.0https://www.cepheid.com/pl-PL/systems/connectivity.htmldaily1.0https://www.cepheid.com/pl-PL/systems/connectivity/cepheid-c360.htmldaily1.0https://www.cepheid.com/pl-PL/systems/connectivity/interface-capabilities.htmldaily1.0https://www.cepheid.com/pl-PL/systems/data-processing-agreement.htmldaily1.0https://www.cepheid.com/pl-PL/systems/partner-communities.htmldaily1.0https://www.cepheid.com/pl-PL/systems/business-associates-agreement.htmldaily1.0https://www.cepheid.com/pl-PL/solutions.htmldaily1.0https://www.cepheid.com/pl-PL/solutions/global-access.htmldaily1.0https://www.cepheid.com/pl-PL/solutions/global-access/eligibility-and-pricing.htmldaily1.0https://www.cepheid.com/pl-PL/solutions/testing-everywhere.htmldaily1.0https://www.cepheid.com/pl-PL/solutions/antibiotic-stewardship.htmldaily1.0https://www.cepheid.com/pl-PL/solutions/customized-testing-institution.htmldaily1.0https://www.cepheid.com/pl-PL/solutions/knowing-more-matters.htmldaily1.0https://www.cepheid.com/pl-PL/solutions/knowing-more-matters/pcr-vs-antigen.htmldaily1.0https://www.cepheid.com/pl-PL/solutions/knowing-more-matters/covid-flu-rsv.htmldaily1.0https://www.cepheid.com/pl-PL/insights.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/all-posts.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/respiratory-health.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/respiratory-health/2024/09/proactive-surveillance-to-ensure-broad-flu-strain-detection.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/respiratory-health/2024/09/emerging-evolving-respiratory-viruses-test-design-matters.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/respiratory-health/2024/09/the-genexpert-xpress-system-can-change-your-pediatric-practice.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/respiratory-health/2024/09/Norwegian-ED-improves-Resource-Management-with-Rapid-PCR-Testing.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/respiratory-health/2024/09/key-steps-pandemic-preparedness.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/respiratory-health/2025/01/what-does-it-mean-to-have-a-pandemic-ready-pcr-test.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like-ilnesses.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/respiratory-health/2025/03/in-house-pcr-testing-clinical-leaders-explore-the-ripple-effect.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/respiratory-health/2025/04/real-world-clinical-impact-of-in-house-pcr-testing.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/respiratory-health/2025/04/what-is-the-difference-between-pcr-and-antigen-testing.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/respiratory-health/2025/05/a-quick-primer-on-the-adlm-guidance-on-respiratory-virus-testing.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/respiratory-health/2025/09/revolutionizing-respiratory-care-the-power-of-rapid-molecular-testing.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/respiratory-health/2025/09/antigen-testing-vs-pcr-less-haste-more-speed-please.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/respiratory-health/2025/09/the-time-for-widespread-adoption-of-mdx-testing-for-gas-pharyngi.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/respiratory-health/2025/11/why-test-type-matters-pcr-vs-antigen-in-outpatient-respiratory-care.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/respiratory-health/2025/11/transforming-respiratory-tnfection-diagnosis-embracing-molecular-innovation-clinical-practice1.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/respiratory-health/2026/01/staying-ahead-of-influenza.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/respiratory-health/2026/02/revolutionizing-rheumatic-heart-disease-prevention.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2024/09/accelerating-the-pace-for-hep-c-elimination-in-the-us.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2024/09/can-molecular-tests-revolutionize-tuberculosis-control.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2024/09/near-patient-testing-for-hep-c-xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2024/09/danish-hcv-testing-program-improves-patient-management-and-access.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2024/09/faster-prison-testing-for-hcv-drastically-improves-treatment-in-the-uk.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2024/09/innovative-POC-testing-shortens-time-between-testing-and-treatment.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2024/09/finnish-hospital-improves-care-for-expectant-mothers-with-gbs-pcr-screening.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2024/09/a-not-for-profit-in-vietnam-fights-to-end-tuberculosis.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2024/09/cepheid-expands-in-india-to-support-global-efforts-to-fight-tb.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2024/09/covid-19-and-tuberculosis-testing-in-south-africa.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2024/09/cepheid-supports-the-international-mpox-emergency-declared-august-2024.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2024/10/hpv-testing-south-african-clinic-may-prevent-cervical-cancer.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2024/12/strides-toward-early-infant-diagnosis-for-hiv-elimination-in-sou.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2025/02/common-misconceptions-about-vaginitis.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2025/04/tuberculosis-staying-one-step-ahead.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2025/04/how-three-countries-are-fighting-back-against-tuberculosis.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2025/04/a-mdr-tb-survivor-in-india-shares-her-remarkable-story.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2025/05/revisiting-bacterial-vaginosis-evidence-for-sexual-transmission.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2025/05/a-breakthrough-in-hcv-elimination--how-hcv-point-of-care-rna-tes.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2025/05/decentralising-diagnostics-bringing-patient-centred-testing-closer-to-communities.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2025/05/integration-of-poc-viral-diagnostics-with-substance-use-disorder-treatment-to-improve-hepatitis-c-nfection-outcomes.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2025/06/womens-health-testing-advantages-of-same-day-diagnosis-and-treatment.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2025/07/five-surprising-stats-that-reveal-the-hidden-burden-of-vaginitis.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2025/07/5-ways-vaginitis-treatment-goes-wrong-and-how-better-testing-can-fix-It.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2025/03/the-fight-to-end-tuberculosis-in-pakistan.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2025/03/devasena-gnanashanmugam-discusses-cepheids-global-access-program.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2025/03/desmond-tutu-foundation-reduces-impact-of-hiv-and-tb.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2025/03/tuberculosis-care-and-treatment-in-the-republic-of-indonesia.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2025/03/finding-missing-tuberculosis-tb-cases-philippines-need-for-speed.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2025/03/a-decade-of-health-and-economic-benefits-infographic.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2025/03/state-tb-in-us-overlooked-opportunity-better-results.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2025/03/fighting-tb-everything-10-years-of-impact-in-south-africa.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2025/09/in-memory-of-john-bishop-a-visionary-leader-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2025/08/kentucky-viral-hepatitis-treatment-projects-mission-to-eradicate-hcv.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2025/08/the-state-of-vaginitis-testing-in-the-us.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2025/08/improving-vaginitis-care-through-better-diagnostics.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2025/10/time-to-act-stopping-group-b-strep-infections-in-newborn-babies.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2025/10/real-user-experiences-with-xpert-xpress-mvp-oint-of-care-test.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2025/12/wecare-humanitarian-medical-mission.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2026/02/advancing-pandemic-preparedness-through-public-private-collaboration.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/community-and-global-health/2026/02/hepatitis-c-elimination-in-the-us-is-within-reach-experts-report.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/tech-disease-trends.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/tech-disease-trends/2024/09/candida-auris--rising-threat-and-future-implications.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/tech-disease-trends/2024/09/discussing-pharma-clinical-trials-utilizing-poc-diagnostics.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/tech-disease-trends/2024/09/poc-testing-increases-the-efficiency-of-patient-management-in-the-ed.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/tech-disease-trends/2024/10/dave-persing-legacy-and-leadership-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/tech-disease-trends/2024/11/invasive-group-streptococcal-disease.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/tech-disease-trends/2024/11/what-is-pcr--understanding-the-magic.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/tech-disease-trends/2024/11/decentralized-pcr-testing-and-the-quadruple-aim-insights-for-health-systems.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/tech-disease-trends/2025/01/how-a-cepheid-molecular-test-is-made.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/tech-disease-trends/2025/04/standardization-of-pcr-testing-across-healthcare-testing-sites.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/tech-disease-trends/2025/06/innovation-in-times-of-need-cepheids-legacy-of-outbreak-response.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/tech-disease-trends/2025/07/celebrating-the-cepheid-bike-where-art-meets-innovation.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/tech-disease-trends/2025/09/cepheid-advances-innovation-and-reach-with-key-partnerships.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/tech-disease-trends/2025/10/learn-about-cepheid-system-innovation.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/tech-disease-trends/2025/11/multiplex-with-meaning--cepheid-s-smart-approach-to-molecular-di.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/antimicrobial-stewardship.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/antimicrobial-stewardship/2024/09/a-public-health-dialogue-on-antibiotic-resistance-surveillance.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/antimicrobial-stewardship/2024/09/mortality-associated-with-carbapenem-resistant-gram-negative-infections.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/antimicrobial-stewardship/2024/09/decentralized-testing-for-the-surveillance-of-hospital-acquired-infections.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/antimicrobial-stewardship/2024/09/rapid-mrsa-screening-of-ortho-trauma-patients-improves-experience.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/antimicrobial-stewardship/2024/09/pcr-screening-at-a-british-hospital-enables-timely-infection-control.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/antimicrobial-stewardship/2024/10/fleming-initiative-cepheid-announce-partnership-tackle-amr.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/antimicrobial-stewardship/2024/10/link-between-colonization-multi-drug-resistant-infection.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/antimicrobial-stewardship/2024/12/point-of-care-testing-emergency-department-faster-decision-making-halle.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-schulz.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/antimicrobial-stewardship/2025/05/antimicrobial-and-diagnostic-stewardship-frost-and-sullivan-visual-whitepaper.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/antimicrobial-stewardship/2025/08/industry-voices-time-to-rethink-our-approach-to-using-modern-medicine.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/antimicrobial-stewardship/2025/09/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/antimicrobial-stewardship/2025/10/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/antimicrobial-stewardship/2025/11/vanessa-carter-s-journey--inspiring-action-against-amr.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/antimicrobial-stewardship/2025/11/advancing-antimicrobial-stewardship-in-small-and-rural-hospital.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/expert-spotlight.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/expert-spotlight/2025/10/expert-spotlight--michael-loeffelholz.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--devasena-gnanashanmugam-vice-president--me.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--jennifer-rakeman-cagno-senior-director--sc.htmldaily1.0https://www.cepheid.com/pl-PL/insights/insight-hub/expert-spotlight/2026/02/expert-spotlight-jordan-chase.htmldaily1.0https://www.cepheid.com/pl-PL/insights/webinars.htmldaily1.0https://www.cepheid.com/pl-PL/insights/resources.htmldaily1.0https://www.cepheid.com/pl-PL/support.htmldaily1.0https://www.cepheid.com/pl-PL/support/ivdr-update.htmldaily1.0https://www.cepheid.com/pl-PL/support/contact-us.htmldaily1.0https://www.cepheid.com/pl-PL/about.htmldaily1.0https://www.cepheid.com/pl-PL/about/mission-history.htmldaily1.0https://www.cepheid.com/pl-PL/about/leadership.htmldaily1.0https://www.cepheid.com/pl-PL/about/leadership/vitor-rocha.htmldaily1.0https://www.cepheid.com/pl-PL/about/leadership/laurent-bellon.htmldaily1.0https://www.cepheid.com/pl-PL/about/leadership/anette-engelhardt.htmldaily1.0https://www.cepheid.com/pl-PL/about/leadership/peter-farrell.htmldaily1.0https://www.cepheid.com/pl-PL/about/leadership/deborah-gonyea.htmldaily1.0https://www.cepheid.com/pl-PL/about/leadership/nichole-halsey.htmldaily1.0https://www.cepheid.com/pl-PL/about/leadership/luben-li.htmldaily1.0https://www.cepheid.com/pl-PL/about/leadership/luke-maitland.htmldaily1.0https://www.cepheid.com/pl-PL/about/leadership/david-h-persing.htmldaily1.0https://www.cepheid.com/pl-PL/about/leadership/ammar-qadan.htmldaily1.0https://www.cepheid.com/pl-PL/about/leadership/charles-mwangi.htmldaily1.0https://www.cepheid.com/pl-PL/about/leadership/samson-wu.htmldaily1.0https://www.cepheid.com/pl-PL/about/leadership/anupama-mokkapati.htmldaily1.0https://www.cepheid.com/pl-PL/about/leadership/traci-wicks.htmldaily1.0https://www.cepheid.com/pl-PL/about/leadership/scott-campbell.htmldaily1.0https://www.cepheid.com/pl-PL/about/leadership/anne-beauburn.htmldaily1.0https://www.cepheid.com/pl-PL/about/leadership/patrick-harkins.htmldaily1.0https://www.cepheid.com/pl-PL/about/leadership/ephraim-tsalik.htmldaily1.0https://www.cepheid.com/pl-PL/about/leadership/somesh-lalithraj.htmldaily1.0https://www.cepheid.com/pl-PL/about/leadership/connie-savor.htmldaily1.0https://www.cepheid.com/pl-PL/about/sustainability.htmldaily1.0https://www.cepheid.com/pl-PL/about/sustainability/environmental-sustainability.htmldaily1.0https://www.cepheid.com/pl-PL/about/sustainability/product-stewardship.htmldaily1.0https://www.cepheid.com/pl-PL/about/sustainability/conflict-materials.htmldaily1.0https://www.cepheid.com/pl-PL/about/policies-reports.htmldaily1.0https://www.cepheid.com/pl-PL/about/business-development-opportunities.htmldaily1.0https://www.cepheid.com/pl-PL/about/events.htmldaily1.0https://www.cepheid.com/pl-PL/about/innovation-form.htmldaily1.0https://www.cepheid.com/pl-PL/about/innovation-form/unsolicited-submission-agreement.htmldaily1.0https://www.cepheid.com/pl-PL/about/sars-cov-2-test-development-information.htmldaily1.0https://www.cepheid.com/pl-PL/about/sars-cov-2-product-resources.htmldaily1.0https://www.cepheid.com/pl-PL/contact/select-info-path.htmldaily1.0https://www.cepheid.com/pl-PL/contact/messages/thank-you.htmldaily1.0https://www.cepheid.com/pl-PL/contact/messages/thank-you-patient-pathways.htmldaily1.0https://www.cepheid.com/pl-PL/contact/messages/thank-you-patient-pathways-fr.htmldaily1.0https://www.cepheid.com/pl-PL/contact/messages/thank-you-patient-pathways-de.htmldaily1.0https://www.cepheid.com/pl-PL/contact/messages/thank-you-patient-pathways-it.htmldaily1.0https://www.cepheid.com/pl-PL/contact/messages/thank-you-patient-pathways-sp.htmldaily1.0https://www.cepheid.com/pl-PL/contact/messages/thank-you-patient-pathways-pl.htmldaily1.0https://www.cepheid.com/pl-PL/contact/messages/thank-you-patient-pathways-pt.htmldaily1.0https://www.cepheid.com/pl-PL/contact/request-cd-international.htmldaily1.0https://www.cepheid.com/pl-PL/personas/laboratory-professionals.htmldaily1.0https://www.cepheid.com/pl-PL/personas/healthcare-professsional.htmldaily1.0https://www.cepheid.com/pl-PL/personas/health-system-administrators.htmldaily1.0https://www.cepheid.com/pl-PL/legal/privacy.htmldaily1.0https://www.cepheid.com/pl-PL/legal/terms-of-use.htmldaily1.0https://www.cepheid.com/pl-PL/legal/product-security-updates.htmldaily1.0https://www.cepheid.com/pl-PL/legal/terms-of-sale.htmldaily1.0https://www.cepheid.com/pl-PL/legal/trademarks.htmldaily1.0https://www.cepheid.com/pl-PL/legal/cookies-notice.htmldaily1.0https://www.cepheid.com/pl-PL/campaigns/2020-emea-renewed-messaging/french/patient-pathways.htmldaily1.0https://www.cepheid.com/pl-PL/campaigns/2020-emea-renewed-messaging/german/patient-pathways.htmldaily1.0https://www.cepheid.com/pl-PL/campaigns/2020-emea-renewed-messaging/italian/patient-pathways.htmldaily1.0https://www.cepheid.com/pl-PL/campaigns/2020-emea-renewed-messaging/portuguese/patient-pathways.htmldaily1.0https://www.cepheid.com/pl-PL/campaigns/2020-emea-renewed-messaging/polish/patient-pathways.htmldaily1.0https://www.cepheid.com/pl-PL/campaigns/india/cepheid-india.htmldaily1.0https://www.cepheid.com/pl-PL/campaigns/india/india-submission.htmldaily1.0https://www.cepheid.com/pl-PL/campaigns/india/cepheid-india-display.htmldaily1.0https://www.cepheid.com/pl-PL/campaigns/india/cepheid-india-bangladesh.htmldaily1.0https://www.cepheid.com/pl-PL/campaigns/pcr-plus.htmldaily1.0https://www.cepheid.com/pl-PL/coronavirus-portfolio.htmldaily1.0https://www.cepheid.com/pt-PT.htmldaily1.0https://www.cepheid.com/pt-PT/tests.htmldaily1.0https://www.cepheid.com/pt-PT/tests/respiratory.htmldaily1.0https://www.cepheid.com/pt-PT/tests/respiratory/xpert-xpress-strep-a.htmldaily1.0https://www.cepheid.com/pt-PT/tests/respiratory/xpert-xpress-cov-2-plus.htmldaily1.0https://www.cepheid.com/pt-PT/tests/respiratory/xpert-xpress-flu-rsv.htmldaily1.0https://www.cepheid.com/pt-PT/tests/respiratory/xpert-xpress-cov-2-flu-rsv-plus.htmldaily1.0https://www.cepheid.com/pt-PT/tests/hai-other-infectious-diseases.htmldaily1.0https://www.cepheid.com/pt-PT/tests/hai-other-infectious-diseases/xpert-sa-nasal-complete.htmldaily1.0https://www.cepheid.com/pt-PT/tests/hai-other-infectious-diseases/xpert-mrsa-sa-ssti.htmldaily1.0https://www.cepheid.com/pt-PT/tests/hai-other-infectious-diseases/xpert-c-difficile-bt.htmldaily1.0https://www.cepheid.com/pt-PT/tests/hai-other-infectious-diseases/xpert-norovirus.htmldaily1.0https://www.cepheid.com/pt-PT/tests/hai-other-infectious-diseases/xpert-mrsa-sa-blood-culture.htmldaily1.0https://www.cepheid.com/pt-PT/tests/hai-other-infectious-diseases/xpert-vana-vanb.htmldaily1.0https://www.cepheid.com/pt-PT/tests/hai-other-infectious-diseases/xpert-mrsa-nxg.htmldaily1.0https://www.cepheid.com/pt-PT/tests/hai-other-infectious-diseases/xpert-carba-r.htmldaily1.0https://www.cepheid.com/pt-PT/tests/blood-virology-womens-health-sexual-health.htmldaily1.0https://www.cepheid.com/pt-PT/tests/blood-virology-womens-health-sexual-health/xpert-hbv-viral-load.htmldaily1.0https://www.cepheid.com/pt-PT/tests/blood-virology-womens-health-sexual-health/resistanceplusmg-flexible.htmldaily1.0https://www.cepheid.com/pt-PT/tests/blood-virology-womens-health-sexual-health/xpert-xpress-gbs.htmldaily1.0https://www.cepheid.com/pt-PT/tests/blood-virology-womens-health-sexual-health/xpert-ct-ng.htmldaily1.0https://www.cepheid.com/pt-PT/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-qual-xc.htmldaily1.0https://www.cepheid.com/pt-PT/tests/blood-virology-womens-health-sexual-health/xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/pt-PT/tests/blood-virology-womens-health-sexual-health/xpert-hiv-1-viral-load-xc.htmldaily1.0https://www.cepheid.com/pt-PT/tests/blood-virology-womens-health-sexual-health/xpert-tv.htmldaily1.0https://www.cepheid.com/pt-PT/tests/blood-virology-womens-health-sexual-health/xpert-hpv-v2.htmldaily1.0https://www.cepheid.com/pt-PT/tests/blood-virology-womens-health-sexual-health/xpert-hcv-viral-load.htmldaily1.0https://www.cepheid.com/pt-PT/tests/tb-emerging-infectious-diseases.htmldaily1.0https://www.cepheid.com/pt-PT/tests/tb-emerging-infectious-diseases/xpert-mtb-xdr.htmldaily1.0https://www.cepheid.com/pt-PT/tests/tb-emerging-infectious-diseases/xpert-mtb-rif-ultra.htmldaily1.0https://www.cepheid.com/pt-PT/tests/oncology-human-genetics.htmldaily1.0https://www.cepheid.com/pt-PT/tests/oncology-human-genetics/expert-bladder-cancer-monitor.htmldaily1.0https://www.cepheid.com/pt-PT/tests/oncology-human-genetics/xpert-fii-fv.htmldaily1.0https://www.cepheid.com/pt-PT/tests/oncology-human-genetics/xpert-bcr-abl-ultra-p190.htmldaily1.0https://www.cepheid.com/pt-PT/tests/oncology-human-genetics/xpert-breast-cancer-strat4.htmldaily1.0https://www.cepheid.com/pt-PT/tests/oncology-human-genetics/xpert-bladder-cancer-detection.htmldaily1.0https://www.cepheid.com/pt-PT/tests/oncology-human-genetics/xpert-bcr-abl-ultra.htmldaily1.0https://www.cepheid.com/pt-PT/tests/oncology-human-genetics/xpert-npm1-mutation.htmldaily1.0https://www.cepheid.com/pt-PT/systems.htmldaily1.0https://www.cepheid.com/pt-PT/systems/genexpert-family-of-systems.htmldaily1.0https://www.cepheid.com/pt-PT/systems/genexpert-family-of-systems/genexpert-system.htmldaily1.0https://www.cepheid.com/pt-PT/systems/genexpert-family-of-systems/genexpert-infinity.htmldaily1.0https://www.cepheid.com/pt-PT/systems/genexpert-software.htmldaily1.0https://www.cepheid.com/pt-PT/systems/genexpert-software/gx-software.htmldaily1.0https://www.cepheid.com/pt-PT/systems/genexpert-software/xpertise-software.htmldaily1.0https://www.cepheid.com/pt-PT/systems/connectivity.htmldaily1.0https://www.cepheid.com/pt-PT/systems/connectivity/cepheid-c360.htmldaily1.0https://www.cepheid.com/pt-PT/systems/connectivity/interface-capabilities.htmldaily1.0https://www.cepheid.com/pt-PT/systems/data-processing-agreement.htmldaily1.0https://www.cepheid.com/pt-PT/systems/partner-communities.htmldaily1.0https://www.cepheid.com/pt-PT/systems/business-associates-agreement.htmldaily1.0https://www.cepheid.com/pt-PT/solutions.htmldaily1.0https://www.cepheid.com/pt-PT/solutions/global-access.htmldaily1.0https://www.cepheid.com/pt-PT/solutions/global-access/eligibility-and-pricing.htmldaily1.0https://www.cepheid.com/pt-PT/solutions/testing-everywhere.htmldaily1.0https://www.cepheid.com/pt-PT/solutions/antibiotic-stewardship.htmldaily1.0https://www.cepheid.com/pt-PT/solutions/customized-testing-institution.htmldaily1.0https://www.cepheid.com/pt-PT/solutions/knowing-more-matters.htmldaily1.0https://www.cepheid.com/pt-PT/solutions/knowing-more-matters/pcr-vs-antigen.htmldaily1.0https://www.cepheid.com/pt-PT/solutions/knowing-more-matters/covid-flu-rsv.htmldaily1.0https://www.cepheid.com/pt-PT/insights.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/all-posts.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/respiratory-health.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/respiratory-health/2024/09/proactive-surveillance-to-ensure-broad-flu-strain-detection.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/respiratory-health/2024/09/emerging-evolving-respiratory-viruses-test-design-matters.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/respiratory-health/2024/09/the-genexpert-xpress-system-can-change-your-pediatric-practice.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/respiratory-health/2024/09/Norwegian-ED-improves-Resource-Management-with-Rapid-PCR-Testing.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/respiratory-health/2024/09/key-steps-pandemic-preparedness.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/respiratory-health/2025/01/what-does-it-mean-to-have-a-pandemic-ready-pcr-test.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like-ilnesses.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/respiratory-health/2025/03/in-house-pcr-testing-clinical-leaders-explore-the-ripple-effect.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/respiratory-health/2025/04/real-world-clinical-impact-of-in-house-pcr-testing.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/respiratory-health/2025/04/what-is-the-difference-between-pcr-and-antigen-testing.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/respiratory-health/2025/05/a-quick-primer-on-the-adlm-guidance-on-respiratory-virus-testing.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/respiratory-health/2025/09/revolutionizing-respiratory-care-the-power-of-rapid-molecular-testing.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/respiratory-health/2025/09/antigen-testing-vs-pcr-less-haste-more-speed-please.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/respiratory-health/2025/09/the-time-for-widespread-adoption-of-mdx-testing-for-gas-pharyngi.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/respiratory-health/2025/11/why-test-type-matters-pcr-vs-antigen-in-outpatient-respiratory-care.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/respiratory-health/2025/11/transforming-respiratory-tnfection-diagnosis-embracing-molecular-innovation-clinical-practice1.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/respiratory-health/2026/01/staying-ahead-of-influenza.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/respiratory-health/2026/02/revolutionizing-rheumatic-heart-disease-prevention.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2024/09/accelerating-the-pace-for-hep-c-elimination-in-the-us.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2024/09/can-molecular-tests-revolutionize-tuberculosis-control.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2024/09/near-patient-testing-for-hep-c-xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2024/09/danish-hcv-testing-program-improves-patient-management-and-access.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2024/09/faster-prison-testing-for-hcv-drastically-improves-treatment-in-the-uk.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2024/09/innovative-POC-testing-shortens-time-between-testing-and-treatment.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2024/09/finnish-hospital-improves-care-for-expectant-mothers-with-gbs-pcr-screening.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2024/09/a-not-for-profit-in-vietnam-fights-to-end-tuberculosis.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2024/09/cepheid-expands-in-india-to-support-global-efforts-to-fight-tb.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2024/09/covid-19-and-tuberculosis-testing-in-south-africa.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2024/09/cepheid-supports-the-international-mpox-emergency-declared-august-2024.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2024/10/hpv-testing-south-african-clinic-may-prevent-cervical-cancer.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2024/12/strides-toward-early-infant-diagnosis-for-hiv-elimination-in-sou.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2025/02/common-misconceptions-about-vaginitis.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2025/05/revisiting-bacterial-vaginosis-evidence-for-sexual-transmission.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2025/05/a-breakthrough-in-hcv-elimination--how-hcv-point-of-care-rna-tes.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2025/05/decentralising-diagnostics-bringing-patient-centred-testing-closer-to-communities.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2025/05/integration-of-poc-viral-diagnostics-with-substance-use-disorder-treatment-to-improve-hepatitis-c-nfection-outcomes.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2025/06/womens-health-testing-advantages-of-same-day-diagnosis-and-treatment.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2025/04/tuberculosis-staying-one-step-ahead.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2025/04/how-three-countries-are-fighting-back-against-tuberculosis.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2025/04/a-mdr-tb-survivor-in-india-shares-her-remarkable-story.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2025/07/five-surprising-stats-that-reveal-the-hidden-burden-of-vaginitis.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2025/07/5-ways-vaginitis-treatment-goes-wrong-and-how-better-testing-can-fix-It.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2025/03/the-fight-to-end-tuberculosis-in-pakistan.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2025/03/devasena-gnanashanmugam-discusses-cepheids-global-access-program.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2025/03/desmond-tutu-foundation-reduces-impact-of-hiv-and-tb.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2025/03/tuberculosis-care-and-treatment-in-the-republic-of-indonesia.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2025/03/finding-missing-tuberculosis-tb-cases-philippines-need-for-speed.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2025/03/a-decade-of-health-and-economic-benefits-infographic.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2025/03/state-tb-in-us-overlooked-opportunity-better-results.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2025/03/fighting-tb-everything-10-years-of-impact-in-south-africa.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2025/09/in-memory-of-john-bishop-a-visionary-leader-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2025/12/wecare-humanitarian-medical-mission.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2025/10/time-to-act-stopping-group-b-strep-infections-in-newborn-babies.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2025/10/real-user-experiences-with-xpert-xpress-mvp-oint-of-care-test.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2025/08/kentucky-viral-hepatitis-treatment-projects-mission-to-eradicate-hcv.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2025/08/the-state-of-vaginitis-testing-in-the-us.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2025/08/improving-vaginitis-care-through-better-diagnostics.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2026/02/advancing-pandemic-preparedness-through-public-private-collaboration.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/community-and-global-health/2026/02/hepatitis-c-elimination-in-the-us-is-within-reach-experts-report.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/tech-disease-trends.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/tech-disease-trends/2024/09/candida-auris--rising-threat-and-future-implications.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/tech-disease-trends/2024/09/discussing-pharma-clinical-trials-utilizing-poc-diagnostics.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/tech-disease-trends/2024/09/poc-testing-increases-the-efficiency-of-patient-management-in-the-ed.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/tech-disease-trends/2024/10/dave-persing-legacy-and-leadership-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/tech-disease-trends/2024/11/invasive-group-streptococcal-disease.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/tech-disease-trends/2024/11/what-is-pcr--understanding-the-magic.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/tech-disease-trends/2024/11/decentralized-pcr-testing-and-the-quadruple-aim-insights-for-health-systems.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/tech-disease-trends/2025/01/how-a-cepheid-molecular-test-is-made.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct-.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/tech-disease-trends/2025/04/standardization-of-pcr-testing-across-healthcare-testing-sites.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/tech-disease-trends/2025/06/innovation-in-times-of-need-cepheids-legacy-of-outbreak-response.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/tech-disease-trends/2025/07/celebrating-the-cepheid-bike-where-art-meets-innovation.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/tech-disease-trends/2025/09/cepheid-advances-innovation-and-reach-with-key-partnerships.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/tech-disease-trends/2025/10/learn-about-cepheid-system-innovation.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/tech-disease-trends/2025/11/multiplex-with-meaning--cepheid-s-smart-approach-to-molecular-di.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/antimicrobial-stewardship.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/antimicrobial-stewardship/2024/09/a-public-health-dialogue-on-antibiotic-resistance-surveillance.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/antimicrobial-stewardship/2024/09/mortality-associated-with-carbapenem-resistant-gram-negative-infections.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/antimicrobial-stewardship/2024/09/decentralized-testing-for-the-surveillance-of-hospital-acquired-infections.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/antimicrobial-stewardship/2024/09/rapid-mrsa-screening-of-ortho-trauma-patients-improves-experience.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/antimicrobial-stewardship/2024/09/pcr-screening-at-a-british-hospital-enables-timely-infection-control.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/antimicrobial-stewardship/2024/10/fleming-initiative-cepheid-announce-partnership-tackle-amr.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/antimicrobial-stewardship/2024/10/link-between-colonization-multi-drug-resistant-infection.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/antimicrobial-stewardship/2024/12/point-of-care-testing-emergency-department-faster-decision-making-halle.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-shulz.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-schulz.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/antimicrobial-stewardship/2025/05/antimicrobial-and-diagnostic-stewardship-frost-and-sullivan-visual-whitepaper.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/antimicrobial-stewardship/2025/08/industry-voices-time-to-rethink-our-approach-to-using-modern-medicine.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/antimicrobial-stewardship/2025/09/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/antimicrobial-stewardship/2025/10/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/antimicrobial-stewardship/2025/11/vanessa-carter-s-journey--inspiring-action-against-amr.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/antimicrobial-stewardship/2025/11/advancing-antimicrobial-stewardship-in-small-and-rural-hospital.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/expert-spotlight.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/expert-spotlight/2025/10/expert-spotlight--michael-loeffelholz.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--devasena-gnanashanmugam-vice-president--me.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--jennifer-rakeman-cagno-senior-director--sc.htmldaily1.0https://www.cepheid.com/pt-PT/insights/insight-hub/expert-spotlight/2026/02/expert-spotlight-jordan-chase.htmldaily1.0https://www.cepheid.com/pt-PT/insights/webinars.htmldaily1.0https://www.cepheid.com/pt-PT/insights/resources.htmldaily1.0https://www.cepheid.com/pt-PT/support.htmldaily1.0https://www.cepheid.com/pt-PT/support/ivdr-update.htmldaily1.0https://www.cepheid.com/pt-PT/support/contact-us.htmldaily1.0https://www.cepheid.com/pt-PT/about.htmldaily1.0https://www.cepheid.com/pt-PT/about/mission-history.htmldaily1.0https://www.cepheid.com/pt-PT/about/leadership.htmldaily1.0https://www.cepheid.com/pt-PT/about/leadership/vitor-rocha.htmldaily1.0https://www.cepheid.com/pt-PT/about/leadership/laurent-bellon.htmldaily1.0https://www.cepheid.com/pt-PT/about/leadership/anette-engelhardt.htmldaily1.0https://www.cepheid.com/pt-PT/about/leadership/peter-farrell.htmldaily1.0https://www.cepheid.com/pt-PT/about/leadership/deborah-gonyea.htmldaily1.0https://www.cepheid.com/pt-PT/about/leadership/nichole-halsey.htmldaily1.0https://www.cepheid.com/pt-PT/about/leadership/luben-li.htmldaily1.0https://www.cepheid.com/pt-PT/about/leadership/luke-maitland.htmldaily1.0https://www.cepheid.com/pt-PT/about/leadership/david-h-persing.htmldaily1.0https://www.cepheid.com/pt-PT/about/leadership/ammar-qadan.htmldaily1.0https://www.cepheid.com/pt-PT/about/leadership/charles-mwangi.htmldaily1.0https://www.cepheid.com/pt-PT/about/leadership/samson-wu.htmldaily1.0https://www.cepheid.com/pt-PT/about/leadership/anupama-mokkapati.htmldaily1.0https://www.cepheid.com/pt-PT/about/leadership/traci-wicks.htmldaily1.0https://www.cepheid.com/pt-PT/about/leadership/scott-campbell.htmldaily1.0https://www.cepheid.com/pt-PT/about/leadership/anne-beauburn.htmldaily1.0https://www.cepheid.com/pt-PT/about/leadership/patrick-harkins.htmldaily1.0https://www.cepheid.com/pt-PT/about/leadership/ephraim-tsalik.htmldaily1.0https://www.cepheid.com/pt-PT/about/leadership/somesh-lalithraj.htmldaily1.0https://www.cepheid.com/pt-PT/about/leadership/connie-savor.htmldaily1.0https://www.cepheid.com/pt-PT/about/sustainability.htmldaily1.0https://www.cepheid.com/pt-PT/about/sustainability/environmental-sustainability.htmldaily1.0https://www.cepheid.com/pt-PT/about/sustainability/product-stewardship.htmldaily1.0https://www.cepheid.com/pt-PT/about/sustainability/conflict-materials.htmldaily1.0https://www.cepheid.com/pt-PT/about/policies-reports.htmldaily1.0https://www.cepheid.com/pt-PT/about/business-development-opportunities.htmldaily1.0https://www.cepheid.com/pt-PT/about/events.htmldaily1.0https://www.cepheid.com/pt-PT/about/innovation-form.htmldaily1.0https://www.cepheid.com/pt-PT/about/innovation-form/unsolicited-submission-agreement.htmldaily1.0https://www.cepheid.com/pt-PT/about/sars-cov-2-test-development-information.htmldaily1.0https://www.cepheid.com/pt-PT/about/sars-cov-2-product-resources.htmldaily1.0https://www.cepheid.com/pt-PT/contact/select-info-path.htmldaily1.0https://www.cepheid.com/pt-PT/contact/messages/thank-you.htmldaily1.0https://www.cepheid.com/pt-PT/contact/messages/thank-you-patient-pathways.htmldaily1.0https://www.cepheid.com/pt-PT/contact/messages/thank-you-patient-pathways-fr.htmldaily1.0https://www.cepheid.com/pt-PT/contact/messages/thank-you-patient-pathways-de.htmldaily1.0https://www.cepheid.com/pt-PT/contact/messages/thank-you-patient-pathways-it.htmldaily1.0https://www.cepheid.com/pt-PT/contact/messages/thank-you-patient-pathways-sp.htmldaily1.0https://www.cepheid.com/pt-PT/contact/messages/thank-you-patient-pathways-pl.htmldaily1.0https://www.cepheid.com/pt-PT/contact/messages/thank-you-patient-pathways-pt.htmldaily1.0https://www.cepheid.com/pt-PT/contact/request-cd-international.htmldaily1.0https://www.cepheid.com/pt-PT/personas/laboratory-professionals.htmldaily1.0https://www.cepheid.com/pt-PT/personas/healthcare-professsional.htmldaily1.0https://www.cepheid.com/pt-PT/personas/health-system-administrators.htmldaily1.0https://www.cepheid.com/pt-PT/legal/privacy.htmldaily1.0https://www.cepheid.com/pt-PT/legal/terms-of-use.htmldaily1.0https://www.cepheid.com/pt-PT/legal/product-security-updates.htmldaily1.0https://www.cepheid.com/pt-PT/legal/terms-of-sale.htmldaily1.0https://www.cepheid.com/pt-PT/legal/trademarks.htmldaily1.0https://www.cepheid.com/pt-PT/legal/cookies-notice.htmldaily1.0https://www.cepheid.com/pt-PT/campaigns/2020-emea-renewed-messaging/french/patient-pathways.htmldaily1.0https://www.cepheid.com/pt-PT/campaigns/2020-emea-renewed-messaging/german/patient-pathways.htmldaily1.0https://www.cepheid.com/pt-PT/campaigns/2020-emea-renewed-messaging/italian/patient-pathways.htmldaily1.0https://www.cepheid.com/pt-PT/campaigns/2020-emea-renewed-messaging/portuguese/patient-pathways.htmldaily1.0https://www.cepheid.com/pt-PT/campaigns/2020-emea-renewed-messaging/polish/patient-pathways.htmldaily1.0https://www.cepheid.com/pt-PT/campaigns/india/cepheid-india.htmldaily1.0https://www.cepheid.com/pt-PT/campaigns/india/india-submission.htmldaily1.0https://www.cepheid.com/pt-PT/campaigns/india/cepheid-india-display.htmldaily1.0https://www.cepheid.com/pt-PT/campaigns/india/cepheid-india-bangladesh.htmldaily1.0https://www.cepheid.com/pt-PT/campaigns/pcr-plus.htmldaily1.0https://www.cepheid.com/pt-PT/coronavirus-portfolio.htmldaily1.0https://www.cepheid.com/en-KR.htmldaily1.0https://www.cepheid.com/en-KR/tests.htmldaily1.0https://www.cepheid.com/en-KR/tests/respiratory.htmldaily1.0https://www.cepheid.com/en-KR/tests/respiratory/xpert-xpress-cov-2-plus.htmldaily1.0https://www.cepheid.com/en-KR/tests/respiratory/xpert-xpress-cov-2-flu-rsv-plus.htmldaily1.0https://www.cepheid.com/en-KR/tests/hai-other-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-KR/tests/hai-other-infectious-diseases/xpert-sa-nasal-complete.htmldaily1.0https://www.cepheid.com/en-KR/tests/hai-other-infectious-diseases/xpert-mrsa-sa-blood-culture.htmldaily1.0https://www.cepheid.com/en-KR/tests/blood-virology-womens-health-sexual-health.htmldaily1.0https://www.cepheid.com/en-KR/tests/blood-virology-womens-health-sexual-health/resistanceplusmg-flexible.htmldaily1.0https://www.cepheid.com/en-KR/tests/blood-virology-womens-health-sexual-health/xpert-ct-ng.htmldaily1.0https://www.cepheid.com/en-KR/tests/blood-virology-womens-health-sexual-health/xpert-hpv-v2.htmldaily1.0https://www.cepheid.com/en-KR/tests/tb-emerging-infectious-diseases.htmldaily1.0https://www.cepheid.com/en-KR/tests/oncology-human-genetics.htmldaily1.0https://www.cepheid.com/en-KR/systems.htmldaily1.0https://www.cepheid.com/en-KR/systems/genexpert-family-of-systems.htmldaily1.0https://www.cepheid.com/en-KR/systems/genexpert-family-of-systems/genexpert-system.htmldaily1.0https://www.cepheid.com/en-KR/systems/genexpert-family-of-systems/genexpert-infinity.htmldaily1.0https://www.cepheid.com/en-KR/systems/genexpert-software.htmldaily1.0https://www.cepheid.com/en-KR/systems/genexpert-software/gx-software.htmldaily1.0https://www.cepheid.com/en-KR/systems/genexpert-software/xpertise-software.htmldaily1.0https://www.cepheid.com/en-KR/systems/connectivity.htmldaily1.0https://www.cepheid.com/en-KR/systems/connectivity/cepheid-c360.htmldaily1.0https://www.cepheid.com/en-KR/systems/connectivity/interface-capabilities.htmldaily1.0https://www.cepheid.com/en-KR/systems/data-processing-agreement.htmldaily1.0https://www.cepheid.com/en-KR/systems/partner-communities.htmldaily1.0https://www.cepheid.com/en-KR/systems/business-associates-agreement.htmldaily1.0https://www.cepheid.com/en-KR/solutions.htmldaily1.0https://www.cepheid.com/en-KR/solutions/global-access.htmldaily1.0https://www.cepheid.com/en-KR/solutions/global-access/eligibility-and-pricing.htmldaily1.0https://www.cepheid.com/en-KR/solutions/testing-everywhere.htmldaily1.0https://www.cepheid.com/en-KR/solutions/antibiotic-stewardship.htmldaily1.0https://www.cepheid.com/en-KR/solutions/customized-testing-institution.htmldaily1.0https://www.cepheid.com/en-KR/solutions/knowing-more-matters.htmldaily1.0https://www.cepheid.com/en-KR/solutions/knowing-more-matters/pcr-vs-antigen.htmldaily1.0https://www.cepheid.com/en-KR/solutions/knowing-more-matters/covid-flu-rsv.htmldaily1.0https://www.cepheid.com/en-KR/insights.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/all-posts.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/respiratory-health.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/respiratory-health/2024/09/proactive-surveillance-to-ensure-broad-flu-strain-detection.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/respiratory-health/2024/09/emerging-evolving-respiratory-viruses-test-design-matters.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/respiratory-health/2024/09/the-genexpert-xpress-system-can-change-your-pediatric-practice.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/respiratory-health/2024/09/Norwegian-ED-improves-Resource-Management-with-Rapid-PCR-Testing.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/respiratory-health/2024/09/key-steps-pandemic-preparedness.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/respiratory-health/2025/01/what-does-it-mean-to-have-a-pandemic-ready-pcr-test.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/respiratory-health/2025/01/point-of-care-pcr-testing-yields-cost-savings-for-influenza-like-ilnesses.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/respiratory-health/2025/03/in-house-pcr-testing-clinical-leaders-explore-the-ripple-effect.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/respiratory-health/2025/04/real-world-clinical-impact-of-in-house-pcr-testing.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/respiratory-health/2025/04/what-is-the-difference-between-pcr-and-antigen-testing.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/respiratory-health/2025/05/a-quick-primer-on-the-adlm-guidance-on-respiratory-virus-testing.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/respiratory-health/2025/09/revolutionizing-respiratory-care-the-power-of-rapid-molecular-testing.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/respiratory-health/2025/09/antigen-testing-vs-pcr-less-haste-more-speed-please.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/respiratory-health/2025/09/the-time-for-widespread-adoption-of-mdx-testing-for-gas-pharyngi.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/respiratory-health/2025/11/why-test-type-matters-pcr-vs-antigen-in-outpatient-respiratory-care.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/respiratory-health/2025/11/transforming-respiratory-tnfection-diagnosis-embracing-molecular-innovation-clinical-practice1.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/respiratory-health/2026/01/staying-ahead-of-influenza.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/respiratory-health/2026/02/revolutionizing-rheumatic-heart-disease-prevention.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2024/09/accelerating-the-pace-for-hep-c-elimination-in-the-us.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2024/09/can-molecular-tests-revolutionize-tuberculosis-control.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2024/09/near-patient-testing-for-hep-c-xpert-hcv-vl-fingerstick.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2024/09/danish-hcv-testing-program-improves-patient-management-and-access.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2024/09/faster-prison-testing-for-hcv-drastically-improves-treatment-in-the-uk.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2024/09/innovative-POC-testing-shortens-time-between-testing-and-treatment.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2024/09/finnish-hospital-improves-care-for-expectant-mothers-with-gbs-pcr-screening.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2024/09/a-not-for-profit-in-vietnam-fights-to-end-tuberculosis.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2024/09/cepheid-expands-in-india-to-support-global-efforts-to-fight-tb.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2024/09/covid-19-and-tuberculosis-testing-in-south-africa.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2024/09/cepheid-supports-the-international-mpox-emergency-declared-august-2024.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2024/10/hpv-testing-south-african-clinic-may-prevent-cervical-cancer.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2024/12/strides-toward-early-infant-diagnosis-for-hiv-elimination-in-sou.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2025/02/common-misconceptions-about-vaginitis.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2025/05/revisiting-bacterial-vaginosis-evidence-for-sexual-transmission.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2025/05/a-breakthrough-in-hcv-elimination--how-hcv-point-of-care-rna-tes.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2025/05/decentralising-diagnostics-bringing-patient-centred-testing-closer-to-communities.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2025/05/integration-of-poc-viral-diagnostics-with-substance-use-disorder-treatment-to-improve-hepatitis-c-nfection-outcomes.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2025/06/womens-health-testing-advantages-of-same-day-diagnosis-and-treatment.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2025/04/tuberculosis-staying-one-step-ahead.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2025/04/how-three-countries-are-fighting-back-against-tuberculosis.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2025/04/a-mdr-tb-survivor-in-india-shares-her-remarkable-story.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2025/07/five-surprising-stats-that-reveal-the-hidden-burden-of-vaginitis.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2025/07/5-ways-vaginitis-treatment-goes-wrong-and-how-better-testing-can-fix-It.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2025/03/the-fight-to-end-tuberculosis-in-pakistan.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2025/03/devasena-gnanashanmugam-discusses-cepheids-global-access-program.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2025/03/desmond-tutu-foundation-reduces-impact-of-hiv-and-tb.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2025/03/tuberculosis-care-and-treatment-in-the-republic-of-indonesia.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2025/03/finding-missing-tuberculosis-tb-cases-philippines-need-for-speed.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2025/03/a-decade-of-health-and-economic-benefits-infographic.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2025/03/state-tb-in-us-overlooked-opportunity-better-results.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2025/03/fighting-tb-everything-10-years-of-impact-in-south-africa.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2025/09/in-memory-of-john-bishop-a-visionary-leader-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2025/12/wecare-humanitarian-medical-mission.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2025/10/time-to-act-stopping-group-b-strep-infections-in-newborn-babies.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2025/10/real-user-experiences-with-xpert-xpress-mvp-oint-of-care-test.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2025/08/kentucky-viral-hepatitis-treatment-projects-mission-to-eradicate-hcv.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2025/08/the-state-of-vaginitis-testing-in-the-us.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2025/08/improving-vaginitis-care-through-better-diagnostics.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2026/02/advancing-pandemic-preparedness-through-public-private-collaboration.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/community-and-global-health/2026/02/hepatitis-c-elimination-in-the-us-is-within-reach-experts-report.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/tech-disease-trends.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/tech-disease-trends/2024/09/candida-auris--rising-threat-and-future-implications.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/tech-disease-trends/2024/09/discussing-pharma-clinical-trials-utilizing-poc-diagnostics.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/tech-disease-trends/2024/09/poc-testing-increases-the-efficiency-of-patient-management-in-the-ed.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/tech-disease-trends/2024/10/dave-persing-legacy-and-leadership-in-molecular-diagnostics.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/tech-disease-trends/2024/11/invasive-group-streptococcal-disease.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/tech-disease-trends/2024/11/what-is-pcr--understanding-the-magic.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/tech-disease-trends/2024/11/decentralized-pcr-testing-and-the-quadruple-aim-insights-for-health-systems.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/tech-disease-trends/2025/01/how-a-cepheid-molecular-test-is-made.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct-.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/tech-disease-trends/2025/01/7-best-practices-for-molecular-poct.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/tech-disease-trends/2025/04/standardization-of-pcr-testing-across-healthcare-testing-sites.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/tech-disease-trends/2025/06/innovation-in-times-of-need-cepheids-legacy-of-outbreak-response.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/tech-disease-trends/2025/07/celebrating-the-cepheid-bike-where-art-meets-innovation.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/tech-disease-trends/2025/09/cepheid-advances-innovation-and-reach-with-key-partnerships.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/tech-disease-trends/2025/10/learn-about-cepheid-system-innovation.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/tech-disease-trends/2025/11/multiplex-with-meaning--cepheid-s-smart-approach-to-molecular-di.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/antimicrobial-stewardship.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/antimicrobial-stewardship/2024/09/a-public-health-dialogue-on-antibiotic-resistance-surveillance.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/antimicrobial-stewardship/2024/09/mortality-associated-with-carbapenem-resistant-gram-negative-infections.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/antimicrobial-stewardship/2024/09/decentralized-testing-for-the-surveillance-of-hospital-acquired-infections.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/antimicrobial-stewardship/2024/09/rapid-mrsa-screening-of-ortho-trauma-patients-improves-experience.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/antimicrobial-stewardship/2024/09/pcr-screening-at-a-british-hospital-enables-timely-infection-control.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/antimicrobial-stewardship/2024/10/fleming-initiative-cepheid-announce-partnership-tackle-amr.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/antimicrobial-stewardship/2024/10/link-between-colonization-multi-drug-resistant-infection.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/antimicrobial-stewardship/2024/12/point-of-care-testing-emergency-department-faster-decision-making-halle.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-shulz.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/antimicrobial-stewardship/2025/01/expert-spotlight-lucas-schulz.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/antimicrobial-stewardship/2025/05/antimicrobial-and-diagnostic-stewardship-frost-and-sullivan-visual-whitepaper.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/antimicrobial-stewardship/2025/08/industry-voices-time-to-rethink-our-approach-to-using-modern-medicine.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/antimicrobial-stewardship/2025/09/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/antimicrobial-stewardship/2025/10/keeping-patients-safe-from-escalating-antibiotic-resistance.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/antimicrobial-stewardship/2025/11/vanessa-carter-s-journey--inspiring-action-against-amr.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/antimicrobial-stewardship/2025/11/advancing-antimicrobial-stewardship-in-small-and-rural-hospital.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/expert-spotlight.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/expert-spotlight/2025/10/expert-spotlight--michael-loeffelholz.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--devasena-gnanashanmugam-vice-president--me.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/expert-spotlight/2025/11/expert-spotlight--dr--jennifer-rakeman-cagno-senior-director--sc.htmldaily1.0https://www.cepheid.com/en-KR/insights/insight-hub/expert-spotlight/2026/02/expert-spotlight-jordan-chase.htmldaily1.0https://www.cepheid.com/en-KR/insights/webinars.htmldaily1.0https://www.cepheid.com/en-KR/insights/resources.htmldaily1.0https://www.cepheid.com/en-KR/support.htmldaily1.0https://www.cepheid.com/en-KR/support/ivdr-update.htmldaily1.0https://www.cepheid.com/en-KR/support/contact-us.htmldaily1.0https://www.cepheid.com/en-KR/about.htmldaily1.0https://www.cepheid.com/en-KR/about/mission-history.htmldaily1.0https://www.cepheid.com/en-KR/about/leadership.htmldaily1.0https://www.cepheid.com/en-KR/about/leadership/vitor-rocha.htmldaily1.0https://www.cepheid.com/en-KR/about/leadership/laurent-bellon.htmldaily1.0https://www.cepheid.com/en-KR/about/leadership/anette-engelhardt.htmldaily1.0https://www.cepheid.com/en-KR/about/leadership/peter-farrell.htmldaily1.0https://www.cepheid.com/en-KR/about/leadership/deborah-gonyea.htmldaily1.0https://www.cepheid.com/en-KR/about/leadership/nichole-halsey.htmldaily1.0https://www.cepheid.com/en-KR/about/leadership/luben-li.htmldaily1.0https://www.cepheid.com/en-KR/about/leadership/luke-maitland.htmldaily1.0https://www.cepheid.com/en-KR/about/leadership/david-h-persing.htmldaily1.0https://www.cepheid.com/en-KR/about/leadership/ammar-qadan.htmldaily1.0https://www.cepheid.com/en-KR/about/leadership/charles-mwangi.htmldaily1.0https://www.cepheid.com/en-KR/about/leadership/samson-wu.htmldaily1.0https://www.cepheid.com/en-KR/about/leadership/anupama-mokkapati.htmldaily1.0https://www.cepheid.com/en-KR/about/leadership/traci-wicks.htmldaily1.0https://www.cepheid.com/en-KR/about/leadership/scott-campbell.htmldaily1.0https://www.cepheid.com/en-KR/about/leadership/anne-beauburn.htmldaily1.0https://www.cepheid.com/en-KR/about/leadership/patrick-harkins.htmldaily1.0https://www.cepheid.com/en-KR/about/leadership/ephraim-tsalik.htmldaily1.0https://www.cepheid.com/en-KR/about/leadership/somesh-lalithraj.htmldaily1.0https://www.cepheid.com/en-KR/about/leadership/connie-savor.htmldaily1.0https://www.cepheid.com/en-KR/about/sustainability.htmldaily1.0https://www.cepheid.com/en-KR/about/sustainability/environmental-sustainability.htmldaily1.0https://www.cepheid.com/en-KR/about/sustainability/product-stewardship.htmldaily1.0https://www.cepheid.com/en-KR/about/sustainability/conflict-materials.htmldaily1.0https://www.cepheid.com/en-KR/about/policies-reports.htmldaily1.0https://www.cepheid.com/en-KR/about/business-development-opportunities.htmldaily1.0https://www.cepheid.com/en-KR/about/events.htmldaily1.0https://www.cepheid.com/en-KR/about/innovation-form.htmldaily1.0https://www.cepheid.com/en-KR/about/innovation-form/unsolicited-submission-agreement.htmldaily1.0https://www.cepheid.com/en-KR/about/sars-cov-2-test-development-information.htmldaily1.0https://www.cepheid.com/en-KR/about/sars-cov-2-product-resources.htmldaily1.0https://www.cepheid.com/en-KR/contact/request-info2.htmldaily1.0https://www.cepheid.com/en-KR/contact/select-info-path.htmldaily1.0https://www.cepheid.com/en-KR/contact/messages/thank-you.htmldaily1.0https://www.cepheid.com/en-KR/contact/messages/thank-you-patient-pathways.htmldaily1.0https://www.cepheid.com/en-KR/contact/messages/thank-you-patient-pathways-fr.htmldaily1.0https://www.cepheid.com/en-KR/contact/messages/thank-you-patient-pathways-de.htmldaily1.0https://www.cepheid.com/en-KR/contact/messages/thank-you-patient-pathways-it.htmldaily1.0https://www.cepheid.com/en-KR/contact/messages/thank-you-patient-pathways-sp.htmldaily1.0https://www.cepheid.com/en-KR/contact/messages/thank-you-patient-pathways-pl.htmldaily1.0https://www.cepheid.com/en-KR/contact/messages/thank-you-patient-pathways-pt.htmldaily1.0https://www.cepheid.com/en-KR/contact/request-cd-international.htmldaily1.0https://www.cepheid.com/en-KR/personas/laboratory-professionals.htmldaily1.0https://www.cepheid.com/en-KR/personas/healthcare-professsional.htmldaily1.0https://www.cepheid.com/en-KR/personas/health-system-administrators.htmldaily1.0https://www.cepheid.com/en-KR/legal/privacy.htmldaily1.0https://www.cepheid.com/en-KR/legal/terms-of-use.htmldaily1.0https://www.cepheid.com/en-KR/legal/product-security-updates.htmldaily1.0https://www.cepheid.com/en-KR/legal/terms-of-sale.htmldaily1.0https://www.cepheid.com/en-KR/legal/trademarks.htmldaily1.0https://www.cepheid.com/en-KR/legal/cookies-notice.htmldaily1.0https://www.cepheid.com/en-KR/campaigns/2020-emea-renewed-messaging/french/patient-pathways.htmldaily1.0https://www.cepheid.com/en-KR/campaigns/2020-emea-renewed-messaging/german/patient-pathways.htmldaily1.0https://www.cepheid.com/en-KR/campaigns/2020-emea-renewed-messaging/italian/patient-pathways.htmldaily1.0https://www.cepheid.com/en-KR/campaigns/2020-emea-renewed-messaging/portuguese/patient-pathways.htmldaily1.0https://www.cepheid.com/en-KR/campaigns/2020-emea-renewed-messaging/polish/patient-pathways.htmldaily1.0https://www.cepheid.com/en-KR/campaigns/india/cepheid-india.htmldaily1.0https://www.cepheid.com/en-KR/campaigns/india/india-submission.htmldaily1.0https://www.cepheid.com/en-KR/campaigns/india/cepheid-india-display.htmldaily1.0https://www.cepheid.com/en-KR/campaigns/india/cepheid-india-bangladesh.htmldaily1.0https://www.cepheid.com/en-KR/campaigns/pcr-plus.htmldaily1.0https://www.cepheid.com/en-KR/coronavirus-portfolio.htmldaily1.0https://www.cepheid.com/global-support.htmldaily1.0https://www.cepheid.com/global-products.htmldaily1.0